Amedeo Smart

Free Medical Literature Service

 

Amedeo

COVID-19
  Free Subscription

Articles published in
J Med Virol
    May 2024
  1. HSU AY, Lin CJ, Hsia NY, Wang YH, et al
    Reply to comment on "The risk assessment of uveitis after COVID-19 diagnosis by Wu et al. 2024".
    J Med Virol. 2024;96:e29636.
    >> Share

  2. HEWEL C, Schmidt H, Runkel S, Kohnen W, et al
    Nanopore adaptive sampling of a metagenomic sample derived from a human monkeypox case.
    J Med Virol. 2024;96:e29610.
    >> Share

  3. ZHAO XJ, Liu XL, Liang YM, Zhang S, et al
    Epidemiological characteristics and antibody kinetics of elderly population with booster vaccination following both Omicron BA.5 and XBB waves in China.
    J Med Virol. 2024;96:e29640.
    >> Share

  4. TANG Z, Mao Y, Ruan P, Li J, et al
    Drugs targeting CMPK2 inhibit pyroptosis to alleviate severe pneumonia caused by multiple respiratory viruses.
    J Med Virol. 2024;96:e29643.
    >> Share

  5. MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al
    JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV.
    J Med Virol. 2024;96:e29631.
    >> Share

  6. GAO R, Feng C, Sheng Z, Li F, et al
    Research progress in Fc-effector functions against SARS-CoV-2.
    J Med Virol. 2024;96:e29638.
    >> Share

  7. WANG F, Gao Y, Wagner AL, Lu Y, et al
    A systematic review and meta-analysis of herpes zoster occurrence/recurrence after COVID-19 infection and vaccination.
    J Med Virol. 2024;96:e29629.
    >> Share

  8. THOMAS S, Smatti MK, Alsulaiti H, Zedan HT, et al
    Antibody-dependent enhancement (ADE) of SARS-CoV-2 in patients exposed to MERS-CoV and SARS-CoV-2 antigens.
    J Med Virol. 2024;96:e29628.
    >> Share

    April 2024
  9. GUNGOR K, Bukavaz S, Ekuklu G
    Measles outbreak in the adult age group: Clinical, laboratory, and epidemiological features of the 11 patients admitted to the hospital.
    J Med Virol. 2024;96:e29583.
    >> Share

  10. HE S, Liu SQ, Teng XY, He JY, et al
    Comparative single-cell RNA sequencing analysis of immune response to inactivated vaccine and natural SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29577.
    >> Share

  11. WOO HG, Kim HJ, Park J, Lee J, et al
    Global burden of vaccine-associated multiple sclerosis, 1967-2022: A comprehensive analysis of the international pharmacovigilance database.
    J Med Virol. 2024;96:e29591.
    >> Share

  12. GANDIKOTA C, Vaddadi K, Sivasami P, Huang C, et al
    The use of human iPSC-derived alveolar organoids to explore SARS-CoV-2 variant infections and host responses.
    J Med Virol. 2024;96:e29579.
    >> Share

  13. YANG H, Guan L, Yang T, Ma H, et al
    Two- and 3-year outcomes in convalescent individuals with COVID-19: A prospective cohort study.
    J Med Virol. 2024;96:e29566.
    >> Share

  14. MELE D, Ottolini S, Lombardi A, Conteianni D, et al
    Long-term dynamics of natural killer cells in response to SARS-CoV-2 vaccination: Persistently enhanced activity postvaccination.
    J Med Virol. 2024;96:e29585.
    >> Share

  15. FAN Y, Huang S, Wu D, Chu M, et al
    Immune features revealed by single-cell RNA and single-cell TCR/BCR sequencing in patients with rheumatoid arthritis receiving COVID-19 booster vaccination.
    J Med Virol. 2024;96:e29573.
    >> Share

  16. HUNG KC, Yu TS, Wang KF, Chen IW, et al
    Influenza vaccination on SARS-CoV-2 infection risk: A subgroup analysis on geographic factor.
    J Med Virol. 2024;96:e29576.
    >> Share

  17. ARUNAN B, Talukdar D, Swain S, Varadarajan A, et al
    Metagenomic insights into fungal community composition of the nasopharyngeal region of COVID-19 associated mucormycosis patients from India.
    J Med Virol. 2024;96:e29601.
    >> Share

  18. LI Y, Yu J, Wang Y, Yi J, et al
    Cocirculation and coinfection of multiple respiratory viruses during autumn and winter seasons of 2023 in Beijing, China: A retrospective study.
    J Med Virol. 2024;96:e29602.
    >> Share

  19. PARK D, Kim SM, Jang H, Kim K, et al
    Differential beta-coronavirus infection dynamics in human bronchial epithelial organoids.
    J Med Virol. 2024;96:e29600.
    >> Share

  20. SVIERCZ F, Jarmoluk P, Godoy Coto J, Cevallos C, et al
    The abortive SARS-CoV-2 infection of osteoclast precursors promotes their differentiation into osteoclasts.
    J Med Virol. 2024;96:e29597.
    >> Share

  21. RAI P, Marano JM, Kang L, Coutermarsh-Ott S, et al
    Obesity fosters severe disease outcomes in a mouse model of coronavirus infection associated with transcriptomic abnormalities.
    J Med Virol. 2024;96:e29587.
    >> Share

  22. KURYLOWICZ A, Babicki M, Wasowski M, Jankowski P, et al
    Triglicerydes/high-density lipoprotein ratio as a risk factor of post-Covid-19 sinus tachycardia: A retrospective study.
    J Med Virol. 2024;96:e29586.
    >> Share

  23. YE G, Tang Y, Yang Q, Zhang C, et al
    A peptide derived from SARS-CoV-2 nucleocapsid protein with broad-spectrum anti-coronavirus activity.
    J Med Virol. 2024;96:e29492.
    >> Share

  24. MENG H, Wang Y, Zhai Y, Luo W, et al
    Unveiling the micronutrient-immunity puzzle in inactivated COVID-19 vaccination: A comprehensive analysis of circulating micronutrient levels and humoral responses in healthy adults.
    J Med Virol. 2024;96:e29611.
    >> Share

  25. MAHLA RS, Dustin LB
    COVID-19 vaccination and autoimmunity: Do we need more evidence?
    J Med Virol. 2024;96:e29623.
    >> Share

  26. WEI M, Li S, Lu X, Hu K, et al
    Changing respiratory pathogens infection patterns after COVID-19 pandemic in Shanghai, China.
    J Med Virol. 2024;96:e29616.
    >> Share

  27. OKITSU S, Khamrin P, Hikita T, Onda Y, et al
    Remarkable increase in the detection and molecular characterization of adenovirus F41 in children with acute gastroenteritis in Japan, 2017-2023.
    J Med Virol. 2024;96:e29615.
    >> Share

  28. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    >> Share

  29. CHEN IW, Weng HL, Lai YC, Hung KC, et al
    Incidence of fatigue 2 years after SARS-CoV-2 infection: An updated meta-analysis and subgroup analysis.
    J Med Virol. 2024;96:e29619.
    >> Share

  30. DESTREMAU M, Chaussade H, Hemar V, Beguet M, et al
    Convalescent plasma transfusion for immunocompromised viremic patients with COVID-19: A retrospective multicenter study.
    J Med Virol. 2024;96:e29603.
    >> Share

  31. SUN Q, Gao J, An R, Wang M, et al
    Probing molecular pathways: Illuminating the connection between COVID-19 and Alzheimer's disease through the endocannabinoid system dynamics.
    J Med Virol. 2024;96:e29590.
    >> Share

  32. SONG G, Li R, Cheng MQ
    Safety, immunogenicity, and protective effective of inhaled COVID-19 vaccines: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29625.
    >> Share

    March 2024
  33. ZHANG N, Ye Z, Li C, Zhou J, et al
    A subunit-based influenza/SARS-CoV-2 Omicron combined vaccine induced potent protective immunity in BALB/c mice.
    J Med Virol. 2024;96:e29479.
    >> Share

  34. XIAO J, Luo Y, Li Y, Yao X, et al
    The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
    J Med Virol. 2024;96:e29488.
    >> Share

  35. WU P, Yii CY, Yong SB
    Comment on "The risk assessment of uveitis after COVID-19 diagnosis".
    J Med Virol. 2024;96:e29494.
    >> Share

  36. CHEN IW, Lin HJ, Lin YT, Hung KC, et al
    Comment on "The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis".
    J Med Virol. 2024;96:e29495.
    >> Share

  37. LIU Y, Li M, Cui T, Chen Z, et al
    A superior heterologous prime-boost vaccination strategy against COVID-19: A bivalent vaccine based on yeast-derived RBD proteins followed by a heterologous vaccine.
    J Med Virol. 2024;96:e29454.
    >> Share

  38. KIM JW, Lee JH, Kim HJ, Heo K, et al
    Empowering SARS-CoV-2 variant neutralization with a bifunctional antibody engineered with tandem heptad repeat 2 peptides.
    J Med Virol. 2024;96:e29506.
    >> Share

  39. ZHANG R, Yan H, Zhou J, Yan G, et al
    Improved fluorescence-based assay for rapid screening and evaluation of SARS-CoV-2 main protease inhibitors.
    J Med Virol. 2024;96:e29498.
    >> Share

  40. XIONG N, Sun Q
    Identifying COVID-19 subtypes by single-sample gene set enrichemnt analysis and providing guidance for sensitive drug selection.
    J Med Virol. 2024;96:e29497.
    >> Share

  41. WU N, Chen Z, Zha G, Deng Z, et al
    Clinical and immunological features of COVID-19 in patients with anti-MDA5 dermatomyositis during the omicron wave in Chongqing, China.
    J Med Virol. 2024;96:e29493.
    >> Share


  42. Retraction: "Safety and immunogenicity of a recombinant receptor-binding domain-based protein subunit vaccine (Noora vaccine) against COVID-19 in adults: A randomized, double-blind, placebo-controlled, Phase 1 trial".
    J Med Virol. 2024;96:e29509.
    >> Share


  43. Correction to "Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting".
    J Med Virol. 2024;96:e29518.
    >> Share

  44. ZHENG Y, Feng J, Song Y, Yu Y, et al
    Design and synthesis of APN and 3CLpro dual-target inhibitors based on STSBPT with anticoronavirus activity.
    J Med Virol. 2024;96:e29512.
    >> Share

  45. ROJO-ALBA S, Martinez ZP, Gonzalez-Alba JM, Boga JA, et al
    Respiratory syncytial virus incidence and typing in the last six seasons in the north of Spain (Asturias). Genetic characterization during the SARS-CoV-2 pandemic.
    J Med Virol. 2024;96:e29499.
    >> Share

  46. YEH LT, Chan CH, Wang YH, Lee CY, et al
    Exploring the incidence of peripheral arterial occlusive disease following COVID-19 infection: A retrospective cohort study.
    J Med Virol. 2024;96:e29519.
    >> Share

  47. TAI CG, Haviland MJ, Kissler SM, Lucia RM, et al
    Low antibody levels associated with significantly increased rate of SARS-CoV-2 infection in a highly vaccinated population from the US National Basketball Association.
    J Med Virol. 2024;96:e29505.
    >> Share

  48. LEE C, Greenwood DC, Master H, Balasundaram K, et al
    Prevalence of orthostatic intolerance in long covid clinic patients and healthy volunteers: A multicenter study.
    J Med Virol. 2024;96:e29486.
    >> Share

  49. ROBERTS SC, Jolley SE, Beaty LE, Aggarwal NR, et al
    Association between monoclonal antibody therapy, vaccination, and longer-term symptom resolution after acute COVID-19.
    J Med Virol. 2024;96:e29541.
    >> Share

  50. DE AGUIRRE PM, Carlos S, Pina-Sanchez M, Mbikayi S, et al
    High pre-Delta and early-Omicron SARS-CoV-2 seroprevalence detected in dried blood samples from Kinshasa (D.R. Congo).
    J Med Virol. 2024;96:e29529.
    >> Share

  51. TRANTER E, Frentsch M, Hutter-Kronke ML, Vuong GL, et al
    Comparable CD8(+) T-cell responses to SARS-CoV-2 vaccination in single-cell transcriptomics of recently allogeneic transplanted patients and healthy individuals.
    J Med Virol. 2024;96:e29539.
    >> Share

  52. ZHOU J, Zhou Y, Wei XF, Fan L, et al
    TRIM6 facilitates SARS-CoV-2 proliferation by catalyzing the K29-typed ubiquitination of NP to enhance the ability to bind viral genomes.
    J Med Virol. 2024;96:e29531.
    >> Share

  53. JITOBAOM K, Peerapen P, Boonyuen U, Meewan I, et al
    Identification of inositol monophosphatase as a broad-spectrum antiviral target of ivermectin.
    J Med Virol. 2024;96:e29552.
    >> Share

  54. HUANG M, Cui T, Liu S, Su X, et al
    Blended BA.5 infection within 8 days after a boosted bivalent mRNA vaccination strengthens and lengthens the host immunity.
    J Med Virol. 2024;96:e29544.
    >> Share

  55. ZHANG H, Guo H
    Optimization of a DNA-launched SARS-CoV-2 replicon with RNA splicing inhibitor Isoginkgetin.
    J Med Virol. 2024;96:e29547.
    >> Share

  56. ZHA G, Chen Z, Wu N, Huang T, et al
    Clinical characteristics and immunogenicity after Omicron breakthrough infection in patients with chronic hepatitis B infection: A longitudinal observational study.
    J Med Virol. 2024;96:e29548.
    >> Share

  57. KUO YM, Kang CM, Lai ZY, Huang TY, et al
    Temporal changes in biomarkers of neutrophil extracellular traps and NET-promoting autoantibodies following adenovirus-vectored, mRNA, and recombinant protein COVID-19 vaccination.
    J Med Virol. 2024;96:e29556.
    >> Share

  58. ZEDAN HT, Smatti MK, Al-Sadeq DW, Al Khatib HA, et al
    SARS-CoV-2 infection triggers more potent antibody-dependent cellular cytotoxicity (ADCC) responses than mRNA-, vector-, and inactivated virus-based COVID-19 vaccines.
    J Med Virol. 2024;96:e29527.
    >> Share

  59. FU X, Wang Z, Chen B, Sun H, et al
    Detection of SARS-CoV-2 virus in middle ear effusions and its association with otitis media with effusion.
    J Med Virol. 2024;96:e29545.
    >> Share

  60. FROHLICH GC, Gregianini TS, Pinheiro FG, Nascimento R, et al
    Resurgence of human respiratory syncytial virus during COVID-19 pandemic in Southern Brazil.
    J Med Virol. 2024;96:e29551.
    >> Share

  61. HUNG KC, Lin HJ, Chen IW
    New-onset neurodegenerative diseases following SARS-CoV-2 infection: An analysis of prediction interval.
    J Med Virol. 2024;96:e29563.
    >> Share

  62. WANG A
    Integrating Frechet distance and AI reveals the evolutionary trajectory and origin of SARS-CoV-2.
    J Med Virol. 2024;96:e29557.
    >> Share

  63. HUANG J, Qiu Y, Luo L, Wu J, et al
    Long-term immunogenicity and safety of heterologous boosting with a SARS-CoV-2 mRNA vaccine (SYS6006) in Chinese participants who had received two or three doses of inactivated vaccine.
    J Med Virol. 2024;96:e29542.
    >> Share

  64. BROGNA C, Montano L, Zanolin ME, Bisaccia DR, et al
    A retrospective cohort study on early antibiotic use in vaccinated and unvaccinated COVID-19 patients.
    J Med Virol. 2024;96:e29507.
    >> Share

  65. ZHENG L, Wang H, Liu X, Xu C, et al
    A panel of multivalent nanobodies broadly neutralizing Omicron subvariants and recombinant.
    J Med Virol. 2024;96:e29528.
    >> Share

  66. OGUNJINMI OD, Abdullahi T, Somji RA, Bevan CL, et al
    The antiviral potential of the antiandrogen enzalutamide and the viral-androgen signaling interplay in seasonal coronaviruses.
    J Med Virol. 2024;96:e29540.
    >> Share

  67. ZHENG Z, Wu H, Sun X, Lu Y, et al
    Evaluation of the effectiveness and safety of sequential vaccination with inactivated SARS-CoV-2 vaccine and Ad5-nCoV booster in pediatric liver transplant recipients.
    J Med Virol. 2024;96:e29543.
    >> Share

  68. FARAONE JN, Wang X, Qu P, Zheng YM, et al
    Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
    J Med Virol. 2024;96:e29520.
    >> Share

    February 2024
  69. LIU P, Xing Z, Peng X, Zhang M, et al
    Machine learning versus multivariate logistic regression for predicting severe COVID-19 in hospitalized children with Omicron variant infection.
    J Med Virol. 2024;96:e29447.
    >> Share

  70. ANGUINZE RS, Toure A, Cisse F, Grayo S, et al
    Viral etiology of measles-like rash in Guinean children during the COVID epidemic in 2022.
    J Med Virol. 2024;96:e29437.
    >> Share

  71. CHEN Y, Liu X, Zhaohui T
    Reply to: Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain.
    J Med Virol. 2024;96:e29441.
    >> Share

  72. CAMPS-VILARO A, Pinsach-Abuin ML, Degano IR, Ramos R, et al
    Genetic characteristics involved in COVID-19 severity. The CARGENCORS case-control study and meta-analysis.
    J Med Virol. 2024;96:e29404.
    >> Share

  73. VIRTANEN J, Korhonen EM, Salonen S, Vapalahti O, et al
    SARS-CoV-2 infections among pregnant women, 2020, Finland-Cross-testing of neutralization assays.
    J Med Virol. 2024;96:e29415.
    >> Share

  74. SOUZA MS, Farias JP, Andreata-Santos R, Silva MP, et al
    Neutralizing antibody response after immunization with a COVID-19 bivalent vaccine: Insights to the future.
    J Med Virol. 2024;96:e29416.
    >> Share

  75. HE M, Cao L, Liu L, Jin X, et al
    Reconstitution of RNA cap methylation reveals different features of SARS-CoV-2 and SARS-CoV methyltransferases.
    J Med Virol. 2024;96:e29411.
    >> Share

  76. SELVAVINAYAGAM ST, Suvaithenamudhan S, Yong YK, Hemashree K, et al
    Genomic surveillance of omicron B.1.1.529 SARS-CoV-2 and its variants between December 2021 and March 2023 in Tamil Nadu, India-A state-wide prospective longitudinal study.
    J Med Virol. 2024;96:e29456.
    >> Share

  77. CHANG LC, Chen IW, Hung KC
    Additional analyses support superior efficacy of nirmatrelvir/ritonavir over molnupiravir for COVID-19.
    J Med Virol. 2024;96:e29464.
    >> Share

  78. PASSOS V, Henkel LM, Wang J, Zapatero-Belinchon FJ, et al
    Innate immune response to SARS-CoV-2 infection contributes to neuronal damage in human iPSC-derived peripheral neurons.
    J Med Virol. 2024;96:e29455.
    >> Share

  79. NEDELCU I, Florian P, Ion D, Militaru E, et al
    Dynamics of serum cross-neutralization capacity against SARS-CoV-2 Delta variant in convalescent COVID-19 patients.
    J Med Virol. 2024;96:e29448.
    >> Share

  80. GAN M, Cao J, Zhang Y, Fu H, et al
    Landscape of T cell epitopes displays hot mutations of SARS-CoV-2 variant spikes evading cellular immunity.
    J Med Virol. 2024;96:e29452.
    >> Share

  81. COLSON P, Delerce J, Pontarotti P, Devaux C, et al
    Resistance-associated mutations to the anti-SARS-CoV-2 agent nirmatrelvir: Selection not induction.
    J Med Virol. 2024;96:e29462.
    >> Share

  82. SADAT LARIJANI M, Javadi A, Eskandari SE, Doroud D, et al
    The impact of ABO blood types on humoral immunity responses and antibody persistency after different COVID-19 vaccine regimens.
    J Med Virol. 2024;96:e29438.
    >> Share

  83. CENAT JM, Farahi SMMM, Dalexis RD, Yaya S, et al
    COVID-19 vaccine uptake, conspiracy theories, and health literacy among Black individuals in Canada: Racial discrimination, confidence in health, and COVID-19 stress as mediators.
    J Med Virol. 2024;96:e29467.
    >> Share

  84. KWOK KO, Wei WI, Mcneil EB, Tang A, et al
    Comparative analysis of symptom profile and risk of death associated with infection by SARS-CoV-2 and its variants in Hong Kong.
    J Med Virol. 2024;96:e29326.
    >> Share

  85. KIM D, Kim M, Kim J, Baek K, et al
    A mouse xenograft long-term replication yields a SARS-CoV-2 Delta mutant with increased lethality.
    J Med Virol. 2024;96:e29459.
    >> Share

  86. ZHAN H, Xie Y, Liu Y, Cheng L, et al
    Omicron BA.4/5 neutralization and cell-mediated immune responses in relation to baseline immune status and breakthrough infection among PLWH: A follow-up cohort study.
    J Med Virol. 2024;96:e29446.
    >> Share

  87. GAN J, Zhang H, Wu J, Liu Y, et al
    Effect of inactivated vaccine boosters against severe and critical COVID-19 during the Omicron BA.5 wave: A retrospective analysis of hospitalized patients in China.
    J Med Virol. 2024;96:e29402.
    >> Share

  88. CHIRUMBOLO S, Tirelli U
    On coming back, the scaring COVID-19 concern. Addressing indoor microclimates with innovative and straightforward solutions to prevent SARS-CoV2 spreading.
    J Med Virol. 2024;96:e29490.
    >> Share

  89. OMBELET S, Castanares-Zapatero D, Desimpel F, Hulstaert F, et al
    Effectiveness of nirmatrelvir-ritonavir on severe outcomes of COVID-19 in the era of vaccination and Omicron: An updated meta-analysis.
    J Med Virol. 2024;96:e29434.
    >> Share

  90. YANG D, Chan JF, Yoon C, Luk TY, et al
    Type-II IFN inhibits SARS-CoV-2 replication in human lung epithelial cells and ex vivo human lung tissues through indoleamine 2,3-dioxygenase-mediated pathways.
    J Med Virol. 2024;96:e29472.
    >> Share

    January 2024
  91. PALOMINO-CABRERA R, Tejerina F, Molero-Salinas A, Veintimilla C, et al
    No emergence of resistance mutations in COVID-19 patients receiving nirmatrelvir/ritonavir.
    J Med Virol. 2024;96:e29337.
    >> Share

  92. ALESSANDRI F, d'Ettorre G, Ciccozzi M, Migliara G, et al
    Early recognition of a superinfection: This is the problem in the critically ill COVID-19 patients.
    J Med Virol. 2024;96:e29345.
    >> Share

  93. QI F, Cao Y, Shen Y, Wang H, et al
    Nasopharyngeal neutrophilic-retention signatures could predict disease progression in early SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29328.
    >> Share

  94. LI C, Ye G, Jiang Y, Wang Z, et al
    Artificial Intelligence in battling infectious diseases: A transformative role.
    J Med Virol. 2024;96:e29355.
    >> Share

  95. KIM MJ, Park PG, Hwang SJ, Bang SJ, et al
    Saliva-based Proteinase K method: A rapid and reliable diagnostic tool for the detection of SARS-COV-2 in children.
    J Med Virol. 2024;96:e29361.
    >> Share

  96. DURSTENFELD MS, Peluso MJ, Lin F, Peyser ND, et al
    Association of nirmatrelvir for acute SARS-CoV-2 infection with subsequent Long COVID symptoms in an observational cohort study.
    J Med Virol. 2024;96:e29333.
    >> Share

  97. CICCOZZI A, Fiori PL, Casu M, Sanna D, et al
    The mutation point of view of the SARS-CoV-2 HV.1 lineage.
    J Med Virol. 2024;96:e29359.
    >> Share

  98. PONTIROLI AE, Scovenna F, Carlini V, Tagliabue E, et al
    Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2024;96:e29343.
    >> Share

  99. LIANG Z, Tong J, Sun Z, Liu S, et al
    Rational prediction of immunogenicity clustering through cross-reactivity analysis of thirteen SARS-CoV-2 variants.
    J Med Virol. 2024;96:e29314.
    >> Share

  100. HU L, Yang Y, Lin J, Yan Q, et al
    Epidemiological characteristics of respiratory syncytial virus infection in pediatric patients before, during the COVID-19 pandemic and after easing of COVID-19 restrictive measures in China.
    J Med Virol. 2024;96:e29374.
    >> Share

  101. ZHANG Y, Ma Y, Sun W, Zhou X, et al
    Exploring gut-lung axis crosstalk in SARS-CoV-2 infection: Insights from a hACE2 mouse model.
    J Med Virol. 2024;96:e29336.
    >> Share

  102. FAVRESSE J, Gillot C, Closset M, Cabo J, et al
    Durability of humoral and cellular immunity six months after the BNT162b2 bivalent booster.
    J Med Virol. 2024;96:e29365.
    >> Share

  103. CHOI CY, Gadhave K, Villano J, Pekosz A, et al
    Generation and characterization of a humanized ACE2 mouse model to study long-term impacts of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29349.
    >> Share

  104. LEE HM, Shih PC, Wei JC
    Comment on Shao et al.'s "Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic".
    J Med Virol. 2024;96:e29383.
    >> Share

  105. LI J, Zhang K, Lin G, Li J, et al
    CRISPR-Cas system: A promising tool for rapid detection of SARS-CoV-2 variants.
    J Med Virol. 2024;96:e29356.
    >> Share

  106. CAPELLI N, Domitien Payet L, Alcocer Cordellat C, Pisoni A, et al
    SARS-CoV-2 nucleocapsid antigen in plasma of children hospitalized for COVID-19 or with incidental detection of SARS-CoV-2 infection.
    J Med Virol. 2024;96:e29358.
    >> Share

  107. CORPECHOT C, Verdoux M, Frank-Soltysiak M, Duclos-Vallee JC, et al
    Exploring the impact of ursodeoxycholic acid therapy on COVID-19 in a real-word setting.
    J Med Virol. 2024;96:e29418.
    >> Share


  108. Corrigendum to "A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus".
    J Med Virol. 2024;96:e29421.
    >> Share

  109. ROMERO-OLMEDO AJ, Schulz AR, Das Gupta D, Staudenraus D, et al
    Unusual T(SCM) -like cells with poly-chemokine-receptor expression in a B-cell-depleted survivor of severe COVID-19.
    J Med Virol. 2024;96:e29367.
    >> Share

  110. HUANG J, Liu Y, Wang J, Xu D, et al
    Pregnancy outcomes after frozen-thawed embryo transfer in women with COVID-19 history: A prospective cohort study.
    J Med Virol. 2024;96:e29377.
    >> Share

  111. LIN WC, Wu MC, Wang YH, Lin CH, et al
    The prevalence of obstructive sleep apnea syndrome after COVID-19 infection.
    J Med Virol. 2024;96:e29392.
    >> Share

  112. SHARMA S, Thiriard A, Olislagers V, Lechien JR, et al
    Mucosal antibody response and SARS-CoV-2 shedding in patients with COVID-19 related olfactory dysfunction.
    J Med Virol. 2024;96:e29398.
    >> Share

  113. VASBINDER A, Padalia K, Pizzo I, Machado K, et al
    SuPAR, biomarkers of inflammation, and severe outcomes in patients hospitalized for COVID-19: The International Study of Inflammation in COVID-19.
    J Med Virol. 2024;96:e29389.
    >> Share

  114. HUANG Y, Dong Q, Liu G, Wang T, et al
    A novel three-plasmid packaging system for chimeric SFV/SIN VRPs derived from Semliki Forest virus and Sindbis virus as a candidate gene delivery vector.
    J Med Virol. 2024;96:e29376.
    >> Share

  115. YANG L, Zeng XT, Luo RH, Ren SX, et al
    SARS-CoV-2 NSP12 utilizes various host splicing factors for replication and splicing regulation.
    J Med Virol. 2024;96:e29396.
    >> Share

  116. WANG WT, Chen IW, Hung KC
    Inspiratory muscle training for COVID-19: Benefits appear promising but findings remain uncertain.
    J Med Virol. 2024;96:e29387.
    >> Share

  117. GUO F, Adekanmbi V, Hsu CD, Polychronopoulou E, et al
    One dose versus two doses of COVID-19 vaccine for the prevention of breakthrough infections among people previously infected with SARS-Cov-2.
    J Med Virol. 2024;96:e29391.
    >> Share

  118. ATZLER F, Dahms F, Paul G, Perisic S, et al
    The swab site of the upper airways influences the diagnostic sensitivity for the omicron variant of SARS-CoV-2.
    J Med Virol. 2024;96:e29390.
    >> Share

  119. WANG Y, Lan X, Qiao Y, Huo Y, et al
    Safety and immunogenicity of homologous prime-boost CoronaVac vaccine in people living with HIV in China: A multicenter prospective cohort study.
    J Med Virol. 2024;96:e29395.
    >> Share

  120. WANG E, Yang QJ, Xu XX, Zou QC, et al
    Differential pathogenic and molecular features in neurological infection of SARS-CoV-2 Omicron BA.5.2 and BA.2.75 and Delta.
    J Med Virol. 2024;96:e29357.
    >> Share


  121. Correction to "Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19".
    J Med Virol. 2024;96:e29378.
    >> Share

  122. YANG X, Wang Y, Liang Z, Cui T, et al
    Immune escape of BA.2.86 is comparable to XBB subvariants from the plasma of BA.5- and BA.5-XBB-convalescent subpopulations.
    J Med Virol. 2024;96:e29417.
    >> Share

  123. ZHANG T, Magazine N, McGee MC, Carossino M, et al
    Th2 and Th17-associated immunopathology following SARS-CoV-2 breakthrough infection in Spike-vaccinated ACE2-humanized mice.
    J Med Virol. 2024;96:e29408.
    >> Share

  124. JIA J, Garbarino E, Wang Y, Li J, et al
    Generation of SARS-CoV-2 spike receptor binding domain mutants and functional screening for immune evaders using a novel lentivirus-based system.
    J Med Virol. 2024;96:e29425.
    >> Share

  125. SUN Y, Zhou J, Nie W, Tian D, et al
    Study on the epidemiological characteristics of enterovirus among pediatric patients in Hangzhou, China: A comparison between the pre-COVID-19, COVID-19 pandemic, and post-COVID-19 periods.
    J Med Virol. 2024;96:e29412.
    >> Share

    December 2023
  126. HUANG PY, Lai CC, Hsu CK
    Assessing risk factors for COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease.
    J Med Virol. 2023;95:e29281.
    >> Share

  127. LI J, Liu Y, Wei X, Liu Z, et al
    Antibody responses to SARS-CoV-2 Omicron infection in patients with hematological malignancies: A multicenter, prospective cohort study.
    J Med Virol. 2023;95:e29300.
    >> Share

  128. SONG R, Chen X, Li B, Ni J, et al
    Nasal spray of an IgM-like ACE2 fusion protein HH-120 prevents SARS-CoV-2 infection: Two investigator-initiated postexposure prophylaxis trials.
    J Med Virol. 2023;95:e29275.
    >> Share

  129. HORA S, Pahwa P, Siddiqui H, Saxena A, et al
    Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS-CoV-2.
    J Med Virol. 2023;95:e29257.
    >> Share

  130. YANG J, Kim HJ, Kim JW, Baek JY, et al
    Evolution of neutralizing antibodies through vaccination and breakthrough infections in the era of COVID-19 endemicity.
    J Med Virol. 2023;95:e29285.
    >> Share

  131. GE P, Luo Y, Liu J, Liu J, et al
    Eliminating COVID-19 as the immediate culprit for igniting pancreatitis.
    J Med Virol. 2023;95:e29272.
    >> Share

  132. BAY P, Rodriguez C, Caruso S, Demontant V, et al
    Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients.
    J Med Virol. 2023;95:e29268.
    >> Share

  133. YU H, Yang L, Han Z, Zhou X, et al
    SARS-CoV-2 nucleocapsid protein enhances the level of mitochondrial reactive oxygen species.
    J Med Virol. 2023;95:e29270.
    >> Share

  134. TSOI JYH, Cai J, Situ J, Lam WJ, et al
    Autoantibodies against angiotensin-converting enzyme 2 (ACE2) after COVID-19 infection or vaccination.
    J Med Virol. 2023;95:e29313.
    >> Share

  135. MEISTER TL, Kirchhoff L, Bruggemann Y, Todt D, et al
    Stability of pathogens on banknotes and coins: A narrative review.
    J Med Virol. 2023;95:e29312.
    >> Share

  136. CHEN Q, Qin S, Zhou HY, Deng YQ, et al
    Competitive fitness and homologous recombination of SARS-CoV-2 variants of concern.
    J Med Virol. 2023;95:e29278.
    >> Share

  137. YIN ZJ, Xiao H, McDonald S, Brusic V, et al
    Dynamically adjustable SVEIR(MH) model of multiwave epidemics: Estimating the effects of public health measures against COVID-19.
    J Med Virol. 2023;95:e29301.
    >> Share

  138. LI J, Mao H, Song W, Chen Y, et al
    Low neutralization of SARS-CoV-2 Omicron BA.5.2.48, BF.7.14, XBB.1 subvariants by homologous or heterologous booster.
    J Med Virol. 2023;95:e29306.
    >> Share

  139. BENNING L, Bartenschlager M, Kim H, Kalble F, et al
    Live-virus serum neutralization after bivalent SARS-CoV-2 mRNA vaccination in hemodialysis patients.
    J Med Virol. 2023;95:e29303.
    >> Share

  140. FUKUDA Y, Togashi A, Hirakawa S, Yamamoto M, et al
    Resurgence of human metapneumovirus infection and influenza after three seasons of inactivity in the post-COVID-19 era in Hokkaido, Japan, 2022-2023.
    J Med Virol. 2023;95:e29299.
    >> Share

  141. WANG R, Guo J, Lu J, Du P, et al
    A potential broad-spectrum neutralizing antibody against Betacoronavirus.
    J Med Virol. 2023;95:e29252.
    >> Share

  142. XIAO Y, Chang L, Ji H, Sun H, et al
    Posttranslational modifications of ACE2 protein: Implications for SARS-CoV-2 infection and beyond.
    J Med Virol. 2023;95:e29304.
    >> Share

  143. LIU W, Gong F, Zheng X, Pei L, et al
    Factors associated with prolonged viral shedding of SARS-CoV-2 Omicron variant infection in Shanghai: A multicenter, retrospective, observational study.
    J Med Virol. 2023;95:e29342.
    >> Share

  144. LEE DH, Han E, Ryu S, Choi HJ, et al
    Clinical performance of the STANDARD M10 SARS-CoV-2 rapid RT-PCR assay in patients visiting an emergency department.
    J Med Virol. 2023;95:e29330.
    >> Share

  145. KAPUSTA J, Babicki M, Pieniawska-Smiech K, Kaluzinska-Kolat Z, et al
    Clinical and electrocardiographic correlates of myocardial dysfunction after COVID-19 in nonhospitalised patients in long-term follow-up. Data from the polish long-covid cardiovascular study.
    J Med Virol. 2023;95:e29331.
    >> Share

  146. ZHOU Y, Liu Y, Jiang L, Zhang R, et al
    Azvudine and nirmatrelvir-ritonavir in hospitalized patients with moderate-to-severe COVID-19: Emulation of a randomized target trial.
    J Med Virol. 2023;95:e29318.
    >> Share

  147. SULLIVAN DJ, Focosi D, Hanley DF, Cruciani M, et al
    Outpatient randomized controlled trials to reduce COVID-19 hospitalization: Systematic review and meta-analysis.
    J Med Virol. 2023;95:e29310.
    >> Share

  148. LI Y, Yamamoto S, Horii K, Mizoue T, et al
    Long COVID during the Omicron predominant waves among Japanese healthcare workers.
    J Med Virol. 2023;95:e29322.
    >> Share

  149. FEGHOUL L, Caillault A, Peyrony O, Salmona M, et al
    Respiratory torque teno virus load at emergency department visit predicts intensive care unit admission of SARS-CoV-2 infected patients.
    J Med Virol. 2023;95:e29319.
    >> Share

  150. LEE B, Ko JH, Kim YC, Baek JY, et al
    Clinical utility of quantitative immunoassays and surrogate virus neutralization tests for predicting neutralizing activity against the SARS-CoV-2 Omicron BA.1 and BA.5 variants.
    J Med Virol. 2023;95:e29329.
    >> Share

  151. LI J, Nie L, Guo C, Deng Y, et al
    Immunogenicity and safety of inactivated SARS-CoV-2 vaccines in people living with HIV: A longitudinal cohort study.
    J Med Virol. 2023;95:e29334.
    >> Share

    November 2023
  152. LI S, Li X, Liang H, Yu K, et al
    SARS-CoV-2 ORF7a blocked autophagy flux by intervening in the fusion between autophagosome and lysosome to promote viral infection and pathogenesis.
    J Med Virol. 2023;95:e29200.
    >> Share

  153. MAHLA RS
    Interstitial lung diseases and COVID-19 pneumonia.
    J Med Virol. 2023;95:e29207.
    >> Share

  154. KIM IS, Kang CK, Lee SJ, Lee CH, et al
    Tracking antigen-specific TCR clonotypes in SARS-CoV-2 infection reveals distinct severity trajectories.
    J Med Virol. 2023;95:e29199.
    >> Share

  155. ZHANG YN, Zhu GH, Liu W, Chen XX, et al
    Discovery of the covalent SARS-CoV-2 M(pro) inhibitors from antiviral herbs via integrating target-based high-throughput screening and chemoproteomic approaches.
    J Med Virol. 2023;95:e29208.
    >> Share

  156. NGIAM JN, Ng OT, Toh MPHS, Gao Q, et al
    Predictors of disease severity in SARS-CoV-2 omicron variant XBB sublineages and variants of interest.
    J Med Virol. 2023;95:e29204.
    >> Share

  157. COLSON P, Bader W, Fantini J, Dudouet P, et al
    From viral democratic genomes to viral wild bunch of quasispecies.
    J Med Virol. 2023;95:e29209.
    >> Share

  158. WANG Y, Wu L, Yu X, Wang G, et al
    Development of a rapid, sensitive detection method for SARS-CoV-2 and influenza virus based on recombinase polymerase amplification combined with CRISPR-Cas12a assay.
    J Med Virol. 2023;95:e29215.
    >> Share

  159. BERGNA A, Lai A, Ventura CD, Bruzzone B, et al
    Genomic epidemiology of the main SARS-CoV-2 variants in Italy between summer 2020 and winter 2021.
    J Med Virol. 2023;95:e29193.
    >> Share

  160. WANG B, Yang W, Tong Y, Sun M, et al
    Integrative proteomics and metabolomics study reveal enhanced immune responses by COVID-19 vaccine booster shot against Omicron SARS-CoV-2 infection.
    J Med Virol. 2023;95:e29219.
    >> Share

  161. SPRINGER DN, Reuberger E, Borsodi C, Puchhammer-Stockl E, et al
    Comparison of anti-nucleocapsid antibody assays for the detection of SARS-CoV-2 Omicron vaccine breakthroughs after various intervals since the infection.
    J Med Virol. 2023;95:e29229.
    >> Share

  162. KIM Y, Kim Y, Lim HJ, Kim DK, et al
    Integrative single-cell transcriptome analysis provides new insights into post-COVID-19 pulmonary fibrosis and potential therapeutic targets.
    J Med Virol. 2023;95:e29201.
    >> Share

  163. LIU D, Wang Z, Mao M, Zhang Z, et al
    Application of whole-genome tiling array at Shanghai port, China: An alternative method for SARS-CoV-2 surveillance.
    J Med Virol. 2023;95:e29222.
    >> Share

  164. BUCK AM, Deitchman AN, Takahashi S, Lu S, et al
    The breadth of the neutralizing antibody response to original SARS-CoV-2 infection is linked to the presence of Long COVID symptoms.
    J Med Virol. 2023;95:e29216.
    >> Share

  165. LOW K, Moller R, Stegmann C, Becker M, et al
    Luminescent reporter cells enable the identification of broad-spectrum antivirals against emerging viruses.
    J Med Virol. 2023;95:e29211.
    >> Share

  166. ABDOLAHI T, Maamouri G, Behmadi M, Mirzaeian S, et al
    Investigating the impact of Sinopharm COVID-19 vaccination on antibody response in pregnant women and their newborns.
    J Med Virol. 2023;95:e29231.
    >> Share

  167. RIVAS G, Labiod N, Luczkowiak J, Lasala F, et al
    Superior neutralizing response after first versus second SARS-CoV-2 infection in fully vaccinated individuals.
    J Med Virol. 2023;95:e29225.
    >> Share

  168. WU JY, Liu MY, Hung KC, Hsu WH, et al
    Nutritional deficiency anemia and post-acute sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: A six-month retrospective cohort analysis of 30 892 patients.
    J Med Virol. 2023;95:e29246.
    >> Share

  169. KANG SW, Kim JW, Kim JY, Lim SY, et al
    Virological characteristics and the rapid antigen test as deisolation criteria in immunocompromised patients with COVID-19: A prospective cohort study.
    J Med Virol. 2023;95:e29228.
    >> Share

  170. LI Z, Xiong Y, Long J, Li T, et al
    Resurgence of influenza during COVID-19 in Chongqing, China: A retrospective analysis.
    J Med Virol. 2023;95:e29249.
    >> Share

  171. CHENANE HR, Lingas G, Menidjel R, Laouenan C, et al
    High sera levels of SARS-CoV-2 N antigen are associated with death in hospitalized COVID-19 patients.
    J Med Virol. 2023;95:e29247.
    >> Share

  172. WANG Z, Zhao C, Li C, Liu S, et al
    Molecular PET/CT mapping of rhACE2 distribution and quantification in organs to aid in SARS-CoV-2 targeted therapy.
    J Med Virol. 2023;95:e29221.
    >> Share

  173. HU GM, Tai YC, Chen CM
    Unraveling the evolutionary patterns and phylogenomics of coronaviruses: A consensus network approach.
    J Med Virol. 2023;95:e29233.
    >> Share

  174. MAO R, Fan Z, He M, Li J, et al
    Acne and COVID-19 susceptibility, hospitalization, and severity: A genetic correlation study.
    J Med Virol. 2023;95:e29265.
    >> Share

  175. KONDO Y, Kawamura Y, Hattori F, Nakai H, et al
    Serological analysis of severe acute respiratory syndrome coronavirus 2 infection in children with Kawasaki disease.
    J Med Virol. 2023;95:e29274.
    >> Share

  176. ZENG G, Zhang Z, Wang L, Li J, et al
    Risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients.
    J Med Virol. 2023;95:e29235.
    >> Share

    October 2023
  177. SHIH HL, Lee YT, Sun CK, Chang R, et al
    Considerations regarding the long-term risk of herpes zoster following COVID-19.
    J Med Virol. 2023;95:e29130.
    >> Share

  178. FAPPANI C, Gori M, Bianchi S, Terraneo M, et al
    Differential diagnosis of fever and rash cases negative for measles and rubella to complement surveillance activities.
    J Med Virol. 2023;95:e29141.
    >> Share

  179. XU W, Wen X, Cong X, Jiang W, et al
    COVID-19 mRNA vaccine, but not a viral vector-based vaccine, promotes neutralizing anti-type I interferon autoantibody production in a small group of healthy individuals.
    J Med Virol. 2023;95:e29137.
    >> Share

  180. HOLLSTEIN MM, Dierks S, Schon MP, Bergmann A, et al
    Humoral and cellular immune responses in fully vaccinated individuals with or without SARS-CoV-2 breakthrough infection: Results from the CoV-ADAPT cohort.
    J Med Virol. 2023;95:e29122.
    >> Share

  181. WIEDEL NA, Sayles H, Larson J, Wardian JL, et al
    Associations between COVID-19 therapies and inpatient gastrointestinal bleeding: A multisite retrospective study.
    J Med Virol. 2023;95:e29100.
    >> Share

  182. HU M, Wang X, Li B, Wang B, et al
    Fitness evaluation of SARS-CoV-2 variants: A retrospective study.
    J Med Virol. 2023;95:e29123.
    >> Share

  183. RECTOR A, Bloemen M, Van Ranst M, Wollants E, et al
    Used paper tissues for pathogen identification in acute respiratory infection.
    J Med Virol. 2023;95:e29127.
    >> Share

  184. LI X, Zhang Y, Wang J, Han J, et al
    Long-term dynamic shifts in genomic base content and evolutionary trajectories of SARS-CoV-2 variants.
    J Med Virol. 2023;95:e29128.
    >> Share

  185. LIANG T, Guo K, Ni P, Duan G, et al
    The association of sickle cell disorder with adverse outcomes in COVID-19 patients: A meta-analysis.
    J Med Virol. 2023;95:e29120.
    >> Share

  186. SHI T, Xu L, Li X, Huang L, et al
    The CD19(+) B cell as a marker for the febrile children infected with influenza A and Omicron variant.
    J Med Virol. 2023;95:e29097.
    >> Share

  187. FENG S, Fan Z, Zhou K, Ma S, et al
    Subunit vaccine raised against the SARS-CoV-2 spike of Delta and Omicron variants.
    J Med Virol. 2023;95:e29160.
    >> Share

  188. LIU J, Zhang H, Kong J, Liu S, et al
    Alleviated symptoms of SARS-CoV-2 Omicron variant infection in chronic hepatitis B patients with immune control.
    J Med Virol. 2023;95:e29173.
    >> Share

  189. BREZNIK JA, Rahim A, Bhakta H, Clare R, et al
    Early humoral and cellular responses after bivalent SARS-CoV-2 mRNA-1273.214 vaccination in long-term care and retirement home residents in Ontario, Canada: An observational cohort study.
    J Med Virol. 2023;95:e29170.
    >> Share

  190. GAO Y, Zhang Y, Mou K, Liu Y, et al
    Assessment of alterations in the retina and vitreous in pre- and post-COVID-19 patients using swept-source optical coherence tomography and angiography: A comparative study.
    J Med Virol. 2023;95:e29168.
    >> Share

  191. YI J, Li X, Zhang R, Kong L, et al
    The impact of the COVID-19 pandemic on the prevalence and genotype distribution of HPV infection in Beijing, China.
    J Med Virol. 2023;95:e29155.
    >> Share

  192. BA Z, Yang A, Zhu S, Li Y, et al
    Comprehensive evaluation of the effect of inactivated SARS-CoV-2 vaccination on female fertility: A retrospective cohort study.
    J Med Virol. 2023;95:e29161.
    >> Share

  193. HU Z, Jin Z, Zhou M, Zhang C, et al
    CoronaVac and BBIBP-CorV vaccines against SARS-CoV-2 during predominant circulation of Omicron BA.5.2 and BF.7 in China, a retrospective cohort study.
    J Med Virol. 2023;95:e29143.
    >> Share

  194. ABBASI HQ
    Comments on: Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    J Med Virol. 2023;95:e29167.
    >> Share

  195. MATIC S, Milovanovic D, Mijailovic Z, Djurdjevic P, et al
    Its all about IFN-lambda4: Protective role of IFNL4 polymorphism against COVID-19-related pneumonia in females.
    J Med Virol. 2023;95:e29152.
    >> Share

  196. COLSON P, La Scola B, Beye M, Delerce J, et al
    Emergence of a second SARS-CoV-2 variant with a tremendous genetic leap from its ancestors.
    J Med Virol. 2023;95:e29124.
    >> Share

  197. WEI D, Yu X, Li Y, Chen Y, et al
    Sequential reinfection with Omicron variants elicits broader neutralizing antibody profiles in booster vaccinees and reduces the duration of viral shedding.
    J Med Virol. 2023;95:e29151.
    >> Share

  198. CHEN D, Li X, Hao X, Qiu Y, et al
    Reduced neutralization and Fc effector function to Omicron subvariants in sera from SARS-CoV-1 survivors after two doses of CoronaVac plus one dose subunit vaccine.
    J Med Virol. 2023;95:e29136.
    >> Share

  199. JIAO F, Andrianov AM, Wang L, Furs KV, et al
    Repurposing Navitoclax to block SARS-CoV-2 fusion and entry by targeting heptapeptide repeat sequence 1 in S2 protein.
    J Med Virol. 2023;95:e29145.
    >> Share

  200. YANG X, Hu C, Yang X, Yang X, et al
    Evaluation and comparison of immune responses induced by two Mpox mRNA vaccine candidates in mice.
    J Med Virol. 2023;95:e29140.
    >> Share

  201. LIU S, Wang P, Shi X, Weng T, et al
    Maternal antibody transfer rate of vaccination against SARS-CoV-2 before or during early pregnancy and its protective effectiveness on offspring.
    J Med Virol. 2023;95:e29125.
    >> Share

  202. COLSON P, Delerce J, Fantini J, Pontarotti P, et al
    The return of the "Mistigri" (virus adaptative gain by gene loss) through the SARS-CoV-2 XBB.1.5 chimera that predominated in 2023.
    J Med Virol. 2023;95:e29146.
    >> Share

  203. DE FRANCESCO MA, Piva S, Pellizzeri S, Signorini L, et al
    Response to the Letter to the Editor on "Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS-CoV-2 infection than negative patients and are associated to a worse outcome".
    J Med Virol. 2023;95:e29192.
    >> Share

  204. WANG Q, Jia M, Jiang M, Cao Y, et al
    Increased population susceptibility to seasonal influenza during the COVID-19 pandemic in China and the United States.
    J Med Virol. 2023;95:e29186.
    >> Share

  205. MOHAMMADI-PILEHDARBONI H, Shenagari M
    Regarding the article Causal effect of COVID-19 on Alzheimer's disease: A Mendelian randomization study by Baranova et al.
    J Med Virol. 2023;95:e29176.
    >> Share

  206. CACCURI F, Messali S, Scarpa F, Giovanetti M, et al
    First detection of SARS-CoV-2 BA.2.86.1 in Italy.
    J Med Virol. 2023;95:e29175.
    >> Share

  207. LI T, Chen N, Wang X, Chen N, et al
    Epidemiology of influenza A outbreak among children after COVID-19: A single-center retrospective observational study.
    J Med Virol. 2023;95:e29174.
    >> Share

  208. AHN H, Calderon BM, Fan X, Gao Y, et al
    Structural basis of the American mink ACE2 binding by Y453F trimeric spike glycoproteins of SARS-CoV-2.
    J Med Virol. 2023;95:e29163.
    >> Share

  209. MEYERS E, Park J, Coen A, Raman L, et al
    Evaluation of a smartphone-operated point-of-care device using loop-mediated isothermal amplification technology for rapid and remote detection of SARS-CoV-2.
    J Med Virol. 2023;95:e29158.
    >> Share

  210. BASTOS V, Pacheco V, Rodrigues EDL, Moraes CNS, et al
    Neuroimmunology of rabies: New insights into an ancient disease.
    J Med Virol. 2023;95:e29042.
    >> Share

  211. HSIA NY, Hsu AY, Wang YH, Li JX, et al
    The risk assessment of uveitis after COVID-19 diagnosis: A multicenter population-based study.
    J Med Virol. 2023;95:e29188.
    >> Share

  212. QI Z, Yuan S, Wei J, Xia S, et al
    Clinical and pathological features of omicron variant of SARS-CoV-2-associated kidney injury.
    J Med Virol. 2023;95:e29196.
    >> Share

  213. ARONS E, Henry K, Haas C, Gould M, et al
    Characterization of B-cell receptor clonality and immunoglobulin gene usage at multiple time points during active SARS-CoV-2 infection.
    J Med Virol. 2023;95:e29179.
    >> Share

    September 2023

  214. Correction to "Safety and immunogenicity of COVID-19 vaccination in patients with hepatocellular carcinoma (CHESS-NMCID 2101): A multicenter prospective study".
    J Med Virol. 2023;95:e29063.
    >> Share

  215. SENGUPTA S, Shaw SK, Chatterjee S, Bhattacharya G, et al
    Perturbations in spike-specific peripheral T follicular helper cells in SARS-CoV2 breakthrough convalescent individuals immunized by BBV152 vaccine.
    J Med Virol. 2023;95:e29053.
    >> Share

  216. ZHOU H, Xie P, Qiu M, Dong S, et al
    Arbidol increases the survival rate by mitigating inflammation in suckling mice infected with human coronavirus OC43 virus.
    J Med Virol. 2023;95:e29052.
    >> Share

  217. DAS S, Kumar S
    Exploring the mechanisms of long COVID: Insights from computational analysis of SARS-CoV-2 gene expression and symptom associations.
    J Med Virol. 2023;95:e29077.
    >> Share

  218. AHLUWALIA P, Vashisht A, Singh H, Sahajpal NS, et al
    Ethno-demographic disparities in humoral responses to the COVID-19 vaccine among healthcare workers.
    J Med Virol. 2023;95:e29067.
    >> Share

  219. MA J, Qiu S
    Infection with critically ill COVID-19 increases the risk of cardioembolic stroke.
    J Med Virol. 2023;95:e29066.
    >> Share

  220. MOLINA IS, Jimenez-Vasquez V, Lizarraga W, Sevilla N, et al
    Sub-lineage B.1.6 of hMPXV in a global context: Phylogeny and epidemiology.
    J Med Virol. 2023;95:e29056.
    >> Share

  221. CASO JM, Fernandez-Ruiz M, Lopez-Medrano F, Caro-Teller JM, et al
    Nirmatrelvir/ritonavir for the treatment of immunocompromised adult patients with early-stage symptomatic COVID-19: A real-life experience.
    J Med Virol. 2023;95:e29082.
    >> Share

  222. HAO S, Ning K, Kuz CA, Xiong M, et al
    SARS-CoV-2 infection of polarized human airway epithelium induces necroptosis that causes airway epithelial barrier dysfunction.
    J Med Virol. 2023;95:e29076.
    >> Share

  223. SCARPA F, Ciccozzi M
    On the SARS-CoV-2 BA.2.86 lineage: a mutation point of view.
    J Med Virol. 2023;95:e29079.
    >> Share

  224. SCARPA F, Pascarella S, Ciccozzi A, Giovanetti M, et al
    Genetic and structural analyses reveal the low potential of the SARS-CoV-2 EG.5 variant.
    J Med Virol. 2023;95:e29075.
    >> Share

  225. SHAO C, Shi Y, Chen R, Liu X, et al
    Risk factors associated with COVID-19 pneumonia in Chinese patients with pre-existing interstitial lung disease during the SARS-CoV-2 pandemic.
    J Med Virol. 2023;95:e29098.
    >> Share

  226. HOSSAIN MS, Kerkvliet JG, Hoppe AD
    Whole genome CRISPR screening strategy to identify genes contributing to SARS-CoV-2 spike and VSV-G mediated entry.
    J Med Virol. 2023;95:e29087.
    >> Share

  227. ZHANG B, Tsai YW, Wu JY, Liu TH, et al
    Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study.
    J Med Virol. 2023;95:e29096.
    >> Share

  228. TSO WW, Kwan MY, Ip P, Chan JF, et al
    Response to the Letter to the Editor on "Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection".
    J Med Virol. 2023;95:e29095.
    >> Share

  229. HUANG SW, Yeh WB, Chen HY, Yong SB, et al
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e29101.
    >> Share

  230. HANSEN KS, Jorgensen SE, Skouboe MK, Agergaard J, et al
    Examination of autoantibodies to type I interferon in patients suffering from long COVID.
    J Med Virol. 2023;95:e29089.
    >> Share

  231. ZUO T, Liang G, Huang Z, Cao Z, et al
    Baseline gut microbiome features prior to SARS-CoV-2 infection are associated with host symptoms in and post COVID-19.
    J Med Virol. 2023;95:e29083.
    >> Share

  232. CAKIR C, Kuspinar G, Kurt G, Berber M, et al
    Comparison of semen parameters in the same patients before and after diagnosis of COVID-19.
    J Med Virol. 2023;95:e29094.
    >> Share

  233. CHU WM, Hsieh TH, Wei JC
    Comment on Tsai et al.'s "clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data".
    J Med Virol. 2023;95:e29086.
    >> Share

  234. JIANG T, Liu R, Shen J
    CRISPR dual enzyme cleavage triggers DNA and RNA substrate cleavage for SARS-CoV-2 dual gene detection.
    J Med Virol. 2023;95:e29090.
    >> Share

  235. RAFATI A, Jameie M, Amanollahi M, Jameie M, et al
    Association of seizure with COVID-19 vaccines in persons with epilepsy: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29118.
    >> Share

  236. YULUG B, Ayyildiz B, Ayyildiz S, Sayman D, et al
    Infection with COVID-19 is no longer a public emergency: But what about degenerative dementia?
    J Med Virol. 2023;95:e29072.
    >> Share

  237. DE SOUSA LAF, Ferreira LSS, Lobato LFL, Ferreira HLDS, et al
    Molecular epidemiology of SARS-CoV-2 variants in circulation in the state of Maranhao, Brazil.
    J Med Virol. 2023;95:e29092.
    >> Share

  238. XIANG Y, Mou C, Shi K, Chen X, et al
    SADS-CoV nsp1 inhibits the IFN-beta production by preventing TBK1 phosphorylation and inducing CBP degradation.
    J Med Virol. 2023;95:e29104.
    >> Share

  239. TSAI YW, Wu JY, Liu TH, Chuang MH, et al
    Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data.
    J Med Virol. 2023;95:e29085.
    >> Share

  240. BRUZZESI E, Gabrieli A, Bernasconi D, Marchetti G, et al
    HIV-DNA decrease during treatment in primary HIV-1 infection with three different drug regimens: Italian Network of Acute HIV Infection (INACTION) clinical trial.
    J Med Virol. 2023;95:e29114.
    >> Share

  241. ZHAN Y, Ye L, Ouyang Q, Yin J, et al
    The binding profile of SARS-CoV-2 with human leukocyte antigen polymorphisms reveals critical alleles involved in immune evasion.
    J Med Virol. 2023;95:e29113.
    >> Share

  242. LI B, Zhang J, Huang Y, Li X, et al
    A conserved N protein nano-vaccine of COVID-19 exerts potent and cross-reactive humoral and cellular immune responses in mice.
    J Med Virol. 2023;95:e29115.
    >> Share

  243. COELHO GM, Cataneo AHD, Raboni SM, Nogueira MB, et al
    Development of an anti-SARS-CoV-2 monoclonal antibody panel and its applicability as a reagent in high-throughput fluorescence reduction neutralization and immunohistochemistry assays.
    J Med Virol. 2023;95:e29111.
    >> Share

    August 2023
  244. ROY A, Saade C, Josset L, Clement B, et al
    Determinants of protection against SARS-CoV-2 Omicron BA.1 and Delta infections in fully vaccinated outpatients.
    J Med Virol. 2023;95:e28984.
    >> Share

  245. CHEN Y, Liu X, Tong Z
    Can inspiratory muscle training benefit patients with COVID-19? A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28956.
    >> Share

  246. ZENG G, Li J, Wang L, Zhang Z, et al
    Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital.
    J Med Virol. 2023;95:e28988.
    >> Share

  247. YU W, Guo Y, Hu T, Liu Y, et al
    Incidence and severity of SARS-CoV-2 reinfection, a multicenter cohort study in Shanghai, China.
    J Med Virol. 2023;95:e28997.
    >> Share

  248. LI X, Chen N, Wang X, Li T, et al
    Epidemiology of respiratory syncytial virus outbreak among children after the COVID-19 pandemic.
    J Med Virol. 2023;95:e29017.
    >> Share

  249. HIRATA Y, Katano H, Iida S, Mine S, et al
    Genomic analysis of SARS-CoV-2 in forensic autopsy cases of COVID-19.
    J Med Virol. 2023;95:e28990.
    >> Share

  250. VELAZQUEZ-SALINAS L
    Deciphering the evolutionary mechanisms of SARS-CoV-2: Absence of ORF8 protein and its potential advantage in the emergence of viral lineages.
    J Med Virol. 2023;95:e29002.
    >> Share

  251. ZUIN M, Mazzitelli M, Cattelan A
    Long-COVID: Is it time to revise the definition?
    J Med Virol. 2023;95:e29011.
    >> Share

  252. LIU TH, Chuang MH, Wu JY, Huang PY, et al
    Effectiveness of oral antiviral agents on long-term cardiovascular risk in nonhospitalized patients with COVID-19: A multicenter matched cohort study.
    J Med Virol. 2023;95:e28992.
    >> Share

  253. SHANG S, Fu B, Geng Y, Zhang J, et al
    Azvudine therapy of common COVID-19 in hemodialysis patients.
    J Med Virol. 2023;95:e29007.
    >> Share

  254. WANG Y, Zhao D, Xiao W, Shi J, et al
    Paxlovid reduces the risk of Long COVID in patients six months after hospital discharge.
    J Med Virol. 2023;95:e29014.
    >> Share

  255. ZHIYANOV A, Shkurnikov M, Nersisyan A, Hui C, et al
    The signature of SARS-CoV-2 evolution reflects selective pressures within human guts.
    J Med Virol. 2023;95:e28996.
    >> Share

  256. ABBASI HQ
    Comments on: Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection.
    J Med Virol. 2023;95:e29008.
    >> Share

  257. MOHAMMADI B, Dua K, Saghafi M, Singh SK, et al
    COVID-19-induced autoimmune thyroiditis: Exploring molecular mechanisms.
    J Med Virol. 2023;95:e29001.
    >> Share

  258. WASSERMAN EB, Sills AK, Martins D, Casolaro A, et al
    Factors associated with antibody titer levels among an occupational cohort of fully vaccinated individuals and subsequent risk of COVID-19 infection: A cohort study.
    J Med Virol. 2023;95:e28999.
    >> Share

  259. THURLAPATI A, McGann M, Davis JA, Granger K, et al
    Role of tixagevimab-cilgavimab in preventing SARS-CoV-2 in hematopoietic stem cell transplant and chimeric antigen receptor T-cell therapy recipients.
    J Med Virol. 2023;95:e29027.
    >> Share

  260. BAI Y, Shen L, Sun M, Yang Z, et al
    The short and long-term impact of nonpharmaceutical interventions on the prevalence of varicella in Xi'an during the COVID-19 pandemic.
    J Med Virol. 2023;95:e29020.
    >> Share

  261. LIU M, Zhang J, Li L, Tian J, et al
    Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescents.
    J Med Virol. 2023;95:e28998.
    >> Share

  262. GIOVANETTI M, Branda F, Cella E, Scarpa F, et al
    Epidemic history and evolution of an emerging threat of international concern, the severe acute respiratory syndrome coronavirus 2.
    J Med Virol. 2023;95:e29012.
    >> Share

  263. HOQUE SA, Pham NTK, Onda-Shimizu Y, Nishimura S, et al
    Sapovirus infections in Japan before and after the emergence of the COVID-19 pandemic: An alarming update.
    J Med Virol. 2023;95:e29023.
    >> Share

  264. ISHISAKA Y, Aikawa T, Malik A, Kampaktsis PN, et al
    Association of Remdesivir use with bradycardia: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e29018.
    >> Share

  265. SUN Z, Wang S, Sun X, Shi Y, et al
    COVID-19 has causal effects on cancer risk? Something we might ignore.
    J Med Virol. 2023;95:e29034.
    >> Share

  266. BAUER C, Mack E, Hefter V, Fischer A, et al
    Impaired systemic nucleocapsid antigen clearance in severe COVID-19.
    J Med Virol. 2023;95:e29032.
    >> Share

  267. MAK WA, Visser W, van der Vliet M, Markus HY, et al
    Ancestral SARS-CoV-2 and Omicron BA.5-specific neutralizing antibody and T-cell responses after Omicron bivalent booster vaccination in previously infected and infection-naive individuals.
    J Med Virol. 2023;95:e28989.
    >> Share

  268. DAS A, Meng W, Liu Z, Hasib MM, et al
    Molecular and immune signatures, and pathological trajectories of fatal COVID-19 lungs defined by in situ spatial single-cell transcriptome analysis.
    J Med Virol. 2023;95:e29009.
    >> Share

  269. LU S, Luo S, Bai B, Fan Z, et al
    Omicron breakthrough infections in wild-type SARS-CoV-2 vaccinees elicit high levels of neutralizing antibodies against pangolin coronavirus GX_P2V.
    J Med Virol. 2023;95:e29031.
    >> Share

  270. FANG C, Yan W, Chen Y, Dou Z, et al
    Long-term SARS-CoV-2 neutralizing antibody level prediction using multimodal deep learning: A prospective cohort study on longitudinal data in Wuhan, China.
    J Med Virol. 2023;95:e29036.
    >> Share

  271. FOURIE E, Bording ES, Euser SM, Badoux P, et al
    Nasal discharge: A unique enhanced alternative for the detection of respiratory pathogens in adults.
    J Med Virol. 2023;95:e29047.
    >> Share

  272. ZHAO Y, Zhao Y, Zhu J, Lei L, et al
    Association of inactivated COVID-19 vaccination with maternal coagulation function in early pregnancy.
    J Med Virol. 2023;95:e29051.
    >> Share

  273. GUO H, Yin M, Liu Y, Wang B, et al
    COVID-19 infection after oocyte retrieval did not have detrimental effects on embryo implantation for frozen embryo transfer.
    J Med Virol. 2023;95:e29054.
    >> Share

  274. BASTO-ABREU A, Carnalla M, Torres-Ibarra L, Sanchez-Pajaro A, et al
    SARS-CoV-2 seroprevalence and vaccine coverage from August to November 2021: A nationally representative survey in Mexico.
    J Med Virol. 2023;95:e29038.
    >> Share

  275. ZHAO Y, Zhang H, Zhao Z, Liu F, et al
    Efficacy and safety of Oral LL-37 against the Omicron BA.5.1.3 variant of SARS-COV-2: A randomized trial.
    J Med Virol. 2023;95:e29035.
    >> Share

  276. GONDIM RNDG, de Arruda EAG, Neto RDJP, Medeiros MS, et al
    Cytokines, chemokines, and cells growth factors in patients with mild to moderate SARS-CoV-2 infection: A case-control study.
    J Med Virol. 2023;95:e29044.
    >> Share

  277. NGUYEN NN, Houhamdi L, Meddeb L, Colson P, et al
    Reinfection with SARS-CoV-2 Omicron BA.4 and BA.5 variants.
    J Med Virol. 2023;95:e29033.
    >> Share

  278. SILVA MFS, de Oliveira FCE, Pinto ACMD, Luciano MCDS, et al
    Antibody response following the fourth SARS-CoV-2 vaccine dose during the Omicron wave in Brazil.
    J Med Virol. 2023;95:e29055.
    >> Share

  279. GUTERRES A
    Viral load: We need a new look at an old problem?
    J Med Virol. 2023;95:e29061.
    >> Share

  280. YANG H, Wang Z, Zhang Y, Xu M, et al
    Clinical characteristics and factors for serious outcomes among outpatients infected with the Omicron subvariant BF.7.
    J Med Virol. 2023;95:e28977.
    >> Share

  281. LIAO HC, Huang MS, Chiu FF, Chai KM, et al
    Co-delivery of a trimeric spike DNA and protein vaccine with aluminum hydroxide enhanced Th1-dominant humoral and cellular immunity against SARS-CoV-2.
    J Med Virol. 2023;95:e29040.
    >> Share

    July 2023
  282. SOLIS M, Benotmane I, Gallais F, Caillard S, et al
    Torque teno virus viral load predicts SARS-CoV-2 vaccine response in kidney transplant recipients.
    J Med Virol. 2023;95:e28936.
    >> Share

  283. ZHAO Q, Wang X, Zhang Z, Liu X, et al
    Serum neutralization of SARS-CoV-2 Omicron BA.2, BA.2.75, BA.2.76, BA.5, BF.7, BQ.1.1 and XBB.1.5 in individuals receiving Evusheld.
    J Med Virol. 2023;95:e28932.
    >> Share

  284. KHAN M, Khan K, Motwani J
    Comment on "Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients".
    J Med Virol. 2023;95:e28938.
    >> Share

  285. TSO WW, Kwan MY, Kwok JS, Tsang JO, et al
    Clinical characteristics of unvaccinated or incompletely vaccinated children with neurological manifestations due to SARS-CoV-2 Omicron infection.
    J Med Virol. 2023;95:e28895.
    >> Share

  286. GATES S, Andreani J, Dewar R, Smith DB, et al
    Postpandemic rebound of adeno-associated virus type 2 (AAV2) infections temporally associated with an outbreak of unexplained severe acute hepatitis in children in the United Kingdom.
    J Med Virol. 2023;95:e28921.
    >> Share

  287. ALBERT E, Fernandez-Soto D, Gimenez E, Casanovas JM, et al
    Antibody-dependent NK-cell and neutralizing antibody responses against the Spike protein of Wuhan-Hu-1 and Omicron BA.1 SARS-CoV-2 variants in vaccinated experienced and vaccinated naive individuals.
    J Med Virol. 2023;95:e28900.
    >> Share

  288. HUANG PY, Liu TH, Wu JY, Tsai YW, et al
    Response to the letter to the editor on "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials".
    J Med Virol. 2023;95:e28918.
    >> Share

  289. YI S, Zhang SS, Wang XR, Zhou Y, et al
    Dynamics of parainfluenza virus among hospitalized children with acute respiratory tract infection under two-child policy and COVID-19 pandemic in Hubei Province, China, 2014-2022.
    J Med Virol. 2023;95:e28899.
    >> Share

  290. ZHANG H, Lu Z, Yang F, Chen H, et al
    Symptom profiles and vaccination status for COVID-19 after the adjustment of the dynamic zero-COVID policy in China: An observational study.
    J Med Virol. 2023;95:e28893.
    >> Share

  291. RAMUNNO M, Savitz R
    COVID-19 vaccination and decreased death rates: A county-level study in Pennsylvania.
    J Med Virol. 2023;95:e28883.
    >> Share

  292. DE FRANCESCO MA, Signorini L, Piva S, Pellizzeri S, et al
    Bacterial and fungal superinfections are detected at higher frequency in critically ill patients affected by SARS CoV-2 infection than negative patients and are associated to a worse outcome.
    J Med Virol. 2023;95:e28892.
    >> Share

  293. RAHMATI M, Yon DK, Lee SW, Soysal P, et al
    New-onset neurodegenerative diseases as long-term sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28909.
    >> Share

  294. MIELKE A, Denwood M, Christiansen LE
    Estimating true prevalence through questionnaire data.
    J Med Virol. 2023;95:e28908.
    >> Share

  295. CHUNG HY, Jian MJ, Chang CK, Lin JC, et al
    Accelerating pandemic response with the emergency Omicron RT-PCR test: A comprehensive solution for COVID-19 diagnosis and tracking.
    J Med Virol. 2023;95:e28914.
    >> Share

  296. GUO Z, Jin Q, Li P, Xing G, et al
    Potential cross-species transmission risks of emerging swine enteric coronavirus to human beings.
    J Med Virol. 2023;95:e28919.
    >> Share

  297. SENDI P, Widmer N, Branca M, Thierstein M, et al
    Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohort.
    J Med Virol. 2023;95:e28904.
    >> Share

  298. KANG SY, Yoo JR, Park Y, Kim SH, et al
    Fatal outcome of severe fever with thrombocytopenia syndrome (SFTS) and severe and critical COVID-19 is associated with the hyperproduction of IL-10 and IL-6 and the low production of TGF-beta.
    J Med Virol. 2023;95:e28894.
    >> Share

  299. LIN WC, Wei JC
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e28903.
    >> Share

  300. LIU TH, Wu JY, Huang PY, Tsai YW, et al
    The effect of nirmatrelvir-ritonavir on the long-term risk of neuropsychiatric sequelae following COVID-19.
    J Med Virol. 2023;95:e28951.
    >> Share

  301. AN Y, Zhao G, Duan H, Zhang N, et al
    Robust and protective immune responses induced by heterologous prime-boost vaccination with DNA-protein dimeric RBD vaccines for COVID-19.
    J Med Virol. 2023;95:e28948.
    >> Share

  302. MA Q, Xu G
    New-onset and relapsed thrombotic microangiopathy post-COVID-19 vaccination.
    J Med Virol. 2023;95:e28946.
    >> Share

  303. GHAZIZADEH ESSLAMI G, Mamishi S, Pourakbari B, Mahmoudi S, et al
    Systematic review and meta-analysis on the serological, immunological, and cardiac parameters of the multisystem inflammatory syndrome (MIS-C) associated with SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28927.
    >> Share

  304. CHEN YC, Ho CH, Liu TH, Wu JY, et al
    Response to the letter to the editor on "Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients".
    J Med Virol. 2023;95:e28945.
    >> Share

  305. HUANG Y, Zhu X, Guo X, Zhou Y, et al
    Advances in mRNA vaccines for viral diseases.
    J Med Virol. 2023;95:e28924.
    >> Share

  306. HUANG C
    Comment on Huang PS et al. Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials. Med Virol. 2023; 95: e28621.
    J Med Virol. 2023;95:e28907.
    >> Share

  307. CHEN H, Ye B, Su W, Song Y, et al
    The causal role of gut microbiota in susceptibility and severity of COVID-19: A bidirectional Mendelian randomization study.
    J Med Virol. 2023;95:e28880.
    >> Share

  308. KOZAWA K, Kawamura Y, Hattori F, Miura H, et al
    Changes in trends of pediatric beta- and gamma-herpesvirus infections during the COVID-19 pandemic: A single-center observational study.
    J Med Virol. 2023;95:e28925.
    >> Share

  309. KIRSCH JA, Slutske WS, McCarthy DE, Smith SS, et al
    Factors associated with 60-day readmission among inpatients with COVID-19 at 21 United States health systems.
    J Med Virol. 2023;95:e28972.
    >> Share

  310. YANG H, Wang Z, Jiang C, Zhang Y, et al
    Oral azvudine for mild-to-moderate COVID-19 in high risk, nonhospitalized adults: Results of a real-world study.
    J Med Virol. 2023;95:e28947.
    >> Share

  311. PONIEDZIALEK B, Rzymski P, Zarebska-Michaluk D, Rogalska M, et al
    Short-term exposure to ambient air pollution and COVID-19 severity during SARS-CoV-2 Delta and Omicron waves: A multicenter study.
    J Med Virol. 2023;95:e28962.
    >> Share

  312. KIM Y, Kim S, Kim HJ, Kwon R, et al
    National trends in body mass index, overweight, and obesity among adults before and during the COVID-19 pandemic in 2009-2021: A representative longitudinal serial study in South Korea.
    J Med Virol. 2023;95:e28958.
    >> Share

  313. FANG Q, He X, Zheng X, Fu Y, et al
    Verifying AXL and putative proteins as SARS-CoV-2 receptors by DnaE intein-based rapid cell-cell fusion assay.
    J Med Virol. 2023;95:e28953.
    >> Share


  314. Retraction: Zhang, N, Qi, X, Chang, H, et al. Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: a cross-sectional study based on UK Biobank. J Med Virol. 2023; 95:e28726. doi:10.1002/jmv.2
    J Med Virol. 2023;95:e28937.
    >> Share

  315. HE J, Mei Q, Peng Y, Xie J, et al
    Are the original SARS-CoV-2 novel mutants from in vitro culture able to escape the immune response?
    J Med Virol. 2023;95:e28931.
    >> Share


  316. Correction to "Long-Term Risk of Herpes Zoster Following Covid-19: A Retrospective Cohort Study of 2 442 686 Patients".
    J Med Virol. 2023;95:e28944.
    >> Share

  317. QU Y, Wang W, Xiao MZX, Zheng Y, et al
    The interplay between lipid droplets and virus infection.
    J Med Virol. 2023;95:e28967.
    >> Share


  318. Correction to "Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: a systematic review and meta-analysis of randomized control trials".
    J Med Virol. 2023;95:e28916.
    >> Share


  319. Correction to "SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2".
    J Med Virol. 2023;95:e28935.
    >> Share

  320. AUGUSTINE G, Sisila V, Indhu M, Gupta D, et al
    Redirecting the JAK-STAT signal blocks the SARS-CoV-2 replication.
    J Med Virol. 2023;95:e28965.
    >> Share

  321. VISOS-VARELA I, Zapata-Cachafeiro M, Pintos-Rodriguez S, Bugarin-Gonzalez R, et al
    Outpatient atorvastatin use and severe COVID-19 outcomes: A population-based study.
    J Med Virol. 2023;95:e28971.
    >> Share

  322. SHARIQ M, Malik AA, Sheikh JA, Hasnain SE, et al
    Regulation of autophagy by SARS-CoV-2: The multifunctional contributions of ORF3a.
    J Med Virol. 2023;95:e28959.
    >> Share

  323. WATANABE A, Malik A, Aikawa T, Briasoulis A, et al
    Extracorporeal membrane oxygenation for COVID-19-associated acute respiratory distress syndrome: A nationwide analysis.
    J Med Virol. 2023;95:e28961.
    >> Share

    June 2023
  324. LIN YY, Yao R, Zhuang J, Wang B, et al
    PACT inhibits the replication of SARS-CoV-2 through the blockage of GSK-3beta-N-nsp3 cascade.
    J Med Virol. 2023;95:e28832.
    >> Share

  325. RAHMATI M, Yon DK, Lee SW, Udeh R, et al
    New-onset type 1 diabetes in children and adolescents as postacute sequelae of SARS-CoV-2 infection: A systematic review and meta-analysis of cohort studies.
    J Med Virol. 2023;95:e28833.
    >> Share

  326. QIAN X, Wu B, Chen X, Peng H, et al
    Multi-omic and comparative analyses revealed monocyte-derived alpha-defensin-1 correlated with COVID-19 severity and inhibited SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28845.
    >> Share

  327. REN Y, Wang G, Han D
    Statins in hospitalized COVID-19 patients: A systematic review and meta-analysis of randomized controlled trials.
    J Med Virol. 2023;95:e28823.
    >> Share

  328. GUO M, Zhu J, Hu Z, Wang Q, et al
    Histone mRNA polyadenylation-mediated inflammation underlies various virus infections and cancers.
    J Med Virol. 2023;95:e28826.
    >> Share

  329. ZENG G, Wang L, Li J, Zhang Z, et al
    Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19.
    J Med Virol. 2023;95:e28836.
    >> Share

  330. BOSKOVIC B, Bilic I, Soda J, Kero I, et al
    Transcranial magnetic stimulation in assessment of vocal cord paralysis due to post-viral (COVID-19) vagal neuropathy.
    J Med Virol. 2023;95:e28838.
    >> Share

  331. MONDI A, Mastrorosa I, Piselli P, Cimaglia C, et al
    Evolution of SARS-CoV-2 variants of concern over a period of Delta and Omicron cocirculation, among patients hospitalized for COVID-19 in an Italian reference hospital: Impact on clinical outcomes.
    J Med Virol. 2023;95:e28831.
    >> Share

  332. GAULT N, Bachelet D, Laouenan C, Borie R, et al
    Impact of corticosteroids use on midterm sequelae in survivors of COVID-19 admitted to hospital: A prospective cohort study.
    J Med Virol. 2023;95:e28819.
    >> Share

  333. MESSALI S, Rondina A, Giovanetti M, Bonfanti C, et al
    Traceability of SARS-CoV-2 transmission through quasispecies analysis.
    J Med Virol. 2023;95:e28848.
    >> Share

  334. RAHMATI M, Udeh R, Yon DK, Lee SW, et al
    A systematic review and meta-analysis of long-term sequelae of COVID-19 2-year after SARS-CoV-2 infection: A call to action for neurological, physical, and psychological sciences.
    J Med Virol. 2023;95:e28852.
    >> Share

  335. RANARD BL, Chow CC, Megjhani M, Asgari S, et al
    A mathematical model of SARS-CoV-2 immunity predicts paxlovid rebound.
    J Med Virol. 2023;95:e28854.
    >> Share

  336. REDLBERGER-FRITZ M, Springer DN, Aberle SW, Camp JV, et al
    Respiratory syncytial virus surge in 2022 caused by lineages already present before the COVID-19 pandemic.
    J Med Virol. 2023;95:e28830.
    >> Share

  337. YU W, Wang J, Yang Y, Tang C, et al
    SARS-CoV-2 Omicron (B.1.1.529) infection in rhesus macaques, hamsters, and BALB/c mice with severe lung histopathological damage.
    J Med Virol. 2023;95:e28846.
    >> Share

  338. OH T, Kim G, Baek SH, Woo Y, et al
    Comparative spatial transcriptomic profiling of severe acute respiratory syndrome coronavirus 2 Delta and Omicron variants infections in the lungs of cynomolgus macaques.
    J Med Virol. 2023;95:e28847.
    >> Share

  339. LI J, Wang B, He X, Li Z, et al
    Epidemiological characteristics of norovirus infection in pediatric patients during the COVID-19 pandemic.
    J Med Virol. 2023;95:e28874.
    >> Share

  340. TSAI YW, Wu JY, Liu TH, Chuang MH, et al
    Clinical effectiveness of oral antiviral agents in older patients with COVID-19 based on real-world data.
    J Med Virol. 2023;95:e28869.
    >> Share

  341. WU JY, Liu MY, Liu TH, Chuang MH, et al
    Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID-19.
    J Med Virol. 2023;95:e28866.
    >> Share

  342. FENG K, Zhang HJ, Min YQ, Zhou M, et al
    SARS-CoV-2 NSP13 interacts with host IRF3, blocking antiviral immune responses.
    J Med Virol. 2023;95:e28881.
    >> Share

  343. PEREZ-CATALAN I, Gomez-Alfaro I, Garcia-Munoz S, Roig-Marti C, et al
    Antiviral treatment or mAbs for persistent SARS-COV-2 infection in patients with hematologic malignancies: A case series.
    J Med Virol. 2023;95:e28865.
    >> Share

  344. LI F, Xu K, Pan Y, Liu P, et al
    Stability of SARS-CoV-2 and persistence of viral nucleic acids on common foods and widely used packaging material surfaces.
    J Med Virol. 2023;95:e28871.
    >> Share

  345. YE RZ, Gong C, Cui XM, Liu JY, et al
    Continuous evolution and emerging lineage of seasonal human coronaviruses: A multicenter surveillance study.
    J Med Virol. 2023;95:e28861.
    >> Share

  346. DOBROWOLSKA K, Zarebska-Michaluk D, Poniedzialek B, Jaroszewicz J, et al
    Overview of autoantibodies in COVID-19 convalescents.
    J Med Virol. 2023;95:e28864.
    >> Share

  347. KO M, Lee JY, Shin YS, Jeon S, et al
    Novel SARS-CoV-2 entry inhibitors, 2-anilinoquinazolin-4(3H)-one derivatives, show potency as SARS-CoV-2 antivirals in a human ACE2 transgenic mouse model.
    J Med Virol. 2023;95:e28863.
    >> Share

  348. CROOKS CJ, West J, Gazis T, Simmonds M, et al
    Maximal temperature varies by sex and ethnic group in hospital in-patients with Covid-19 infection.
    J Med Virol. 2023;95:e28837.
    >> Share

  349. VASCONCELOS MW, de Barros FRO, Pilonetto JC, Rosa SGB, et al
    Relationship between SARS-CoV-2 vaccination and cases, program breakthrough cases, and deaths in Dois Vizinhos, Parana, Brazil.
    J Med Virol. 2023;95:e28882.
    >> Share

  350. WATANABE Y, Yamamoto H, Matsuba I, Watanabe K, et al
    Time-series transcriptome analysis of peripheral blood mononuclear cells obtained from individuals who received the SARS-CoV-2 mRNA vaccine.
    J Med Virol. 2023;95:e28884.
    >> Share

  351. AHMADI AS, Zadheidar S, Sadeghi K, Nejati A, et al
    SARS-CoV-2 intrahost evolution in immunocompromised patients in comparison with immunocompetent populations after treatment.
    J Med Virol. 2023;95:e28877.
    >> Share

  352. RAMJATTUN K, Ma X, Gao SJ, Singh H, et al
    COVID-19db linkage maps of cell surface proteins and transcription factors in immune cells.
    J Med Virol. 2023;95:e28887.
    >> Share

  353. CAO G, Guo Z, Liu J, Liu M, et al
    Change from low to out-of-season epidemics of influenza in China during the COVID-19 pandemic: A time series study.
    J Med Virol. 2023;95:e28888.
    >> Share

  354. XIE Y, Yang M, Zhou P, Fan J, et al
    New-onset pemphigus foliaceus after COVID-19 infection.
    J Med Virol. 2023;95:e28867.
    >> Share

  355. TRAGNI V, Mercurio I, Paoletti DP, Onofrio A, et al
    Deconstructing SARS-CoV-2 neutralization: A modular molecular framework for computational design and comparison of antibodies and nanobodies targeting the spike RBD.
    J Med Virol. 2023;95:e28875.
    >> Share

  356. LUO J, Zhang J, Tang HT, Wong HK, et al
    Prevalence and risk factors of long COVID 6-12 months after infection with the Omicron variant among nonhospitalized patients in Hong Kong.
    J Med Virol. 2023;95:e28862.
    >> Share

  357. YETMAR ZA, Yao JD, Razonable RR
    SARS-CoV-2 spike codon mutations and risk of hospitalization after antispike monoclonal antibody therapy in solid organ transplant recipients.
    J Med Virol. 2023;95:e28885.
    >> Share

  358. ZHENG L, Wang L, Lu F
    Looking back on the outbreak of acute severe hepatitis with unknown etiology in children in 2022: What do we know now and where do we go from here?
    J Med Virol. 2023;95:e28890.
    >> Share

  359. AMANI B, Akbarzadeh A, Amani B, Shabestan R, et al
    Comparative efficacy and safety of nirmatrelvir/ritonavir and molnupiravir for COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28889.
    >> Share

    May 2023
  360. MUHAMMED OA, Tawfeeq HM, Al-Jaf SMA, Niranji SS, et al
    Comments on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28822.
    >> Share

  361. SONG R, Chen X, Li B, Zhang H, et al
    Nasal spray of an IgM-like ACE2 fusion protein HH-120 accelerates SARS-CoV-2 clearance: A single-center propensity score-matched cohort study.
    J Med Virol. 2023;95:e28805.
    >> Share

  362. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Response to comments to the editor on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28820.
    >> Share

  363. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Corrigendum on "Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers".
    J Med Virol. 2023;95:e28824.
    >> Share

  364. VARGHESE R, Pai S, Kumar D, Sharma R, et al
    SARS-CoV-2 XBB.1.16 variant: India in focus?
    J Med Virol. 2023;95:e28829.
    >> Share

  365. PARCZEWSKI M, Kufel J, Aksak-Was B, Piwnik J, et al
    Artificial neural network based prediction of the lung tissue involvement as an independent in-hospital mortality and mechanical ventilation risk factor in COVID-19.
    J Med Virol. 2023;95:e28787.
    >> Share

  366. ZHANG Y, Liu J, Li H, Yuan F, et al
    Comparison of the immunogenicity of nasal-spray rVSV vector, adenovirus vector, and inactivated COVID-19-based vaccines in rodent models.
    J Med Virol. 2023;95:e28806.
    >> Share

  367. SONG J, Wu Y, Yin X, Ma H, et al
    The causal links between gut microbiota and COVID-19: A Mendelian randomization study.
    J Med Virol. 2023;95:e28784.
    >> Share

  368. ZENG G, He F, Zhang X, Li G, et al
    Antibody response to the third dose of inactivated COVID-19 vaccine in people living with HIV (PLWH): A longitudinal cohort.
    J Med Virol. 2023;95:e28797.
    >> Share

  369. BEGUM F, Srivastava AK, Tripathi PP, Ray U, et al
    A substrate for a cell free in vitro assay system to screen drugs targeting trypsin like protease-based cleavage of SARS-CoV-2 spike glycoprotein and viral entry.
    J Med Virol. 2023;95:e28796.
    >> Share

  370. LIU TH, Huang PY, Wu JY, Chuang MH, et al
    Clinical effectiveness of nirmatrelvir plus ritonavir in patients with COVID-19 and substance use disorders based on real-world data.
    J Med Virol. 2023;95:e28801.
    >> Share

  371. YIN Y, Lin J, Yuan S, Tong S, et al
    Vaccination status for mild and asymptomatic infections with SARS-CoV-2 Omicron BA.2 variant in Shanghai.
    J Med Virol. 2023;95:e28767.
    >> Share

  372. HUESPE IA, Ferraris A, Lalueza A, Valdez PR, et al
    COVID-19 vaccines reduce mortality in hospitalized patients with oxygen requirements: Differences between vaccine subtypes. A multicontinental cohort study.
    J Med Virol. 2023;95:e28786.
    >> Share

  373. SEVGI DY, Demirbas ND, Genc Yaman I, Derin O, et al
    Evaluation of the late presentation and associated factors of people living with HIV in Turkey.
    J Med Virol. 2023;95:e28781.
    >> Share

  374. CHEN L, Zhang Q, Li H, Ma K, et al
    Clinical considerations for a gastric Dieulafoy's disease patient: Cardiac arrhythmias caused by SARS-CoV-2 or terlipressin?
    J Med Virol. 2023;95:e28792.
    >> Share

  375. OGUNBAYO AE, Mogotsi MT, Sondlane H, Sabiu S, et al
    Metagenomics characterization of respiratory viral RNA pathogens in children under five years with severe acute respiratory infection in the Free State, South Africa.
    J Med Virol. 2023;95:e28753.
    >> Share

  376. FONG SW, Goh YS, Torres-Ruesta A, Chang ZW, et al
    Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
    J Med Virol. 2023;95:e28774.
    >> Share

  377. WANLAPAKORN N, Kanokudom S, Phowatthanasathian H, Chansaenroj J, et al
    Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
    J Med Virol. 2023;95:e28758.
    >> Share

  378. RIAD A, Schulz-Weidner N, Dziedzic A, Howaldt HP, et al
    Oral side effects of COVID-19 vaccines in 32 European countries: Analysis of EudraVigilance reports.
    J Med Virol. 2023;95:e28771.
    >> Share

  379. TIRELLI U, Franzini M, Chirumbolo S
    Post-COVID syndrome, the real matter of debate.
    J Med Virol. 2023;95:e28785.
    >> Share

  380. QIU S, Zheng K, Hu Y, Liu G, et al
    Genetic correlation, causal relationship, and shared loci between vitamin D and COVID-19: A genome-wide cross-trait analysis.
    J Med Virol. 2023;95:e28780.
    >> Share

  381. FORTHAL DN
    Comment on the immunogenicity of the Noora vaccine against SARS-CoV-2.
    J Med Virol. 2023;95:e28731.
    >> Share

  382. SAKAI-TAGAWA Y, Yamayoshi S, Halfmann PJ, Wilson N, et al
    Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2.
    J Med Virol. 2023;95:e28788.
    >> Share

  383. SCHUURMANS STEKHOVEN SJ, Winkel KGT, Souverein D, Sondermeijer BM, et al
    Clinical validation of novel dried blood spot based collecting device using serum separation for measuring SARS-CoV-2 antibodies.
    J Med Virol. 2023;95:e28765.
    >> Share

  384. ZHANG Y, Clarke SP, Wu H, Li W, et al
    A comprehensive overview on the transmission, pathogenesis, diagnosis, treatment, and prevention of SARS-CoV-2.
    J Med Virol. 2023;95:e28776.
    >> Share

  385. NASCIMENTO JHFD, Andrade AB, Gusmao-Cunha A, Cunha AMG, et al
    Trends in the morbidity and mortality of coronavirus disease 2019 in different ethnic groups and gender in a large Brazilian city.
    J Med Virol. 2023;95:e28794.
    >> Share

    April 2023
  386. WU J, Liu W, Zhu L, Li N, et al
    Dysbiosis of oropharyngeal microbiome and antibiotic resistance in hospitalized COVID-19 patients.
    J Med Virol. 2023;95:e28727.
    >> Share

  387. BOUKHALFA Y, Stambouli N, Driss A, Daiki M, et al
    sCXCL16 as a prognostic biomarker for COVID-19 outcome.
    J Med Virol. 2023;95:e28728.
    >> Share

  388. ZHANG N, Qi X, Chang H, Li C, et al
    Combined effects of inflammation and coronavirus disease 2019 (COVID-19) on the risks of anxiety and depression: A cross-sectional study based on UK Biobank.
    J Med Virol. 2023;95:e28726.
    >> Share

  389. MENG M, Wu Y, Sha W, Zeng R, et al
    Associations of habitual glucosamine use with SARS-CoV-2 infection and hospital admission and death with COVID-19: Evidence from a large population based cohort study.
    J Med Virol. 2023;95:e28720.
    >> Share

  390. PATINO LH, Ballesteros N, Munoz M, Ramirez AL, et al
    Mu SARS-CoV-2 (B.1.621) variant: A genomic snapshot across the Colombian-Venezuelan border.
    J Med Virol. 2023;95:e28766.
    >> Share

  391. LI J, Bai H, Qiao H, Du C, et al
    Causal effects of COVID-19 on cancer risk: A Mendelian randomization study.
    J Med Virol. 2023;95:e28722.
    >> Share

  392. CENAT JM, Moshirian Farahi SMM, Bakombo SM, Dalexis RD, et al
    Vaccine mistrust among Black individuals in Canada: The major role of health literacy, conspiracy theories, and racial discrimination in the healthcare system.
    J Med Virol. 2023;95:e28738.
    >> Share

  393. CAMACHO J, Albert E, Alvarez-Rodriguez B, Rusu L, et al
    A machine learning model for predicting serum neutralizing activity against Omicron SARS-CoV-2 BA.2 and BA.4/5 sublineages in the general population.
    J Med Virol. 2023;95:e28739.
    >> Share

  394. SHANG W, Zhang S, Qian H, Pan X, et al
    Association of gut microbiota with COVID-19 susceptibility and severity: A two-sample Mendelian randomization study.
    J Med Virol. 2023;95:e28734.
    >> Share

  395. ZHAO Y, Zhao Y, Su X, Zhou Y, et al
    No association of vaccination with inactivated COVID-19 vaccines before conception with pregnancy complications and adverse birth outcomes: A cohort study of 5457 Chinese pregnant women.
    J Med Virol. 2023;95:e28735.
    >> Share

  396. VANLERBERGHE B, Vrij C, Bogaerts K, Vermeersch P, et al
    SARS-CoV-2 vaccine antibody response and breakthrough infections in transplant recipients.
    J Med Virol. 2023;95:e28736.
    >> Share

  397. LU T, Chen Z, Cao Y, Ao L, et al
    Dynamic immunogenicity after primary and booster inactivated SARS-CoV-2 vaccination in people living with HIV: A longitudinal observational study.
    J Med Virol. 2023;95:e28730.
    >> Share

  398. CHEN YC, Ho CH, Liu TH, Wu JY, et al
    Long-term risk of herpes zoster following COVID-19: A retrospective cohort study of 2 442 686 patients.
    J Med Virol. 2023;95:e28745.
    >> Share

  399. YE J, Shao X, Yang Y, Zhu F, et al
    Predicting the negative conversion time of nonsevere COVID-19 patients using machine learning methods.
    J Med Virol. 2023;95:e28747.
    >> Share

  400. ONG DSY, de Man P, Verhagen T, Doejaaren G, et al
    Airborne virus shedding of the alpha, delta, omicron SARS-CoV-2 variants and influenza virus in hospitalized patients.
    J Med Virol. 2023;95:e28748.
    >> Share

  401. SAENZ-ALDEA M, Salgado-Barreira A, Taracido-Trunk M, Pineiro-Lamas M, et al
    RE: Colchicine and risk of hospitalization due to COVID-19: A population-based study.
    J Med Virol. 2023;95:e28741.
    >> Share

  402. CHEN L, Shao Z, Liu H, Shi Q, et al
    Clinical observation of neutralizing antibody DXP-604 for treatment critical COVID-19 patients infected with SARS-CoV-2 Delta variant.
    J Med Virol. 2023;95:e28742.
    >> Share

  403. NING J, Wang Q, Chen Y, He T, et al
    Immunodominant SARS-CoV-2-specific CD4(+) and CD8(+) T-cell responses elicited by inactivated vaccines in healthy adults.
    J Med Virol. 2023;95:e28743.
    >> Share

  404. CHEEMA HA, Rehman AU, Elrashedy AA, Mohsin A, et al
    Antiandrogens for the treatment of COVID-19 patients: A meta-analysis of randomized controlled trials.
    J Med Virol. 2023;95:e28740.
    >> Share

  405. MAO S, Cai X, Niu S, Wei J, et al
    TRIM21 promotes ubiquitination of SARS-CoV-2 nucleocapsid protein to regulate innate immunity.
    J Med Virol. 2023;95:e28719.
    >> Share

  406. DENG G, Li D, Sun Y, Jin L, et al
    Real-world effectiveness of Azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19: A retrospective cohort study.
    J Med Virol. 2023;95:e28756.
    >> Share

  407. CHUANG MH, Wu JY, Liu TH, Hsu WH, et al
    Efficacy of nirmatrelvir and ritonavir for post-acute COVID-19 sequelae beyond 3 months of SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28750.
    >> Share

  408. QUDUS MS, Tian M, Sirajuddin S, Liu S, et al
    The roles of critical pro-inflammatory cytokines in the drive of cytokine storm during SARS-CoV-2 infection.
    J Med Virol. 2023;95:e28751.
    >> Share

  409. TIAN F, Chen Z, Feng Q
    Nirmatrelvir-ritonavir compared with other antiviral drugs for the treatment of COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28732.
    >> Share

  410. SIMADIBRATA DM, Lesmana E, Pratama MIA, Annisa NG, et al
    Gastrointestinal Symptoms of Monkeypox Infection: A systematic review and meta-analysis.
    J Med Virol. 2023;95:e28709.
    >> Share

    March 2023
  411. SCARPA F, Giovanetti M, Azzena I, Locci C, et al
    Genome-based survey of the SARS-CoV-2 BF.7 variant from Asia.
    J Med Virol. 2023 Mar 31. doi: 10.1002/jmv.28714.
    >> Share

  412. LUO G
    Enhancement of SARS-CoV-2 infection and growth by an ACE2-specific monoclonal antibody.
    J Med Virol. 2023 Mar 28. doi: 10.1002/jmv.28711.
    >> Share

  413. ZHENG XQ, Xu QY, Xie L, He Y, et al
    Response and Duration of Serum Anti-SARS-CoV-2 Antibodies Induced by the Third Dose of an Inactivated Vaccine: A Prospective Longitudinal Cohort Study at 21 Serial Time Points over 641 Days.
    J Med Virol. 2023 Mar 25. doi: 10.1002/jmv.28703.
    >> Share

  414. ZHANG Z, Shao S, Liu X, Tong Z, et al
    Effect and safety of mesenchymal stem cells for patients with COVID-19: systematic review and meta-analysis with trial sequential analysis.
    J Med Virol. 2023 Mar 25. doi: 10.1002/jmv.28702.
    >> Share

  415. BARANOVA A, Cao H, Zhang F
    Causal associations and shared genetics between hypertension and COVID-19.
    J Med Virol. 2023 Mar 23. doi: 10.1002/jmv.28698.
    >> Share

  416. ADEN D, Zaheer S, Kumar R, Ranga S, et al
    Monkeypox (Mpox) outbreak during COVID-19 pandemic - Past and the future.
    J Med Virol. 2023 Mar 23. doi: 10.1002/jmv.28701.
    >> Share

  417. MANNAN A, Hoque MN, Noyon SH, Hamidullah Mehedi HM, et al
    SARS-CoV-2 infection alters the gut microbiome in diabetes patients: A cross-sectional study from Bangladesh.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28691.
    >> Share

  418. CHANG HC, Gau SY
    Colchicine and risk of COVID-19-associated hospitalization.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28690.
    >> Share

  419. CHEN Z, Huang T, He T, Zha G, et al
    Humoral responses after primary and booster SARS-CoV-2 inactivated vaccination in patients with chronic hepatitis B virus infection: a longitudinal observational study.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28695.
    >> Share

  420. CHEUNG AKL, Lu Y, Zhu Y, Fung TY, et al
    Consistent neutralization of circulating omicron sub-variants by hybrid immunity up to 6 months after booster vaccination.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28694.
    >> Share

  421. MAI W, Ren Y, Tian X, Al-Mahdi AY, et al
    Comparison of Common Human Respiratory Pathogens Among Hospitalized Children aged
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28692.
    >> Share

  422. DA SILVA AS, Campos GM, Giovanetti M, Zucherato VS, et al
    VIRAL METAGENOMICS UNVEILS MW (MALAWI) POLYOMAVIRUS INFECTION IN BRAZILIAN PEDIATRIC PATIENTS WITH ACUTE RESPIRATORY DISEASE.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28688.
    >> Share

  423. MAHROUM N, Elsalti A, Shoenfeld Y
    Commentary: Herpes simplex virus and SLE: though uncommon yet with significant implications.
    J Med Virol. 2023 Mar 22. doi: 10.1002/jmv.28689.
    >> Share

  424. ZHANG Y, Lu M, Thongpan I, Xu J, et al
    Recombinant measles virus expressing prefusion spike protein stabilized by six rather than two prolines is more efficacious against SARS-CoV-2 infection.
    J Med Virol. 2023 Mar 20. doi: 10.1002/jmv.28687.
    >> Share

  425. BOJKOVA D, Bechtel M, Rothenburger T, Kandler JD, et al
    Omicron-induced interferon signalling prevents influenza A H1N1 and H5N1 virus infection.
    J Med Virol. 2023 Mar 20. doi: 10.1002/jmv.28686.
    >> Share

  426. BIANCONI V, Mannarino MR, Cosentini E, Figorilli F, et al
    The impact of statin therapy on in-hospital prognosis and endothelial function of patients at high-to-very high cardiovascular risk admitted for COVID-19: Statins, endothelial function, and COVID-19 outcomes.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28678.
    >> Share

  427. GARCIA-PEREZ J, Bermejo M, Ramirez-Garcia A, Torre Tarazona HE, et al
    Longer intervals between SARS-CoV-2 infection and mRNA-1273 doses improve the neutralization of different variants of concern.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28679.
    >> Share

  428. DENG J, Zheng SN, Xiao Y, Nan ML, et al
    SARS-CoV-2 NSP8 suppresses type I and III IFN responses by modulating the RIG-I/MDA5, TRIF, and STING signaling pathways.
    J Med Virol. 2023 Mar 17. doi: 10.1002/jmv.28680.
    >> Share

  429. KWON HJ, Zhang J, Kosikova M, Tang W, et al
    Distinct In Vitro and In Vivo Neutralization Profiles of Monoclonal Antibodies Elicited by the Receptor Binding Domain of the Ancestral SARS-CoV-2.
    J Med Virol. 2023 Mar 14. doi: 10.1002/jmv.28673.
    >> Share

  430. YU D, Zhao ZY, Yang YL, Qin Y, et al
    The origin and evolution of emerged swine acute diarrhea syndrome coronavirus with zoonotic potential.
    J Med Virol. 2023 Mar 14. doi: 10.1002/jmv.28672.
    >> Share

  431. FAN Z, Ruan Z, Liuzhi, Guo B, et al
    Causal association of the brain structure with the susceptibility, hospitalisation, and severity of COVID-19: A large-scale genetic correlation study.
    J Med Virol. 2023 Mar 13. doi: 10.1002/jmv.28651.
    >> Share

  432. KAN Q, Lin X, Li T, Ke X, et al
    A novel mAb broadly neutralizes SARS-CoV-2 VOCs in vitro and in vivo, including the Omicron variants.
    J Med Virol. 2023 Mar 13. doi: 10.1002/jmv.28657.
    >> Share

  433. UYGUR A, Sayili U
    Letter to the Editor: The efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac vaccines in patients with cancer.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28664.
    >> Share

  434. MAZZITELLI M, Trunfio M, Sasset L, Scaglione V, et al
    Risk of hospitalization and sequelae in patients with COVID-19 treated with 3-day early remdesivir vs. controls in the vaccine and Omicron era: a real-life cohort study.
    J Med Virol. 2023 Mar 11. doi: 10.1002/jmv.28660.
    >> Share

  435. GAO L, Gao Y, Han K, Wang Z, et al
    FBXO11 amplifies type I interferon signaling to exert antiviral effects by facilitating the assemble of TRAF3-TBK1-IRF3 complex.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28655.
    >> Share

  436. JIA T, Wu Y, Liao G, Lei Y, et al
    Stable and durable antibody responses in SARS-recovered donors vaccinated with inactivated SARS-CoV-2 vaccine.
    J Med Virol. 2023 Mar 10. doi: 10.1002/jmv.28662.
    >> Share

  437. KELLER K, Sagoschen I, Konstantinides S, Gori T, et al
    Incidence and risk factors of myocarditis in hospitalized patients with COVID-19.
    J Med Virol. 2023 Mar 9. doi: 10.1002/jmv.28646.
    >> Share

  438. GUO Z, Zhao S, Mok CKP, So RTY, et al
    Comparing the incubation period, serial interval, and infectiousness profile between SARS-CoV-2 Omicron and Delta variants.
    J Med Virol. 2023 Mar 9. doi: 10.1002/jmv.28648.
    >> Share

  439. XIA S, Jiao F, Wang L, Yu X, et al
    SARS-CoV-2 Omicron XBB subvariants exhibit enhanced fusogenicity and substantial immune evasion in elderly population, but high sensitivity to pan-coronavirus fusion inhibitors.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28641.
    >> Share

  440. YI X, Wang Y, Li Q, Li X, et al
    Pre-existing immunity to SARS-CoV-2 associates with strong T cell responses induced by inactivated COVID-19 vaccines.
    J Med Virol. 2023 Mar 8. doi: 10.1002/jmv.28642.
    >> Share

  441. CORMA-GOMEZ A, Fernandez-Fuertes M, Vinuela L, Dominguez C, et al
    Reduced neutralizing antibody response to SARS-CoV-2 vaccine booster dose in people living with HIV with severe immunosuppression.
    J Med Virol. 2023 Mar 6. doi: 10.1002/jmv.28602.
    >> Share

  442. LY H
    SARS-CoV-2 infection of kidney tissues in some severe and fatal cases of COVID-19.
    J Med Virol. 2023 Mar 6. doi: 10.1002/jmv.28636.
    >> Share

  443. KUITUNEN I
    No signs of "tripledemic" in Finnish children.
    J Med Virol. 2023 Mar 2. doi: 10.1002/jmv.28631.
    >> Share

  444. WANG W, Qu Y, Wang X, Xiao MZX, et al
    Genetic variety of ORF3a shapes SARS-CoV-2 fitness through modulation of lipid droplet.
    J Med Virol. 2023 Mar 2. doi: 10.1002/jmv.28630.
    >> Share

  445. KIM D, Kim J, An S, Kim M, et al
    In vitro and in vivo suppression of SARS-CoV-2 replication by a modified, short, cell-penetrating peptide targeting the C-terminal domain of the viral spike protein.
    J Med Virol. 2023 Mar 1. doi: 10.1002/jmv.28626.
    >> Share

  446. SAHIN A, Karadag-Oncel E, Buyuksen O, Ekemen-Keles Y, et al
    The diversity in the clinical features of children hospitalized with COVID-19 during the nonvariant, Alpha (B.1.1.7), Delta (B.1.617.2), and Omicron (B.1.1.529) variant periods of SARS CoV-2: Caution for neurological symptoms in Omicron variant.
    J Med Virol. 2023 Mar 1. doi: 10.1002/jmv.28628.
    >> Share

    February 2023
  447. SCARPA F, Sanna D, Azzena I, Casu M, et al
    Genome-based comparison between the recombinant SARS-CoV-2 XBB and its parental lineages.
    J Med Virol. 2023 Feb 28. doi: 10.1002/jmv.28625.
    >> Share

  448. ZHANG J, Yang W, Huang F, Zhang K, et al
    Effectiveness of mRNA and viral-vector vaccines in epidemic period led by different SARS-CoV-2 variants: a systematic review and meta-analysis.
    J Med Virol. 2023 Feb 28. doi: 10.1002/jmv.28623.
    >> Share

  449. HUANG PY, Liu TH, Wu JY, Tsai YW, et al
    Clinical efficacy and safety of molnupiravir for nonhospitalized and hospitalized patients with COVID-19: A systematic review and meta-analysis of randomized control trials.
    J Med Virol. 2023 Feb 27. doi: 10.1002/jmv.28621.
    >> Share

  450. LEE AR, Kweon YC, Lee SM, Park CY, et al
    Human coronavirus 3CL proteases cleave Septins and disrupt Hedgehog signaling, causing ciliary dysfunction.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28618.
    >> Share

  451. CHEN JM, Gong HY, Chen RX, Liu ST, et al
    Features and significance of the recent enormous COVID-19 epidemic in China.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28616.
    >> Share

  452. FENG Z, Huo D, Cui S, Lvy B, et al
    Epidemiological features, genomic characteristics, and origin tracing of the COVID-19 outbreaks in Beijing from January to September 2022.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28613.
    >> Share

  453. CHEN Z, Du R, Cooper L, Achi JG, et al
    Sulforaphane is a reversible covalent inhibitor of 3-chymotrypsin-like protease of SARS-CoV-2.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28609.
    >> Share

  454. TAKAHASHI K, Saito M, Sekizuka T, Itokawa K, et al
    Emergence of BS.1 and BS.1.1, highly mutated new SARS-CoV-2 Omicron variants.
    J Med Virol. 2023 Feb 24. doi: 10.1002/jmv.28615.
    >> Share

  455. ZHANG S, Ju J, Yang F, Zheng C, et al
    Ocular Tropism of SARS-CoV-2 Infection.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28594.
    >> Share

  456. JAMAATI H, Karimi S, Ghorbani F, Panahi Y, et al
    Effectiveness of Different Vaccine Platforms in Reducing Mortality and Length of ICU Stay in Severe and Critical Cases of COVID-19 in the Omicron Variant Era: A National Cohort Study in Iran.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28607.
    >> Share

  457. WANG Y, Shi L, Liu D, Mao Y, et al
    Changes in Epstein-Barr virus infections in the children before and after the COVID-19 pandemic in Zhengzhou, China.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28597.
    >> Share

  458. BRANDA F, Scarpa F, Ciccozzi M, Maruotti A, et al
    Is a new COVID-19 wave coming from China due to an unknown variant of concern? Keep calm and look at the data.
    J Med Virol. 2023 Feb 23. doi: 10.1002/jmv.28601.
    >> Share

  459. CHEN Y, Xue Y, Yang J
    Gilteritinib: Repurposing of AXL-targeting kinase inhibitors against COVID-19.
    J Med Virol. 2023 Feb 21. doi: 10.1002/jmv.28592.
    >> Share

  460. RECTOR A, Bloemen M, Thijssen M, Delang L, et al
    Monitoring of SARS-CoV-2 concentration and circulation of variants of concern in wastewater of Leuven, Belgium.
    J Med Virol. 2023 Feb 17. doi: 10.1002/jmv.28587.
    >> Share

  461. ZHU Z, Chen X, Wang C, Zhang S, et al
    An integrated strategy to identify COVID-19 causal genes and characteristics represented by LRRC37A2.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28585.
    >> Share

  462. GERMANO MJ, Giai C, Cargnelutti DE, Colombo MI, et al
    Receptor-binding domain-based SARS-CoV-2 vaccine adjuvanted with cyclic di-adenosine monophosphate enhances humoral and cellular immunity in mice.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28584.
    >> Share

  463. STICH M, Benning L, Speer C, Garbade SF, et al
    Live-virus neutralization of the omicron variant in children and adults 14 months after SARS-CoV-2 wild-type infection.
    J Med Virol. 2023 Feb 16. doi: 10.1002/jmv.28582.
    >> Share

  464. LIN Z, Sun L, Li L, Jiang S, et al
    Nasal mucosa is much more susceptible than oral mucosa to infection of SARS-CoV-2 Omicron subvariants: wearing nasal masks where facial masks cannot be used.
    J Med Virol. 2023 Feb 13. doi: 10.1002/jmv.28577.
    >> Share

  465. RZYMSKI P, Szuster-Ciesielska A, Dzieciatkowski T, Gwenzi W, et al
    mRNA vaccines: The future of prevention of viral infections?
    J Med Virol. 2023 Feb 10. doi: 10.1002/jmv.28572.
    >> Share

  466. YAO M, Huang X, Guo Y, Zhao JV, et al
    Disentangling the common genetic architecture and causality of rheumatoid arthritis and systemic lupus erythematosus with COVID-19 outcomes: genome-wide cross trait analysis and bi-directional Mendelian randomization study.
    J Med Virol. 2023 Feb 10. doi: 10.1002/jmv.28570.
    >> Share

  467. RADOVIC S, Meng W, Chen L, Paniz Mondolfi AE, et al
    SARS-CoV-2 infection of kidney tissues from severe COVID-19 patients.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28566.
    >> Share

  468. NICOT F, Tremeaux P, Latour J, Carcenac R, et al
    WHOLE-GENOME SINGLE MOLECULE REAL-TIME SEQUENCING OF SARS-CoV-2 OMICRON.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28564.
    >> Share

  469. WANG X, Yang Y, Song Z, Wang Y, et al
    Concerns on Bebtelovimab (LY-CoV1404) used to neutralize Omicron subvariants.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28565.
    >> Share

  470. CRADDOCK V, Mahajan A, Spikes L, Krishnamachary B, et al
    Persistent Circulation of Soluble and Extracellular vesicle-linked Spike Protein in Individuals with Post-Acute Sequelae of COVID-19.
    J Med Virol. 2023 Feb 9. doi: 10.1002/jmv.28568.
    >> Share

  471. ZHANG T, Wang Z, Yang J, Xu X, et al
    Immunogenicity of novel DNA vaccines encoding receptor-binding domain (RBD) dimer-Fc fusing antigens derived from different SARS-CoV-2 variants of concern.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28563.
    >> Share

  472. DUTTA D, Ghosh A, Dutta C, Sukla S, et al
    Cross reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28557.
    >> Share

  473. KANG CK, Kim MG, Park SW, Kim YW, et al
    Comparable humoral and cellular immunity against Omicron variant BA.4/5 of once-boosted BA.1/2 convalescents and twice-boosted COVID-19-naive individuals.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28558.
    >> Share

  474. DENG J, Zheng Y, Zheng SN, Nan ML, et al
    SARS-CoV-2 NSP7 inhibits type I and III IFN production by targeting the RIG-I/MDA5, TRIF, and STING signaling pathways.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28561.
    >> Share

  475. CHEN J, Cheng X, Xu Y, Shi T, et al
    Analysis on the Physiological Changes of Residents Before and During the COVID-19 Pandemic: A Cross-Sectional Study.
    J Med Virol. 2023 Feb 8. doi: 10.1002/jmv.28562.
    >> Share

  476. TONYALI A, Karacetin G, Yesilkaya C, Arik FNT, et al
    Appearance of extrapyramidal symptoms in adolescent psychiatry patients during Covid-19 infection.
    J Med Virol. 2023 Feb 4. doi: 10.1002/jmv.28556.
    >> Share

  477. GUO Y, Guo Y, Zhang Y, Li F, et al
    Factors Affecting Prolonged SARS-CoV-2 Infection and Development and Validation of Predictive Nomograms.
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28550.
    >> Share

  478. WEI B, Liu Y, Li H, Peng Y, et al
    Impact of alcohol consumption on COVID-19 severity: A systematic review and meta-analysis.
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28547.
    >> Share

  479. AKIF A, Bhuiyan MA, Islam MR
    SARS-COV-2 omicron subvariant BF.7 is again triggering the Covid fear: What we need to know and what we should do?
    J Med Virol. 2023 Feb 3. doi: 10.1002/jmv.28551.
    >> Share

  480. KHAN A, Imran K, Zhu G, Ji J, et al
    Discovery of Isojacareubin as a covalent inhibitor of SARS-CoV-2 main protease using structural and experimental approaches.
    J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28542.
    >> Share

  481. TORRE-TARAZONA E, Gonzalez-Robles A, Cascajero A, Jimenez P, et al
    Treatment with integrase inhibitors alters SARS-CoV-2 neutralization levels measured with HIV-based pseudotypes in people living with HIV.
    J Med Virol. 2023 Feb 2. doi: 10.1002/jmv.28543.
    >> Share

  482. BAIOCCHI GC, Vojdani A, Rosenberg AZ, Vojdani E, et al
    Cross-sectional analysis reveals autoantibody signatures associated with COVID-19 severity.
    J Med Virol. 2023 Feb 1. doi: 10.1002/jmv.28538.
    >> Share

  483. WANG X, He X, Jiang S, Fu Z, et al
    Limited enhancement of antibody and B-cell responses to prototype booster vaccination following SARS-CoV-2 Delta breakthrough infection.
    J Med Virol. 2023 Feb 1. doi: 10.1002/jmv.28540.
    >> Share

  484. KORSUN N, Trifonova I, Dobrinov V, Madzharova I, et al
    Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria.
    J Med Virol. 2023;95:e28489.
    >> Share

  485. SKINNER JP, Moran LV
    Persistent effects of COVID-19 in patients hospitalized during the first wave of the pandemic: The impact of persistent fatigue on quality of life in a cross-sectional study.
    J Med Virol. 2023;95:e28491.
    >> Share

  486. KUMARI D, Singh Y, Singh S, Dogra V, et al
    "Mitochondrial pathogenic mutations and metabolic alterations associated with COVID-19 disease severity".
    J Med Virol. 2023;95:e28553.
    >> Share

    January 2023
  487. CHEN Z, Li J, Zheng J, Jin Y, et al
    Emerging Omicron subvariants evade neutralizing immunity elicited by vaccine or BA.1/BA.2 infection.
    J Med Virol. 2023 Jan 31. doi: 10.1002/jmv.28539.
    >> Share

  488. HEYDECKE A, Gullsby K
    Evaluation of the performance of a rapid antigen test (Roche) for COVID-19 diagnosis in an emergency setting in Sweden.
    J Med Virol. 2023 Jan 30. doi: 10.1002/jmv.28537.
    >> Share

  489. QUAN NK, Thien DH, Huy NT
    Detect and suppress future zoonotic-derived outbreaks: A lesson from last two decades.
    J Med Virol. 2023 Jan 30. doi: 10.1002/jmv.28530.
    >> Share

  490. SUN C, Yau V, Uy JPN, Lowe S, et al
    Does viral inoculum play a role in disease severity in COVID-19?
    J Med Virol. 2023 Jan 27. doi: 10.1002/jmv.28532.
    >> Share

  491. WANG J, Yin X, Yu L, Cheng W, et al
    Delayed cutaneous hypersensitivity reactions following the use of infliximab or adalimumab in patients with coronavirus disease 2019.
    J Med Virol. 2023 Jan 26. doi: 10.1002/jmv.28518.
    >> Share

  492. BONGIOVANNI M, Barilaro G, Bini F
    Twelve-month clinical, functional and radiological outcomes in patients hospitalized for SARS-CoV-2 pneumonia.
    J Med Virol. 2023 Jan 25. doi: 10.1002/jmv.28524.
    >> Share

  493. SHIRAZ R, Tripathi S
    Enhanced recombination among omicron subvariants of SARS-CoV-2 contributes to viral immune escape.
    J Med Virol. 2023 Jan 24. doi: 10.1002/jmv.28519.
    >> Share

  494. KIM K, Cho K, Song J, Rahmati M, et al
    The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.
    J Med Virol. 2023 Jan 24. doi: 10.1002/jmv.28522.
    >> Share

  495. SHEN F, Yang CX, Lu Y, Zhang M, et al
    Significant neutralizing escapes of Omicron and its sub-lineages in SARS-CoV-2-infected individuals vaccinated with inactivated vaccines.
    J Med Virol. 2023 Jan 21. doi: 10.1002/jmv.28516.
    >> Share

  496. ROBERTO P, Cinti L, Napoli A, Paesani D, et al
    Torque teno virus (TTV): a gentle spy virus of immune status, predictive marker of seroconversion to COVID-19 vaccine in kidney and lung transplant recipients.
    J Med Virol. 2023 Jan 20. doi: 10.1002/jmv.28512.
    >> Share

  497. LIAN XY, Xi L, Zhang ZS, Yang LL, et al
    Impact of air pollutants on influenza-like illness outpatient visits under COVID-19 pandemic in the sub-center of Beijing, China.
    J Med Virol. 2023 Jan 20. doi: 10.1002/jmv.28514.
    >> Share

  498. ZHAO Y, Du J, Li Z, Wu Y, et al
    It Is Time to Improve the Acceptance of COVID-19 Vaccines Among People with Chronic Diseases: A Systematic Review and Meta-analysis.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28509.
    >> Share

  499. HASSEBROEK AM, Sooryanarain H, Lynn Heffron C, Hawks SA, et al
    A hepatitis B virus core antigen-based virus-like particle vaccine expressing SARS-CoV-2 B and T cell epitopes induces epitope-specific humoral and cell-mediated immune responses but confers limited protection against SARS-CoV-2 infection.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28503.
    >> Share

  500. HARADA KH, Phosri A
    A protocol of trial of ivermectin in COVID-19 treatment critically changed after its completion.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28505.
    >> Share

  501. MATIC S, Milovanovic D, Mijailovic Z, Djurdjevic P, et al
    IFNL3/4 polymorphisms as a two-edged sword: an association with COVID-19 outcome.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28506.
    >> Share

  502. ABD-ELSALAM S, Medhat MA, Ramadan HK, Soliman S, et al
    Reply to letter to the editor.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28502.
    >> Share

  503. PAN J, Yang S, Chen X, Che X, et al
    Two-year impact of COVID-19 pandemic on hospitalized patients with skin diseases in China.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28511.
    >> Share

  504. ERDIK B
    Covid Associated Immune Dysfunction (CAID) Leading to Increased Pediatric Hospitalizations.
    J Med Virol. 2023 Jan 19. doi: 10.1002/jmv.28508.
    >> Share

  505. QI T, Jin Y, Wang H, Liao Y, et al
    Nirmatrelvir-ritonavir Therapy and COVID-19 Vaccination Improve Clinical Outcomes of SARS-CoV-2 Omicron Variant Infection.
    J Med Virol. 2023 Jan 18. doi: 10.1002/jmv.28497.
    >> Share

  506. MORALES-ORTEGA A, Farfan-Sedano AI, Martin-Lopez JVS, Escriba-Barcena A, et al
    Baricitinib or imatinib in hospitalized COVID-19 patients: results from COVINIB, an exploratory randomized clinical trial.
    J Med Virol. 2023 Jan 13. doi: 10.1002/jmv.28495.
    >> Share

  507. ALDEA MS, Salgado-Barreira A, Trunk MT, Lamas MP, et al
    Colchicine and risk of hospitalisation due to COVID-19: a population-based study.
    J Med Virol. 2023 Jan 13. doi: 10.1002/jmv.28496.
    >> Share

  508. BERBER NK, Geckil AA, Altan NO, Kiran TR, et al
    Efficacy of Serum Apelin and Galectin-3 as Potential Predictors of Mortality in Severe COVID-19 Patients.
    J Med Virol. 2023 Jan 12. doi: 10.1002/jmv.28494.
    >> Share

  509. KIM SH, Baek JY, Han M, Lee M, et al
    A decrease in the incidence of encephalitis in South Korea during the COVID-19 pandemic: A nationwide study between 2010 and 2021.
    J Med Virol. 2023 Jan 11. doi: 10.1002/jmv.28490.
    >> Share

  510. XIONG N, Sun Q
    How does SARS-CoV-2 Infection impact on immunity, procession and treatment of Pan Cancers.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28487.
    >> Share

  511. YADAV PD, Kumar S, Agarwal K, Jain M, et al
    Needle-free injection system delivery of ZyCoV-D DNA vaccine demonstrated improved immunogenicity and protective efficacy in Rhesus macaques against SARS-CoV-2.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28484.
    >> Share

  512. WANG M, Huang L
    Letter to the Editor Regarding "Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study".
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28486.
    >> Share

  513. KRISHNAMOORTHY P, Raj AS, Kumar H
    Machine learning-driven blood transcriptome-based discovery of SARS-CoV-2 specific severity biomarkers.
    J Med Virol. 2023 Jan 10. doi: 10.1002/jmv.28488.
    >> Share

  514. HUANG HC, Wang SH, Fang GC, Chou WC, et al
    Upregulation of PD-L1 by SARS-CoV-2 promotes immune evasion.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28478.
    >> Share

  515. TENG L, Song X, Zhang M, Han Y, et al
    The pattern of cytokines expression and dynamic changes of renal function at 6 months in patients with Omicron COVID-19.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28477.
    >> Share

  516. FARIAS JP, Pinheiro JR, Andreata-Santos R, Fogaca MMC, et al
    The third vaccine dose significantly reduces susceptibility to the B.1.1.529 (Omicron) SARS-CoV-2 variant.
    J Med Virol. 2023 Jan 7. doi: 10.1002/jmv.28481.
    >> Share

  517. CHEEMA HA, Jafar U, Sohail A, Shahid A, et al
    Nirmatrelvir-ritonavir for the treatment of COVID-19 patients: a systematic review and meta-analysis.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28471.
    >> Share

  518. LEI Z, Zhu L, Pan P, Ruan Z, et al
    A vaccine delivery system promotes strong immune responses against SARS-CoV-2 variants.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28475.
    >> Share

  519. LI X, Yin W, Li A, Li D, et al
    ACE2 PET to Reveal the Dynamic Patterns of ACE2 Recovery in an Infection Model with Pseudo Corona Virus.
    J Med Virol. 2023 Jan 6. doi: 10.1002/jmv.28470.
    >> Share

  520. CHUNG H, Ko H, Lee H, Yon DK, et al
    Development and validation of a deep learning model to diagnose COVID-19 using time-series heart rate values before the onset of symptoms.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28462.
    >> Share

  521. KWON R, Koo MJ, Lee SW, Choi YS, et al
    National trends in physical activity among adolescents in South Korea before and during the COVID-19 pandemic, 2009-2021.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28456.
    >> Share

  522. MERZA MA, Almufty HB, Younis HA, Rasool SO, et al
    Memory impairment among recovered COVID-19 patients: the prevalence and risk factors, a retrospective cohort study.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28459.
    >> Share

  523. VAEZI M, Ravanshad S, Rad MA, Zarrinfar H, et al
    The effect of synbiotic adjunct therapy on clinical and paraclinical outcomes in hospitalized COVID-19 patients: A randomized placebo-controlled trial.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28463.
    >> Share

  524. KOH LP, Chua SL, Vasoo S, Toh MPHS, et al
    Real-World Effectiveness of Sotrovimab and Remdesivir for Early Treatment of High-Risk Hospitalized COVID-19 Patients - a Propensity Score Adjusted Retrospective Cohort Study.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28460.
    >> Share

  525. TOWNSEND JP, Hassler HB, Dornburg A
    Infection by SARS-CoV-2 with alternate frequencies of mRNA vaccine boosting.
    J Med Virol. 2023 Jan 5. doi: 10.1002/jmv.28461.
    >> Share

  526. PRADO CAS, Fonseca DLM, Singh Y, Filgueiras IS, et al
    Title: Integrative systems immunology uncovers molecular networks of the cell cycle that stratify COVID-19 severity.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28450.
    >> Share

  527. LIU X, Du Z, Wang J, Wang Q, et al
    Association between trans fatty acids and COVID-19: a multivariate Mendelian randomization study.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28455.
    >> Share

  528. KIRAZ A, Sezer O, Alemdar A, Canbek S, et al
    Contribution of genotypes in Prothrombin and Factor V Leiden to COVID-19 and disease severity in patients at high risk for hereditary thrombophilia.
    J Med Virol. 2023 Jan 4. doi: 10.1002/jmv.28457.
    >> Share

  529. BELTRAN DM, Villamil Osorio M, Fonseca SLG, Restrepo S, et al
    PREDICTORS OF SEVERITY IN SEVERE RESPIRATORY INFECTION IN CHILDREN WITH COVID-19 RESPIRATORY INFECTION IN A DEVELOPING COUNTRY.
    J Med Virol. 2023 Jan 3. doi: 10.1002/jmv.28453.
    >> Share

  530. FOCOSI D, Maggi F, Shoham S, Casadevall A, et al
    Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of Evusheld.
    J Med Virol. 2023;95:e28277.
    >> Share

  531. LAI CJ, Kim D, Kang S, Li K, et al
    Viral codon optimization on SARS-CoV-2 Spike boosts immunity in the development of COVID-19 mRNA vaccines.
    J Med Virol. 2023;95:e29183.
    >> Share

    December 2022
  532. KIM JG, Zhang A, Rauseo AM, Goss CW, et al
    The salivary and nasopharyngeal microbiomes are associated with SARS-CoV-2 infection and disease severity.
    J Med Virol. 2022 Dec 30. doi: 10.1002/jmv.28445.
    >> Share

  533. LUO J, Zhang J, Tang HT, Wong HK, et al
    Weekly Symptom Profiles of Non-hospitalized Individuals Infected with SARS-CoV-2 During the Omicron Outbreak in Hong Kong: A Retrospective Observational Study from a Telemedicine Centre.
    J Med Virol. 2022 Dec 30. doi: 10.1002/jmv.28447.
    >> Share

  534. WANG Y, Zhao D, Liu X, Chen X, et al
    Early administration of Paxlovid reduces the viral elimination time in patients infected with SARS-CoV-2 omicron variants.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28443.
    >> Share

  535. ACOSTA N, Bautista MA, Waddell BJ, Du K, et al
    Surveillance for SARS-CoV-2 and its variants in wastewater of tertiary care hospitals correlates with increasing case burden and outbreaks.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28442.
    >> Share

  536. HOFFMANN AT, da Silva MS, Gularte JS, Pasqualotto AC, et al
    Dynamics of nosocomial SARS-CoV-2 transmissions: facing the challenge of variants of concern in a Brazilian reference hospital.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28446.
    >> Share

  537. HUANG J, Yang X, Ren L, Jiang W, et al
    A novel, ultrafast, ultrasensitive diagnosis platform for the detection of SARS-COV-2 using restriction endonuclease-mediated reverse transcription multiple cross displacement amplification.
    J Med Virol. 2022 Dec 29. doi: 10.1002/jmv.28444.
    >> Share

  538. AMANI B, Amani B
    Efficacy and safety of nirmatrelvir/ritonavir (Paxlovid) for COVID-19 : a rapid review and meta-analysis.
    J Med Virol. 2022 Dec 28. doi: 10.1002/jmv.28441.
    >> Share

  539. LI S, Wu J, Jiang W, He H, et al
    Characterization of cross-reactive monoclonal antibodies against SARS-CoV-1 and SARS-CoV-2: implication for rational design and development of pan-sarbecovirus vaccines and neutralizing antibodies.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28440.
    >> Share

  540. ZHANG GF, Meng W, Chen L, Ding L, et al
    Infectivity of pseudotyped SARS-CoV-2 variants of concern in different human cell types and inhibitory effects of recombinant spike protein and entry-related cellular factors.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28437.
    >> Share

  541. LI T, Li X, Chen N, Yang J, et al
    Influence of the COVID-19 Pandemic on the Vitamin D Status of Children: A Cross-Sectional Study.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28438.
    >> Share

  542. ZARUR-TORRALVO S, Stand-Nino I, Florez-Garcia V, Mendoza H, et al
    Viruses Responsible for Acute Respiratory Infections Before (2016-2019) and During (2021) Circulation of the SARS-CoV-2 virus in Pediatric Patients in a Reference Center at Barranquilla Colombia: A Pattern Analysis.
    J Med Virol. 2022 Dec 27. doi: 10.1002/jmv.28439.
    >> Share

  543. MACHADO TL, Santos AC, Azamor T, Vieira da Silva AM, et al
    CLEC5A expression can be triggered by spike glycoprotein and may be a potential target for COVID-19 therapy.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28427.
    >> Share

  544. LAI CC, Hsueh PR
    Coronavirus disease 2019 rebounds following nirmatrelvir/ritonavir treatment.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28430.
    >> Share

  545. BARANOVA A, Cao H, Teng S, Su KP, et al
    Shared genetics and causal associations between COVID-19 and multiple sclerosis.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28431.
    >> Share

  546. ZHAN H, Gao H, Liu Y, Zhang X, et al
    Booster shot of inactivated SARS-CoV-2 vaccine induces potent immune responses in people living with HIV.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28428.
    >> Share

  547. LI H, Cai D, Jiang D, Li X, et al
    Risk of waning humoral responses after inactivated or subunit recombinant SARS-CoV-2 vaccination in patients with chronic diseases: Findings from a prospective observational study in China.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28434.
    >> Share

  548. ZHAO Y, Zhao Y, Ai A, Jin L, et al
    Association of inactivated COVID-19 vaccination with in vitro fertilization and early pregnancy outcomes.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28432.
    >> Share

  549. LAI CC, Hsu CK, Hsueh SC, Yen MY, et al
    Multisystem inflammatory syndrome in adults: Characteristics, treatment, and outcomes.
    J Med Virol. 2022 Dec 26. doi: 10.1002/jmv.28426.
    >> Share

  550. RUSSELL SL, Klaver BRA, Harrigan SP, Kamelian K, et al
    Clinical severity of Omicron sub-variants BA.1, BA.2 and BA.5 in a population-based cohort study in British Columbia, Canada.
    J Med Virol. 2022 Dec 22. doi: 10.1002/jmv.28423.
    >> Share

  551. MAHALINGAM G, Periyasami Y, Arjunan P, Subaschandrabose RK, et al
    Omicron infection increases IgG binding to spike protein of predecessor variants.
    J Med Virol. 2022 Dec 22. doi: 10.1002/jmv.28419.
    >> Share

  552. WANG Y, Chen X, Liu X, Zhao D, et al
    Nirmatrelvir-ritonavir might only be effective in elderly patients.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28418.
    >> Share

  553. BANERJEE A, Mazumder A, Roy J, Das J, et al
    Emergence of a unique SARS-CoV-2 Delta sub-cluster harboring a constellation of co-appearing non-Spike mutations.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28413.
    >> Share

  554. FOURIE E, Sijm YE, Badoux P, Merelle ME, et al
    High Detection Rate of Viral Pathogens in Nasal Discharge in Children Aged 0 till 5 Years.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28415.
    >> Share

  555. PRAKASHAN D, Shrikrishna NS, Byakodi M, Nagamani K, et al
    Gold nanoparticle conjugate-based lateral flow immunoassay (LFIA) for rapid detection of RBD antigen of SARS CoV-2 in clinical samples using smartphone-based application.
    J Med Virol. 2022 Dec 21. doi: 10.1002/jmv.28416.
    >> Share

  556. ALZAHRANI MM, Bamashmous S, Alkharobi H, Alghamdi A, et al
    Mouth Rinses Efficacy on Salivary SARS-CoV-2 Viral Load: A Randomized Clinical Trial.
    J Med Virol. 2022 Dec 17. doi: 10.1002/jmv.28412.
    >> Share

  557. JIANG ML, Xu YP, Wu H, Zhu RN, et al
    Changes in endemic patterns of respiratory syncytial virus infection in pediatric patients under the pressure of nonpharmaceutical interventions for COVID-19 in Beijing, China.
    J Med Virol. 2022 Dec 16. doi: 10.1002/jmv.28411.
    >> Share

  558. WANG Q, Ye SB, Zhou ZJ, Song AL, et al
    Key mutations in the spike protein of SARS-CoV-2 affecting neutralization resistance and viral internalization.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28407.
    >> Share

  559. ZHOU C, Wu A, Ye S, Zhou Z, et al
    Possible transmission of COVID-19 epidemic by a dog as a passive mechanical carrier of SARS-CoV-2, Chongqing, China, 2022.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28408.
    >> Share

  560. LI X, Li T, Chen N, Wang X, et al
    Influence of COVID-19 pandemic on inhaled allergens in children with allergic diseases, Henan, China.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28409.
    >> Share

  561. ABEYWARDHANA S, Bandaranayake U, Perera DB, Premathilaka M, et al
    In silico study of SARS-CoV-2 Spike protein RBD and human ACE-2 affinity dynamics across variants and Omicron sub-variants.
    J Med Virol. 2022 Dec 15. doi: 10.1002/jmv.28406.
    >> Share

  562. VIETZEN H, Furlano PL, Traugott M, Totschnig D, et al
    The Natural Killer cell-associated rs9916629-C allele is a novel genetic risk factor for fatal COVID-19.
    J Med Virol. 2022 Dec 14. doi: 10.1002/jmv.28404.
    >> Share

  563. AKRAMI S, Montazeri EA, Saki M, Neisi N, et al
    Bacterial profiles and their antibiotic resistance background in superinfections caused by multidrug-resistant bacteria among COVID-19 ICU patients from southwest Iran.
    J Med Virol. 2022 Dec 14. doi: 10.1002/jmv.28403.
    >> Share

  564. HAYES LJ, Uri H, Bojkova D, Cinatl J Jr, et al
    Impact of the COVID-19 pandemic on the circulation of other pathogens in England.
    J Med Virol. 2022 Dec 13. doi: 10.1002/jmv.28401.
    >> Share

  565. CAMACHO J, Albert E, Zulaica J, Alvarez-Rodriguez B, et al
    A Performance Comparison of two (Electro) chemiluminescence Immunoassays for Detection and Quantitation of Serum Anti-Spike Antibodies According to SARS-CoV-2 Vaccination and Infections Status.
    J Med Virol. 2022 Dec 12. doi: 10.1002/jmv.28397.
    >> Share

  566. PANAHI Y, Ghanei M, Rahimi M, Samim A, et al
    Evaluation the efficacy and safety of N-acetylcysteine inhalation spray in controlling the symptoms of patients with COVID-19: An open-label randomized controlled clinical trial.
    J Med Virol. 2022 Dec 10. doi: 10.1002/jmv.28393.
    >> Share

  567. GOEL A, Ray A, Chavan A, Sahni S, et al
    A study on the morbid Histopathological changes in COVID-19 patients with or without comorbidities using minimally invasive tissue sampling.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28384.
    >> Share

  568. YANG Q, Tang J, Cao J, Liu F, et al
    SARS-CoV-2 infection activates CREB/CBP in cellular cyclic AMP-dependent pathways.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28383.
    >> Share

  569. YAN Q, Zheng W, Jiang Y, Zhou P, et al
    Transcriptomic reveals the ferroptosis features of host response in a mouse model of Zika virus infection.
    J Med Virol. 2022 Dec 8. doi: 10.1002/jmv.28386.
    >> Share

  570. RIZZO A, Foschi A, Bracchitta F, Faggion I, et al
    Persistent detection and sequencing of SARS-CoV-2 in the bloodstream of an immunocompromised patient.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28381.
    >> Share

  571. LI M, Hao J, Jiang T, Deng W, et al
    Maternal and neonatal safety of COVID-19 vaccination during peri-pregnancy period: a prospective study.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28378.
    >> Share

  572. WANG H, Gan M, Wu B, Zeng R, et al
    Humoral and cellular immunity of two-dose inactivated COVID-19 vaccination in Chinese children: a prospective cohort study.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28380.
    >> Share

  573. LIN-WANG HT, Damiani LP, Farias EDS, Bajgelman MC, et al
    Longitudinal study comparing IgG antibodies induced by heterologous prime-boost COVID-19 vaccine.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28379.
    >> Share

  574. ZHENG Z, Lu Y, Wang M, Luo Y, et al
    Low COVID-19 Vaccine Coverage and Guardian Acceptance Among Pediatric Transplant Recipients.
    J Med Virol. 2022 Dec 7. doi: 10.1002/jmv.28377.
    >> Share

  575. SCHULTHEISS C, Willscher E, Paschold L, Gottschick C, et al
    Liquid biomarkers of macrophage dysregulation and circulating spike protein illustrate the biological heterogeneity in patients with post-acute sequelae of COVID-19.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28364.
    >> Share

  576. KANG SW, Kim JY, Park H, Lim SY, et al
    Comparison of Secondary Attack Rate and Viable Virus Shedding between Patients with SARS-CoV-2 Delta and Omicron Variants: A Prospective Cohort Study.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28369.
    >> Share

  577. SHEN KY, Yang CH, Chen CT, Ho HM, et al
    Omicron-specific mRNA vaccine induced cross-protective immunity against ancestral SARS-CoV-2 infection with low neutralizing antibodies.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28370.
    >> Share

  578. VIRSEDA-BERDICES A, Concostrina-Martinez L, Martinez-Gonzalez O, Blancas R, et al
    RELATIVE TELOMERE LENGTH IMPACT ON MORTALITY OF COVID-19: SEX DIFFERENCES.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28368.
    >> Share

  579. WOLF JM, Wolf LM, Bello GL, Maccari JG, et al
    Molecular evolution of SARS-CoV-2 from December 2019 to August 2022.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28366.
    >> Share

  580. LI J, Zheng J, Chen P, Wang B, et al
    Higher SARS-CoV-2 shedding in exhaled aerosol probably contributed to the enhanced transmissibility of Omicron BA.5 subvariant.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28365.
    >> Share

  581. PARKER M, Sawant HB, Flannery T, Tarrant R, et al
    Effect of using a structured pacing protocol on post-exertional symptom exacerbation and health status in a longitudinal cohort with the post-COVID-19 syndrome.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28373.
    >> Share

  582. MOKHTARI MB, Samaniego V, Mokhtari MB, Ishak A, et al
    Relationship of Prior COVID-19 infection and Side Effects of Pfizer-BioNTech Vaccine: Results from a Community Hospital.
    J Med Virol. 2022 Dec 2. doi: 10.1002/jmv.28374.
    >> Share

    November 2022
  583. FATMA B, Yohan N, Domitille C, Anne-Laure L, et al
    Early Plasma Interferon-beta Levels as a Predictive Marker of COVID-19 Severe Clinical Events in Adult Patients.
    J Med Virol. 2022 Nov 30. doi: 10.1002/jmv.28361.
    >> Share

  584. LUO D, Li T, Yang X, Ning N, et al
    The immunodominance of RBD antigen of delta variant as vaccine candidate against SARS-CoV-2 infection.
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28359.
    >> Share

  585. MIHAYLOVA A, Lesichkova S, Baleva M, Nikolova-Vlahova M, et al
    DURABILITY OF HUMORAL AND CELL-MEDIATED IMMUNE RESPONSE AFTER SARS-CoV-2 mRNA VACCINE ADMINISTRATION.
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28360.
    >> Share

  586. PARK SH, Hong SH, Kim K, Lee SW, et al
    Non-Pharmaceutical Interventions Reduce the Incidence, and Mortality of COVID-19: A Study based on the Survey from the International COVID-19 Research Network (ICRN).
    J Med Virol. 2022 Nov 29. doi: 10.1002/jmv.28354.
    >> Share

  587. PAN Y, Wang S, Liu G, Wang L, et al
    The third inactivated vaccine booster dramatically enhanced SARS-CoV-2 antibody responses and did not influence the profile of prothrombotic antibody.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28356.
    >> Share

  588. GHOLAMI M, Zoughi M, Hasanzad M, Larijani B, et al
    Haplotypic variants of COVID-19 related genes are associated with blood pressure and metabolites levels.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28355.
    >> Share

  589. DU M, Wang R, Yuan J, Lv X, et al
    Trends and disparities in 44 national notifiable infectious diseases in China: an analysis of national surveillance data from 2010 to 2019.
    J Med Virol. 2022 Nov 28. doi: 10.1002/jmv.28353.
    >> Share

  590. YAN H, Zhang R, Yan G, Liu Z, et al
    Production of a versatile SARS-CoV-2 main protease biosensor based on a dimerization-dependent red fluorescent protein.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28342.
    >> Share

  591. LI K, Shi J, Liu X, Ward MP, et al
    Early warning signals for Omicron outbreaks in China: a retrospective study.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28341.
    >> Share

  592. JIA C, Zhou Z, Pan W, Zhang P, et al
    Immune Repertoire Sequencing Reveals an Abnormal Adaptive Immune System in COVID-19 Survivors.
    J Med Virol. 2022 Nov 24. doi: 10.1002/jmv.28340.
    >> Share

  593. LIN YF, Wu X, Li Y, Bian J, et al
    Impact of combination preventative interventions on hospitalization and death under the pandemic of SARS-CoV-2 Omicron variant in China.
    J Med Virol. 2022 Nov 23. doi: 10.1002/jmv.28335.
    >> Share

  594. DONG Y, Li X, Li Z, Zhu Y, et al
    Effects of inactivated SARS-CoV-2 vaccination on male fertility: a retrospective cohort study.
    J Med Virol. 2022 Nov 22. doi: 10.1002/jmv.28329.
    >> Share

  595. TAKAKURA K, Suka M, Kajihara M, Koido S, et al
    Clinical features, therapeutic outcomes and recovery period of long COVID.
    J Med Virol. 2022 Nov 22. doi: 10.1002/jmv.28316.
    >> Share

  596. ONG CP, Ye ZW, Tang K, Liang R, et al
    Comparative analysis of SARS-CoV-2 Omicron BA.2.12.1 and BA.5.2 variants.
    J Med Virol. 2022 Nov 21. doi: 10.1002/jmv.28326.
    >> Share

  597. RAHMATI M, Koyanagi A, Banitalebi E, Yon DK, et al
    The effect of SARS-CoV-2 infection on cardiac function in post-COVID-19 survivors: A systematic review and meta-analysis.
    J Med Virol. 2022 Nov 18. doi: 10.1002/jmv.28325.
    >> Share

  598. GAO W, Li Z, Guan Q, Cui W, et al
    Characterisation and analysis of linear epitopes corresponding to SARS-CoV-2 outbreak in Jilin Province, China.
    J Med Virol. 2022 Nov 18. doi: 10.1002/jmv.28323.
    >> Share

  599. DOBROVOLNA M, Brazda V, Warner EF, Bidula S, et al
    Inverted repeats in the monkeypox virus genome are hot spots for mutation.
    J Med Virol. 2022 Nov 18:e28322. doi: 10.1002/jmv.28322.
    >> Share

  600. CHAN CC, Liaw YP
    Letter to the Editor Regarding "The clinical and bioinformatics analysis for the role of antihypertension drugs on mortality among patients with hypertension hospitalized with COVID-19".
    J Med Virol. 2022 Nov 17. doi: 10.1002/jmv.28319.
    >> Share

  601. SMITH H, Mahon A, Moss A, Rao S, et al
    SARS-CoV-2 Infection in Children Evaluated in an Ambulatory Setting During Delta and Omicron Time Periods.
    J Med Virol. 2022 Nov 17. doi: 10.1002/jmv.28318.
    >> Share

  602. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Reply to Letter to the Editor on disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28313.
    >> Share

  603. SCHLESINGER M, McDonald C, Ahuja A, Canete CA, et al
    GLUCOSE AND MANNOSE ANALOGS INHIBIT KSHV REPLICATION BY BLOCKING N-GLYCOSYLATION AND INDUCING THE UNFOLDED PROTEIN RESPONSE.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28314.
    >> Share

  604. LIN L, Deng J, Li J, Zheng L, et al
    Pathogenesis and histological changes of nephropathy associated with COVID-19.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28311.
    >> Share

  605. LOU M, Huang D, Zhou Z, Shi X, et al
    DNA virus oncoprotein HPV18 E7 selectively antagonizes cGAS-STING-triggered innate immune activation.
    J Med Virol. 2022 Nov 15. doi: 10.1002/jmv.28310.
    >> Share

  606. ERGOREN MC, Akan G, Volkan E, Kandemis E, et al
    The "vaccine" hubbub: Viral load comparisons of SARS-CoV-2 Delta and Omicron variants against different vaccine-booster vaccine combinations.
    J Med Virol. 2022 Nov 14. doi: 10.1002/jmv.28309.
    >> Share

  607. ABORODE AT, Huang H, Awuah WA, Mehta A, et al
    Approaching COVID-19 with epidemiological genomic surveillance and the sustainability of biodiversity informatics in Africa.
    J Med Virol. 2022 Nov 13. doi: 10.1002/jmv.28308.
    >> Share

  608. CHEN J, Li F, Tian J, Xie X, et al
    Varicella Zoster Virus Reactivation Following COVID-19 Vaccination in patients with autoimmune inflammatory rheumatic diseases: A cross-sectional Chinese study of 318 cases.
    J Med Virol. 2022 Nov 13. doi: 10.1002/jmv.28307.
    >> Share

  609. REUSCH J, Wagenhauser I, Gabel A, Eggestein A, et al
    Influencing factors of anti-SARS-CoV-2-spike-IgG antibody titers in healthcare workers: A cross-section study.
    J Med Virol. 2022 Nov 11:e28300. doi: 10.1002/jmv.28300.
    >> Share

  610. CHIRUMBOLO S
    The widest use of paracetamol in home therapy might have actually increased the occurrence of severe forms of COVID-19 in Italy, affecting hospitalization and death rates.
    J Med Virol. 2022 Nov 11:e28301. doi: 10.1002/jmv.28301.
    >> Share

  611. YANG Y, Xing H, Zhao Y
    Transplacental transmission of SARS-CoV-2 immunoglobulin G antibody to infants from maternal COVID-19 vaccine immunization before pregnancy.
    J Med Virol. 2022 Nov 11:e28296. doi: 10.1002/jmv.28296.
    >> Share

  612. RAHMATI M, Fatemi R, Yon DK, Lee SW, et al
    The effect of adherence to high-quality dietary pattern on COVID-19 outcomes: A systematic review and meta-analysis.
    J Med Virol. 2022 Nov 11:e28298. doi: 10.1002/jmv.28298.
    >> Share

  613. YE Q, Liu H, Mao J, Shu Q, et al
    Nonpharmaceutical interventions for COVID-19 disrupt the dynamic balance between influenza A virus and human immunity.
    J Med Virol. 2022 Nov 11. doi: 10.1002/jmv.28292.
    >> Share

  614. MOYO E, Moyo P, Mashe T, Dzobo M, et al
    Implementation of Public Health Genomics in Africa: Lessons from the COVID-19 pandemic, challenges, and recommendations.
    J Med Virol. 2022 Nov 11:e28295. doi: 10.1002/jmv.28295.
    >> Share

  615. HAN K, Wang J, Zou Y, Zhang Y, et al
    Association between emphysema and other pulmonary computed tomography patterns in COVID-19 pneumonia.
    J Med Virol. 2022 Nov 10:e28293. doi: 10.1002/jmv.28293.
    >> Share

  616. CHEE YJ, Fan BE, Young BE, Dalan R, et al
    Clinical trials on the pharmacological treatment of long COVID: a systematic review.
    J Med Virol. 2022 Nov 8. doi: 10.1002/jmv.28289.
    >> Share

  617. QIU S, Xu D, Dai J, Zhang L, et al
    Improving the efficiency and biosafety of respiratory syncytial virus identification using a nucleic acid extraction-free reagent.
    J Med Virol. 2022 Nov 7. doi: 10.1002/jmv.28287.
    >> Share

  618. BLANCO S, Aguilar JJ, Spinsanti L, Diaz A, et al
    Neutralization of B.1.617.2 variant through antibodies elicited by ChAdOx1-S, BBIBP-CorV and Gam-COVID-Vac in an Argentinean cohort.
    J Med Virol. 2022 Nov 7. doi: 10.1002/jmv.28286.
    >> Share


  619. Zhu, C, He, G, Yin, Q, et al. Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge. J Med Virol. 2021;93: 5729- 5741.
    J Med Virol. 2022 Nov 4. doi: 10.1002/jmv.28282.
    >> Share

  620. CAMACHO J, Gimenez E, Albert E, Zulaica J, et al
    Cumulative incidence of SARS-CoV-2 infection in the general population of the Valencian Community (Spain) after the surge of the Omicron BA.1 variant.
    J Med Virol. 2022 Nov 4:e28284. doi: 10.1002/jmv.28284.
    >> Share

  621. ZHAO L, Li Y, Yi W, Yan K, et al
    Reply to Chan, et al.
    J Med Virol. 2022 Nov 4. doi: 10.1002/jmv.28283.
    >> Share

  622. LIU C, Zhang J, Zeng Y, Huang C, et al
    Effectiveness of SARS-CoV-2 inactivated vaccine and the correlation to neutralizing antibodies: a test-negative case-control study.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28280.
    >> Share

  623. LI X, Yin Y, Cui Q, Huang W, et al
    Long-term variations and potency of neutralizing antibodies against Omicron subvariants after CoronaVac inactivated booster: a 7-month follow-up study.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28279.
    >> Share

  624. HE ST, Qin H, Guan L, Liu K, et al
    Bovine lactoferrin inhibits SARS-CoV-2 and SARS-CoV-1 by targeting the RdRp complex and alleviates viral infection in the hamster model.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28281.
    >> Share

  625. FURUSE Y
    Cartography of SARS-CoV-2 variants based on the susceptibility to therapeutic monoclonal antibodies.
    J Med Virol. 2022 Nov 3. doi: 10.1002/jmv.28275.
    >> Share

  626. SHMUELIAN Z, Warszawer Y, Or O, Arbel-Alon S, et al
    Post-exposure-vaccine-prophylaxis against COVID-19.
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28274.
    >> Share

  627. HALLMANN E, Sikora D, Poniedzialek B, Szymanski K, et al
    IgG autoantibodies against ACE2 in SARS-CoV-2 infected patients.
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28273.
    >> Share

  628. ROSENBAUER J, Stahl-Pehe A, Schlesinger S, Kuss O, et al
    Comments on Rahmati et al., The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis. J Med Virol. 2022; 1-16 (doi: 10.1002/jmv.27996).
    J Med Virol. 2022 Nov 2. doi: 10.1002/jmv.28272.
    >> Share

  629. LUCZKOWIAK J, Rivas G, Labiod N, Lasala F, et al
    Cross Neutralization of SARS-CoV-2 Omicron Subvariants after repeated doses of COVID-19 mRNA vaccines.
    J Med Virol. 2022 Nov 1. doi: 10.1002/jmv.28268.
    >> Share

  630. WEI Z, Jiang Y, Zhao G, Li C, et al
    Irradiation accelerates SARS-CoV-2 infection by enhancing sphingolipid metabolism.
    J Med Virol. 2022 Nov 1. doi: 10.1002/jmv.28266.
    >> Share

    October 2022
  631. BARANOVA A, Cao H, Teng S, Zhang F, et al
    A phenome-wide investigation of risk factors for severe COVID-19.
    J Med Virol. 2022 Oct 31. doi: 10.1002/jmv.28264.
    >> Share

  632. HUANG J, Fang Z, Huang L, Fan L, et al
    Effect of COVID-19 vaccination on semen parameters: a systematic review and meta-analysis.
    J Med Virol. 2022 Oct 30. doi: 10.1002/jmv.28263.
    >> Share


  633. Corrigendum.
    J Med Virol. 2022 Oct 29. doi: 10.1002/jmv.28261.
    >> Share

  634. ZHOU Y, Li GX, Zhao TS, Du J, et al
    Parents' willingness to vaccinate themselves and their children with the booster vaccine against SARS-CoV-2: a cross-sectional study in Puyang city, China.
    J Med Virol. 2022 Oct 28. doi: 10.1002/jmv.28256.
    >> Share

  635. ROUERS A, Wong N, Goh YS, Torres-Ruesta A, et al
    Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
    J Med Virol. 2022 Oct 27. doi: 10.1002/jmv.28258.
    >> Share

  636. MENG W, Guo S, Cao S, Shuda M, et al
    Development and Characterization of a New Monoclonal Antibody against SARS-CoV-2 NSP12.
    J Med Virol. 2022 Oct 21. doi: 10.1002/jmv.28246.
    >> Share

  637. GUO Z, Zhao S, Sun S, He D, et al
    Estimation of the serial interval of monkeypox during the early outbreak in 2022.
    J Med Virol. 2022 Oct 21. doi: 10.1002/jmv.28248.
    >> Share

  638. SHARMA D, Notarte KI, Fernandez RA, Lippi G, et al
    In silico evaluation of the impact of Omicron variant of concern sublineage BA.4 and BA.5 on the sensitivity of RT-qPCR assays for SARS-CoV-2 detection using whole genome sequencing.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28241.
    >> Share

  639. ZHAO Y, Zhao Y, Zhang Y, Li M, et al
    Association of COVID-19 vaccination before conception with maternal thyroid function during early pregnancy: a single-center study in China.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28245.
    >> Share

  640. BE S, Celikbilek A, Y K, B I, et al
    Neurological symptoms and neuronal damage markers in acute COVID 19: is there a correlation? A pilot study.
    J Med Virol. 2022 Oct 19. doi: 10.1002/jmv.28240.
    >> Share

  641. HE L, Zhong J, Li G, Lin Z, et al
    Development of SARS-CoV-2 animal vaccines using a stable and efficient NDV expression system.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28237.
    >> Share

  642. AL-EMRAN HM, Shaminur Rahman M, Hasan MS, Alam ASMRU, et al
    Microbiome analysis revealing microbial interactions and secondary bacterial infections in COVID-19 patients co-morbidly affected by type 2 diabetes.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28234.
    >> Share

  643. RAMIREZ-VELEZ R, Olabarrieta-Landa L, Rivera D, Izquierdo M, et al
    Factor Structure of the 10-item CES-D Scale Among Patients with Persistent COVID-19.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28236.
    >> Share

  644. GELENER P, Demirtas E
    Autoimmune seronegative limbic encephalitis following ChAdOx1-S/nCoV-19 vaccination in a patient with ankylosing spondylitis.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28235.
    >> Share

  645. ERDIK B
    Antiviral Treatment of COVID-19 is associated with lack of immune response.
    J Med Virol. 2022 Oct 18. doi: 10.1002/jmv.28233.
    >> Share

  646. HORITA N, Fukumoto T
    Global case fatality rate from COVID-19 has decreased by 96.8% during 2.5 years of the pandemic.
    J Med Virol. 2022 Oct 17. doi: 10.1002/jmv.28231.
    >> Share

  647. FISH CS, Owiti P, Begnel ER, Itell HL, et al
    Comparison of nucleocapsid and spike antibody ELISAs for determining SARS-CoV-2 seropositivity in Kenyan women and infants.
    J Med Virol. 2022 Oct 17. doi: 10.1002/jmv.28221.
    >> Share

  648. WU F, Yuan Y, Li Y, Yin D, et al
    The acceptance of SARS-CoV-2 rapid antigen self-testing: a cross-sectional study in China.
    J Med Virol. 2022 Oct 14. doi: 10.1002/jmv.28227.
    >> Share

  649. ZHOU L, Mo C, Yang Y, Zhou Z, et al
    Characterization and application of a series of monoclonal antibodies against SARS-CoV-2 nucleocapsid protein.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28225.
    >> Share

  650. WANG M, Liu Z, Wang Z, Li K, et al
    Clinical characteristics of 1139 mild cases of the SARS-CoV-2 Omicron variant infected patients in Shanghai.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28224.
    >> Share

  651. SHEN S, Rui Y, Wang Y, Su J, et al
    SARS-CoV-2, HIV, HPV: convergent evolution of selective regulation of cGAS-STING signaling.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28220.
    >> Share

  652. LI L, Cui J, Tang J, Shi J, et al
    High titers of neutralizing antibodies in the blood fail to eliminate SARS-CoV-2 viral RNA in the upper respiratory tract.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28219.
    >> Share

  653. PISAREVA E, Badiou S, Mihalovicova L, Mirandola A, et al
    Persistence of Neutrophil extracellular traps and anti-cardiolipin auto-antibodies in post-acute phase COVID-19 patients.
    J Med Virol. 2022 Oct 13. doi: 10.1002/jmv.28209.
    >> Share

  654. C AM, Singh AK, Roy P, Ravichandran M, et al
    Long COVID following Omicron wave in Eastern India - A retrospective cohort study.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28214.
    >> Share

  655. NIRANJI SS, Amin Al-Jaf SM
    In response to: Disease severity and efficacy of homologous vaccination among patients infected with SARS-CoV-2 Delta or Omicron VOCs, compared to unvaccinated using main biomarkers.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28213.
    >> Share

  656. LI X, Yuan H, Li X, Wang H, et al
    Spike protein mediated membrane fusion during SARS-CoV-2 infection.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28212.
    >> Share

  657. GAHUKAR AM, Khairnar K
    Omicron variant of SARS-CoV-2: A pandemic of global concern warrants a cautious approach.
    J Med Virol. 2022 Oct 12. doi: 10.1002/jmv.28211.
    >> Share

  658. ZHANG Y, Ndzouboukou JB, Lin X, Hou H, et al
    SARS-CoV-2 evolves to reduce but not abolish neutralizing action.
    J Med Virol. 2022 Oct 11. doi: 10.1002/jmv.28207.
    >> Share

  659. MUKHERJEE AG, Wanjari UR, Kannampuzha S, Das S, et al
    The pathophysiological and immunological background of the monkeypox virus infection: An update.
    J Med Virol. 2022 Oct 11. doi: 10.1002/jmv.28206.
    >> Share

  660. YEUNG SLA, Wong THT, He B, Luo S, et al
    Does ACE2 mediate the detrimental effect of exposures related to COVID-19 risk: A Mendelian randomization investigation.
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28205.
    >> Share

  661. WANG P, Xu Y, Zhe SU, Xie C, et al
    Impact of COVID-19 Pandemic on Influenza virus Prevalence in Children in Sichuan, China.
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28204.
    >> Share

  662. RENGASAMY KR
    Will Monkeypox Outbreak mirror COVID-19 or AIDs?
    J Med Virol. 2022 Oct 10. doi: 10.1002/jmv.28202.
    >> Share

  663. CAMP JV, Redlberger-Fritz M
    Increased cases of Influenza C virus in children and adults in Austria, 2022.
    J Med Virol. 2022 Oct 9. doi: 10.1002/jmv.28201.
    >> Share

  664. MIGUERES M, Chapuy-Regaud S, Miedouge M, Jamme T, et al
    Current immunoassays and detection of antibodies elicited by Omicron SARS-CoV-2 infection.
    J Med Virol. 2022 Oct 7. doi: 10.1002/jmv.28200.
    >> Share

  665. BARANOVA A, Xu Y, Cao H, Zhang F, et al
    Associations between pulse rate and COVID-19.
    J Med Virol. 2022 Oct 6. doi: 10.1002/jmv.28194.
    >> Share

  666. MIRSHARIF ES, Chenary MR, Bozorgmehr M, Mohammadi S, et al
    Immunophenotyping Characteristics of COVID-19 Patients: Peripheral Blood CD8+ HLA-DR+ T Cells as a Biomarker for Mortality Outcome.
    J Med Virol. 2022 Oct 3. doi: 10.1002/jmv.28192.
    >> Share

  667. VALENTINA M, Alessandro CL, Francesca C, Silvia R, et al
    Viral load decrease in SARS-CoV-2 BA.1 and BA.2 Omicron sublineages infection after treatment with monoclonal antibodies and direct antiviral agents.
    J Med Virol. 2022 Oct 2. doi: 10.1002/jmv.28186.
    >> Share

    September 2022
  668. GUNELL M, Rantasarkka K, Arjonen R, Sanden A, et al
    Clinical evaluation of an automated, rapid mariPOC(R) antigen test in screening of symptomatics and asymptomatics for SARS-CoV-2 infection.
    J Med Virol. 2022 Sep 30. doi: 10.1002/jmv.28189.
    >> Share

  669. XU W, Song D, Liu J, Han X, et al
    Development of chemiluminescent lab-on-fiber immunosensor for rapid point-of-care testing of anti-SARS-CoV-2 antibodies and evaluation of longitudinal immune response kinetics following three-dose inactivation virus vaccination.
    J Med Virol. 2022 Sep 30. doi: 10.1002/jmv.28190.
    >> Share

  670. YEO YH, Wang M, He X, Lv F, et al
    Excess risk for acute myocardial infarction mortality during the COVID-19 pandemic.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28187.
    >> Share

  671. SRIRAMAN K, Shaikh A, Vaswani S, Mestry T, et al
    Impact of COVID-19 vaccination on transmission risk of breakthrough infections: Lessons from Adapted N95 Mask Sampling for Emerging Variants and Interventions.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28188.
    >> Share

  672. NAGASAWA M, Kato T, Yamaguchi Y, Sugita Y, et al
    Rapid decrease of nasopharyngeal SARS-Co-V2 antigen in an outbreak of the Omicron strain.
    J Med Virol. 2022 Sep 29. doi: 10.1002/jmv.28179.
    >> Share

  673. YANG J, Song H, Hao X
    Whole-transcriptome sequencing data reveals a disparate cognitive and immune signature in COVID-19 patients with and without dementia.
    J Med Virol. 2022 Sep 27. doi: 10.1002/jmv.28177.
    >> Share

  674. SU J, Shen S, Hu Y, Chen S, et al
    SARS-CoV-2 ORF3a inhibits cGAS-STING-mediated autophagy flux and antiviral function.
    J Med Virol. 2022 Sep 26. doi: 10.1002/jmv.28175.
    >> Share

  675. ZHOU J, Liu Z, Zhang G, Xu W, et al
    Development of variant-proof SARS-CoV-2, pan-sarbecovirus and pan-beta-coronavirus vaccines.
    J Med Virol. 2022 Sep 25. doi: 10.1002/jmv.28172.
    >> Share

  676. HANAFUSA M, Nawa N, Goto Y, Kawahara T, et al
    Effectiveness of remdesivir with corticosteroids for COVID-19 patients in intensive care unit: a hospital-based observational study.
    J Med Virol. 2022 Sep 23. doi: 10.1002/jmv.28168.
    >> Share

  677. MESSALI S, Bugatti A, Filippini F, Caruso A, et al
    Emergence of S gene-based quasispecies explains an optimal adaptation of Omicron BA.5 subvariant in the immunocompetent vaccinated human host.
    J Med Virol. 2022 Sep 22. doi: 10.1002/jmv.28167.
    >> Share

  678. SILVA MFS, Pinto ACMD, Oliveira FCE, Caetano LF, et al
    Antibody response six months after the booster dose of Pfizer in previous recipients of CoronaVac.
    J Med Virol. 2022 Sep 22. doi: 10.1002/jmv.28169.
    >> Share

  679. FAVRESSE J, Gillot C, Bayart JL, David C, et al
    Vaccine-induced binding and neutralizing antibodies against Omicron 6 months after a homologous BNT162b2 booster.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28164.
    >> Share

  680. DURAND GA, Amroun A, Grard G, Badaut C, et al
    Positive SARS-CoV-2 RT-qPCR of a nasal swab spot after 30 days of conservation on filter paper at room temperature.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28165.
    >> Share

  681. VEGA-RODRIGUEZ W, Ly H
    GETTING AHEAD OF MONKEYPOX: Learning from the COVID-19 pandemic experience to prevent the potentially new monkeypox pandemic.
    J Med Virol. 2022 Sep 21. doi: 10.1002/jmv.28146.
    >> Share

  682. KONG W, Zhong Q, Chen M, Yu P, et al
    Ad5-nCoV booster and Omicron variant breakthrough infection following two doses of inactivated vaccine elicit comparable antibody levels against Omicron variants.
    J Med Virol. 2022 Sep 20. doi: 10.1002/jmv.28163.
    >> Share

  683. KRISHNAMOORTHY S, Li GH, Cheung CL
    Transcriptome-wide Summary Data based Mendelian Randomization analysis reveals 38 novel genes associating with Severe COVID-19.
    J Med Virol. 2022 Sep 20. doi: 10.1002/jmv.28162.
    >> Share

  684. TAN Y, Lu S, Wang B, Duan X, et al
    Single-cell transcriptome atlas reveals protective characteristics of COVID-19 mRNA vaccine.
    J Med Virol. 2022 Sep 19. doi: 10.1002/jmv.28161.
    >> Share

  685. QIU X, Liu Y, Sha A
    SARS-CoV-2 and Natural Infection in Animals.
    J Med Virol. 2022 Sep 19. doi: 10.1002/jmv.28147.
    >> Share

  686. BOYTZ R, Slabicki M, Ramaswamy S, Patten JJ, et al
    Anti-SARS-CoV-2 Activity of Targeted Kinase Inhibitors: Repurposing Clinically Available Drugs for COVID-19 Therapy.
    J Med Virol. 2022 Sep 18. doi: 10.1002/jmv.28157.
    >> Share

  687. CECCARELLI G, d'Ettorre G, Russo A, Fabris S, et al
    SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies?
    J Med Virol. 2022 Sep 17. doi: 10.1002/jmv.28148.
    >> Share

  688. DESINGU PA, Nagarajan K
    Unveiling HERV-K113-ENV as SARS-CoV-2 severity admissible biomarker by mining transcriptome data.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28149.
    >> Share

  689. LI Z, Yong H, Wang W, Gao Y, et al
    GSK3326595 is a promising drug to prevent SARS-CoV-2 Omicron and other variants infection by inhibiting ACE2-R671 di-methylation.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28158.
    >> Share

  690. CENAT JM, Noorishad PG, Moshirian Farahi SMM, Darius WP, et al
    COVID-19 Vaccine Hesitancy and Related Factors in Canada: A Systematic Review and Meta-analysis.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28156.
    >> Share

  691. LI XK, Tu B, Zhang XA, Xu W, et al
    Dysregulation of glutamine/glutamate metabolism in COVID-19 patients: a metabolism study in African population and mini meta-analysis.
    J Med Virol. 2022 Sep 16. doi: 10.1002/jmv.28150.
    >> Share

  692. KLOPFENSTEIN T, Gendrin V, Zayet S
    "Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study": Author's reply.
    J Med Virol. 2022 Sep 15. doi: 10.1002/jmv.28151.
    >> Share

  693. LAN Q, Wang L, Jiao F, Lu L, et al
    Pan-coronavirus fusion inhibitors to combat COVID-19 and other emerging coronavirus infectious diseases.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28143.
    >> Share

  694. CALABRETTO M, D'Alisa R, Faraone S, Mazzuti L, et al
    DETECTION OF SARS-COV-2 RNA AND ANTIBODIES IN BREAST MILK OF INFECTED MOTHERS.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28142.
    >> Share

  695. FRYE CJ, Shine M, Makowski JA, Kensinger AH, et al
    Bioinformatics Analysis of the s2m Mutations within the SARS-CoV-2 Omicron Lineages.
    J Med Virol. 2022 Sep 13. doi: 10.1002/jmv.28141.
    >> Share

  696. ZHOU Y, Zhi H, Teng Y
    The outbreak of SARS-CoV-2 Omicron lineages, immune escape and vaccine effectivity.
    J Med Virol. 2022 Sep 12. doi: 10.1002/jmv.28138.
    >> Share

  697. LIANG LG, Zhu MJ, He R, Shi DR, et al
    Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, Influenza A and B.
    J Med Virol. 2022 Sep 11. doi: 10.1002/jmv.28139.
    >> Share

  698. QUEROMES G, Frobert E, Bouscambert-Duchamp M, Oblette A, et al
    Rapid and reliable inactivation protocols for the diagnostics of emerging viruses: the example of SARS-CoV-2 and monkeypox virus.
    J Med Virol. 2022 Sep 11. doi: 10.1002/jmv.28126.
    >> Share

  699. JIANG W, Johnson D, Adekunle R, Heather H, et al
    COVID-19 is associated with bystander polyclonal autoreactive B cell activation as reflected by a broad autoantibody production, but none is linked to disease severity.
    J Med Virol. 2022 Sep 10. doi: 10.1002/jmv.28134.
    >> Share

  700. LI Y, Yang J, Shen S, Wang W, et al
    SARS-CoV-2-encoded Inhibitors of Human LINE-1 Retrotransposition.
    J Med Virol. 2022 Sep 9. doi: 10.1002/jmv.28135.
    >> Share

  701. MARCHI L, Vidiri A, Fera EA, Pallottini M, et al
    SARS-CoV-2 IgG "heritage" in newborn: a credit of maternal natural infection.
    J Med Virol. 2022 Sep 7. doi: 10.1002/jmv.28133.
    >> Share

  702. CELIK E, Ozcan G, Vatansever C, Paerhati E, et al
    Alterations in Vaginal Microbiota among Pregnant Women with COVID-19.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28132.
    >> Share

  703. RZYMSKI P, Kasianchuk N, Sikora D, Poniedzialek B, et al
    COVID-19 Vaccinations and Rates of Infections, Hospitalizations, ICU Admissions, and Deaths in Europe during SARS-CoV-2 Omicron wave in the first quarter of 2022.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28131.
    >> Share

  704. FAIZO AA, Qashqari FS, El-Kafrawy SA, Barasheed O, et al
    A Potential Association between Obesity and Reduced Effectiveness of COVID-19 Vaccine-Induced Neutralizing Humoral Immunity.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28130.
    >> Share

  705. ABDALLA M, El-Arabey AA, Gai Z
    Hypertension is still a moving target in the context of COVID-19 and post-acute COVID-19 syndrome.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28128.
    >> Share

  706. AKASH S, Rahman MM, Islam MR, Sharma R, et al
    Emerging global concern of Langya Henipavirus: Pathogenicity, Virulence, Genomic features, and Future perspectives.
    J Med Virol. 2022 Sep 6. doi: 10.1002/jmv.28127.
    >> Share

  707. SCARPA F, Sanna D, Azzena I, Giovanetti M, et al
    On the SARS-CoV-2 BA.2.75 variant: a genetic and structural point of view.
    J Med Virol. 2022 Sep 4. doi: 10.1002/jmv.28119.
    >> Share

  708. NICOT F, Tremeaux P, Latour J, Nicolas J, et al
    WHOLE GENOME SEQUENCING OF SARS-CoV-2: COMPARISON OF TARGET CAPTURE AND AMPLICON SINGLE MOLECULAR REAL TIME SEQUENCING PROTOCOLS.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28123.
    >> Share

  709. ARISH M, Qian W, Narasimhan H, Sun J, et al
    COVID-19 immunopathology: From acute diseases to chronic sequelae.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28122.
    >> Share

  710. WETTSTEIN L, Immenschuh P, Weil T, Conzelmann C, et al
    Native and activated antithrombin inhibits TMPRSS2 activity and SARS-CoV-2 infection.
    J Med Virol. 2022 Sep 3. doi: 10.1002/jmv.28124.
    >> Share

  711. YU T, Liu F, Yi N, Yin H, et al
    Evaluating agreement in different diagnosis methods is necessary.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28117.
    >> Share

  712. WANG C, Liu B, Zhang S, Huang N, et al
    Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: a world-wide review.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28118.
    >> Share

  713. WANG Q, Ye SB, Zhou ZJ, Li JY, et al
    Key mutations on spike protein altering ACE2 receptor utilization and potentially expanding host range of emerging SARS-CoV-2 variants.
    J Med Virol. 2022 Sep 2. doi: 10.1002/jmv.28116.
    >> Share

    August 2022
  714. KAYA Y, Gulcu O, Aksakal E, Kalkan K, et al
    A Significant Predictor of In-Hospital and Long-term Mortality and Progression In COVID-19 Patients: The End-Stage Liver Disease (MELD) Score Model.
    J Med Virol. 2022 Aug 31. doi: 10.1002/jmv.28109.
    >> Share

  715. BARANOVA A, Cao H, Zhang F
    Causal Effect of COVID-19 on Alzheimer's Disease: A Mendelian Randomization Study.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28107.
    >> Share

  716. GENG Y, Wang Y
    Stability and transmissibility of SARS-CoV-2 in the environment.
    J Med Virol. 2022 Aug 30. doi: 10.1002/jmv.28103.
    >> Share

  717. YAO Y, Song H, Zhang F, Liu J, et al
    Genetic predisposition to blood cell indices in relation to severe COVID-19.
    J Med Virol. 2022 Aug 29. doi: 10.1002/jmv.28104.
    >> Share

  718. COLSON P, Gautret P, Delerce J, Chaudet H, et al
    The emergence, spread and vanishing of a French SARS-CoV-2 variant exemplifies the fate of RNA virus epidemics and obeys the Mistigri rule.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28102.
    >> Share

  719. LIU S, Cai J, Li Y, Ying L, et al
    Outbreak of acute respiratory disease caused by human adenovirus type 7 and Human Coronavirus-229E in Zhejiang Province, China.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28101.
    >> Share

  720. XIE J, Klemsz MJ, Kacena MA, Sandusky G, et al
    Inhibition of MEK signaling prevents SARS-CoV2-induced lung damage and improves the survival of infected mice.
    J Med Virol. 2022 Aug 28. doi: 10.1002/jmv.28094.
    >> Share

  721. GHANG B, Kim S, Kim J
    Autoimmune rheumatic disease after SARS-CoV-2 vaccination.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28092.
    >> Share

  722. CAO H, Baranova A, Wei X, Wang C, et al
    Bidirectional causal associations between type 2 diabetes and COVID-19.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28100.
    >> Share

  723. SALIMIAN J, Ahmadi A, Amani J, Olad G, et al
    Safety and Immunogenicity of a Recombinant Receptor Binding Domain-Based Protein Subunit Vaccine (Noora Vaccine) Against COVID-19 in Adults: A Randomized, Double-Blind, Placebo-Controlled, Phase 1 Trial.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28097.
    >> Share

  724. ALI AM, Tofiq AM, Rostam HM, Ali KM, et al
    Disease Severity and Efficacy of Homologous Vaccination Among Patients Infected with SARS-CoV-2 Delta or Omicron VOCs, Compared to Unvaccinated using Main Biomarkers.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28098.
    >> Share

  725. LIU H, Chang S, Chen S, Du Y, et al
    Highly sensitive and rapid detection of SARS-CoV-2 via a portable CRISPR-Cas13a-based lateral flow assay.
    J Med Virol. 2022 Aug 27. doi: 10.1002/jmv.28096.
    >> Share

  726. PATERSON C, Davis D, Roche M, Bissett B, et al
    What are the long-term holistic health consequences of COVID-19 among survivors? An umbrella systematic review.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28086.
    >> Share

  727. MENG Y, Zeng F, Sun H, Li Y, et al
    Clinical characteristics and outcomes of patients with COVID-19 and psoriasis.
    J Med Virol. 2022 Aug 24. doi: 10.1002/jmv.28085.
    >> Share

  728. DING C, Ni S, Zhang X, Xie J, et al
    Evaluation of humoral immune responses induced by different SARS-CoV-2 spike trimers from wild-type and emerging variants with individual, sequential, and combinational delivered strategies.
    J Med Virol. 2022 Aug 19. doi: 10.1002/jmv.28081.
    >> Share

  729. DE MICHELENA P, Olea B, Torres I, Gonzalez-Candelas F, et al
    SARS-CoV-2 RNA load in nasopharyngeal specimens from outpatients with breakthrough COVID-19 due to Omicron BA.1 and BA.2.
    J Med Virol. 2022 Aug 19. doi: 10.1002/jmv.28079.
    >> Share

  730. MA Z, Mao Y, Wang Y, Duan Z, et al
    Suicidal ideation and attempted suicide among cancer patients during the COVID-19 pandemic.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28076.
    >> Share

  731. ALI MA, Zhang GF, Hu C, Yuan B, et al
    Ultra-Rapid and Ultra-Sensitive Detection of SARS-CoV-2 Antibodies in COVID-19 Patients via A 3D-Printed Nanomaterial-Based Biosensing Platform.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28075.
    >> Share

  732. LIU H, Li Q, Xiang Y, Li H, et al
    An Outbreak of Acute Respiratory Disease Caused by HAdV-55 in Beijing, China, 2020.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28074.
    >> Share

  733. CUI A, Xie Z, Xu J, Hu K, et al
    Comparative analysis of the clinical and epidemiological characteristics of human influenza virus vs. human respiratory syncytial virus vs. human metapneumovirus infection in nine provinces of China during 2009-2021.
    J Med Virol. 2022 Aug 18. doi: 10.1002/jmv.28073.
    >> Share

  734. TAO SS, Wang XY, Yang XK, Liu YC, et al
    COVID-19 and inflammatory bowel disease crosstalk: from emerging association to clinical proposal.
    J Med Virol. 2022 Aug 16. doi: 10.1002/jmv.28067.
    >> Share

  735. MOHEBI L, Karami H, Mirsalehi N, Ardestani NH, et al
    A delayed resurgence of respiratory syncytial virus (RSV) during the COVID-19 pandemic: An unpredictable outbreak in a small proportion of children in the Southwest of Iran, April 2022.
    J Med Virol. 2022 Aug 12. doi: 10.1002/jmv.28065.
    >> Share

  736. YU W, Guo Y, Zhang S, Kong Y, et al
    Proportion of asymptomatic infection and non-severe disease caused by SARS-CoV-2 Omicron variant: a systematic review.
    J Med Virol. 2022 Aug 12. doi: 10.1002/jmv.28066.
    >> Share

  737. GEISEN UM, Rose R, Neumann F, Ciripoi M, et al
    The long term vaccine-induced anti-SARS-CoV-2 immune response is impaired in quantity and quality under TNFalpha blockade.
    J Med Virol. 2022 Aug 9. doi: 10.1002/jmv.28063.
    >> Share

  738. THAKUR N, Das S, Kumar S, Maurya VK, et al
    Tracing the origin of Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): A systematic review and narrative synthesis.
    J Med Virol. 2022 Aug 9. doi: 10.1002/jmv.28060.
    >> Share

  739. JIA M, Wang X, Gong W, Zhong J, et al
    Humoral responses after inactivated COVID-19 vaccination in individuals with and without prior SARS-CoV-2 infection: A prospective cohort study.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28055.
    >> Share

  740. CHEUNG PH, Ye ZW, Lui WY, Ong CP, et al
    Production of single-cycle infectious SARS-CoV-2 through a trans-complemented replicon.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28057.
    >> Share

  741. INFANTINO M, Manfredi M, Alessio MG, Previtali G, et al
    CLINICAL UTILITY OF CIRCULATING CALPROTECTIN TO ASSIST PREDICTION AND MONITORING OF COVID-19 SEVERITY: AN ITALIAN STUDY.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28056.
    >> Share

  742. KUMBHAKAR R, Neradilek M, Barnabas RV, Stewart J, et al
    Using Time Weighted Average Change from Baseline of SARS-CoV-2 Viral Load to Assess Impact of Hydroxychloroquine (HCQ) as Post-exposure Prophylaxis and Early Treatment for COVID-19.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28054.
    >> Share

  743. WANG H, Guo S, Yang H
    Rapid quantitative monitoring of SARS-CoV-2 spike protein mediated syncytia formation using split NanoLuc.
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28053.
    >> Share

  744. ELBAYIYEV S, Simsek GK, Ceran B, Akin MS, et al
    Could red cell distribution width be used for predicting cardiac injury in neonates with COVID-19?
    J Med Virol. 2022 Aug 8. doi: 10.1002/jmv.28050.
    >> Share

  745. ZOU L, Zhang H, Zheng Z, Jiang Y, et al
    Serosurvey in SARS-CoV-2 inactivated vaccine-elicited neutralizing antibodies against authentic SARS-CoV-2 and its viral variants.
    J Med Virol. 2022 Aug 5. doi: 10.1002/jmv.28049.
    >> Share

  746. ZHANG H, Ding Q, Yuan J, Han F, et al
    Susceptibility to mice and potential evolutionary characteristics of porcine deltacoronavirus.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28048.
    >> Share


  747. Corrigendum.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28046.
    >> Share

  748. SUNTRONWONG N, Kanokudom S, Auphimai C, Assawakosri S, et al
    Effects of boosted mRNA and adenoviral-vectored vaccines on immune responses to omicron BA.1 and BA.2 following the heterologous CoronaVac/AZD1222 vaccination.
    J Med Virol. 2022 Aug 4. doi: 10.1002/jmv.28044.
    >> Share


  749. Corrigendum.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28043.
    >> Share

  750. LIM CC, Leeu JJ, Mok IY, Tan HZ, et al
    Influenza Vaccine Awareness and Acceptance in Kidney Disease during the Corononavirus Disease 2019 pandemic.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28039.
    >> Share

  751. KOJIMA Y, Nakakubo S, Kamada K, Yamashita Y, et al
    Combination therapy with remdesivir and immunomodulators improves respiratory status in COVID-19: A retrospective study.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28037.
    >> Share

  752. LIANG W, Wang S, Wang H, Li X, et al
    When 3D genome technology meets viral infection, including SARS-CoV-2.
    J Med Virol. 2022 Aug 2. doi: 10.1002/jmv.28040.
    >> Share

    July 2022
  753. PENG P, Deng H, Li Z, Chen Y, et al
    Distinct immune responses in the early phase to natural SARS-CoV-2 infection or vaccination.
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28034.
    >> Share

  754. MURPHY H, Ly H
    What are the levels of risk of humans contracting SARS-CoV-2 from pets and vice versa?
    J Med Virol. 2022 Jul 29. doi: 10.1002/jmv.28035.
    >> Share

  755. ALEXIEV I, Giovanetti M, Cella E, Ivanov I, et al
    Initial Introduction and Spread of the SARS-CoV-2 AY.4.2.1 Delta Variant in Bulgaria, a Genomic Insight.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28033.
    >> Share

  756. ZHANG GF, Meng W, Chen L, Ding L, et al
    Neutralizing Antibodies to SARS-CoV-2 Variants of Concern Including Delta and Omicron in Subjects Receiving mRNA-1273, BNT162b2 and Ad26.COV2.S Vaccines.
    J Med Virol. 2022 Jul 28. doi: 10.1002/jmv.28032.
    >> Share

  757. KOJIMA N, Desai V, Klausner JD
    Distributing Effective SARS-CoV-2 Medicines in a Timely Manner.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28030.
    >> Share

  758. POURAKBARI B, Mirbeyk M, Mahmoudi S, Sadeghi RH, et al
    Evaluation of response to different COVID-19 vaccines in vaccinated healthcare workers in a single center in Iran.
    J Med Virol. 2022 Jul 26. doi: 10.1002/jmv.28029.
    >> Share

  759. JANG EJ, Choe YJ, Yun GW, Wang S, et al
    Reinfection with SARS-CoV-2 in general population, South Korea; nationwide retrospective cohort study.
    J Med Virol. 2022 Jul 25. doi: 10.1002/jmv.28026.
    >> Share

  760. DU Y, Li W, Guo Y, Li L, et al
    Epidemiology and genetic characterization of human metapneumovirus in pediatric patients from Hangzhou China.
    J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28024.
    >> Share

  761. LIU R, Lin X, Chen B, Hou Z, et al
    The mutation features and geographical distributions of the surface glycoprotein (S gene) in SARS-CoV-2 strains: a comparative analysis of the early and current strains.
    J Med Virol. 2022 Jul 24. doi: 10.1002/jmv.28023.
    >> Share

  762. PENG H, Zheng B, Yang S, Du J, et al
    A soluble DR5-Fc chimeric protein (sDR5-Fc) attenuates inflammatory responses induced by coronavirus MHV-A59 and SARS-CoV-2.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28021.
    >> Share

  763. WANG X, Zhao X, Cui Y, Qiao R, et al
    Neutralization of Distinct Omicron Sublineages by Longitudinal Vaccination Sera.
    J Med Virol. 2022 Jul 22. doi: 10.1002/jmv.28017.
    >> Share

  764. OSTERDAHL MF, Christakou E, Hart D, Harris F, et al
    Concordance of B and T cell responses to SARS-CoV-2 infection, irrespective of symptoms suggestive of COVID-19.
    J Med Virol. 2022 Jul 21. doi: 10.1002/jmv.28016.
    >> Share

  765. LIANG Y, Gong Z, Guo J, Cheng Q, et al
    Spatiotemporal analysis of the morbidity of global Omicron from November 2021 to February 2022.
    J Med Virol. 2022 Jul 21. doi: 10.1002/jmv.28013.
    >> Share

  766. WANG Y, Wang X, Luu LDW, Li J, et al
    Single-cell transcriptomic atlas reveals distinct immunological responses between COVID-19 vaccine and natural SARS-CoV-2 infection.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28012.
    >> Share

  767. YANG Y, Zhao R, Wang Y, Song D, et al
    Rapid and universal detection of SARS-CoV-2 and influenza A virus using a reusable dual-channel optic fiber immunosensor.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28015.
    >> Share

  768. CHEEMA HA, Shahid A, Aziz H
    Severe acute pediatric hepatitis: the undue emphasis on adenovirus needs to be reassessed.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28014.
    >> Share

  769. DE VITO A, Colpani A, Bitti A, Zauli B, et al
    Safety and efficacy of molnupiravir in SARS-CoV-2 infected patients: a real-life experience.
    J Med Virol. 2022 Jul 20. doi: 10.1002/jmv.28011.
    >> Share

  770. HUANG D, Lin S, He J, Wang Q, et al
    Association between COVID-19 and telomere length: a bidirectional Mendelian randomization study.
    J Med Virol. 2022 Jul 19. doi: 10.1002/jmv.28008.
    >> Share

  771. MONARI C, Pisaturo M, Maggi P, Macera M, et al
    EARLY PREDICTORS OF CLINICAL DETERIORATION IN A COHORT OF OUTPATIENTS WITH COVID-19 IN SOUTHERN ITALY: A MULTICENTER OBSERVATIONAL STUDY.
    J Med Virol. 2022 Jul 19. doi: 10.1002/jmv.28007.
    >> Share

  772. HUANG N, Wang C, Han B, Zhao T, et al
    Change in willingness to COVID-19 vaccination in China: two online surveys during the pandemic.
    J Med Virol. 2022 Jul 18. doi: 10.1002/jmv.28004.
    >> Share

  773. BAUER G, Struck F, Staschik E, Maile J, et al
    Differential avidity determination of IgG directed towards the receptor-binding domain (RBD) of SARS-CoV-2 wild-type and its variants in one assay: Rational tool for the assessment of protective immunity.
    J Med Virol. 2022 Jul 18. doi: 10.1002/jmv.28006.
    >> Share

  774. CHEN J, Liu X, Liu W, Yang C, et al
    Comparison of the respiratory tract microbiome in hospitalized COVID-19 patients with different disease severity.
    J Med Virol. 2022 Jul 15. doi: 10.1002/jmv.28002.
    >> Share

  775. JASIM SA, Mahdi RS, Bokov DO, Najm MAA, et al
    The deciphering of the immune cells and marker signature in COVID-19 pathogenesis: An update.
    J Med Virol. 2022 Jul 14. doi: 10.1002/jmv.28000.
    >> Share

  776. VAIRA LA, De Riu G, Boscolo-Rizzo P, Hopkins C, et al
    In response to: Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: The ANOSVID study.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27999.
    >> Share

  777. FERRAVANTE C, Arslan-Gatz BS, Dell'Annunziata F, Palumbo D, et al
    Dynamics of nasopharyngeal tract phageome and association with disease severity and age of patients during three waves of COVID-19.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27998.
    >> Share

  778. FILHO FFD, Chaves EBM, D'Avila KG, Neyeloff JL, et al
    Clinical characteristics and outcomes of healthcare workers with COVID-19 pre- and postvaccination.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27997.
    >> Share

  779. RAHMATI M, Keshvari M, Mirnasuri S, Yon DK, et al
    The global impact of COVID-19 pandemic on the incidence of pediatric new-onset type 1 diabetes and ketoacidosis: A systematic review and meta-analysis.
    J Med Virol. 2022 Jul 13. doi: 10.1002/jmv.27996.
    >> Share

  780. CHEN J, Song J, Dai L, Post SR, et al
    SARS-CoV-2 Infection and Lytic Reactivation of Herpesviruses: a Potential Threat at Post-pandemic Era?
    J Med Virol. 2022 Jul 12. doi: 10.1002/jmv.27994.
    >> Share

  781. FARHEEN S, Araf Y, Tang YD, Zheng C, et al
    The Deltacron conundrum: its origin and potential health risks.
    J Med Virol. 2022 Jul 11. doi: 10.1002/jmv.27990.
    >> Share

  782. RANKIN DA, Yanis A, Talj R, Howe HL, et al
    Clinical Presentations of Adult and Pediatric SARS-CoV-2-Positive Cases in a Community Cohort, Nashville, Tennessee.
    J Med Virol. 2022 Jul 11. doi: 10.1002/jmv.27988.
    >> Share

  783. DUMAN N, Tuncel G, Bisgin A, Bozdogan ST, et al
    "Analysis of ACE2 and TMPRSS2 coding variants as a risk factor for SARS-CoV-2 from 946 whole exome sequencing data in the Turkish Population.
    J Med Virol. 2022 Jul 10. doi: 10.1002/jmv.27976.
    >> Share

  784. ALMUFTY HB, Mamani MMA, Ali AH, Merza MA, et al
    COVID-19 vaccine breakthrough infection among fully vaccinated healthcare workers in Duhok governorate, Iraqi Kurdistan; a retrospective cohort study.
    J Med Virol. 2022 Jul 10. doi: 10.1002/jmv.27985.
    >> Share

  785. TEO KW, Patel D, Sisodia S, Roland D, et al
    Rhinovirus persistence during the COVID-19 pandemic - impact on paediatric acute wheezing admissions.
    J Med Virol. 2022 Jul 10. doi: 10.1002/jmv.27986.
    >> Share

  786. QI X, Wang J, Zhang Q, Ai J, et al
    Safety and Immunogenicity of COVID-19 Vaccination in Patients with Hepatocellular Carcinoma (CHESS-NMCID 2101): A Multicenter Prospective Study.
    J Med Virol. 2022 Jul 10. doi: 10.1002/jmv.27992.
    >> Share

  787. CARDENOSO DOMINGO L, Roy Vallejo E, Zurita Cruz ND, Chicot Llano M, et al
    Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: prospective cohort study and validation cohort.
    J Med Virol. 2022 Jul 10. doi: 10.1002/jmv.27989.
    >> Share

  788. CHENG ZJ, Huang H, Liu Q, Zhong R, et al
    Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine.
    J Med Virol. 2022 Jul 8. doi: 10.1002/jmv.27983.
    >> Share

  789. PETRIE JG, Eisenberg MC, Lauring AS, Gilbert J, et al
    Variant-specific burden of SARS-CoV-2 in Michigan: March 2020 through November 2021.
    J Med Virol. 2022 Jul 7. doi: 10.1002/jmv.27982.
    >> Share

  790. CHIRUMBOLO S
    Myopericarditis in young subjects after vaccination, clearing the clouds of misunderstanding.
    J Med Virol. 2022 Jul 7. doi: 10.1002/jmv.27981.
    >> Share

  791. ZENG G, Wang X
    Ending the COVID-19 pandemic: We still have a long way to go.
    J Med Virol. 2022 Jul 7. doi: 10.1002/jmv.27980.
    >> Share

  792. VELAZQUEZ-SALINAS L
    The complex evolutionary dynamics of SARS-CoV-2, a big challenge to control the pandemic of COVID-19.
    J Med Virol. 2022 Jul 7. doi: 10.1002/jmv.27979.
    >> Share

  793. YUASA S, Nakajima J, Takatsuki Y, Takahashi Y, et al
    Viral load of SARS-CoV-2 Omicron is not high despite its high infectivity.
    J Med Virol. 2022 Jul 5. doi: 10.1002/jmv.27974.
    >> Share

  794. AKSAK T, Satar DA, Ridvan B, Gultekin EO, et al
    INVESTIGATION OF THE EFFECT OF COVID-19 ON SPERM COUNT, MOTILITY AND MORPHOLOGY.
    J Med Virol. 2022 Jul 1. doi: 10.1002/jmv.27971.
    >> Share

    June 2022
  795. DESINGU PA, Nagarajan K
    The emergence of Omicron lineages BA.4 and BA.5, and the global spreading trend.
    J Med Virol. 2022 Jun 30. doi: 10.1002/jmv.27967.
    >> Share

  796. HAN L, Zheng Y, Deng J, Nan ML, et al
    SARS-CoV-2 ORF10 antagonizes STING-dependent interferon activation and autophagy.
    J Med Virol. 2022 Jun 28. doi: 10.1002/jmv.27965.
    >> Share

  797. CRUZ CA, Medina PM
    Temporal Changes in the Accessory Protein Mutations of SARS-CoV-2 Variants and Their Predicted Structural and Functional Effects.
    J Med Virol. 2022 Jun 28. doi: 10.1002/jmv.27964.
    >> Share

  798. AKCAY N, Bektas G, Menentoglu ME, Sevketoglu E, et al
    Response to Finsterer on the letter to the editor ''Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials''.
    J Med Virol. 2022 Jun 27. doi: 10.1002/jmv.27960.
    >> Share

  799. TAVAKOLI N, Nafissi N, Shokri S, Fallahpour M, et al
    Pediatric and Adolescent COVID-19 Vaccination Side Effects: A Retrospective Cohort Study of Iranian Teenage group in 2021.
    J Med Virol. 2022 Jun 27. doi: 10.1002/jmv.27962.
    >> Share

  800. CIMOLAI N
    Disinfection and Decontamination in the Context of SARS-CoV-2 Specific Data.
    J Med Virol. 2022 Jun 27. doi: 10.1002/jmv.27959.
    >> Share

  801. LI D, Xiong L, Pan G, Wang T, et al
    Molecular Imaging on ACE2-dependent Transocular Infection of Coronavirus.
    J Med Virol. 2022 Jun 26. doi: 10.1002/jmv.27958.
    >> Share

  802. UMAIR M, Ikram A, Rehman Z, Haider SA, et al
    Genomic diversity of SARS-CoV-2 in Pakistan during the fourth wave of pandemic.
    J Med Virol. 2022 Jun 26. doi: 10.1002/jmv.27957.
    >> Share

  803. TANG K, Wei Z, Wu X
    Impaired serological response to COVID-19 vaccination following anti-cancer therapy: a systematic review and meta-analysis.
    J Med Virol. 2022 Jun 24. doi: 10.1002/jmv.27956.
    >> Share

  804. KONTOPOULOU K, Nakas CT, Belai C, Papazisis G, et al
    Antibody Titers After a Third Dose of the SARS-CoV-2 BNT162b2 Vaccine in immunocompromised adults in Greece: is a fourth dose necessary?
    J Med Virol. 2022 Jun 23. doi: 10.1002/jmv.27954.
    >> Share

  805. MIAO G, Peng H, Tang H, Liu Y, et al
    Antiviral efficacy of selective estrogen receptor modulators against SARS-CoV-2 infection in vitro and in vivo reveals bazedoxifene acetate as an entry inhibitor.
    J Med Virol. 2022 Jun 22. doi: 10.1002/jmv.27951.
    >> Share

  806. TASEEN S, Nasir F, Abbas M, Altaf M, et al
    Post-pandemic World at the Mercy of Monkeypox Virus Outbreak: Time to worry or not?
    J Med Virol. 2022 Jun 22. doi: 10.1002/jmv.27948.
    >> Share

  807. CHEN JM, Li GH, Ji YF, Sun MH, et al
    A highly powerful non-specific strategy to reduce COVID-19 deaths.
    J Med Virol. 2022 Jun 21. doi: 10.1002/jmv.27949.
    >> Share

  808. PHAN T, Boes S, McCullough M, Gribschaw J, et al
    Emergence of SARS-CoV-2 Omicron BA.5 variant of concern in Western Pennsylvania, United States.
    J Med Virol. 2022 Jun 17. doi: 10.1002/jmv.27945.
    >> Share

  809. STAERK-OSTERGAARD J, Kirkeby C, Christiansen LE, Andersen MA, et al
    Evaluation of diagnostic test procedures for SARS-CoV-2 using latent class models.
    J Med Virol. 2022 Jun 17. doi: 10.1002/jmv.27943.
    >> Share

  810. WOLF JM, Petek H, Maccari JG, Nasi LA, et al
    COVID-19 pandemic in Southern Brazil: Hospitalizations, intensive care unit admissions, lethality rates, and length of stay between March 2020 and April 2022.
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27942.
    >> Share

  811. CEYLAN MR, Kankilic N, Oz O
    Are H1 and H3 haplotypes of endothelial protein C receptor (PROCR) an important factor in contracting COVID-19?
    J Med Virol. 2022 Jun 16. doi: 10.1002/jmv.27938.
    >> Share

  812. TIAN F, Yang R
    Safety and Efficacy of COVID-19 Vaccines in Children and Adolescents: a Systematic Review of Randomized Controlled Trials.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27940.
    >> Share

  813. WANG L, Zhou HY, Li JY, Cheng YX, et al
    Potential Inter-variant and Intra-variant Recombination of Delta and Omicron Variants.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27939.
    >> Share

  814. WELLS DA, Cantoni D, Mayora-Neto M, Di Genova C, et al
    Human seasonal coronavirus neutralisation and COVID-19 severity.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27937.
    >> Share

  815. AKASH K, Sharma A, Kumar D, Singh SK, et al
    MOLECULAR ASPECTS OF OMICRON, VACCINE DEVELOPMENT AND RECOMBINANT STRAIN XE: A REVIEW.
    J Med Virol. 2022 Jun 15. doi: 10.1002/jmv.27936.
    >> Share

  816. LYTRAS T, Kontopidou F, Lambrou A, Tsiodras S, et al
    Comparative effectiveness and durability of COVID-19 vaccination against death and severe disease in an ongoing nationwide mass vaccination campaign.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27934.
    >> Share

  817. ATLURI VL, Stalter RM, McGuffin SA, Johnson L, et al
    Patient Characteristics Associated with Conversion from Negative to Positive SARS-CoV2 PCR Test Results: Implications for Clinical False-Negativity from a Single-Center: A Case-Control Study.
    J Med Virol. 2022 Jun 14. doi: 10.1002/jmv.27932.
    >> Share

  818. RUDIANSYAH M, Jasim SA, Mohammad Pour ZG, Athar SS, et al
    Coronavirus disease 2019 (COVID-19) update: From metabolic reprogramming to immunometabolism.
    J Med Virol. 2022 Jun 10. doi: 10.1002/jmv.27929.
    >> Share

  819. KUMAR S, Karuppanan K, Subramaniam G
    Omicron (BA.1) and sub-variants (BA.1.1, BA.2, and BA.3) of SARS-CoV-2 spike infectivity and pathogenicity: A comparative sequence and structural-based computational assessment.
    J Med Virol. 2022 Jun 9. doi: 10.1002/jmv.27927.
    >> Share

  820. GIRAY BG, Acik GG
    SARS-CoV-2and Mutation RT-qPCR Test Positivity Correlation with ABO and Rh Blood Types.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27923.
    >> Share

  821. CHEN YQ, Ji YF, Chen JM
    Dual impacts of the COVID-19 non-pharmaceutical interventions on other infectious diseases.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27922.
    >> Share

  822. LI H, Chen Z, Liu X, Hu P, et al
    T cell epitopes are largely conserved in the SARS-CoV-2 Omicron subvariant (BA.1, BA.2, BA.3 and GKA).
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27925.
    >> Share

  823. CHEUNG CL, Ho SC, Krishnamoorthy S, Li GH, et al
    COVID-19 and Platelet Traits: A Bi-directional Mendelian Randomization Study.
    J Med Virol. 2022 Jun 8. doi: 10.1002/jmv.27920.
    >> Share

  824. MERCIER J, Osman M, Bouiller K, Tipirdamaz C, et al
    Olfactory dysfunction in COVID-19, new insights from a cohort of 353 patients: the ANOSVID study.
    J Med Virol. 2022 Jun 7. doi: 10.1002/jmv.27918.
    >> Share

  825. IDIZ UO, Yurttas TT, Degirmencioglu S, Orhan B, et al
    Immunophenotyping of lymphocytes and monocytes and the status of cytokines in the clinical course of Covid-19 patients.
    J Med Virol. 2022 Jun 6. doi: 10.1002/jmv.27917.
    >> Share

  826. TSAGKARIS C, Eleftheriades A, Laubscher L, Vladyckuk V, et al
    Viruses monkeying around with surgical safety: Monkeypox preparedness in surgical settings.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27915.
    >> Share

  827. BREHM TT, Pfefferle S, von Possel R, Karolyi M, et al
    Clinical efficacy and in vitro neutralization capacity of monoclonal antibodies for SARS-CoV-2 delta and omicron variants.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27916.
    >> Share

  828. ZHAO L, Li Y, Yi W, Yan K, et al
    The clinical and bioinformatics analysis for the role of anti-hypertension drugs on mortality among patients with hypertension hospitalized with COVID-19.
    J Med Virol. 2022 Jun 3. doi: 10.1002/jmv.27914.
    >> Share

  829. AU TY, Assavarittirong C
    The potential rationale of COVID-19 vaccine-induced myopericarditis.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27910.
    >> Share

  830. SAIED AA, Nascimento MSL, Rangel AHDN, Skowron K, et al
    Transchromosomic bovines (TcB)-derived broadly neutralizing antibodies as potent biotherapeutics to counter important emerging viral pathogens with a special focus on SARS-CoV-2, MERS-CoV, Ebola, Zika, HIV-1 and Influenza A virus.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27907.
    >> Share

  831. MAK GCK, Lau SSY, Wong KKY, Lau CS, et al
    Analytical sensitivity of the Rapid Antigen Test kits for detection of SARS-CoV-2 Omicron variant BA.2 sublineage.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27908.
    >> Share

  832. NAH EH, Cho S, Park H, Kim S, et al
    Antibody response after two doses of homologous or heterologous SARS-CoV-2 vaccines in healthcare workers at health promotion centers: a prospective observational study.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27911.
    >> Share

  833. OKTAY GULTEKIN E, Gultekin O, Coskun A, Aksak T, et al
    Antibody response three months after SARS-CoV-2 infection.
    J Med Virol. 2022 Jun 2. doi: 10.1002/jmv.27909.
    >> Share

  834. URSIC T, Kogoj R, Sikonja J, Roskaric D, et al
    Performance of nasopharyngeal swab and saliva in detecting Delta and Omicron SARS-CoV-2 variants.
    J Med Virol. 2022 Jun 1. doi: 10.1002/jmv.27898.
    >> Share

    May 2022
  835. LIU P, Xu M, Lu L, Ma A, et al
    The changing pattern of common respiratory and enteric viruses among outpatient children in Shanghai, China: Two years of the COVID-19 pandemic.
    J Med Virol. 2022 May 31. doi: 10.1002/jmv.27896.
    >> Share

  836. KOZAWA K, Miura H, Kawamura Y, Higashimoto Y, et al
    Unremarkable antibody responses against various infectious agents after inoculation with the BNT162b2 COVID-19 vaccine.
    J Med Virol. 2022 May 31. doi: 10.1002/jmv.27895.
    >> Share

  837. MESTANZA O, Lizarraga W, Padilla-Rojas C, Jimenez-Vasquez V, et al
    GENOMIC SURVEILLANCE OF LAMBDA SARS-COV-2 VARIANT IN A GLOBAL PHYLOGENETIC CONTEXT.
    J Med Virol. 2022 May 29. doi: 10.1002/jmv.27889.
    >> Share

  838. KHORATTANAKULCHAI N, Manopwisedjaroen S, Rattanapisit K, Panapitakkul C, et al
    Receptor Binding Domain Proteins of SARS-CoV-2 Variants Produced in Nicotiana benthamiana Elicit Neutralizing Antibodies Against Variants of Concern.
    J Med Virol. 2022 May 26. doi: 10.1002/jmv.27881.
    >> Share

  839. FLEISCHER B, Olum R, Nakwagala FN, Nassozi DR, et al
    Higher intensive care unit consultations for COVID-19 patients living with HIV compared to those without HIV coinfection in Uganda.
    J Med Virol. 2022 May 26. doi: 10.1002/jmv.27887.
    >> Share

  840. GAO X, Hao J, Yu L, Cao Y, et al
    Evaluation of enterovirus nucleic acids detection method based on ultra-fast real-time fluorescence RT-PCR technology - A pilot study.
    J Med Virol. 2022 May 26. doi: 10.1002/jmv.27886.
    >> Share

  841. NGUYEN-KIM H, Beckmann C, Redondo M, Ziliox J, et al
    COVID Salivary diagnostics: a comparative technical study.
    J Med Virol. 2022 May 25. doi: 10.1002/jmv.27883.
    >> Share

  842. DU P, Li N, Xiong X, Tang S, et al
    A bivalent vaccine containing D614G and BA.1 spike trimer proteins or a BA.1 spike trimer protein booster shows broad neutralizing immunity.
    J Med Virol. 2022 May 25. doi: 10.1002/jmv.27885.
    >> Share

  843. JIANG Y, Zhang H, Yu J, Huang D, et al
    Humoral immune response to authentic circulating SARS-CoV-2 variants elicited by booster vaccination with distinct RBD subunits in mice.
    J Med Virol. 2022 May 25. doi: 10.1002/jmv.27882.
    >> Share

  844. SIVAN M, Preston N, Parkin A, Makower S, et al
    The modified COVID-19 Yorkshire Rehabilitation Scale (C19-YRSm) patient-reported outcome measure for Long Covid or Post-COVID-19 syndrome.
    J Med Virol. 2022 May 23. doi: 10.1002/jmv.27878.
    >> Share

  845. LIU S, Li W, Jiang S
    Disease of influenza virus and SARS-CoV-2 coinfection: Flurona or Flucovid?
    J Med Virol. 2022 May 19. doi: 10.1002/jmv.27874.
    >> Share

  846. LEE CJ, Woo W, Kim AY, Yon DK, et al
    Clinical Manifestations of COVID-19 Breakthrough Infections: A Systematic Review and Meta-Analysis.
    J Med Virol. 2022 May 19. doi: 10.1002/jmv.27871.
    >> Share

  847. TORRES I, Gimenez E, Albert E, Zulaica J, et al
    SARS-CoV-2 Omicron BA.1 variant breakthrough infections in nursing home residents after an homologous third dose of the Comirnaty(R) COVID-19 vaccine: Looking for correlates of protection.
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27867.
    >> Share

  848. VILLACRES B, Paz E, Burbano MJ, Villacres-Granda I, et al
    Neutralizing activity to SARS-CoV-2 in 1.2 to 10.0 month convalescent plasma samples of COVID-19: a transversal surrogate in vitro study performed in Quito-Ecuador.
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27866.
    >> Share

  849. CAI S, Liao G, Yu T, Gao Q, et al
    Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV: A cross-sectional study.
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27872.
    >> Share

  850. CHIRUMBOLO S
    May the concurrent use of indomethacin and an anti-oxidant in the SARS-CoV2 infection treatment induce an exacerbation of COVID-19?
    J Med Virol. 2022 May 18. doi: 10.1002/jmv.27868.
    >> Share

  851. YE Y, Ye Z, Yang L, Xiang B, et al
    Unignorable public health risk of avian influenza virus during COVID-19 pandemic.
    J Med Virol. 2022 May 17. doi: 10.1002/jmv.27864.
    >> Share

  852. NILGIRIWALA K, Kadam P, Patel G, Shaikh A, et al
    Genomics of Post-Vaccination SARS-CoV-2 Infections During the Delta Dominated Second Wave of COVID-19 Pandemic, from Mumbai Metropolitan Region (MMR), India.
    J Med Virol. 2022 May 16. doi: 10.1002/jmv.27861.
    >> Share

  853. KUITUNEN I, Artama M, Haapanen M, Renko M, et al
    Respiratory virus circulation in children after relaxation of COVID-19 restrictions in fall 2021 - a nationwide register study in Finland.
    J Med Virol. 2022 May 16. doi: 10.1002/jmv.27857.
    >> Share

  854. BEAUDOIN CA, Pandurangan AP, Kim SY, Hamaia SW, et al
    In silico analysis of mutations near S1/S2 cleavage site in SARS-CoV-2 spike protein reveals increased propensity of glycosylation in Omicron strain.
    J Med Virol. 2022 May 16. doi: 10.1002/jmv.27845.
    >> Share

  855. YU T, Ling Q, Xu M, Wang N, et al
    ORF8 protein of SARS-CoV-2 reduces male fertility in mice.
    J Med Virol. 2022 May 15. doi: 10.1002/jmv.27855.
    >> Share

  856. CHO K, Park S, Kim EY, Koyanagi A, et al
    Immunogenicity of COVID-19 Vaccines in Patients with Diverse Health Conditions: a Comprehensive Systematic Review.
    J Med Virol. 2022 May 13. doi: 10.1002/jmv.27828.
    >> Share

  857. VAKIL MK, Mansoori Y, Al-Awsi GRL, Hosseinipour A, et al
    Individual Genetic Variability Mainly of Proinflammatory Cytokines, Cytokine Receptors and Toll-like receptors Dictates Pathophysiology of COVID-19 Disease.
    J Med Virol. 2022 May 10. doi: 10.1002/jmv.27849.
    >> Share

  858. CLEMENTINO M, Cavalcante KF, Viana VAF, Silva DO, et al
    Detection of SARS-CoV-2 in Different Human Biofluids Using the Loop-Mediated Isothermal Amplification Assay: A Prospective Diagnostic Study in Fortaleza, Brazil.
    J Med Virol. 2022 May 10. doi: 10.1002/jmv.27842.
    >> Share

  859. LEVESQUE S, Beauchemin S, Vallee M, Longtin J, et al
    Evaluation of water gargle samples for SARS-CoV-2 detection using Abbott ID NOW COVID-19 assay.
    J Med Virol. 2022 May 9. doi: 10.1002/jmv.27847.
    >> Share

  860. PHAN T, Boes S, McCullough M, Gribschaw J, et al
    First detection of SARS-CoV-2 Omicron BA.4 variant in Western Pennsylvania, United States.
    J Med Virol. 2022 May 9. doi: 10.1002/jmv.27846.
    >> Share

  861. ZERBINATI RM, Palmieri M, Schwab G, Felix AC, et al
    Use of Saliva and RT-PCR Screening for SARS-CoV-2 Variants of Concern: Surveillance and Monitoring.
    J Med Virol. 2022 May 6. doi: 10.1002/jmv.27839.
    >> Share

  862. WENG Y, Yi GY
    Estimation of the COVID-19 Mean Incubation Time: Systematic Review, Meta-analysis, and Sensitivity Analysis.
    J Med Virol. 2022 May 6. doi: 10.1002/jmv.27841.
    >> Share

  863. LIN Z, Cheng M, Zhu F, Yang X, et al
    Immunogenicity and safety of different platforms of COVID-19 vaccines given as a 3rd (booster) dose in healthy adults.
    J Med Virol. 2022 May 6. doi: 10.1002/jmv.27836.
    >> Share

  864. DAI Y, Zhong J, Lan Y
    Virus-virus interactions of febrile respiratory syndrome among patients in China based on surveillance data from February 2011 to December 2020.
    J Med Virol. 2022 May 5. doi: 10.1002/jmv.27833.
    >> Share

  865. SIMSEK M, Yasin AI, Besiroglu M, Topcu A, et al
    The Efficacy of BNT162b2 (Pfizer-BioNTech) and CoronaVac Vaccines in Patients with Cancer.
    J Med Virol. 2022 May 5. doi: 10.1002/jmv.27835.
    >> Share

  866. KIM KW, Wang X, Adhikari A, Yeang M, et al
    Persistent high-level shedding of cultivable SARS-CoV-2 Delta virus 33 days after onset of COVID-19 in a hospitalized patient with pneumonia.
    J Med Virol. 2022 May 4. doi: 10.1002/jmv.27832.
    >> Share

  867. KEIJSERS CJPW, Broeders MEAC, Baptista Lopes V, Klinkert AF, et al
    Memory impairment and concentration problems in COVID-19 survivors eight weeks after non-ICU hospitalization: a retrospective cohort study.
    J Med Virol. 2022 May 4. doi: 10.1002/jmv.27831.
    >> Share

  868. ISLAM F, Dhawan M, Mitra S, Bin Emran T, et al
    Assessing the risks associated with the emergence of Florona and possible preventive measures.
    J Med Virol. 2022 May 4. doi: 10.1002/jmv.27830.
    >> Share

  869. PEIXOTO SG, Wolf JM, Glaeser AB, Maccari JG, et al
    Longer length of stay, days between discharge/first readmission, and pulmonary involvement >/=50% increase prevalence of admissions in ICU in unplanned readmissions after COVID-19 hospitalizations.
    J Med Virol. 2022 May 4. doi: 10.1002/jmv.27792.
    >> Share

  870. WU F, Yuan Y, Deng Z, Yin D, et al
    Acceptance of COVID-19 Booster Vaccination Based on the Protection Motivation Theory (PMT): A Cross-Sectional Study in China.
    J Med Virol. 2022 May 4. doi: 10.1002/jmv.27825.
    >> Share

  871. FONSECA MHG, Silva MFS, Pinto ACMD, Melo ACL, et al
    Persistently positive SARS-CoV-2 specific IgM during one-year follow-up.
    J Med Virol. 2022 May 3. doi: 10.1002/jmv.27822.
    >> Share

  872. SHAFIEE A, Aghajanian S, Athar MMT, Gargari OK, et al
    Epstein-Barr virus and COVID-19.
    J Med Virol. 2022 May 3. doi: 10.1002/jmv.27823.
    >> Share

  873. KHOKHER W, Beran A, Iftikhar S, Malhas SE, et al
    Pulse versus Non-pulse Steroid Regimens in Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis.
    J Med Virol. 2022 May 3. doi: 10.1002/jmv.27824.
    >> Share

  874. SEDIGHI M, Amanollahi A, Moghaddam OM, Ghafouri HB, et al
    Linear mixed model analysis to evaluate correlations between remdesivir adverse effects with age and gender of patients with mild Covid-19 pneumonia.
    J Med Virol. 2022 May 2. doi: 10.1002/jmv.27800.
    >> Share

  875. MAJUMDAR S, Sarkar R
    Mutational and phylogenetic analyses of the two lineages of the Omicron variant.
    J Med Virol. 2022;94:1777-1779.
    >> Share

    April 2022
  876. BANERJEE S, Wang X, Du S, Zhu C, et al
    Comprehensive Role of SARS-CoV-2 Spike Glycoprotein in Regulating Host Signaling Pathway.
    J Med Virol. 2022 Apr 29. doi: 10.1002/jmv.27820.
    >> Share

  877. KHAN YH, Mallhi TH, Alanazi AS, Butt MH, et al
    Outbreak of Acute Hepatitis of Unknown etiology in Children; The Critical Role of Healthcare Professionals in Neutralizing Misleading Narratives during the COVID-19 Pandemic.
    J Med Virol. 2022 Apr 29. doi: 10.1002/jmv.27819.
    >> Share

  878. TASAR S, Karadag-Oncel E, Yilmaz-Ciftdogan D, Kara-Aksay A, et al
    Influenza is More Severe than Our Newest Enemy (COVID-19) in Hospitalized Children: Experience from a Tertiary Center.
    J Med Virol. 2022 Apr 27. doi: 10.1002/jmv.27817.
    >> Share

  879. QAMAR N, Rukh G, Khan SN
    Vaccines for Covid-19: An Insight on Their Effectiveness and Adverse Effects.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27810.
    >> Share

  880. LI Y, Wang X, Jin J, Ma Z, et al
    T cell responses to SARS-CoV-2 Omicron spike epitopes with mutations after the third booster dose of an inactivated vaccine.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27814.
    >> Share

  881. SUN ZP, Yang SY, Cai X, Han WD, et al
    Survival of SARS-CoV-2 in artificial seawater and on the surface of inanimate materials.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27807.
    >> Share

  882. GUPTA N, Wilson W, Ravindra P, Raghu R, et al
    Coinfection of leptospirosis and Coronavirus disease 2019: a retrospective case series from a coastal region in South India.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27816.
    >> Share

  883. PRAZUCK T, Gravier A, Pires-Roteira D, Theillay A, et al
    Evaluation of A NEW "All in One" SARS-CoV-2 antigen-detecting rapid diagnostic test AND self-test: diagnostic performance and usability in child and adult populationS.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27812.
    >> Share

  884. ZHOU B, Song S, Guo H, Zhou X, et al
    A fourth dose of Omicron RBD vaccine enhances broad neutralization against SARS-CoV-2 variants including BA.1 and BA.2 in vaccinated mice.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27811.
    >> Share

  885. RAMIREZ AL, Luna N, Patino LH, Castaneda S, et al
    Impact of SARS-CoV-2 Mu variant on vaccine effectiveness: a comparative genomics study at the peak of the third wave in Bogota, Colombia.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27808.
    >> Share

  886. ZHANG J, Cao J, Ye Q
    Nonpharmaceutical interventions against the COVID-19 pandemic significantly decreased the spread of enterovirus in children.
    J Med Virol. 2022 Apr 26. doi: 10.1002/jmv.27806.
    >> Share

  887. JAIN S, Meena R, Kumar V, Kaur R, et al
    Comparison of haematologic abnormalities between hospitalized Coronavirus disease 2019 (COVID-19) positive and negative patients with correlation to disease severity and outcome.
    J Med Virol. 2022 Apr 25. doi: 10.1002/jmv.27793.
    >> Share

  888. COLSON P, Fournier PE, Delerce J, Million M, et al
    Culture and identification of a "Deltamicron" SARS-CoV-2 in a three cases cluster in southern France.
    J Med Virol. 2022 Apr 25. doi: 10.1002/jmv.27789.
    >> Share

  889. LANZAFAME M, Gibbin E, Lattuada E, Vento S, et al
    Is monoclonal antibody administration necessary in all vaccinated patients with breakthrough COVID-19 infections?
    J Med Virol. 2022 Apr 22. doi: 10.1002/jmv.27802.
    >> Share

  890. PHAN T, Cravener Z, McCullough M, Mays A, et al
    Clinical evaluation of the Cue's COVID-19 diagnostic test to detect.
    J Med Virol. 2022 Apr 22. doi: 10.1002/jmv.27805.
    >> Share

  891. GUO J, Zhang J, Du P, Lu J, et al
    Generation and Characterization of Humanized Synergistic Neutralizing Antibodies against SARS-CoV-2.
    J Med Virol. 2022 Apr 21. doi: 10.1002/jmv.27801.
    >> Share

  892. WANG C, Yang YN, Xi L, Yang LL, et al
    Dynamics of influenza-like illness under urbanization procedure and COVID-19 pandemic in the sub-center of Beijing during 2013-2021.
    J Med Virol. 2022 Apr 21. doi: 10.1002/jmv.27803.
    >> Share

  893. TORRES I, Bellido-Blasco JB, Gimeno C, Burgos JS, et al
    SARS-CoV-2 Delta-variant breakthrough infections in nursing home residents at mid-term after Comirnaty(R) COVID-19 vaccination.
    J Med Virol. 2022 Apr 20. doi: 10.1002/jmv.27799.
    >> Share

  894. YE Q, Shao W, Meng H
    Performance and Application Evaluation of SARS-CoV-2 Antigen Assay.
    J Med Virol. 2022 Apr 20. doi: 10.1002/jmv.27798.
    >> Share


  895. Corrigendum.
    J Med Virol. 2022 Apr 20. doi: 10.1002/jmv.27776.
    >> Share

  896. SUBRAMONEY K, Mtileni N, Bharuthram A, Davis A, et al
    Identification of SARS-CoV-2 Omicron variant using spike gene target failure and genotyping assays, Gauteng, South Africa, 2021.
    J Med Virol. 2022 Apr 20. doi: 10.1002/jmv.27797.
    >> Share

  897. KUMAR N, Misra BR, Reddy MM, Deval H, et al
    COVID-19 transmission among vaccinated laboratory workers during the second wave in eastern Uttar Pradesh, India.
    J Med Virol. 2022 Apr 17. doi: 10.1002/jmv.27788.
    >> Share

  898. YAVUZ E, Gunal O, Basbulut E, Sen A, et al
    SARS-CoV-2 specific antibody responses in healthcare workers after a third booster dose of CoronaVac or BNT162b2 vaccine.
    J Med Virol. 2022 Apr 17. doi: 10.1002/jmv.27794.
    >> Share

  899. LIN-WANG HT, Lemes RC, Farias EDS, Bajgelman MC, et al
    Sequential IgG antibody monitoring for virus-inactivated and adenovirus-vectored COVID-19 vaccine in Brazilian healthcare workers.
    J Med Virol. 2022 Apr 14. doi: 10.1002/jmv.27782.
    >> Share

  900. STEPANEK L, Janosikova M, Stepanek L, Nakladalova M, et al
    The kinetics and predictors of anti-SARS-CoV-2 antibodies up to eight months after symptomatic COVID-19: a Czech cross-sectional study.
    J Med Virol. 2022 Apr 14. doi: 10.1002/jmv.27784.
    >> Share

  901. LUCIJANIC M, Soric E, Lacko MS, Sabljic A, et al
    Gradual increase in RDW is similarly prognostic for in-hospital mortality in both anemic and non-anemic COVID-19 patients.
    J Med Virol. 2022 Apr 14. doi: 10.1002/jmv.27785.
    >> Share

  902. LIN YF, Li Y, Duan Q, Lei H, et al
    Vaccination strategy for preventing the spread of SARS-CoV-2 in the limited supply condition: a mathematical modelling study.
    J Med Virol. 2022 Apr 14. doi: 10.1002/jmv.27783.
    >> Share

  903. OZUDOGRU O, Acer O, Genc Bahce Y
    Risks of catching COVID-19 according to vaccination status of healthcare workers during the SARS COV-2 Delta variant dominant period and their clinical characteristics.
    J Med Virol. 2022 Apr 13. doi: 10.1002/jmv.27778.
    >> Share

  904. IN E, Altintop Geckil A, Kavuran G, Sahin M, et al
    Using Artificial Intelligence to Improve the Diagnostic Efficiency of Pulmonologists in Differentiating COVID-19 Pneumonia from Community-Acquired Pneumonia.
    J Med Virol. 2022 Apr 13. doi: 10.1002/jmv.27777.
    >> Share

  905. MOHAPATRA RK, Kandi V, Tuli HS, Chakraborty C, et al
    The recombinant variants of SARS-CoV-2: concerns continues amid COVID-19 pandemic.
    J Med Virol. 2022 Apr 13. doi: 10.1002/jmv.27780.
    >> Share

  906. ALLEN RA, Williams CL, Penrod Y, McCloskey C, et al
    A pyrosequencing protocol for rapid identification of SARS-CoV-2 variants.
    J Med Virol. 2022 Apr 13. doi: 10.1002/jmv.27770.
    >> Share

  907. AHMED KAHM, Hasabo EA, Haroun MS, Eljack MMF, et al
    Clinical Characteristics, Complications and Predictors of Outcome of Hospitalized Adult Sudanese Patients with COVID-19 and Malaria Co-Infection in Sudan: A Multi-Center Retrospective Cross-sectional Study.
    J Med Virol. 2022 Apr 12. doi: 10.1002/jmv.27771.
    >> Share

  908. ZHAI SL, Li CL, Sun MF, Zhang JF, et al
    Natural infections of SARS-CoV-2 increased in animals: How should humans get along with animals?
    J Med Virol. 2022 Apr 12. doi: 10.1002/jmv.27772.
    >> Share

  909. LAPIC I, Antolic MR, Horvat I, Premuzic V, et al
    Association of polymorphisms in genes encoding prothrombotic and cardiovascular risk factors with disease severity in COVID-19 patients: a pilot study.
    J Med Virol. 2022 Apr 12. doi: 10.1002/jmv.27774.
    >> Share

  910. BOGLIONE L, Dodaro V, Meli G, Rostagno R, et al
    Remdesivir treatment in hospitalized patients affected by COVID-19 pneumonia: a case-control study.
    J Med Virol. 2022 Apr 11. doi: 10.1002/jmv.27768.
    >> Share

  911. MEHRAEEN E, SeyedAlinaghi S, Karimi A
    The Post-Omicron Situation: The End of the Pandemic or a Bigger Challenge?
    J Med Virol. 2022 Apr 6. doi: 10.1002/jmv.27765.
    >> Share

  912. GAMA S
    RDW shows prognostic potential in hospitalised patients with COVID-19.
    J Med Virol. 2022 Apr 6. doi: 10.1002/jmv.27764.
    >> Share

  913. AL-BASSAM WW, Al-Karaawi IA, Sharquie IK, Ad'hiah AH, et al
    Evaluation of interleukin-38 levels in serum of patients with coronavirus disease 2019.
    J Med Virol. 2022 Apr 6. doi: 10.1002/jmv.27762.
    >> Share

  914. ABORODE AT, Awuah WA, Mehta A, Abdul-Rahman T, et al
    Concern over Nipah Virus Cases Amidst the COVID-19 Pandemic in India.
    J Med Virol. 2022 Apr 5. doi: 10.1002/jmv.27745.
    >> Share

  915. ELIE B, Roquebert B, Sofonea MT, Trombert-Paolantoni S, et al
    Variant-specific SARS-CoV-2 within-host kinetics.
    J Med Virol. 2022 Apr 4. doi: 10.1002/jmv.27757.
    >> Share


  916. Dominant clade-featured SARS-CoV-2 co-occurring mutations reveal plausible epistasis: An in silico based hypothetical model.
    J Med Virol. 2022 Apr 4. doi: 10.1002/jmv.27733.
    >> Share

  917. YE C, Lv Y, Kuang W, Yang L, et al
    Inactivated vaccines prevent severe COVID-19 in patients infected with the Delta variant: a comparative study of the Delta and Alpha variants from China.
    J Med Virol. 2022 Apr 2. doi: 10.1002/jmv.27759.
    >> Share

  918. BHATNAGAR S, Jones K, Montoya A
    COVID-19 Vaccine Side Effects among Nursing Home Residents and Staff.
    J Med Virol. 2022 Apr 1. doi: 10.1002/jmv.27756.
    >> Share

  919. KWOK CS, Muntean EA, Mallen CD
    The impact of COVID-19 on the patient, clinician, healthcare services and society: A patient pathway review.
    J Med Virol. 2022 Apr 1. doi: 10.1002/jmv.27758.
    >> Share

  920. KAYGUSUZ S, Korukluoglu G, Cosgun Y, Sahin O, et al
    INVESTIGATION AND LONG-TERM MONITORING OF THE PRESENCE OF NEUTRALIZING ANTIBODY IN PATIENTS WITH COVID-19 DISEASE OF DIFFERENT CLINICAL SEVERITY.
    J Med Virol. 2022 Apr 1. doi: 10.1002/jmv.27751.
    >> Share

  921. GAUTRET P, Hoang VT, Jimeno MT, Lagier JC, et al
    Severity of the first 207 infections with the SARS-CoV-2 Omicron BA.2 variant, in Marseille, France, December, 2021-February, 2022.
    J Med Virol. 2022 Apr 1. doi: 10.1002/jmv.27760.
    >> Share

  922. CHIRUMBOLO S
    Antioxidants associated with NSAIDs might even exacerbate the progress of SARS-CoV2 disease.
    J Med Virol. 2022;94:1264-1266.
    >> Share

    March 2022
  923. CHAI C, Chen K, Li S, Cheng G, et al
    Effect of elevated fasting blood glucose level on the one-year mortality and sequelae in hospitalized COVID-19 patients: a bidirectional cohort study.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27737.
    >> Share

  924. PENNEY J, Jung A, Koethe B, Doron S, et al
    Cycle Threshold Values and SARS-CoV-2: Relationship to Demographic Characteristics and Disease Severity.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27752.
    >> Share

  925. TAMARIZ L, Bast E, Abad M, Klimas N, et al
    Letter to the editor: Post COVID-19 joint pain: Preliminary report of the relationship with antinuclear antibodies and inflammation.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27753.
    >> Share

  926. CHEN C, Feng Y, Chen Z, Xia Y, et al
    SARS-CoV-2 cold-chain transmission: Characteristics, risks and strategies.
    J Med Virol. 2022 Mar 31. doi: 10.1002/jmv.27750.
    >> Share

  927. YANG S, Cao L, Xu W, Xu T, et al
    Comparison of model-specific histopathology in mouse models of COVID-19.
    J Med Virol. 2022 Mar 30. doi: 10.1002/jmv.27747.
    >> Share

  928. COTO E, Albaiceta GM, Amado-Rodriguez L, Garcia-Clemente M, et al
    FURIN gene variants (rs6224/rs4702) as potential markers of deat hand cardiovascular traits in severe COVID-19.
    J Med Virol. 2022 Mar 30. doi: 10.1002/jmv.27748.
    >> Share

  929. RAJPAL VR, Sharma S, Kumar A, Chand S, et al
    'Is Omicron mild'? Testing this narrative with the mutational landscape of its three lineages and response to existing vaccines and therapeutic antibodies.
    J Med Virol. 2022 Mar 30. doi: 10.1002/jmv.27749.
    >> Share

  930. SINGH R, Kaur U, Singh A, Chakrabarti SS, et al
    Refractory hyper-eosinophilia associated with newly diagnosed rheumatoid arthritis following inactivated BBV152 COVID-19 vaccine.
    J Med Virol. 2022 Mar 29. doi: 10.1002/jmv.27742.
    >> Share

  931. REITER RJ, Sharma R, Tan DX, Neel RL, et al
    Melatonin Use for SARS-CoV-2 Infection:Time to Diversify the Treatment Portfolio.
    J Med Virol. 2022 Mar 26. doi: 10.1002/jmv.27740.
    >> Share

  932. WANG W, Peng X, Jin Y, Pan JA, et al
    Reverse genetics systems for SARS-CoV-2.
    J Med Virol. 2022 Mar 24. doi: 10.1002/jmv.27738.
    >> Share

  933. CHEN Q, Huang XY, Liu Y, Sun MX, et al
    Comparative characterization of SARS-CoV-2 variants of concern and mouse-adapted strains in mice.
    J Med Virol. 2022 Mar 23. doi: 10.1002/jmv.27735.
    >> Share

  934. ZHU G, Zhou S, Xu Y, Gao R, et al
    Mendelian randomization study on the causal effects of COVID-19 on childhood intelligence.
    J Med Virol. 2022 Mar 23. doi: 10.1002/jmv.27736.
    >> Share

  935. YANG S, Zhou H, Liu M, Jaijyan D, et al
    SARS-CoV-2, SARS-CoV and MERS-CoV encode circular RNAs of spliceosome-independent origin.
    J Med Virol. 2022 Mar 22. doi: 10.1002/jmv.27734.
    >> Share

  936. OZTAS M, Bektas M, Karacan I, Aliyeva N, et al
    Frequency and Severity of COVID-19 in Patients with Various Rheumatic Diseases Treated Regularly with Colchicine or Hydroxychloroquine.
    J Med Virol. 2022 Mar 21. doi: 10.1002/jmv.27731.
    >> Share

  937. MASYENI S, Iqhrammullah M, Frediansyah A, Nainu F, et al
    Molnupiravir: a lethal mutagenic drug against rapidly mutating SARS-CoV-2 - A narrative review.
    J Med Virol. 2022 Mar 21. doi: 10.1002/jmv.27730.
    >> Share

  938. FERNANDEZ-DE-LAS-PENAS C, Martin-Guerrero JD, Navarro-Pardo E, Torres-Macho J, et al
    Exploring the recovery curve for gastrointestinal symptoms from the acute COVID-19 phase to long-term post-COVID: The LONG-COVID-EXP-CM Multicenter Study.
    J Med Virol. 2022 Mar 21. doi: 10.1002/jmv.27727.
    >> Share

  939. MAGALIS BR, Mavian C, Tagliamonte M, Rich SN, et al
    Low-frequency variants in mildly symptomatic vaccine breakthrough infections presents a doubled-edged sword.
    J Med Virol. 2022 Mar 20. doi: 10.1002/jmv.27726.
    >> Share

  940. HASSANIAZAD M, Farshidi H, Gharibzadeh A, Bazram A, et al
    Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with covid-19: a randomized clinical trial.
    J Med Virol. 2022 Mar 16. doi: 10.1002/jmv.27724.
    >> Share

  941. TSAGKARIS C, Loudovikou A, Matiashova L, Papadakis M, et al
    Public health concerns over polio in war-torn Ukraine and nearby regions: Four lessons and a warning from the history of epidemics.
    J Med Virol. 2022 Mar 15. doi: 10.1002/jmv.27723.
    >> Share

  942. MISHRA AR, Nayak D, Byrareddy SN
    Are we moving towards ending SARS-CoV-2?
    J Med Virol. 2022 Mar 14. doi: 10.1002/jmv.27722.
    >> Share

  943. YAN Y, Tang YD, Zheng C
    When cyclin-dependent kinases meet viral infections, including SARS-CoV-2.
    J Med Virol. 2022 Mar 14. doi: 10.1002/jmv.27719.
    >> Share

  944. QIN S, Li R, Zheng Z, Zeng X, et al
    Review of selected animal models for respiratory coronavirus infection and its application in drug research.
    J Med Virol. 2022 Mar 13. doi: 10.1002/jmv.27718.
    >> Share

  945. DHEIR H, Tocoglu A, Toptan H, Pinar M, et al
    Short and mid-term SARS-CoV-2 antibody response after inactivated COVID-19 vaccine in hemodialysis and kidney transplant patients.
    J Med Virol. 2022 Mar 12. doi: 10.1002/jmv.27714.
    >> Share

  946. SHEN L, Sun M, Song S, Hu Q, et al
    The impact of anti-COVID-19 non-pharmaceutical interventions on hand, foot, and mouth disease-a spatiotemporal perspective in Xi'an, northwestern China.
    J Med Virol. 2022 Mar 11. doi: 10.1002/jmv.27715.
    >> Share

  947. CHAVDA VP, Patel AB, Vaghasiya DD
    SARS-CoV-2 variants and vulnerability at the global level.
    J Med Virol. 2022 Mar 11. doi: 10.1002/jmv.27717.
    >> Share

  948. ARCANI R, Cauchois R, Suchon P, Jean R, et al
    Factors associated with dexamethasone efficacy in COVID-19. A retrospective investigative cohort study.
    J Med Virol. 2022 Mar 11. doi: 10.1002/jmv.27712.
    >> Share

  949. YOSHIOKA N, Deguchi M, Hagiya H, Kagita M, et al
    Comparison of Extraction-based and Elution-based Polymerase Chain Reaction Testing, and Automated and Rapid Antigen Testing for the Diagnosis of Severe Acute Respiratory Syndrome Coronavirus 2.
    J Med Virol. 2022 Mar 10. doi: 10.1002/jmv.27709.
    >> Share

  950. GHAFOURI M, Saadati H, Taghavi MR, Azimian A, et al
    Survival of the hospitalized patients with COVID-19 receiving Atorvastatin: a randomized clinical trial.
    J Med Virol. 2022 Mar 10. doi: 10.1002/jmv.27710.
    >> Share

  951. XIAO F, Wan P, Wei Q, Wei G, et al
    Prolonged fecal shedding of SARS-CoV-2 in a young immunocompetent COVID-19 patient: a case report and literature overview.
    J Med Virol. 2022 Mar 10. doi: 10.1002/jmv.27694.
    >> Share

  952. ARORA G, Taneja J, Bhardwaj P, Goyal S, et al
    Adverse events and Breakthrough infections associated with COVID-19 vaccination in the Indian population.
    J Med Virol. 2022 Mar 8. doi: 10.1002/jmv.27708.
    >> Share

  953. DIRICAN E, Savrun ST, Aydin IE, Gulbay G, et al
    ANALYSIS OF MITOCHONDRIAL DNA CYTOCHROME-B (CYB) and ATPase-6 GENE MUTATIONS IN COVID-19 PATIENTS.
    J Med Virol. 2022 Mar 8. doi: 10.1002/jmv.27704.
    >> Share

  954. CAI C, Tang YD, Zheng C
    When RING Finger Family Proteins meet SARS-CoV-2.
    J Med Virol. 2022 Mar 7. doi: 10.1002/jmv.27701.
    >> Share

  955. LIU N, Long H, Sun J, Li H, et al
    New laboratory evidence for the association between endothelial dysfunction and COVID-19 disease progression.
    J Med Virol. 2022 Mar 5. doi: 10.1002/jmv.27693.
    >> Share

  956. CHENCHULA S, Karunakaran P
    Current Evidence on Efficacy of COVID-19 Booster Dose Vaccination Against the Omicron Variant. A Systematic Review.
    J Med Virol. 2022 Mar 4. doi: 10.1002/jmv.27697.
    >> Share

  957. RAMIREZ JD, Castaneda S, Ballesteros N, Munoz M, et al
    Hotspots for SARS-CoV-2 Omicron Variant Spread: Lessons from New York City.
    J Med Virol. 2022 Mar 3. doi: 10.1002/jmv.27691.
    >> Share

  958. COLSON P, Delerce J, Beye M, Levasseur A, et al
    First cases of infection with the 21L/BA.2 Omicron variant in Marseille, France.
    J Med Virol. 2022 Mar 3. doi: 10.1002/jmv.27695.
    >> Share

  959. TSUCHIDA T, Hirose M, Inoue Y, Kunishima H, et al
    Relationship between changes in symptoms and antibody titers after a single vaccination in patients with Long COVID.
    J Med Virol. 2022 Mar 2. doi: 10.1002/jmv.27689.
    >> Share

  960. MARGIOTTI K, Fabiani M, Mesoraca A, Giorlandino C, et al
    Survey of fully vaccinated anti-COVID 19 people from June to November 2021: Single Italian centre study.
    J Med Virol. 2022 Mar 2. doi: 10.1002/jmv.27690.
    >> Share

  961. OLIVEIRA GS, Silva-Flannery L, da Silva JF, Siza C, et al
    Active surveillance and early detection of community transmission of SARS-CoV-2 Mu variant (B.1.621) in the Brazilian Amazon.
    J Med Virol. 2022 Mar 2. doi: 10.1002/jmv.27686.
    >> Share

  962. CICCARESE G, Drago F, Marinaro E, Parodi A, et al
    PITYRIASIS ROSEA DURING COVID-19: PATHOGENESIS, DIAGNOSIS AND TREATMENT.
    J Med Virol. 2022 Mar 1. doi: 10.1002/jmv.27672.
    >> Share

  963. LIMA ARJ, Ribeiro G, Viala VL, Lima LPO, et al
    SARS-COV-2 GENOMIC MONITORING IN THE STATE OF SAO PAULO UNVEILS TWO EMERGING AY.43 SUBLINEAGES.
    J Med Virol. 2022 Mar 1. doi: 10.1002/jmv.27674.
    >> Share

    February 2022
  964. GIANNOS P, Prokopidis K
    Gut Dysbiosis and Long COVID-19: Feeling Gutted.
    J Med Virol. 2022 Feb 28. doi: 10.1002/jmv.27684.
    >> Share

  965. NOTARTE KI, Guerrero-Arguero I, Velasco JV, Ver AT, et al
    Characterization of the significant decline in humoral immune response six months post-SARS-CoV-2 mRNA vaccination: A systematic review.
    J Med Virol. 2022 Feb 28. doi: 10.1002/jmv.27688.
    >> Share

  966. LETAFATI A, Aghamirmohammadali FS, Rahimi-Foroushani A, Hasani SA, et al
    No Human Respiratory Syncytial Virus but SARS-CoV-2 in children under 5 years old referred to Children Medical Center in 2021, Tehran, Iran.
    J Med Virol. 2022 Feb 28. doi: 10.1002/jmv.27685.
    >> Share

  967. CHIU W, Verschueren L, Eynde CVD, Buyck C, et al
    Development and optimisation of a high-throughput screening assay for in vitro anti-SARS-CoV-2 activity: evaluation of 5676 phase 1 passed structures.
    J Med Virol. 2022 Feb 28. doi: 10.1002/jmv.27683.
    >> Share

  968. HAUSLER M, Kleines M
    The SARS-CoV-2 pandemic in Germany may represent the sum of a large number of local but independent epidemics each initiated by individuals aged 10 - 19 years, middle aged males, or elderly individuals.
    J Med Virol. 2022 Feb 28. doi: 10.1002/jmv.27682.
    >> Share

  969. ZENG L, Zang F, Song N, Li Z, et al
    Analysis of influenza trend and impact of COVID-19 in Kezhou, Xinjiang for 8 consecutive years.
    J Med Virol. 2022 Feb 25. doi: 10.1002/jmv.27678.
    >> Share

  970. LINSSEN J, Schapendonk C, Munster M, Daemen P, et al
    A method comparison study of the high throughput automated HISCL((R)) SARS-CoV-2 antigen assay using nasopharyngeal swab samples from symptomatic and asymptomatic subjects against conventional RT-PCR.
    J Med Virol. 2022 Feb 25. doi: 10.1002/jmv.27679.
    >> Share

  971. BORDINO V, Marengo N, Garlasco J, Cornio AR, et al
    Cross-sectional study of SARS-CoV-2 seropositivity among health-care workers and residents of long-term facilities in Italy, January 2021.
    J Med Virol. 2022 Feb 24. doi: 10.1002/jmv.27670.
    >> Share

  972. ACER O, Bahce YG, Ozudogru O
    Association of viral load with age, gender, disease severity and death in SARS-CoV-2 variants.
    J Med Virol. 2022 Feb 24. doi: 10.1002/jmv.27677.
    >> Share

  973. LEFEUVRE C, Pivert A, Przyrowski E, Bouthry E, et al
    Comparison of performance between three SARS-CoV-2 molecular assays (Aptima, Laboratory developed test-Fusion and R-GENE(R)) with a special attention on turn-around time, key point in the laboratory management.
    J Med Virol. 2022 Feb 24. doi: 10.1002/jmv.27675.
    >> Share

  974. DUAN Y, Yuan C, Suo X, Cao L, et al
    TET2 is Required for Type I IFN-mediated Inhibition of Bat-Origin Swine Acute Diarrhea Syndrome Coronavirus.
    J Med Virol. 2022 Feb 24. doi: 10.1002/jmv.27673.
    >> Share

  975. YADAV PD, Nyayanit DA, Gupta N, Shastri J, et al
    Detection and isolation of SARS-CoV-2 Eta variant from the international travelers and local residents of India.
    J Med Virol. 2022 Feb 24. doi: 10.1002/jmv.27676.
    >> Share

  976. SOBOLEWSKI KA, Smoke SM, Brophy A, Vassallo AV, et al
    Real world evaluation of the impact of two Anti-SARS-CoV-2 monoclonal antibody regimens on COVID-19 hospitalizations in older adults.
    J Med Virol. 2022 Feb 23. doi: 10.1002/jmv.27668.
    >> Share

  977. PAPPA S, Haidopoulou K, Zarras C, Theodorakou E, et al
    Early initiation of the respiratory syncytial virus season in 2021-2022, Greece.
    J Med Virol. 2022 Feb 23. doi: 10.1002/jmv.27671.
    >> Share

  978. BUSIC N, Lucijanic T, Barsic B, Luksic I, et al
    Vaccination provides protection from respiratory deterioration and death among hospitalized COVID-19 patients: differences between vector and mRNA vaccines.
    J Med Virol. 2022 Feb 20. doi: 10.1002/jmv.27666.
    >> Share

  979. ATA S, Cil T, Duman BB, Unal N, et al
    EVALUATION OF ANTIBODY RESPONSE AFTER TWO DOSES OF THE SINOVAC VACCINE AND THE POTENTIAL NEED FOR BOOSTER DOSES IN CANCER PATIENTS.
    J Med Virol. 2022 Feb 18. doi: 10.1002/jmv.27665.
    >> Share

  980. DESINGU PA, Nagarajan K
    Omicron variant losing its critical mutations in the receptor-binding domain.
    J Med Virol. 2022 Feb 18. doi: 10.1002/jmv.27667.
    >> Share

  981. PASCARELLA S, Bianchi M, Giovanetti M, Narzi D, et al
    The SARS-CoV-2 mu variant shouldn't be left aside: it warrants attention for its immuo-escaping ability.
    J Med Virol. 2022 Feb 16. doi: 10.1002/jmv.27663.
    >> Share

  982. ZHOU JQ, Liu GX, Huang XL, Gan HT, et al
    The importance of fecal nucleic acid detection in patients with coronavirus disease(COVID-19):a systematic review and meta-analysis.
    J Med Virol. 2022 Feb 16. doi: 10.1002/jmv.27652.
    >> Share

  983. HERNANDEZ MM, Riollano-Cruz M, Boyle MC, Banu R, et al
    Food for thought: Eating before saliva collection and interference with SARS-CoV-2 detection.
    J Med Virol. 2022 Feb 16. doi: 10.1002/jmv.27660.
    >> Share

  984. CROSS GB, Naftalin CM, Ngiam JN, Bagdasarian N, et al
    Discrepant serological findings in SARS-CoV-2 PCR negative, hospitalised patients with fever and acute respiratory symptoms during the pandemic.
    J Med Virol. 2022 Feb 16. doi: 10.1002/jmv.27656.
    >> Share

  985. CHEN JM
    Novel statistics predict the COVID-19 pandemic could terminate in 2022.
    J Med Virol. 2022 Feb 11. doi: 10.1002/jmv.27661.
    >> Share

  986. DESINGU PA, Nagarajan K
    Omicron BA.2 lineage spreads in clusters and is concentrated in Denmark.
    J Med Virol. 2022 Feb 11. doi: 10.1002/jmv.27659.
    >> Share

  987. PARIDA SP, Sahu DP, Singh AK, Alekhya G, et al
    Adverse Events Following Immunization of COVID-19 (Covaxin) vaccine at a Tertiary Care Center of India.
    J Med Virol. 2022 Feb 11. doi: 10.1002/jmv.27655.
    >> Share

  988. LAMPEJO DT
    The impact of the COVID-19 pandemic on the global burden of influenza.
    J Med Virol. 2022 Feb 10. doi: 10.1002/jmv.27653.
    >> Share

  989. ZHANG H, Fischer DK, Shuda M, Moore PS, et al
    Construction and characterization of two SARS-CoV-2 minigenome replicon systems.
    J Med Virol. 2022 Feb 9. doi: 10.1002/jmv.27650.
    >> Share

  990. PARK J, Il Shin J, Kim DH, Park J, et al
    Association of atrial fibrillation with infectivity and severe complications of COVID-19: A nationwide cohort study.
    J Med Virol. 2022 Feb 7. doi: 10.1002/jmv.27647.
    >> Share

  991. GUMUS H, Erat T, Ozturk I, Demir A, et al
    Oxidative Stress and Decreased Nrf2 Level in Paediatric Patients with COVID-19.
    J Med Virol. 2022 Feb 6. doi: 10.1002/jmv.27640.
    >> Share

  992. DUNDAR B, Karahangil K, Elgormus CS, Topsakal HNH, et al
    Efficacy of Antibody Response Following the Vaccination of SARS-CoV-2 Infected and Non-Infected Healthcare Workers by Two-Dose Inactive Vaccine against COVID-19.
    J Med Virol. 2022 Feb 6. doi: 10.1002/jmv.27649.
    >> Share

  993. STAUFT CB, Selvaraj P, Lien CZ, Starost MF, et al
    Long-Term Immunity in Convalescent Syrian Hamsters Provides Protection against New-Variant SARS-CoV-2 Infection of the Lower but not Upper Respiratory Tract.
    J Med Virol. 2022 Feb 6. doi: 10.1002/jmv.27641.
    >> Share

  994. TIAN D, Sun Y, Xu H, Ye Q, et al
    The emergence and epidemic characteristics of the highly mutated SARS-CoV-2 Omicron variant.
    J Med Virol. 2022 Feb 3. doi: 10.1002/jmv.27643.
    >> Share

  995. PETRELLI F, Luciani A, Borgonovo K, Ghilardi M, et al
    Third Dose of SARS-CoV-2 Vaccine: A Systematic Review of 30 Published Studies.
    J Med Virol. 2022 Feb 3. doi: 10.1002/jmv.27644.
    >> Share

  996. MOHAPATRA RK, Tiwari R, Sarangi AK, Islam DR, et al
    COMMENTARYOmicron (B.1.1.529) variant of SARS-CoV-2- Concerns, challenges and recent updates.
    J Med Virol. 2022 Feb 3. doi: 10.1002/jmv.27633.
    >> Share

  997. R M, K S
    An exploratory study on the propagation of SARS-CoV-2 variants: Omicron is the most predominant variant.
    J Med Virol. 2022 Feb 3. doi: 10.1002/jmv.27634.
    >> Share

  998. CHIRUMBOLO S, Pandolfi S
    Escaping from COVID-19 emergency accounting on previously infected subjects?
    J Med Virol. 2022 Feb 2. doi: 10.1002/jmv.27645.
    >> Share

  999. TIAN D, Song Y, Zhang M, Pan Y, et al
    Genomic, immunological and clinical analysis of COVID-19 vaccine breakthrough infections in Beijing, China.
    J Med Virol. 2022 Feb 2. doi: 10.1002/jmv.27636.
    >> Share

  1000. LUAN N, Wang Y, Cao H, Lin K, et al
    Comparison of immune responses induced by two or three doses of an alum-adjuvanted inactivated SARS-CoV-2 vaccine in mice.
    J Med Virol. 2022 Feb 2. doi: 10.1002/jmv.27637.
    >> Share

  1001. DESINGU PA, Nagarajan K
    SARS-CoV-2 Omicron variant is spreading in different parts of the world in three different trends.
    J Med Virol. 2022 Feb 2. doi: 10.1002/jmv.27646.
    >> Share

  1002. WALKER GJ, Stelzer-Braid S, Shorter C, Honeywill C, et al
    Viruses associated with acute respiratory infection in a community-based cohort of healthy New Zealand children.
    J Med Virol. 2022;94:454-460.
    >> Share

  1003. BARBOSA G, Cunha Chaves AP, Kleber de Souza Luna L, Bellei N, et al
    SARS-CoV-2 breakthrough infection and viral load among health care workers after COVID-19 vaccines.
    J Med Virol. 2022 Feb 1. doi: 10.1002/jmv.27639.
    >> Share

  1004. MILANO E, Ricciardi A, Casciaro R, Pallara E, et al
    Immunogenicity and safety of the BNT162b2 COVID-19 mRNA vaccine in PLWH: a monocentric study in Bari, Italy.
    J Med Virol. 2022 Feb 1. doi: 10.1002/jmv.27629.
    >> Share

    January 2022
  1005. YADAV PD, Niyas VKM, Arjun R, Sahay RR, et al
    Detection of Zika virus disease in Thiruvananthapuram, Kerala, India 2021 during second wave of COVID-19 pandemic.
    J Med Virol. 2022 Jan 31. doi: 10.1002/jmv.27638.
    >> Share

  1006. GHAYDA RA, Lee KH, Han YJ, Ryu S, et al
    Global case fatality rate of coronavirus disease 2019 (COVID-19) by continents and national income: a meta-analysis.
    J Med Virol. 2022 Jan 31. doi: 10.1002/jmv.27610.
    >> Share

  1007. DARIA S, Islam MR
    The SARS-CoV-2 omicron wave is indicating the end of the pandemic phase but the COVID-19 will continue.
    J Med Virol. 2022 Jan 30. doi: 10.1002/jmv.27635.
    >> Share

  1008. SILVA SJRD
    Comparing studies of SARS-CoV-2 viral loads requires caution.
    J Med Virol. 2022 Jan 28. doi: 10.1002/jmv.27631.
    >> Share

  1009. NUNES PR, Romao-Veiga M, Ribeiro VR, Peracoli JC, et al
    COVID-19: a new risk factor or just a new imitator of preeclampsia? NLRP3 activation: a possible commom mechanism.
    J Med Virol. 2022 Jan 28. doi: 10.1002/jmv.27632.
    >> Share

  1010. LIN WT, Hung SH, Lai CC, Wang CY, et al
    The impact of neutralizing monoclonal antibodies on the outcomes of COVID-19 outpatients: A systematic review and meta-analysis of randomized controlled trials.
    J Med Virol. 2022 Jan 27. doi: 10.1002/jmv.27623.
    >> Share

  1011. ZHAO W, Li H, Li J, Xu B, et al
    The mechanism of multiple organ dyfunction syndrome in patients with COVID-19.
    J Med Virol. 2022 Jan 27. doi: 10.1002/jmv.27627.
    >> Share

  1012. SHARMA V, Rai H, Gautam DNS, Prajapati PK, et al
    Emerging evidence on Omicron (B.1.1.529) SARS-CoV-2 variant.
    J Med Virol. 2022 Jan 26. doi: 10.1002/jmv.27626.
    >> Share

  1013. XIANYU Y, Wang M, Yue F, Xu X, et al
    One year follow-up of 18 women who infected COVID-19 while pregnant.
    J Med Virol. 2022 Jan 26. doi: 10.1002/jmv.27628.
    >> Share

  1014. HU Y, Jo H, DeGrado WF, Wang J, et al
    Brilacidin, a COVID-19 Drug Candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E and NL63 through targeting both the virus and the host cell.
    J Med Virol. 2022 Jan 25. doi: 10.1002/jmv.27616.
    >> Share

  1015. YE Q, Lu D, Zhang T, Mao J, et al
    Recent advances and clinical application in point-of-care testing of SARS-CoV-2.
    J Med Virol. 2022 Jan 25. doi: 10.1002/jmv.27617.
    >> Share

  1016. CAGLAYAN D, Suner AF, Siyve N, Guzel I, et al
    An analysis of antibody response following the second dose of CoronaVac and humoral response after booster dose with BNT162b2 or CoronaVac among healthcare workers in Turkey.
    J Med Virol. 2022 Jan 25. doi: 10.1002/jmv.27620.
    >> Share

  1017. ADLI A, Rahimi M, Khodaie R, Hashemzaei N, et al
    Role of Genetic Variants and Host Polymorphisms on COVID-19: From Viral Entrance Mechanisms to Immunological Reactions.
    J Med Virol. 2022 Jan 24. doi: 10.1002/jmv.27615.
    >> Share

  1018. HUANG C, Yang L, Pan J, Xu X, et al
    Correlation between vaccine coverage and the COVID-19 pandemic throughout the world: based on real-world data.
    J Med Virol. 2022 Jan 24. doi: 10.1002/jmv.27609.
    >> Share

  1019. WANG L, Guo X, Zhao N, Ouyang Y, et al
    Effects of the Enhanced Public Health Intervention during the COVID-19 Epidemic on Respiratory and Gastrointestinal Infectious Diseases in China.
    J Med Virol. 2022 Jan 23. doi: 10.1002/jmv.27619.
    >> Share

  1020. LEON FJF, Silva LLD, Santos AC, Duarte da Costa V, et al
    Immunological and virological aspects of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and hepatitis C virus.
    J Med Virol. 2022 Jan 22. doi: 10.1002/jmv.27614.
    >> Share

  1021. FILIPPATOS F, Tatsi EB, Dellis C, Efthymiou V, et al
    Seroepidemiology of SARS-CoV-2 in pediatric population during a 16-month period prior to vaccination.
    J Med Virol. 2022 Jan 21. doi: 10.1002/jmv.27608.
    >> Share

  1022. SCHMITT G, Labdouni S, Soulimani R, Delamare C, et al
    Oxidative stress status and vitamin D levels of asymptomatic to mild symptomatic COVID-19 infections during the third trimester of pregnancy: A retrospective study in Metz, France.
    J Med Virol. 2022 Jan 21. doi: 10.1002/jmv.27606.
    >> Share

  1023. SAXENA SK, Kumar S, Ansari S, Paweska JT, et al
    Transmission dynamics and mutational prevalence of the novel SARS-CoV-2 Omicron Variant of Concern.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27611.
    >> Share

  1024. FONSECA MHG, de Souza TFG, de Carvalho Araujo FM, de Andrade LOM, et al
    Dynamics of antibody response to CoronaVac vaccine.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27604.
    >> Share

  1025. BSHESH K, Khan W, Vattoth AL, Janjua E, et al
    Lymphadenopathy Post-COVID-19 Vaccination with Increased FDG Uptake May Be Falsely Attributed to Oncological Disorders: A Systematic Review.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27599.
    >> Share

  1026. ETEROVIC A, Speranca MA, Campos IB, Colpas DR, et al
    SARS-CoV-2 intralineage variation and temporal patterns of COVID-19 risk factors in three cities of Southeastern Brazil: age, sex, and race.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27607.
    >> Share

  1027. HOUHAMDI L, Gautret P, Hoang VT, Fournier PE, et al
    Characteristics of the first 1,119 SARS-CoV-2 Omicron variant cases, in Marseille, France, November-December 2021.
    J Med Virol. 2022 Jan 20. doi: 10.1002/jmv.27613.
    >> Share

  1028. WANG ZH, Fu BQ, Lin YW, Wei XB, et al
    Red Blood Cell Distribution Width: a severity indicator in patients with COVID-19.
    J Med Virol. 2022 Jan 19. doi: 10.1002/jmv.27602.
    >> Share

  1029. BIANCOFIORE A, Mirijello A, Puteo MA, Viesti MPD, et al
    Remdesivir significantly reduces SARS-CoV-2 viral load on nasopharyngeal swabs in hospitalized patients with COVID-19: a retrospective case-control study.
    J Med Virol. 2022 Jan 18. doi: 10.1002/jmv.27598.
    >> Share

  1030. DESINGU PA, Nagarajan K, Dhama K
    Emergence of Omicron third lineage BA.3 and its importance.
    J Med Virol. 2022 Jan 18. doi: 10.1002/jmv.27601.
    >> Share

  1031. MARUOTTI A, Giovanetti M, Divino F, Broccolo F, et al
    Prisoners of variants, or free to act as prisoners of swabs? The case of Italy.
    J Med Virol. 2022 Jan 17. doi: 10.1002/jmv.27597.
    >> Share

  1032. ESMAEILI ED, Fakhari A, Naghili B, Khodamoradi F, et al
    Case fatality, mortality, socio-demographic, and screening of COVID-19 in the elderly population: A population-based registry study in Iran.
    J Med Virol. 2022 Jan 15. doi: 10.1002/jmv.27594.
    >> Share

  1033. SIMSEK A, Kizmaz MA, Cagan E, Dombaz F, et al
    Assessment of CD39 expression in regulatory T cell subsets by disease severity in adult and juvenile COVID -19 cases.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27593.
    >> Share

  1034. LI T, Cui Z, Jia Y, Liang Z, et al
    Aggregation of high-frequency RBD mutations of SARS-CoV-2 with three VOCs did not cause significant antigenic drift.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27596.
    >> Share

  1035. LAN SH, Lee HZ, Chao CM, Chang SP, et al
    Efficacy of Melatonin in the Treatment of Patients With COVID-19: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27595.
    >> Share

  1036. ALI MA, Hu C, Zhang F, Jahan S, et al
    N protein-based ultrasensitive SARS-CoV-2 antibody detection in seconds via 3D nanoprinted, microarchitected array electrodes.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27591.
    >> Share

  1037. DUGGAL P, Penson T, Manley HN, Vergara C, et al
    Post-sequelae symptoms and comorbidities after COVID-19.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27586.
    >> Share

  1038. NETO AS, Landoni G, Ostermann M, Lumlertgul N, et al
    Angiotensin II Infusion in COVID-19: An International, Multicenter, Registry-based Study.
    J Med Virol. 2022 Jan 14. doi: 10.1002/jmv.27592.
    >> Share

  1039. MENG H, Mao J, Ye Q
    Booster vaccination strategy: Necessity, Immunization Objectives, Immunization Strategy and Safety.
    J Med Virol. 2022 Jan 13. doi: 10.1002/jmv.27590.
    >> Share

  1040. ARAF Y, Akter F, Tang YD, Fatemi R, et al
    Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines.
    J Med Virol. 2022 Jan 12. doi: 10.1002/jmv.27588.
    >> Share

  1041. DEVRIM I, Boncuoglu E, Kiymet E, Sahinkaya S, et al
    Comparison of the pediatric hospitalizations due to COVID-19 and H1N1pdm09 virus infections during the pandemic period.
    J Med Virol. 2022 Jan 12. doi: 10.1002/jmv.27589.
    >> Share

  1042. CELEBI MY, Kiymet E, Boncuoglu E, Sahinkaya S, et al
    Evaluation of childhood hospitalization rates and degree of severity of SARS-CoV-2 variants including of the B.1.1.7 (Alpha), B.1.315/P.1 (Beta/Gamma), and B.1.617.2 (Delta).
    J Med Virol. 2022 Jan 11. doi: 10.1002/jmv.27587.
    >> Share

  1043. MOHAPATRA RK, Tiwari R, Sarangi AK, Sharma SK, et al
    Twin combination of Omicron and Delta variant triggering a Tsunami wave of ever high surges in COVID-19 cases: a challenging global threat with a special focus on Indian sub-continent.
    J Med Virol. 2022 Jan 10. doi: 10.1002/jmv.27585.
    >> Share

  1044. CHEN Y, Li S, Wu W, Geng S, et al
    Distinct mutations and lineages of SARS-CoV-2 virus in the early phase of COVID-19 pandemic and subsequent one-year global expansion.
    J Med Virol. 2022 Jan 9. doi: 10.1002/jmv.27580.
    >> Share

  1045. KERGET B, Celik E, Kerget F, Aksakal A, et al
    Evaluation of 3-month follow-up of patients with post-acute COVID-19 syndrome.
    J Med Virol. 2022 Jan 9. doi: 10.1002/jmv.27579.
    >> Share

  1046. FANTINI J, Yahi N, Colson P, Chahinian H, et al
    The puzzling mutational landscape of the SARS-2-variant Omicron.
    J Med Virol. 2022 Jan 8. doi: 10.1002/jmv.27577.
    >> Share

  1047. YUAN S, Jiang SC, Zhang ZW, Fu YF, et al
    Arrhythmia May Contribute to Neuropsychiatric Symptoms in COVID-19 Patients.
    J Med Virol. 2022 Jan 8. doi: 10.1002/jmv.27583.
    >> Share

  1048. NIKOLOVA M, Todorova Y, Emilova R, Trifonova I, et al
    INDUCTION OF HUMORAL AND CELLULAR IMMUNE RESPONSES TO COVID-19 mRNA AND VECTOR VACCINES: A PROSPECTIVE COHORT STUDY IN BULGARIAN HEALTHCARE WORKERS.
    J Med Virol. 2022 Jan 7. doi: 10.1002/jmv.27572.
    >> Share

  1049. ARTIK Y, Cosgun AB, Cesur NP, Hizel N, et al
    COMPARISON OF COVID-19 LABORATORY DIAGNOSIS BY COMMERCIAL KITS: EFFECTIVITY OF RT-PCR TO THE RT-LAMP.
    J Med Virol. 2022 Jan 7. doi: 10.1002/jmv.27559.
    >> Share

  1050. FERRAVANTE C, Sanna G, Melone V, Fromentier A, et al
    Nasopharyngeal virome analysis of COVID-19 patients during three different waves in Campania Region of Italy.
    J Med Virol. 2022 Jan 6. doi: 10.1002/jmv.27571.
    >> Share

  1051. SOHAN M, Hossain MJ, Islam MR
    The SARS-CoV-2 Omicron (B.1.1.529) variant and effectiveness of existing vaccines: What we know so far.
    J Med Virol. 2022 Jan 6. doi: 10.1002/jmv.27574.
    >> Share

  1052. LIPPI G, Mattiuzzi C, Henry BM
    Neutralizing potency of COVID-19 vaccines against the SARS-CoV-2 Omicron (B.1.1.529) variant.
    J Med Virol. 2022 Jan 5. doi: 10.1002/jmv.27575.
    >> Share

  1053. EVANGELOU K, Rozani S, Tsagkaris C
    Monoclonal antibodies as a trick or treat for COVID-19? The example of abciximab.
    J Med Virol. 2022 Jan 4. doi: 10.1002/jmv.27573.
    >> Share

  1054. YE Q, Wang D
    Epidemiological changes of common respiratory viruses in children during the COVID-19 pandemic.
    J Med Virol. 2022 Jan 4. doi: 10.1002/jmv.27570.
    >> Share

  1055. KHAN YH, Salman M, Butt MH, Mallhi TH, et al
    Viral Fever of unknown Origin during COVID-19 and Dengue Outbreaks in Pakistan; Is Media spreading panic during pandemic?
    J Med Virol. 2022 Jan 4. doi: 10.1002/jmv.27569.
    >> Share

  1056. KOW CS, Ramachandram DS, Hasan SS
    The effectiveness of mRNA-1273 vaccine against COVID-19 caused by delta variant: A systematic review and meta-analysis.
    J Med Virol. 2022 Jan 3. doi: 10.1002/jmv.27568.
    >> Share

  1057. MOUSAVI SH, Qaderi S, Ahmadi A, Arman SI, et al
    The daunting task of fighting HIV in Afghanistan: Current evidence and future recommendationsThe daunting task of fighting HIV in Afghanistan: Current evidence and future recommendations.
    J Med Virol. 2022 Jan 3. doi: 10.1002/jmv.27566.
    >> Share

  1058. ANDREATA-SANTOS R, Janini LMR, Duraes-Carvalho R
    From Alpha to Omicron SARS-CoV-2 variants: What their evolutionary signatures can tell us?
    J Med Virol. 2022 Jan 3. doi: 10.1002/jmv.27555.
    >> Share

  1059. ADACHI E, Saito M, Nagai H, Ikeuchi K, et al
    Transient depletion of T cells during COVID-19 and seasonal influenza in people living with HIV.
    J Med Virol. 2022 Jan 2. doi: 10.1002/jmv.27543.
    >> Share

    December 2021
  1060. YAKOOT M
    Non-significant Trends in COVID-19 Trials: Is There a Significance?
    J Med Virol. 2021 Dec 31. doi: 10.1002/jmv.27565.
    >> Share

  1061. ITO K, Piantham C, Nishiura H
    Relative Instantaneous Reproduction Number of Omicron SARS-CoV-2 variant with respect to the Delta variant in Denmark.
    J Med Virol. 2021 Dec 30. doi: 10.1002/jmv.27560.
    >> Share

  1062. BASTUG A, Bodur H, Aydos O, Filazi N, et al
    The changing dynamics of neutralizing antibody response within ten months of SARS-CoV-2 infections.
    J Med Virol. 2021 Dec 30. doi: 10.1002/jmv.27544.
    >> Share

  1063. LIU W, Long X, Wan K, Yin M, et al
    The endogenous factors affecting the detection of serum SARS-CoV-2 IgG/IgM antibodies by ELISA.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27557.
    >> Share

  1064. XIAO F, Zhou Y, Zhang M, Chen D, et al
    Hyperglycemia and blood glucose deterioration are risk factors for severe COVID-19 with diabetes: a two-center cohort study.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27556.
    >> Share

  1065. WU K, Wu X, Wang W, Hong L, et al
    Epidemiology of influenza under the coronavirus disease 2019 pandemic in Nanjing, China.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27553.
    >> Share

  1066. MOHAPATRA RK, Sarangi AK, Kandi V, Azam M, et al
    Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27561.
    >> Share

  1067. LI A, Maier A, Carter M, Hugh Guan T, et al
    Omicron and S-Gene Target Failure Cases in the Highest COVID-19 Case Rate Region in Canada - December 2021.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27562.
    >> Share

  1068. RAHMANI S, Rezaei N
    Omicron (B.1.1.529) Variant: Development, Dissemination, and Dominance.
    J Med Virol. 2021 Dec 29. doi: 10.1002/jmv.27563.
    >> Share

  1069. DRAGIOTI E, Li H, Tsitsas G, Lee KH, et al
    A large scale meta-analytic atlas of mental health problems prevalence during the COVID-19 early pandemic.
    J Med Virol. 2021 Dec 27. doi: 10.1002/jmv.27549.
    >> Share

  1070. KERGET B, Kerget F, Aydin M, Karasahin O, et al
    Effect of montelukast therapy on clinical course, pulmonary function, and mortality in patients with COVID-19.
    J Med Virol. 2021 Dec 27. doi: 10.1002/jmv.27552.
    >> Share

  1071. HE L, Zeng C, Zeng Y, Xu W, et al
    Antibody Responses of the First Wave of Survivors infected with SARS-CoV-2 One Year Ago.
    J Med Virol. 2021 Dec 25. doi: 10.1002/jmv.27551.
    >> Share

  1072. NEMR WA, Radwan NK
    TYPING OF ALPHA AND BETA CORONAVIRUSES BY DNA BAR CODING OF NSP12 GENE.
    J Med Virol. 2021 Dec 24. doi: 10.1002/jmv.27550.
    >> Share

  1073. PAPAROUPA M, Aldemyati R, Roggenkamp H, Berinson B, et al
    The Prevalence of Early- and Late-Onset Bacterial, Viral and Fungal Respiratory Superinfections in Invasively Ventilated COVID-19 Patients.
    J Med Virol. 2021 Dec 24. doi: 10.1002/jmv.27548.
    >> Share

  1074. ISLAM R, Hossain J
    Detection of Omicron (B.1.1.529) variant has created panic among the people across the world: What should we do right now?
    J Med Virol. 2021 Dec 23. doi: 10.1002/jmv.27546.
    >> Share

  1075. RAHAMAN MM, Sarkar MMH, Rahman MS, Islam MR, et al
    Genomic characterization of the dominating Beta variant carrying vaccinated (Oxford-AstraZeneca) and non-vaccinated COVID-19 patient samples in Bangladesh: A metagenomics and whole genome approach.
    J Med Virol. 2021 Dec 23. doi: 10.1002/jmv.27537.
    >> Share

  1076. SHAH NN, Dar KA, Quibtiya S, Din Azad AMU, et al
    Repurposing of Mycobacterium indicus pranii for the severe form of COVID -19 patients in India: A cohort study.
    J Med Virol. 2021 Dec 23. doi: 10.1002/jmv.27547.
    >> Share

  1077. HOSSAIN G, Tang YD, Akter S, Zheng C, et al
    Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination.
    J Med Virol. 2021 Dec 22. doi: 10.1002/jmv.27539.
    >> Share

  1078. XIANG HR, He B, Li Y, Cheng X, et al
    Bamlanivimab plus etesevimab treatment have a better outcome against COVID-19: A meta-analysis.
    J Med Virol. 2021 Dec 22. doi: 10.1002/jmv.27542.
    >> Share

  1079. THAKUR V, Kanta Ratho R
    OMICRON (B.1.1.529): A new SARS-CoV-2 Variant of Concern mounting worldwide fear.
    J Med Virol. 2021 Dec 22. doi: 10.1002/jmv.27541.
    >> Share

  1080. WANG Z, Yang L
    In the age of Omicron variant: Paxlovid raises new hopes of COVID-19 recovery.
    J Med Virol. 2021 Dec 22. doi: 10.1002/jmv.27540.
    >> Share

  1081. WU J, Tang J, Zhang T, Chen YC, et al
    Follow-up CT of "Reversed Halo Sign" in SARS-CoV-2 Delta VOC pneumonia: A report of two cases.
    J Med Virol. 2021 Dec 21. doi: 10.1002/jmv.27533.
    >> Share

  1082. YE Q, Wang B, Liu H
    Influence of the COVID-19 pandemic on the incidence and exacerbation of childhood allergic diseases.
    J Med Virol. 2021 Dec 21. doi: 10.1002/jmv.27536.
    >> Share

  1083. HUSSAIN N, Agarwala P, Iqbal K, Omar HMS, et al
    A systematic review of acute telogen effluvium, a harrowing post-COVID-19 manifestation.
    J Med Virol. 2021 Dec 20. doi: 10.1002/jmv.27534.
    >> Share

  1084. MARTORA F, Picone V, Fornaro L, Fabbrocini G, et al
    Can COVID 19 cause atypical forms of Pityriasis Rosea refractory to conventional therapies?
    J Med Virol. 2021 Dec 20. doi: 10.1002/jmv.27535.
    >> Share

  1085. LI X
    Omicron: call for updated vaccines.
    J Med Virol. 2021 Dec 20. doi: 10.1002/jmv.27530.
    >> Share

  1086. SHANMUGARAJ B, Malla A, Khorattanakulchai N, Phoolcharoen W, et al
    SARS-CoV-2 Omicron Variant: Could it be Another Threat?
    J Med Virol. 2021 Dec 19. doi: 10.1002/jmv.27532.
    >> Share

  1087. SOYTAS RB, Cengiz M, Islamoglu MS, Uysal BB, et al
    Antibody responses to COVID-19 vaccines in older adults.
    J Med Virol. 2021 Dec 17. doi: 10.1002/jmv.27531.
    >> Share

  1088. PASCARELLA S, Ciccozzi M, Bianchi M, Benvenuto D, et al
    The Electrostatic Potential of the Omicron Variant Spike is Higher than in Delta and Delta-plus Variants: a Hint to Higher Transmissibility?
    J Med Virol. 2021 Dec 16. doi: 10.1002/jmv.27528.
    >> Share

  1089. DIVINO F, Maruotti A, Farcomeni A, Jona-Lasinio G, et al
    On the severity of COVID-19 infections in 2021 in Italy.
    J Med Virol. 2021 Dec 16. doi: 10.1002/jmv.27529.
    >> Share

  1090. NESR G, Saleem Z, Arami S
    Outcome of COVID-19 in patients with chronic myeloid leukemia: A single centre UK experience.
    J Med Virol. 2021 Dec 15. doi: 10.1002/jmv.27527.
    >> Share

  1091. KUMAR S, Thambiraja TS, Karuppanan K, Subramaniam G, et al
    Omicron and Delta Variant of SARS-CoV-2: A Comparative Computational Study of Spike Protein.
    J Med Virol. 2021 Dec 15. doi: 10.1002/jmv.27526.
    >> Share

  1092. JIANG P, Wu SH, Zhu T, Guo Y, et al
    A rare case of drug-induced bradycardia associated with the just low dose use of methylprednisolone in a child with COVID-19.
    J Med Virol. 2021 Dec 15. doi: 10.1002/jmv.27525.
    >> Share

  1093. SAXENA SK, Kumar S, Ansari S, Paweska JT, et al
    Characterization of the novel SARS-CoV-2 Omicron (B.1.1.529) Variant of Concern and its global perspective.
    J Med Virol. 2021 Dec 14. doi: 10.1002/jmv.27524.
    >> Share

  1094. KUMAR A
    Mucormycosis in COVID-19 recovered patients.
    J Med Virol. 2021 Dec 14. doi: 10.1002/jmv.27522.
    >> Share

  1095. XIE C, Ding H, Ding J, Xue Y, et al
    Preparation of highly specific monoclonal antibodies against SARS-CoV-2 nucleocapsid protein and the preliminary development of antigen detection test strips.
    J Med Virol. 2021 Dec 13. doi: 10.1002/jmv.27520.
    >> Share

  1096. WANG L, Cheng G
    Sequence analysis of the Emerging Sars-CoV-2 Variant Omicron in South Africa.
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27516.
    >> Share

  1097. BORSETTI A, Scarpa F, Maruotti A, Divino F, et al
    The unresolved question on COVID-19 virus origin: The three cards game?
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27519.
    >> Share

  1098. SIM AYC, Naffi AA, Fai TS, Kori N, et al
    Bilateral intermediate uveitis in a healthy teenager with the multisystem inflammatory syndrome in children secondary to COVID-19 infection.
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27521.
    >> Share

  1099. OUOBA S, Okimoto M, Nagashima S, Kitahara Y, et al
    Sequential dynamics of virological and serological changes in the serum of SARS-CoV-2 infected patients.
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27518.
    >> Share

  1100. WANG Z, Yang L
    Broad-spectrum prodrugs with anti-SARS-CoV-2 activities: Strategies, benefits, and challenges.
    J Med Virol. 2021 Dec 12. doi: 10.1002/jmv.27517.
    >> Share

  1101. KANDEEL M, Mohamed MEM, Abd El-Lateef HM, Venugopala KN, et al
    Omicron variant genome evolution and phylogenetics.
    J Med Virol. 2021 Dec 10. doi: 10.1002/jmv.27515.
    >> Share

  1102. HAN X, Ye Q
    The variants of SARS-CoV-2 and the challenges of vaccines.
    J Med Virol. 2021 Dec 9. doi: 10.1002/jmv.27513.
    >> Share

  1103. CHENG Q, Zhao G, Chen J, Jia Q, et al
    Efficacy and safety of current treatment interventions for patients with severe COVID-19 infection: A network meta-analysis of randomized controlled trials.
    J Med Virol. 2021 Dec 9. doi: 10.1002/jmv.27512.
    >> Share

  1104. KHAN N, Arshad A, Azam M, Al-Marshadi AH, et al
    Modelling and Forecasting the Total Number of Cases and Deaths Due to Pandemic.
    J Med Virol. 2021 Dec 8. doi: 10.1002/jmv.27506.
    >> Share

  1105. HERNANDEZ MM, Banu R, Gonzalez-Reiche AS, van de Guchte A, et al
    Robust clinical detection of SARS-CoV-2 variants by RT-PCR/MALDI-TOF multi-target approach.
    J Med Virol. 2021 Dec 7. doi: 10.1002/jmv.27510.
    >> Share

  1106. ROGER S, Lefeuvre C, Pivert A, Ducancelle A, et al
    What is the true place of the SARS-CoV-2 rapid point-of-care antigen test in the hospital setting? Lessons learned from real life.
    J Med Virol. 2021 Dec 6. doi: 10.1002/jmv.27505.
    >> Share

  1107. PARK AK, Rhee JE, Kim IH, Kim HM, et al
    Genomic evidence of SARS-CoV-2 reinfection in the Republic of Korea.
    J Med Virol. 2021 Dec 4. doi: 10.1002/jmv.27499.
    >> Share

  1108. DARIA S, Bhuiyan MA, Islam MR
    Detection of highly muted coronavirus variant Omicron (B.1.1.529) is triggering the alarm for South Asian countries: Associated risk factors and preventive actions.
    J Med Virol. 2021 Dec 4. doi: 10.1002/jmv.27503.
    >> Share

  1109. GAO X, Li G, Wang J, Xu T, et al
    Spatiotemporal evolution, pattern of diffusion and influencing factors of the COVID-19 epidemic in Hainan Province, China.
    J Med Virol. 2021 Dec 4. doi: 10.1002/jmv.27502.
    >> Share

  1110. WOO W, Kim AY, Yon DK, Lee SW, et al
    Clinical characteristics and prognostic factors of myocarditis associated with the mRNA COVID-19 vaccine.
    J Med Virol. 2021 Dec 4. doi: 10.1002/jmv.27501.
    >> Share

  1111. YAGHOUBI N, Youssefi M, Jabbari Azad F, Farzad F, et al
    Total antioxidant capacity (TAC) as a marker of severity of COVID-19 infection; possible prognostic and therapeutic clinical application.
    J Med Virol. 2021 Dec 4. doi: 10.1002/jmv.27500.
    >> Share

  1112. ZHANG X, Meng H, Liu H, Ye Q, et al
    Advances in laboratory detection methods and technology application of SARS-CoV-2.
    J Med Virol. 2021 Dec 2. doi: 10.1002/jmv.27494.
    >> Share

  1113. SHANG Y, Liang Y, Liu T, Li J, et al
    Public screening for COVID-19 in Wuhan, China and beware of the antibody positive in women and tumor patients.
    J Med Virol. 2021 Dec 1. doi: 10.1002/jmv.27483.
    >> Share

  1114. KOBAYASHI S, Taniguchi Y, Kida I, Tamura N, et al
    SARS-CoV2-triggered acute arthritis: Viral arthritis rather than reactive arthritis.
    J Med Virol. 2021;93:6458-6459.
    >> Share

    November 2021
  1115. GAO SJ, Guo H, Luo G
    Omicron variant (B.1.1.529) of SARS-CoV-2, a global urgent public health alert!
    J Med Virol. 2021 Nov 30. doi: 10.1002/jmv.27491.
    >> Share

  1116. SCHAEFER JW, Riley JM, Li M, Cheney-Peters DR, et al
    Comparing Reliability of ICD-10-Based COVID-19 Comorbidity Data to Manual Chart Review, a Retrospective Cross-Sectional Study.
    J Med Virol. 2021 Nov 30. doi: 10.1002/jmv.27492.
    >> Share

  1117. MOOSAZADEH M, Mousavi T
    Combination therapy of tocilizumab and steroid for COVID-19 patients: A meta-analysis.
    J Med Virol. 2021 Nov 30. doi: 10.1002/jmv.27489.
    >> Share

  1118. LIN Z, Niu J, Xu Y, Qin L, et al
    Clinical efficacy and adverse events of baricitinib treatment for coronavirus disease-2019 (COVID-19): A systematic review and meta-analysis.
    J Med Virol. 2021 Nov 30. doi: 10.1002/jmv.27482.
    >> Share

  1119. MILLAN MAD, Plaza NM, Santillan MG, Ortega AM, et al
    Prognostic factors and combined use of tocilizumab and corticosteroids in a Spanish cohort of elderly COVID-19 patients.
    J Med Virol. 2021 Nov 29. doi: 10.1002/jmv.27488.
    >> Share

  1120. LEVRING MB, Holm DK, Nilsson AC, Bauer JM, et al
    SARS-CoV-2 antibody kinetics in blood donors with a previously positive SARS-CoV-2 antibody test within a seroprevalence survey.
    J Med Virol. 2021 Nov 29. doi: 10.1002/jmv.27486.
    >> Share

  1121. MOHAMED K, Rzymski P, Islam MS, Makuku R, et al
    COVID-19 vaccinations: The unknowns, challenges, and hopes.
    J Med Virol. 2021 Nov 29. doi: 10.1002/jmv.27487.
    >> Share

  1122. FALAHI S, Kenarkoohi A
    Host Factors and Vaccine Efficacy: Implications for COVID- 19 Vaccines.
    J Med Virol. 2021 Nov 29. doi: 10.1002/jmv.27485.
    >> Share

  1123. YU M, Wang DC, Li S, Lei YH, et al
    Meta-analysis of arbidol versuslopinavir/ritonavir in the treatment of coronavirus disease 2019.
    J Med Virol. 2021 Nov 27. doi: 10.1002/jmv.27481.
    >> Share

  1124. TANI-SASSA C, Iwasaki Y, Ichimura N, Nagano K, et al
    Viral loads and profile of the patients infected with SARS-CoV-2 Delta, Alpha or R.1 variants in Tokyo.
    J Med Virol. 2021 Nov 26. doi: 10.1002/jmv.27479.
    >> Share

  1125. MAAN HS, Chaurasia D, Kapoor G, Dave L, et al
    Intestinal viral infections of nSARS-CoV2 in the Indian community; Risk of virus spread in India.
    J Med Virol. 2021 Nov 26. doi: 10.1002/jmv.27480.
    >> Share

  1126. FALLAHZADEH M, Pourhoseingholi MA, Boroujeni MG, Besharati S, et al
    Study of the Effects of Interferon beta-1a on Hospitalized Patients with COVID-19; SBMU Taskforce on the COVIFERON Study.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27475.
    >> Share

  1127. NIA MH, Rokni M, Mirinejad S, Kargar M, et al
    Association of polymorphisms in tumor necrosis factors with SARS-CoV-2 infection and mortality rate: a case-control study and in silico analyses.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27477.
    >> Share

  1128. YU J, Sun S, Tang Q, Wang C, et al
    Establish reference sequences for each clade of SARS-CoV-2 to provide a basis for virus variation and function research.
    J Med Virol. 2021 Nov 25. doi: 10.1002/jmv.27476.
    >> Share

  1129. MARSICO C, Capretti MG, Aceti A, Vocale C, et al
    Severe neonatal COVID-19: challenges in management and therapeutic approach.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27472.
    >> Share

  1130. MALTEZOU HC, Krumbholz B, Mavrouli M, Tseroni M, et al
    A study of the evolution of the third COVID-19 pandemic wave in the Athens metropolitan area, Greece, through two cross-sectional seroepidemiological surveys: March, June 2021.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27465.
    >> Share

  1131. KUMAR A, Parashar R, Kumar S, Faiq MA, et al
    Emerging SARS-CoV-2 variants can potentially break set epidemiological barriers in COVID-19.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27467.
    >> Share

  1132. LABRIOLA L, Ruelle J, Scohy A, Seghers F, et al
    Dynamics of spreading of SARS-CoV-2 in a Belgian hemodialysis facility: the importance of the analysis of viral strains.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27471.
    >> Share

  1133. OZER M, Goksu SY, Conception R, Ulker E, et al
    Effectiveness and Safety of Ivermectin in COVID-19 Patients: A Prospective Study at A Safety-Net Hospital.
    J Med Virol. 2021 Nov 23. doi: 10.1002/jmv.27469.
    >> Share

  1134. NAGHASHPOUR M, Ghiassian H, Mobarak S, Adelipour M, et al
    Profiling serum levels of glutathione reductase and interleukin-10 in positive and negative-PCR COVID-19 outpatients: a comparative study from southwestern Iran.
    J Med Virol. 2021 Nov 20. doi: 10.1002/jmv.27464.
    >> Share

  1135. RASHEDI R, Samieefar N, Masoumi N, Mohseni S, et al
    COVID-19 vaccines Mix-and-Match: The Concept, the Efficacy and the Doubts.
    J Med Virol. 2021 Nov 19. doi: 10.1002/jmv.27463.
    >> Share

  1136. GARCIA-SALGUERO C, Culebras E, Merino P, Baos E, et al
    Usefulness of SARS-CoV-2 Antigen Test Sample as input for SARS-CoV-2 RT-PCR analysis.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27459.
    >> Share

  1137. VALIAN NK, Pourakbari B, Ashari KA, Sadeghi RH, et al
    Evaluation of human coronavirus OC43 and SARS-COV-2 in children with respiratory tract infection during the COVID-19 pandemic.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27460.
    >> Share

  1138. SINGH UB, Rophina M, Chaudhry R, Senthivel V, et al
    Variants of Concern responsible for SARS-CoV-2 vaccine breakthrough infections from India.
    J Med Virol. 2021 Nov 16. doi: 10.1002/jmv.27461.
    >> Share

  1139. CHANDAN S, Khan SR, Deliwala S, Mohan BP, et al
    Postvaccination SARS-CoV-2 infection among healthcare workers - A Systematic Review and meta-analysis.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27457.
    >> Share

  1140. SIVAN M, Parkin A, Makower S, Greenwood DC, et al
    Post-COVID Syndrome symptoms, functional disability and clinical severity phenotypes in hospitalised and non-hospitalised individuals: a cross-sectional evaluation from a community COVID rehabilitation service.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27456.
    >> Share

  1141. BENJAMANUKUL S, Traiyan S, Yorsaeng R, Vichaiwattana P, et al
    Safety and immunogenicity of inactivated COVID-19 vaccine in health care workers.
    J Med Virol. 2021 Nov 15. doi: 10.1002/jmv.27458.
    >> Share

  1142. LIU K, Yang X, Feng C, Chen M, et al
    Clinical features and independent predictors for recurrence of positive SARS-CoV-2 RNA: A propensity score-matched analysis.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27450.
    >> Share

  1143. ANGELETTI S, Giovanetti M, Fogolari M, Cella E, et al
    SARS-CoV-2 AY.4.2 variant circulating in Italy: Genomic preliminary insight.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27451.
    >> Share

  1144. OZGOCER T, Dagli SN, Ceylan MR, Disli F, et al
    Analysis of long-term antibody response in COVID-19 patients by symptoms grade, gender, age, BMI, and medication.
    J Med Virol. 2021 Nov 12. doi: 10.1002/jmv.27452.
    >> Share

  1145. SONG J, Li C, Rivailler P, Wang H, et al
    Molecular evolution and genomic characteristics of genotype H1 of measles virus.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27448.
    >> Share

  1146. FORERO-PENA DA, Carrion-Nessi FS, Mendoza-Millan DL, Omana-Avila OD, et al
    First wave of COVID-19 in Venezuela: Epidemiological, clinical, and paraclinical characteristics of first cases.
    J Med Virol. 2021 Nov 11. doi: 10.1002/jmv.27449.
    >> Share

  1147. SAM IC, Chong YM, Abdullah A, Fu JYL, et al
    Changing predominant SARS-CoV-2 lineages drive successive COVID-19 waves in Malaysia, February 2020 to March 2021.
    J Med Virol. 2021 Nov 10. doi: 10.1002/jmv.27441.
    >> Share

  1148. LEROUX X, Schock M, Augereau O, Lessire H, et al
    Factors associated with mechanical ventilation in SARS-CoV-2 patients treated with high flow nasal cannula oxygen and outcomes.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27442.
    >> Share

  1149. BRONSTEIN Y, Adler A, Katash H, Halutz O, et al
    Evolution of spike mutations following antibody treatment in two immunocompromised patients with persistent COVID-19 infection.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27445.
    >> Share

  1150. BARRERA-AVALOS C, Luraschi R, Vallejos-Vidal E, Figueroa M, et al
    ANALYSIS BY REAL-TIME PCR OF FIVE TRANSPORT AND CONSERVATION MEDIUM OF NASOPHARYNGEAL SWAB SAMPLES TO COVID-19 DIAGNOSIS IN SANTIAGO OF CHILE.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27446.
    >> Share

  1151. KERBAGE A, Haddad S, Nasr L, Riachy A, et al
    Impact of ABO and Rhesus Blood Groups on COVID-19 Susceptibility and Severity: A Case-control Study.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27444.
    >> Share

  1152. FORERO-PENA DA, Hernandez MM, Herrera IPM, Espinal IBC, et al
    Remitting Neuropsychiatric Symptoms in COVID-19 Patients: Viral Cause or Drug Effect?
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27443.
    >> Share

  1153. FENG R, Wang B, Ma Z, Guo X, et al
    ALB level and COVID-19Dynamic change of serum albumin level can predict the prognosis of COVID-19 patients with hypoalbuminemia.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27439.
    >> Share

  1154. ALBAYAT SS, Arshad S, Arshad MA, Jabbar A, et al
    Precautionary measures for more transmissible C.1.2 COVID-19 variant: A caution for Qatar and the rest of the world.
    J Med Virol. 2021 Nov 9. doi: 10.1002/jmv.27438.
    >> Share

  1155. SKOREK A, Jazwinska-Curyllo A, Romanowicz A, Kwasniewski K, et al
    Assessment of anti-SARS-CoV-2 antibodies level in convalescents plasma.
    J Med Virol. 2021 Nov 5. doi: 10.1002/jmv.27433.
    >> Share

  1156. KIM HJ, Park MS, Il Shin J, Park J, et al
    Associations of heart failure with susceptibility and severe complications of COVID-19: A nationwide cohort study.
    J Med Virol. 2021 Nov 5. doi: 10.1002/jmv.27435.
    >> Share

  1157. UMAIR M, Ikram A, Salman M, Haider SA, et al
    Genomic surveillance reveals the detection of SARS-CoV-2 Delta, Beta and Gamma VOCs during the third wave in Pakistan.
    J Med Virol. 2021 Nov 2. doi: 10.1002/jmv.27429.
    >> Share

    October 2021
  1158. ADAMS O, Andree M, Rabl D, Ostermann PN, et al
    Humoral response to SARS-CoV-2 and seasonal coronaviruses in COVID-19 patients.
    J Med Virol. 2021 Oct 30. doi: 10.1002/jmv.27427.
    >> Share

  1159. CHEN W, Yao M, Hu L, Zhang Y, et al
    Development and Validation of clinical prediction model to estimate the risk of critical patients with COVID-19.
    J Med Virol. 2021 Oct 30. doi: 10.1002/jmv.27428.
    >> Share

  1160. FARAH Y, Syed Hasan A, Irfan U
    Norovirus Outbreak amid COVID-19 in the United Kingdom; Priorities for Achieving Control.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27426.
    >> Share

  1161. SAHIN D, Tanacan A, Erol SA, Yetiskin FDY, et al
    Management of Pregnant Women with COVID-19: A Tertiary Pandemic Center Experience on 1416 Cases.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27423.
    >> Share

  1162. CATTEL L, Giordano S, Traina S, Lupia T, et al
    Vaccine development and technology for SARS-CoV-2: current insights.
    J Med Virol. 2021 Oct 29. doi: 10.1002/jmv.27425.
    >> Share

  1163. KIM MS, Jung SY, Ahn JG, Park SJ, et al
    Comparative safety of mRNA COVID-19 vaccines to influenza vaccines: a pharmacovigilance analysis of WHO international database.
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27424.
    >> Share

  1164. YAMAMOTO Y, Shiroyama T, Hirata H, Kuge T, et al
    Prolonged corticosteroid therapy and cytomegalovirus infection in patients with severe COVID-19.
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27421.
    >> Share

  1165. PAPADOPOULOU A, Fragkou PC, Maratou E, Dimopoulou D, et al
    "Angiotensin-Converting-Enzyme Insertion/Deletion (I/D) polymorphism, ACE activity and COVID-19: a rather controversial hypothesis. A case - control study".
    J Med Virol. 2021 Oct 28. doi: 10.1002/jmv.27417.
    >> Share

  1166. UYSAL EB, Gumus S, Bektore B, Bozkurt H, et al
    EVALUATION OF ANTIBODY RESPONSE AFTER COVID-19 VACCINATION OF HEALTHCARE WORKERS.
    J Med Virol. 2021 Oct 27. doi: 10.1002/jmv.27420.
    >> Share

  1167. LAINE P, Nihtila H, Mustanoja E, Lyyski A, et al
    SARS-CoV-2 variant with mutations in N gene affecting detection by widely used PCR primers.
    J Med Virol. 2021 Oct 26. doi: 10.1002/jmv.27418.
    >> Share

  1168. RUBAYET UL ALAM ASM, Islam OK, Hasan MS, Islam MR, et al
    Dominant Clade-featured SARS-CoV-2 Co-occurring Mutations Reveals Plausible Epistasis: An in silico based Hypothetical Model.
    J Med Virol. 2021 Oct 22. doi: 10.1002/jmv.27416.
    >> Share

  1169. MONTALVO VILLALBA MC, Sosa Glaria E, Rodriguez Lay LLA, Valdes Ramirez O, et al
    Performance evaluation of Elecsys SARS-CoV-2 Antigen immunoassay for diagnostic of COVID-19.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27412.
    >> Share

  1170. ARSLAN GULEN T, Bayraktar M, Yaksi N, Kayabas U, et al
    Is the course of COVID-19 associated with tuberculin skin test diameter? A retrospective study.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27414.
    >> Share

  1171. O'CONNOR RJ, Preston N, Parkin A, Makower S, et al
    The COVID-19 Yorkshire Rehabilitation Scale (C19-YRS): application and psychometric analysis in a post-COVID-19 syndrome cohort.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27415.
    >> Share

  1172. KOMURCU SZM, Artik Y, Cesur NP, Tanriverdi A, et al
    THE EVALUATION POTENTIAL GLOBAL IMPACT OF THE N501Y MUTATION IN SARS-COV-2 POSITIVE PATIENTS.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27413.
    >> Share

  1173. BARROS-LEITE BRAF, Lima MRO, Caminha M, Santos K, et al
    Short-term functional changes after hospital discharge by COVID-19 through teleconsultation at a reference service in Northeast Brazil: a cross-sectional study.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27410.
    >> Share

  1174. ASADI-POOYA AA, Akbari A, Emami A, Lotfi M, et al
    Long COVID syndrome-associated brain fog.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27404.
    >> Share

  1175. MANIK M, Singh RK
    Role of toll-like receptors in modulation of cytokine storm signaling in SARS-CoV-2-induced COVID-19.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27405.
    >> Share

  1176. GOBEILLE PARE S, Bestman-Smith J, Fafard J, Doualla-Bell F, et al
    Natural spring water gargle samples as an alternative to nasopharyngeal swabs for SARS-CoV-2 detection using a laboratory-developed test.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27407.
    >> Share

  1177. LI X
    Concerns on the multiple nomenclature systems for SARS-CoV-2.
    J Med Virol. 2021 Oct 21. doi: 10.1002/jmv.27406.
    >> Share

  1178. KAYA H, Usuda D
    Duration from onset to discharge is longer in COVID-19 patients with low blood regulatory T-cell counts.
    J Med Virol. 2021 Oct 18. doi: 10.1002/jmv.27401.
    >> Share

  1179. D'ETTORRE G, Gentilini Cacciola E, Santinelli L, De Girolamo G, et al
    Covid-19 sequelae in working age patients: A systematic review.
    J Med Virol. 2021 Oct 16. doi: 10.1002/jmv.27399.
    >> Share

  1180. ISLAM K, Molla MA, Hasan P, Sharif M, et al
    Title: Persistence of Sleep Disturbance among Post-Covid Patients: Findings from a two-month follow-up study in a Bangladeshi cohort.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27397.
    >> Share

  1181. QUINCOZES-SANTOS A, Rosa RLD, Bobermin LD, Tureta EF, et al
    Association between molecular markers of COVID-19 and Alzheimer's disease.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27391.
    >> Share

  1182. KASHIMA S, Slavov SN, Giovanetti M, Rodrigues ES, et al
    INTRODUCTION OF SARS-COV-2 C.37 (WHO VOI LAMBDA) IN THE SAO PAULO STATE, SOUTHEAST BRAZIL.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27389.
    >> Share

  1183. LINO K, Alves LS, Raposo JV, Medeiros T, et al
    Presence and clinical impact of human Herpesvirus-6 infection in patients with moderate to critical Coronavirus disease-19.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27392.
    >> Share

  1184. ULHAQ ZS, Soraya GV, Indriana K, Devitasari R, et al
    The level of Ig anti-RBD SARS-CoV-2 after two doses of CoronaVac vaccine.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27390.
    >> Share

  1185. ALEXIEV I, Ivanov I, Philipova I, Korsun N, et al
    Postvaccination SARS-CoV-2 Alpha (B.1.1.7) Lineage Infection among Healthcare Workers on the Background of IgG Antibodies.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27394.
    >> Share

  1186. TONG L, Ji L, Li D, Xu H, et al
    The occurrence of COVID-19 is associated with air quality and relative humidity.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27395.
    >> Share

  1187. SILVA VO, Yamashiro R, Ahagon CM, Campos IB, et al
    Inhibition of Receptor-Binding Domain - ACE2 interaction after two doses of Sinovac's CoronaVac or AstraZeneca/Oxford's AZD1222 SARS-CoV-2 vaccines.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27396.
    >> Share

  1188. KUNO T, Sahashi Y, Kawahito S, Takahashi M, et al
    Prediction of in-hospital mortality with machine learning for COVID-19 patients treated with steroid and Remdesivir.
    J Med Virol. 2021 Oct 14. doi: 10.1002/jmv.27393.
    >> Share

  1189. DEHNEN D, Dehnen K, Trilling M, Fiedler M, et al
    Discrepancy between frequent occurrence of COVID-19-like symptoms and low seroconversion rates among healthcare workers.
    J Med Virol. 2021 Oct 11. doi: 10.1002/jmv.27385.
    >> Share

  1190. NANCHAL R, Patel D, Guddati AK, Sakhuja A, et al
    Outcomes of Covid 19 Patients - Are Hispanics at greater risk?
    J Med Virol. 2021 Oct 11. doi: 10.1002/jmv.27384.
    >> Share

  1191. DASH GC, Subhadra S, Turuk J, Parai D, et al
    Breakthrough SARS-CoV-2 infections among BBV-152 (COVAXIN(R)) and AZD1222 (COVISHIELDT(M) ) recipients: Report from eastern state of India.
    J Med Virol. 2021 Oct 8. doi: 10.1002/jmv.27382.
    >> Share

  1192. DUMONT S, Balduyck J, Reynders M, Vanwalleghem L, et al
    Acute SARS-CoV-2 Alpha variant infection leading to placental insufficiency and fetal distress.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27379.
    >> Share

  1193. TREGGIARI D, Piubelli C, Caldrer S, Mistretta M, et al
    SARS-CoV-2 rapid antigen test in comparison to RT-PCR targeting different genes: a real-life evaluation among unselected patients in a regional hospital of Italy.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27378.
    >> Share

  1194. BORETTI A, Banik B
    Modulation of Covid-19 cytokine storm by Tocilizumab.
    J Med Virol. 2021 Oct 7. doi: 10.1002/jmv.27380.
    >> Share

  1195. TIAN D, Sun Y, Zhou J, Ye Q, et al
    The global epidemic of SARS-CoV-2 variants and their mutational immune escape.
    J Med Virol. 2021 Oct 5. doi: 10.1002/jmv.27376.
    >> Share

  1196. KUNO T, So M, Takahashi M, Egorova NN, et al
    The association between famotidine and in-hospital mortality of patients with COVID-19.
    J Med Virol. 2021 Oct 5. doi: 10.1002/jmv.27375.
    >> Share

  1197. WOLF JM, Kipper D, Borges GR, Streck AF, et al
    Temporal spread and evolution of SARS-CoV-2 in the second pandemic wave in Brazil.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27371.
    >> Share

  1198. MUTNAL MB, Johnson S, Mohamed N, Abddelgader R, et al
    Surveillance genome sequencing reveal multiple SARS-CoV-2 variants circulating in the central Texas, USA with a predominance of Delta variant and review of vaccine breakthrough cases.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27373.
    >> Share

  1199. LI H, Liu T, Wang L, Wang M, et al
    SARS-CoV-2 Delta Variant infects ACE2(low) primary human bronchial epithelial cells more efficiently than other variants.
    J Med Virol. 2021 Oct 1. doi: 10.1002/jmv.27372.
    >> Share

    September 2021
  1200. MAK GCK, Au SSM, Yeung MCW, Lau DMW, et al
    Evaluation of rapid antigen detection test for individuals at risk of SARS-CoV-2 under quarantine.
    J Med Virol. 2021 Sep 30. doi: 10.1002/jmv.27369.
    >> Share

  1201. MORELAND A, Gillezeau C, Alpert N, Taioli E, et al
    Assessing influenza vaccination success to inform COVID-19 vaccination campaign.
    J Med Virol. 2021 Sep 30. doi: 10.1002/jmv.27368.
    >> Share

  1202. BERNARDINI N, Skroza N, Mambrin A, Proietti I, et al
    Herpes Zoster Ophthalmicus in two women after Pfizer-Biontech(BNT162b2) vaccine.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27366.
    >> Share

  1203. CHENEY-PETERS DR, Crystal Y Lee M P H, Mitsuhashi S, Zaret DS, et al
    Association of race/ethnicity and socioeconomic status with COVID-19 30-day mortality at a Philadelphia medical center using a retrospective cohort study.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27365.
    >> Share

  1204. BIRD PW, Riff R, Folwell A, Holmes CW, et al
    Increased incidence of COVID-19 in younger patients (May-July 2021) - an argument for extending vaccination?
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27363.
    >> Share

  1205. BOSTAN E, Jarbou A
    Atypical Pityriasis Rosea Associated with mRNA Covid-19 Vaccine.
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27364.
    >> Share

  1206. GULHAN PY, Eroz R, Ataoglu O, Ince N, et al
    Can Caspase-3 Gene Expression Levels Show the Degree of Injury in Cells in SARS-CoV-2 Infection?
    J Med Virol. 2021 Sep 29. doi: 10.1002/jmv.27362.
    >> Share

  1207. GOLBETS E, Kaplan A, Shafat T, Yagel Y, et al
    Secondary Organizing Pneumonia After Recovery of Mild COVID-19 Infection.
    J Med Virol. 2021 Sep 28. doi: 10.1002/jmv.27360.
    >> Share

  1208. WU J, Tang J, Zhang T, Chen YC, et al
    SARS-CoV-2 Delta VOC pneumonia with CT follow-ups: a case report.
    J Med Virol. 2021 Sep 28. doi: 10.1002/jmv.27361.
    >> Share

  1209. SONI S, Pudake RN, Jain U, Chauhan N, et al
    A systematic review on SARS-CoV-2 Associated Fungal Co-Infections.
    J Med Virol. 2021 Sep 27. doi: 10.1002/jmv.27358.
    >> Share

  1210. KUMAR G, Patel D, Hererra M, Jefferies D, et al
    Do High Dose Corticosteroids Improve Outcomes in Hospitalized COVID-19 Patients?
    J Med Virol. 2021 Sep 24. doi: 10.1002/jmv.27357.
    >> Share

  1211. MESQUITA JR, Barradas P, Silva PGD, Ferreira AS, et al
    SARS-CoV-2 and blood donations in Portugal, June-July 2020.
    J Med Virol. 2021 Sep 21. doi: 10.1002/jmv.27353.
    >> Share

  1212. SEBASTIAO CS, Gaston C, Paixao JP, Sacomboio ENM, et al
    Coinfection between SARS-CoV-2 and vector-borne diseases in Luanda, Angola.
    J Med Virol. 2021 Sep 21. doi: 10.1002/jmv.27354.
    >> Share

  1213. ZHANG RK, Xiao Q, Zhu SL, Lin HY, et al
    Using Different Machine Learning Models to Classify Patients with Mild and Severe Cases of COVID-19 Based on Multivariate Blood Testing.
    J Med Virol. 2021 Sep 20. doi: 10.1002/jmv.27352.
    >> Share

  1214. YAQOOB H, Greenberg D, Hwang F, Lee C, et al
    COMPARISON OF PULSE-DOSE AND HIGH-DOSE CORTICOSTEROIDS WITH NO CORTICOSTEROID TREATMENT FOR COVID-19 PNEUMONIA IN THE INTENSIVE CARE UNIT.
    J Med Virol. 2021 Sep 20. doi: 10.1002/jmv.27351.
    >> Share

  1215. KESKIN AU, Bolukcu S, Ciragil P, Topkaya AE, et al
    SARS-CoV-2 specific antibody responses after third CoronaVac or BNT162b2 vaccine following two-dose CoronaVac vaccine regimen.
    J Med Virol. 2021 Sep 18. doi: 10.1002/jmv.27350.
    >> Share

  1216. LI D, Liu Y, Lu Y, Gao S, et al
    Palmitoylation of SARS-CoV-2 S protein is critical for S-mediated syncytia formation and virus entry.
    J Med Virol. 2021 Sep 16. doi: 10.1002/jmv.27339.
    >> Share

  1217. BANO I, Sharif M, Alam S
    Genetic drift in the genome of SARS COV-2 and its global health concern.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27337.
    >> Share

  1218. KITAGAWA Y, Imai K, Matsuoka M, Fukada A, et al
    Evaluation of the correlation between the Access SARS-CoV-2 IgM and IgG II antibody tests with the SARS-CoV-2 surrogate virus neutralization test.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27338.
    >> Share

  1219. LIU H, Li J, Lin Y, Bo X, et al
    Assessment of two-pool multiplex long-amplicon nanopore sequencing of SARS-CoV-2.
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27336.
    >> Share

  1220. CHEN JM
    Should the world collaborate imminently to develop neglected live attenuated vaccines for COVID-19?
    J Med Virol. 2021 Sep 15. doi: 10.1002/jmv.27335.
    >> Share

  1221. YUE L, Xie T, Yang T, Zhou J, et al
    A third booster dose may be necessary to mitigate neutralizing antibody fading after inoculation with two doses of an inactivated SARS-CoV-2 vaccine.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27334.
    >> Share

  1222. PHILLIPS MC, Sarff L, Banerjee J, Coffey C, et al
    Effect of Mortality from COVID-19 on Inpatient Outcomes.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27332.
    >> Share

  1223. MESSALI S, Campisi G, Giovanetti M, Ciccozzi M, et al
    The first Italian outbreak of SARS-CoV-2 B.1.1.7 lineage in Corzano, Lombardy.
    J Med Virol. 2021 Sep 13. doi: 10.1002/jmv.27333.
    >> Share

  1224. WANG S, Xu X, Wei C, Li S, et al
    Molecular evolutionary characteristics of SARS-CoV-2 emerging in the United States.
    J Med Virol. 2021 Sep 10. doi: 10.1002/jmv.27331.
    >> Share

  1225. KAZMI SK, Khan FMA, Natoli V, Hunain R, et al
    Viral hepatitis amidst COVID-19 in Africa: Implications and Recommendations.
    J Med Virol. 2021 Sep 10. doi: 10.1002/jmv.27330.
    >> Share

  1226. UMAIR M, Ikram A, Badar N, Haider SA, et al
    Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27328.
    >> Share

  1227. TSANG AKL, Mak GCK, Leung PKL, Cheng PKC, et al
    Emergence of SARS-CoV-2 lineage B.1.617.2 in the local community of Hong Kong.
    J Med Virol. 2021 Sep 9. doi: 10.1002/jmv.27326.
    >> Share

  1228. DIVINO F, Ciccozzi M, Farcomeni A, Lasinio GJ, et al
    Unreliable predictions about COVID-19 infections and hospitalizations make people worry: the case of Italy.
    J Med Virol. 2021 Sep 8. doi: 10.1002/jmv.27325.
    >> Share

  1229. CHAUDHRY R, Sreenath K, Batra P, Vinayaraj EV, et al
    Atypical bacterial co-infections among patients with COVID-19: a study from India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27324.
    >> Share

  1230. PANDOLFI S, Chirumbolo S
    On reaching herd immunity during COVID-19 pandemic and further issues.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27322.
    >> Share

  1231. TANISLAV C, Kostev K
    Fewer non-Covid-19 respiratory tract infections and gastro-intestinal infections during the Covid-19 pandemic.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27321.
    >> Share

  1232. SARGIN ALTUNOK E, Satici C, Dinc V, Kamat S, et al
    Comparison of demographic and clinical characteristics of hospitalized COVID-19 patients with severe/critical illness in the first wave vs the second wave.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27319.
    >> Share

  1233. KAUR U, Bala S, Mbbs BO, Mbbs SJ, et al
    Occurrence of COVID-19 in priority groups receiving ChAdOx1 nCoV-19 coronavirus vaccine (recombinant): a preliminary analysis from north India.
    J Med Virol. 2021 Sep 7. doi: 10.1002/jmv.27320.
    >> Share

  1234. YIGIT M, Ozkaya-Parlakay A, Cosgun Y, Ince YE, et al
    SHOULD A THIRD BOOSTER DOSE BE SCHEDULED AFTER TWO DOSES OF CORONAVAC? A SINGLE CENTER EXPERIENCE.
    J Med Virol. 2021 Sep 6. doi: 10.1002/jmv.27318.
    >> Share

  1235. FINSTERER J, Almas T
    Guillain-Barre syndrome is immunogenic in SARS-CoV-2 infected.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27314.
    >> Share

  1236. SODEIFIAN F, Nikfarjam M, Kian N, Mohamed K, et al
    The Role of Type I Interferon in the Treatment of COVID-19.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27317.
    >> Share

  1237. PANDA S, Roy S, Garg RK, Hui G, et al
    COVID-19 Disease in Hospitalised Young Adults in India and China: Evaluation of Risk Factors Predicting Progression Across Two Major Ethnic Groups.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27315.
    >> Share

  1238. YALCIN TY, Topcu DI, Dogan O, Aydin S, et al
    Immunogenicity After Two Doses of Inactivated Virus Vaccine in Healthcare Workers with and without Previous COVID-19 Infection: Prospective Observational Study.
    J Med Virol. 2021 Sep 1. doi: 10.1002/jmv.27316.
    >> Share

    August 2021
  1239. MALIK P, Patel K, Pinto C, Jaiswal R, et al
    Post-acute COVID-19 syndrome (PCS) and Health related Quality of life (HRQoL)- A systematic review and Meta-analysis.
    J Med Virol. 2021 Aug 31. doi: 10.1002/jmv.27309.
    >> Share

  1240. MOUSAVI SA, Heydari K, Mehravaran H, Saeedi M, et al
    Melatonin effects on sleep quality and outcomes of COVID-19 patients: An open-label, Randomized, Controlled Trial.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27312.
    >> Share

  1241. AKINOSOGLOU K, Delastic AL, Dimakopoulou V, Marangos M, et al
    Elements of Th1 / Th2 response and disease severity in COVID-19 patients: A short report.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27313.
    >> Share

  1242. FERNANDEZ J, Bruneau N, Fasce R, Martin HS, et al
    Neutralization of Alpha, Gamma, and D614G SARS-CoV-2 variants by CoronaVac vaccine-induced antibodies.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27310.
    >> Share

  1243. XIE XP, Sheng LP, Han CQ, Jin Y, et al
    Features of capsule endoscopy in COVID-19 patients with a six-month follow up: a prospective observational study.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27308.
    >> Share

  1244. MISHRA B, Ranjan J, Purushotham P, Saha S, et al
    High proportion of low cycle threshold value as an early indicator of COVID-19 surge.
    J Med Virol. 2021 Aug 30. doi: 10.1002/jmv.27307.
    >> Share

  1245. WASIM U, Tahir MJ, Siddiqi AR, Jabbar A, et al
    The impact of the COVID-19 pandemic on impending cancer deaths due to delays in diagnosis in the UK.
    J Med Virol. 2021 Aug 28. doi: 10.1002/jmv.27305.
    >> Share

  1246. RATHORE SS, Hussain N, Manju AH, Wen Q, et al
    Prevalence and clinical outcomes of pleural effusion in COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27301.
    >> Share

  1247. OLEA B, Albert E, Torres I, Gozalbo-Rovira R, et al
    SARS-CoV-2 N-antigenemia in critically ill adult COVID-19 patients: frequency and association with inflammatory and tissue-damage biomarkers.
    J Med Virol. 2021 Aug 27. doi: 10.1002/jmv.27300.
    >> Share

  1248. PLASENCIA-DUENAS R, Failoc-Rojas VE, Rodriguez-Morales AJ
    Impact of the COVID-19 pandemic on the incidence of dengue fever in Peru.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27298.
    >> Share

  1249. SARKAR S, Kannan S, Khanna P, Singh AK, et al
    Role of platelet-to-lymphocyte count ratio (PLR), as a prognostic indicator in COVID-19: A systematic review and meta-analysis.
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27297.
    >> Share

  1250. CATALAN IP, Marti CR, Sota DP, Alvarez AC, et al
    "Corticosteroids for COVID-19 symptoms and quality of life at one year from admission".
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27296.
    >> Share

  1251. CABRELLE G, Zanon C, Crimi F, Quaia E, et al
    Can rapid antibody tests and chest computed tomography really substitute real-time polymerase chain reaction in COVID-19?
    J Med Virol. 2021 Aug 26. doi: 10.1002/jmv.27295.
    >> Share

  1252. PORTILHO AI, Silva VO, Ahagon CM, Matsuda EM, et al
    Humoral response to spike S1 and S2 and nucleocapsid proteins on microarray after SARS-CoV-2 infection.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27290.
    >> Share

  1253. BAYRAKTAR N, Turan H, Bayraktar M, Ozturk A, et al
    Analysis of serum cytokine and protective vitamin D levels in severe cases of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27294.
    >> Share

  1254. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Incomplete IgG avidity maturation after seasonal coronavirus infections.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27291.
    >> Share

  1255. YAZDANPANAH N, Rezaei N
    Autoimmune Complications of COVID-19.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27292.
    >> Share

  1256. MURAT K, Ediz TE
    The Effectiveness of Inactivated SARS-CoV-2 Vaccine (CoronaVac) on Antibody Response in Participants Aged 65 Years and Older.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27289.
    >> Share

  1257. ZAWBAA HM, Osama H, El-Gendy A, Saeed H, et al
    Effect of mutation and vaccination on spread, severity, and mortality of COVID-19 disease.
    J Med Virol. 2021 Aug 24. doi: 10.1002/jmv.27293.
    >> Share

  1258. OZDEMIR O
    Re-activation or Re-infection of COVID-19 disease?
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27286.
    >> Share

  1259. BOSHIER FAT, Pang J, Penner J, Parker M, et al
    Evolution of viral variants in remdesivir treated and untreated SARS-CoV-2 infected paediatrics patients.
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27285.
    >> Share

  1260. DOLSCHEID-POMMERICH R, Bartok E, Renn M, Kummerer BM, et al
    Correlation Between a Quantitative Anti-SARS-CoV-2 IgG ELISA and Neutralization Activity.
    J Med Virol. 2021 Aug 20. doi: 10.1002/jmv.27287.
    >> Share

  1261. KAWASUJI H, Morinaga Y, Tani H, Yoshida Y, et al
    SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.
    J Med Virol. 2021 Aug 19. doi: 10.1002/jmv.27282.
    >> Share

  1262. GHORBANI SS, Taherpour N, Bayat S, Ghajari H, et al
    Epidemiologic characteristics of cases with re-infection, recurrence and hospital readmission due to COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2021 Aug 19. doi: 10.1002/jmv.27281.
    >> Share

  1263. SHAKERI H, Azimian A, Ghasemzadeh-Moghaddam H, Safdari M, et al
    Evaluation of the Relationship Between Serum levels of Zinc, Vitamin B12, Vitamin D and Clinical outcomes in Patients with COVID-19.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27277.
    >> Share

  1264. STOECKLE K, Witting B, Kapadia S, An A, et al
    Elevated Inflammatory Markers Are Associated With Poor Outcomes in COVID-19 Patients Treated With Remdesivir.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27280.
    >> Share

  1265. AI S, Awford A, Roncolato F
    Hemophagocytic lymphohistiocytosis following ChAdOx1 nCov-19 vaccination.
    J Med Virol. 2021 Aug 18. doi: 10.1002/jmv.27279.
    >> Share

  1266. HASAN MM, Mohanan P, Emmanuella N, Costa ACDS, et al
    Challenges of HIV amidst COVID-19 in Africa: Can we conquer them?
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27276.
    >> Share

  1267. TANG F, Zhang X, Zhang B, Zhu B, et al
    A nomogram prediction of outcome in patients with COVID-19 based on individual characteristics incorporating immune response-related indicators.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27275.
    >> Share

  1268. YAN X, Chen G, Jin Z, Zhang Z, et al
    Anti-SARS-CoV-2 IgG levels in relation to disease severity of COVID-19.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27274.
    >> Share

  1269. EBRAHIMI M, Farhadian N, Amiri AR, Hataminia F, et al
    Evaluating the efficacy of extracted squalene from seed oil in the form of microemulsion for the treatment of COVID-19: A clinical study.
    J Med Virol. 2021 Aug 17. doi: 10.1002/jmv.27273.
    >> Share

  1270. YILMAZ G, Ebru O, Ibrahim B, Ulkem C, et al
    ASSESSMENT OF CLINICAL OUTCOMES IN RENAL TRANSPLANT RECIPIENTS WITH COVID-19.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27271.
    >> Share

  1271. FARI G, de Sire A, Giorgio V, Rizzo L, et al
    Impact of COVID-19 on the mental health in a cohort of Italian Rehabilitation health care workers.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27272.
    >> Share

  1272. STRUCK F, Schreiner P, Staschik E, Wochinz-Richter K, et al
    Vaccination versus infection with SARS-CoV-2: Establishment of a high avidity IgG response versus incomplete avidity maturation.
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27270.
    >> Share

  1273. DENG J, Heybati K, Zhou F
    Letter to the editor in response to "Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis".
    J Med Virol. 2021 Aug 13. doi: 10.1002/jmv.27269.
    >> Share

  1274. ABBASS S, Salama M, Salman T, Sabry A, et al
    fficacy and safety of Sofosbuvir plus Daclatasvir or Ravidasvir in patients with COVID-19, A Randomized Controlled Trial.
    J Med Virol. 2021 Aug 11. doi: 10.1002/jmv.27264.
    >> Share

  1275. ZHOU R, Liu L, Wang Y
    Viral Proteins Recognized by Different TLRs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27265.
    >> Share

  1276. CICCOZZI M, Maruotti A, Ceccarelli G, Divino F, et al
    While we are discussing...the SARS-CoV-2 virus laughs.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27266.
    >> Share

  1277. MUNGMUNPUNTIPANTIP R, Wiwanitkit V
    Antibody response to SARS-CoV-2 vaccination, previous SARS-CoV-2 infection and change to single dose vaccination.
    J Med Virol. 2021 Aug 10. doi: 10.1002/jmv.27263.
    >> Share

  1278. CHI G, Memar Montazerin S, Lee JJ, Kazmi SHA, et al
    Effect of Azithromycin and Hydroxychloroquine in Patients Hospitalized with COVID-19: Network Meta-Analysis of Randomized Controlled Trials.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27259.
    >> Share

  1279. PADILLA-ROJAS C, Jimenez-Vasquez V, Hurtado V, Mestanza O, et al
    Genomic analysis reveals a rapid spread and predominance of Lambda (C.37) SARS-COV-2 lineage in Peru despite circulation of variants of concern.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27261.
    >> Share

  1280. KUNO T, So M, Miyamoto Y, Iwagami M, et al
    The association of COVID-19 antibody with in-hospital outcomes in COVID-19 infected patients.
    J Med Virol. 2021 Aug 9. doi: 10.1002/jmv.27260.
    >> Share

  1281. ESSAR MY, Kazmi SK, Hasan MM, Santos Costa ACD, et al
    The rampant use of cow-dung to treat COVID-19: Is India at the brink of a zoonotic disease outbreak?
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27258.
    >> Share

  1282. QURESHI QH, Ashraf T, Rehman K, Khosa MK, et al
    Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population.
    J Med Virol. 2021 Aug 5. doi: 10.1002/jmv.27256.
    >> Share

  1283. GUAN Y, Chen C, Guo A, Wei J, et al
    Prolonged Symptom Onset to Admission Time is Associated with Severe Coronavirus Disease: A Meta combined Propensity-adjusted Analysis.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27253.
    >> Share

  1284. ABDULAH DM
    ABDULAHPrevalence and correlates of COVID-19 vaccine hesitancy in general public in Iraqi Kurdistan: A cross-sectional study.
    J Med Virol. 2021 Aug 4. doi: 10.1002/jmv.27255.
    >> Share

    July 2021
  1285. WERFEL S, Jakob CEM, Borgmann S, Schneider J, et al
    Development and Validation of a Simplified Risk Score for the Prediction of Critical COVID-19 Illness in Newly Diagnosed Patients.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27252.
    >> Share

  1286. UNSALER S, Okan A, Tekin S, Hafiz AM, et al
    Comparison of nasopharyngeal swab and nasopharyngeal aspiration in adults for SARS-CoV-2 identification using reverse transcription-polymerase chain reaction.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27250.
    >> Share

  1287. DESHPANDE K, Pt U, Kaduskar O, Vijay N, et al
    Performance assessment of seven SARS-CoV-2 IgG enzyme linked immunosorbent assays.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27251.
    >> Share

  1288. CASSUTO NG, Gravier A, Colin M, Theillay A, et al
    Evaluation of a SARS-CoV-2 antigen-detecting rapid diagnostic test as a self-test: diagnostic performance and usability.
    J Med Virol. 2021 Jul 31. doi: 10.1002/jmv.27249.
    >> Share

  1289. MESSALI S, Bertelli A, Campisi G, Zani A, et al
    A cluster of the new SARS-CoV-2 B.1.621 lineage in Italy and sensitivity of the viral isolate to the BNT162b2 vaccine.
    J Med Virol. 2021 Jul 30. doi: 10.1002/jmv.27247.
    >> Share

  1290. GHOLIPOUR E, Vizvari B, Babaqi T, Takacs S, et al
    Statistical analysis of the Hungarian COVID-19 victims.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27242.
    >> Share

  1291. BUTT MH, Safdar A, Amir A, Zaman M, et al
    Arboviral Diseases and COVID-19 Coincidence: Challenges for Pakistan's Derelict Healthcare System.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27241.
    >> Share

  1292. BENOIT P, Labbe AC, Lalancette L, Gagnon S, et al
    Comparison of SARS-CoV-2 detection with the cobas(R) 6800/8800 system on gargle samples using two sample processing methods with combined oropharyngeal/nasopharyngeal swab.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27245.
    >> Share

  1293. ZHANG F, Li W, Feng J, Ramos da Silva S, et al
    SARS-CoV-2 pseudovirus infectivity and expression of viral entry-related factors ACE2, TMPRSS2, Kim-1 and NRP-1 in human cells from respiratory, urinary, digestive, reproductive and immune systems.
    J Med Virol. 2021 Jul 29. doi: 10.1002/jmv.27244.
    >> Share

  1294. KARA AA, Boncuoglu E, Kiymet E, Arikan KO, et al
    Evaluation of predictors of severe-moderate COVID-19 infections at children: a review of 292 children.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27237.
    >> Share

  1295. WAN Z, Zhao Y, Lu R, Dong Y, et al
    Rapid antigen detection alone may not be sufficient for early diagnosis and/or mass screening of COVID-19.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27236.
    >> Share

  1296. KERGET F, Kerget B, Kahraman CY, Araz O, et al
    Evaluation of the relationship between pentraxin 3 (PTX3) rs2305619 (281A/G) and rs1840680 (1449A/G) polymorphisms and the clinical course of COVID-19.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27238.
    >> Share

  1297. NAGANO K, Tani-Sassa C, Iwasaki Y, Takatsuki Y, et al
    SARS-CoV-2 R.1 lineage variants prevailed in Tokyo in March 2021.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27240.
    >> Share

  1298. BAJ A, Novazzi F, Ferrante FD, Genoni A, et al
    Introduction of SARS-COV-2 C.37 (WHO VOI lambda) from Peru to Italy.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27235.
    >> Share

  1299. WU B, Zhang H, Wang YC, Tang A, et al
    Sequencing on an imported case in China of COVID-19 Delta variant emerging from India in a cargo ship in Zhoushan, China.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27239.
    >> Share

  1300. SAADATIAN-ELAHI M, Amour S, Elias C, Henaff L, et al
    Tobacco smoking and severity of COVID-19: Experience from a hospital-based prospective cohort study in Lyon-France.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27233.
    >> Share

  1301. LI XQ, Liu H, Yin HY, Gao WY, et al
    Critical roles of cytokine storm and secondary bacterial infection in acute kidney injury development in COVID-19: A multi-center retrospective cohort study.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27234.
    >> Share

  1302. KANEKO S, Kurosaki M, Sugiyama T, Takahashi Y, et al
    The dynamics of quantitative SARS-CoV-2 anti-spike IgG response to BNT162b2 vaccination.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27231.
    >> Share

  1303. MORENO-ESCOBAR MC, Feizi P, Podury S, Tandon M, et al
    Acute Cerebellitis following SARS-CoV-2 infection: A Case Report and Review of Literature.
    J Med Virol. 2021 Jul 27. doi: 10.1002/jmv.27232.
    >> Share

  1304. LIU T, Chen Z, Xu J
    Epidemiological characteristics and incubation period of SARS-CoV-2 during the 2020-2021 winter pandemic wave in north China: an observational study.
    J Med Virol. 2021 Jul 24. doi: 10.1002/jmv.27226.
    >> Share

  1305. REICH N, Lowe CF, Puddicombe D, Matic N, et al
    Repeat virological and serological profiles in hospitalized patients initially tested by nasopharyngeal RT-PCR for SARS-CoV-2.
    J Med Virol. 2021 Jul 23. doi: 10.1002/jmv.27227.
    >> Share

  1306. LIN Z, Qing H, Li R, Zheng L, et al
    Evolution Trace of SARS-CoV-2 from January 19 to March 12, 2020 in the United States.
    J Med Virol. 2021 Jul 22. doi: 10.1002/jmv.27225.
    >> Share

  1307. SPRENGHOLZ P, Betsch C
    Previous SARS-CoV-2 infection is linked to lower vaccination intentions.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27221.
    >> Share

  1308. SUVVARI TK, Kutikuppala LS, Tsagkaris C, Corriero AC, et al
    Post COVID-19 Complications: Multi-Systemic Approach.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27222.
    >> Share

  1309. UWISHEMA O, Nnagha EM, Chalhoub E, Nchasi G, et al
    Dengue fever outbreak in Cook Island: A rising concern, Efforts, Challenges and Future recommendations.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27223.
    >> Share

  1310. NEISES JZ, Hossain MS, Sultana R, Wanniarachchi KN, et al
    Seroprevalence of SARS-CoV-2 Antibodies Among Rural Healthcare Workers.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27224.
    >> Share

  1311. HATTATOGLU DG, Yildiz BP
    Comparison Of Clinical And Biochemical Features Of Hospitalized COVID-19 And Influenza Pneumonia Patients.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27218.
    >> Share

  1312. CARBONELL-SAHUQUILLO S, Lazaro-Carreno MI, Camacho J, Barres-Fernandez A, et al
    Evaluation of a rapid antigen detection test (Panbio COVID-19 Ag Rapid Test Device) as a point-of-care diagnostic tool for COVID-19 in a Pediatric Emergency Department.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27220.
    >> Share

  1313. UWISHEMA O, Alshareif BAA, Yousif MYE, Omer MEA, et al
    Lassa fever amidst the COVID-19 Pandemic in Africa: A rising concern, Efforts, Challenges and Future recommendations.
    J Med Virol. 2021 Jul 21. doi: 10.1002/jmv.27219.
    >> Share

  1314. WENBAN C, Heer RS, Baktash V, Kandiah P, et al
    Dexamethasone treatment may mitigate adverse effects of vitamin D deficiency in hospitalised Covid-19 patients.
    J Med Virol. 2021 Jul 17. doi: 10.1002/jmv.27215.
    >> Share

  1315. NICHOLS L, Thompson M, Bentz GL
    Comparison of clinical characteristics of a patient with Epstein-Barr virus-associated seizure and patients with COVID-19-associated seizure.
    J Med Virol. 2021 Jul 16. doi: 10.1002/jmv.27197.
    >> Share

  1316. AL KHAMES AGA QA, Alkhaffaf WH, Hatem TH, Nassir KF, et al
    SAFETY OF COVID-19 VACCINES.
    J Med Virol. 2021 Jul 16. doi: 10.1002/jmv.27214.
    >> Share

  1317. LING Y, Zhong J, Luo J
    Safety and Effectiveness of SARS-CoV-2 Vaccines: A Systematic Review and Meta-Analysis.
    J Med Virol. 2021 Jul 15. doi: 10.1002/jmv.27203.
    >> Share

  1318. ARANHA C, Patel V, Bhor V, Gogoi D, et al
    Cycle threshold values in RT-PCR to determine dynamics of SARS-CoV-2 viral load: An approach to reduce isolation period for COVID-19 patients.
    J Med Virol. 2021 Jul 15. doi: 10.1002/jmv.27206.
    >> Share

  1319. ABOBAKER A, Darrat M
    The association between biochemically confirmed thyroid gland disorder and morbidity and mortality in patients with COVID-19.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27213.
    >> Share

  1320. UWISHEMA O, Adanur I, Babatunde AO, Hasan MM, et al
    Viral Infections amidst COVID-19 in Africa: Implications and Recommendations.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27211.
    >> Share

  1321. PASCARELLA S, Ciccozzi M, Zella D, Bianchi M, et al
    SARS-CoV-2 B.1.617 Indian variants: are electrostatic potential changes responsible for a higher transmission rate?
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27210.
    >> Share

  1322. GULEC EY, Cesur NP, Fazlioglu GY, Kazezoglu C, et al
    Effect of Different Storage Conditions on Covid-19 RT-PCR Results.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27204.
    >> Share

  1323. AKDEMIR Y, Haciseyitoglu D, Celebi G, Aydemir C, et al
    Probable viremia and positive placental swabs for SARS-CoV-2 in a preterm pregnant woman with mild COVID-19.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27202.
    >> Share

  1324. OZTURK A, Bozok T, Bozok TS
    Evaluation of Rapid Antibody Test and Chest Computed Tomography Results of COVID-19 Patients: A Retrospective Study.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27209.
    >> Share

  1325. RAHMAN FI, Islam MR, Bhuiyan MA
    Mucormycosis or black fungus infection is a new scare in South Asian countries during COVID-19 pandemic: Associated risk factors and preventive measures.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27207.
    >> Share

  1326. BORGOGNA C, De Andrea M, Griffante G, Lai A, et al
    SARS-CoV-2 re-infection in a cancer patient with a defective neutralizing humoral response.
    J Med Virol. 2021 Jul 14. doi: 10.1002/jmv.27200.
    >> Share

  1327. ZHANG S, Ning Y, Rong Y, Nie Y, et al
    Rapid immunoassay and clinical evaluation of the SARS-CoV-2 antibody assay on the Real Express-6 analyzer.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27201.
    >> Share

  1328. KALANTARI S, Fard SR, Maleki D, Taher MT, et al
    Comparing the effectiveness of Atazanavir/Ritonavir/Dolutegravir/Hydroxychloroquine and Lopinavir/Ritonavir/Hydroxychloroquine treatment regimens in COVID-19 patients.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27195.
    >> Share

  1329. KAYAASLAN B, Eser F, Kalem AK, Kaya G, et al
    Post-covid Syndrome: A Single-Center Questionnaire Study On 1007 Participants Recovered from COVID-19.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27198.
    >> Share

  1330. ZELLA D, Giovanetti M, Benedetti F, Unali F, et al
    The variants question: what is the problem?
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27196.
    >> Share

  1331. ELGENDY MO, Abdelrahim MEA
    Public awareness about coronavirus vaccine, vaccine acceptance, and hesitancy.
    J Med Virol. 2021 Jul 13. doi: 10.1002/jmv.27199.
    >> Share

  1332. CONTICINI E, D'Alessandro M, Bergantini L, Bargagli E, et al
    Relapse of microscopic polyangiitis after vaccination against COVID-19: a case report.
    J Med Virol. 2021 Jul 12. doi: 10.1002/jmv.27192.
    >> Share

  1333. FANG S, Liu S, Shen J, Lu AZ, et al
    Updated SARS-CoV-2 Single Nucleotide Variants and Mortality Association.
    J Med Virol. 2021 Jul 10. doi: 10.1002/jmv.27191.
    >> Share

  1334. ABUSREWIL Z, Alhudiri IM, Kaal HH, Meshri SEE, et al
    Time scale performance of rapid antigen testing for SARS-COV-2: evaluation of ten rapid antigen assays.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27186.
    >> Share

  1335. SAHIN E, Bozdayi G, Yigit S, Muftah H, et al
    Genomic Characterization of SARS-CoV-2 Isolates from Patients in Turkey Reveals the Presence of Novel Mutations in Spike and nsp12 Proteins.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27188.
    >> Share

  1336. AFSHAR ZM, Babazadeh A, Hasanpour A, Barary M, et al
    Dermatological manifestations associated with COVID-19: A comprehensive review of the current knowledge.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27187.
    >> Share

  1337. AKSAKAL A, Kerget B, Kerget F, Askin S, et al
    Evaluation of the relationship between macrophage migration inhibitory factor level and clinical course in patients with COVID-19 pneumonia.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27189.
    >> Share

  1338. SLAVOV SN, Patane JSL, Bezerra RDS, Giovanetti M, et al
    GENOMIC MONITORING UNVEIL THE EARLY DETECTION OF THE SARS-COV-2 B.1.351 (BETA) VARIANT (20H/501Y.V2) IN BRAZIL.
    J Med Virol. 2021 Jul 9. doi: 10.1002/jmv.27190.
    >> Share

  1339. ALAY H, Laloglu E
    The Role of Angiopoietin-2 and Surfactant Protein-D Levels in SARS-CoV-2-related lung injury: A prospective, observational, cohort study.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27184.
    >> Share

  1340. TANBOGA IH
    Statistical modelling, dichotomization and non-linearity.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27183.
    >> Share

  1341. SUVVARI TK, Rajesh E, D Silva RG, Corriero AC, et al
    SARS-CoV-2 Vaccine-Induced Prothrombotic Immune Thrombocytopenia (VIPIT): Promoting Awareness to Improve Patient-Doctor Trust.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27176.
    >> Share

  1342. SINGH Y, Fuloria NK, Fuloria S, Subramaniyan V, et al
    N-terminal domain of SARS CoV-2 spike protein mutation associated reduction in effectivity of neutralizing antibody with vaccinated individuals.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27181.
    >> Share

  1343. BISTROVIC P, Lucijanic M
    Remdesivir might induce changes in electrocardiogram beyond bradycardia in patients with Coronavirus disease 2019 (COVID-19) - the pilot study.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27177.
    >> Share

  1344. YU JL, Hou S, Feng YT, Bu G, et al
    Emergence of a young case infected with avian influenza A (H5N6) in Anhui Province, East China during the COVID-19 pandemic.
    J Med Virol. 2021 Jul 7. doi: 10.1002/jmv.27179.
    >> Share

  1345. KUITUNEN I, Artama M, Haapanen M, Renko M, et al
    Rhinovirus spread in children during the COVID-19 pandemic despite social restrictions-a nationwide register study in Finland.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27180.
    >> Share

  1346. SHAHID S, Raza M, Junejo S, Maqsood S, et al
    Clinical Features and Outcome of COVID-19 positive children from a tertiary healthcare Hospital in Karachi.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27178.
    >> Share

  1347. MOUSAVI-ROKNABADI RS, Haddad F, Fazlzadeh A, Kheirabadi D, et al
    Investigation of plasma exchange and hemoperfusion effects and complications for the treatment of patients with severe COVID-19 (SARS-CoV-2) disease: a systematic scoping review.
    J Med Virol. 2021 Jul 6. doi: 10.1002/jmv.27182.
    >> Share

  1348. RASHKI A, Hoseinpour Dehkordi A, Nemati R, Tavousi P, et al
    What does COVID-19 Testing Results Really Say? The Real Statistics Concealed Behind the Accessible Data.
    J Med Virol. 2021 Jul 5. doi: 10.1002/jmv.27173.
    >> Share

  1349. MARCO C, Sheyda K, Angelo C, Riccardo C, et al
    AstraZeneca (AZD1222) Covid 19 vaccine-associated adverse drug event: a case report.
    J Med Virol. 2021 Jul 2. doi: 10.1002/jmv.27175.
    >> Share

  1350. ASGHAR MS, Yasmin F, Dapke K, Phadke R, et al
    Derangements of Biochemical Markers and Thyroid Function Analysis Among COVID-19 Positive Patients: A Developing Country Single-Center Experience.
    J Med Virol. 2021 Jul 2. doi: 10.1002/jmv.27174.
    >> Share

  1351. RAMIREZ-HINOJOSA JP, Rodriguez-Sanchez Y, Romero-Gonzalez AK, Chavez-Gutierrez M, et al
    Association between cycle threshold (Ct) values and clinical and laboratory data in inpatients with COVID-19 and asymptomatic health workers.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27170.
    >> Share

  1352. LUKASZEWICZ AC, Venet F, Faure A, Vignot E, et al
    Immunostimulation with Interferon-gamma in protracted SARS-Cov-2 pneumonia.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27172.
    >> Share

  1353. CAMARGO JF, Lin RY, Komanduri KV
    Lack of correlation between the SARS-CoV-2 cycle threshold (Ct) value and clinical outcomes in patients with COVID-19.
    J Med Virol. 2021 Jul 1. doi: 10.1002/jmv.27171.
    >> Share

    June 2021
  1354. HASAN MM, Costa ACDS, Xenophontos E, Mohanan P, et al
    Lassa Fever and COVID-19 in Africa: A double crisis on the fragile health system.
    J Med Virol. 2021 Jun 30. doi: 10.1002/jmv.27169.
    >> Share

  1355. ABE H, Ushijima Y, Bikangui R, Zoa-Assoumou S, et al
    Unrecognized introduction of SARS-CoV-2 variants of concern to Central Africa: Import and local transmission of B.1.1.7 in Gabon in the very early stage of the variant spread to the African continent.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27164.
    >> Share

  1356. IVANOV A, Semenova E
    Long-term monitoring of the development and extinction of IgA and IgG responses to SARS-CoV-2 infection.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27166.
    >> Share

  1357. JUSCAMAYTA-LOPEZ E, Carhuaricra D, Tarazona D, Valdivia F, et al
    Phylogenomics reveals multiple introductions and early spread of SARS-CoV-2 into Peru.
    J Med Virol. 2021 Jun 29. doi: 10.1002/jmv.27167.
    >> Share

  1358. UWISHEMA O, Adriano LF, Torbati T, Onyeaka H, et al
    Measles crisis in Africa amidst the COVID-19 pandemic: Delayed measles vaccine administration may cause a measles outbreak in Africa.
    J Med Virol. 2021 Jun 28. doi: 10.1002/jmv.27150.
    >> Share

  1359. BIRD PW, Sandhu K, Fletcher O, Ames B, et al
    Retrospective SARS-CoV-2 IgG screening during the first wave (March-June 2020) of the COVID-19 pandemic in the UK.
    J Med Virol. 2021 Jun 26. doi: 10.1002/jmv.27162.
    >> Share

  1360. ABDELRAHMAN MM, Abd-Elrahman NM, Bakheet TM
    Persistence of symptoms after improvement of acute COVID19 infection, a longitudinal study.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27156.
    >> Share

  1361. CELIK SK, Genc GC, Piskin N, Acikgoz B, et al
    Polymorphisms of ACE (I/D) and ACE2 Receptor Gene (Rs2106809, Rs2285666) are not Related to the Clinical Course of COVID-19; A Case Study.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27160.
    >> Share

  1362. PANDOLFI S, Simonetti V, Ricevuti G, Chirumbolo S, et al
    Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients?
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27158.
    >> Share

  1363. MATSUZAKI N, Orihara Y, Kodana M, Kitagawa Y, et al
    Evaluation of a chemiluminescent enzyme immunoassay-based high-throughput SARS-CoV-2 antigen assay for the diagnosis of COVID-19: The VITROS((R)) SARS-CoV-2 Antigen Test.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27153.
    >> Share

  1364. KHAN F, Sharma P, Pandey S, Sharma D, et al
    COVID-19-associated Guillain Barre syndrome: Post-infectious alone or neuroinvasive too?
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27159.
    >> Share

  1365. TANG CY, Wang Y, McElroy JA, Li T, et al
    Reinfection with two genetically distinct SARS-CoV-2 viruses within 19 days.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27154.
    >> Share

  1366. PERCHETTI GA, Zhu H, Mills MG, Shrestha L, et al
    Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR detects B.1.1.7 lineage in Washington State.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27155.
    >> Share

  1367. ZENG F, Wu M, Wang J, Li J, et al
    Over one-year duration and age difference of SARS-CoV-2 antibody in convalescent COVID-19 patients.
    J Med Virol. 2021 Jun 25. doi: 10.1002/jmv.27152.
    >> Share

  1368. DURMAZ B, Abdulmajed O, Durmaz R, Koroglu M, et al
    RESPIRATORY VIRUSES IN HEALTHY MIDDLE EAR AND MIDDLE EAR WITH OTITIS MEDIA WITH EFFUSION.
    J Med Virol. 2021 Jun 23. doi: 10.1002/jmv.27151.
    >> Share

  1369. ELEFTHERIOU I, Dasoula F, Dimopoulou D, Lebessi E, et al
    Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.
    J Med Virol. 2021 Jun 22. doi: 10.1002/jmv.27149.
    >> Share

  1370. ANGELETTI S, Travaglino F, Spoto S, Pascarella MC, et al
    COVID-19 Sniffer Dog experimental training: which protocol and which implications for reliable identification?
    J Med Virol. 2021 Jun 21. doi: 10.1002/jmv.27147.
    >> Share

  1371. POURHOSEINGHOLI MA, Jafari R, Jafari NJ, Rahimi-Bashar F, et al
    Predicting One-year post-COVID-19 mortality based on chest computed tomography scan.
    J Med Virol. 2021 Jun 21. doi: 10.1002/jmv.27146.
    >> Share

  1372. ULLAH I, Hassan W, Tahir MJ, Ahmed A, et al
    Antiretrovirals shortage in Kenya amid COVID-19.
    J Med Virol. 2021 Jun 18. doi: 10.1002/jmv.27134.
    >> Share

  1373. HIROI S, Kubota-Koketsu R, Sasaki T, Morikawa S, et al
    Infectivity Assay for Detection of SARS-CoV-2 in Samples from Patients with COVID-19.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27145.
    >> Share

  1374. LEI J, Li M, Wang X
    Predicting the development trend of the second wave of COVID-19 in five European countries.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27143.
    >> Share

  1375. PICCHI G, Di Norcia M, Cofini V, Sinatti G, et al
    Laboratory Parameters related to Severe Disease and Death in SARS-CoV-2 Pneumonia: Retrospective Analysis.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27141.
    >> Share

  1376. LUNDSTROM A, Ziegler L, Havervall S, Rudberg AS, et al
    Soluble angiotensin-converting enzyme 2 is transiently elevated in COVID-19 and correlates with specific inflammatory and endothelial markers.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27144.
    >> Share

  1377. MOHAN A, Temitope RA, Cavdaroglu S, Hasan MM, et al
    Measles returns to the Democratic Republic of Congo: A new predicament amid the COVID-19 crisis.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27137.
    >> Share

  1378. BARUA S, Hoque M, Kelly PJ, Bai J, et al
    High-resolution melting curve FRET-PCR rapidly identifies SARS-CoV-2 mutations.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27139.
    >> Share

  1379. MORENO-PEREZ O, Ramos JM, Gimeno A, Rodriguez JC, et al
    Medium-term serostatus in Spanish case series recovered from SARS-CoV-2 infection.
    J Med Virol. 2021 Jun 17. doi: 10.1002/jmv.27135.
    >> Share

  1380. ZHU C, He G, Yin Q, Zeng L, et al
    Molecular biology of the SARs-CoV-2 spike protein: A review of current knowledge.
    J Med Virol. 2021 Jun 14. doi: 10.1002/jmv.27132.
    >> Share

  1381. NAKHLBAND A, Fakhari A, Azizi H
    Interferon-alpha position in combating with COVID-19: A systematic review.
    J Med Virol. 2021 Jun 8. doi: 10.1002/jmv.27072.
    >> Share

  1382. POON KS, Tee NW
    Detecting SARS-CoV-2 RNA in fecal specimens: The practical challenges.
    J Med Virol. 2021 Jun 8. doi: 10.1002/jmv.27071.
    >> Share

  1383. AL-JARALLAH M, Rajan R, Dashti R, Saber AA, et al
    In-hospital Mortality in SARS-CoV-2 stratified by serum 25-Hydroxy-Vitamin D levels: A Retrospective Study.
    J Med Virol. 2021 Jun 7. doi: 10.1002/jmv.27133.
    >> Share

  1384. RODRIGUEZ-VIDALES EP, Garza-Carrillo D, Perez-Trujillo JJ, Robles-Rodriguez OA, et al
    PREVALENCE OF IgG ANTIBODIES INDUCED BY THE SARS-COV-2 VIRUS IN ASYMPTOMATIC ADULTS IN NUEVO LEON, MEXICO.
    J Med Virol. 2021 Jun 7. doi: 10.1002/jmv.27131.
    >> Share

  1385. KARCIOGLU BATUR L, Hekim N
    Correlation between interleukin gene polymorphisms and current prevalence and mortality rates due to novel coronavirus disease 2019 (COVID-2019) in 23 countries.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27127.
    >> Share

  1386. UWISHEMA O, Adriano LF, Chalhoub E, Onyeaka H, et al
    Bird Flu Outbreak Amidst COVID-19 Pandemic in South Africa: Efforts and Challenges at Hand.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27124.
    >> Share

  1387. DEGERLI E, Derin S, Oruc K, Samanci NS, et al
    The Demographic Characteristic, Prognosis and the Relationship with Cancer Subtypes of Hospitalised Covid-19 Patients with Malignancy: A Single-Center Experience.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27123.
    >> Share

  1388. FINSTERER J
    Diagnose SARS-CoV-2 associated Guillain-Barre syndrome upon appropriate criteria and after exclusion of differentials.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27129.
    >> Share

  1389. SINACI S, Ocal DF, Seven B, Anuk AT, et al
    Vertical Transmission of SARS-CoV-2: a prospective cross-sectional study from a tertiary center.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27128.
    >> Share

  1390. BARCHUK A, Shirokov D, Sergeeva M, Tursun Zade R, et al
    Evaluation of the performance of SARS-CoV-2 antibody assays for the longitudinal population-based study of COVID-19 spread in St. Petersburg, Russia: Interpretation.
    J Med Virol. 2021 Jun 3. doi: 10.1002/jmv.27126.
    >> Share

  1391. ABD-ELSALAM S, Noor RA, Badawi R, Khalaf M, et al
    Clinical study evaluating the efficacy of ivermectin in COVID-19 treatment: A randomized controlled study.
    J Med Virol. 2021 Jun 2. doi: 10.1002/jmv.27122.
    >> Share

  1392. NIGAR S, Tanjil Shah SM, Setu MAA, Dip SD, et al
    Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27112.
    >> Share

  1393. MOHAN A, Fakhor H, Nimavat N, Wara UU, et al
    Dengue and COVID-19: A risk of coepidemic in Ethiopia.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27116.
    >> Share

  1394. YANG Y, Yang P, Huang C, Wu Y, et al
    Inhibitory effect on SARS-CoV-2 infection of neferine by blocking Ca(2+) -dependent membrane fusion.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27117.
    >> Share

  1395. WANG Y, Feng R, Xu J, Hou H, et al
    An updated meta-analysis on the association between tuberculosis and COVID-19 severity and mortality.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27119.
    >> Share

  1396. EMMERICH P, von Possel R, Hemmer CJ, Fritzsche C, et al
    Longitudinal detection of SARS-CoV-2-specific antibody responses with different serological methods.
    J Med Virol. 2021 Jun 1. doi: 10.1002/jmv.27113.
    >> Share

    May 2021
  1397. KARATAS M, Tatar E, Simsek C, Yildirim AM, et al
    COVID-19 pneumonia in kidney transplant recipients: A promising treatment algorithm in the absence of a disease-specific drug.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27110.
    >> Share

  1398. WOLTERS F, Grunberg M, Huber M, Kessler HH, et al
    European multicenter evaluation of Xpert(R) Xpress SARS-CoV-2/Flu/RSV test.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27111.
    >> Share

  1399. ABI ZEID DAOU C, Natout MA, El Hadi N
    Biphasic anaphylaxis after exposure to the first dose of Pfizer-BioNTech COVID-19 mRNA vaccine.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27109.
    >> Share

  1400. BLAIRON L, Cupaiolo R, Thomas I, Piteus S, et al
    Efficacy comparison of three rapid antigen tests for SARS-CoV-2 and how viral load impact their performance.
    J Med Virol. 2021 May 29. doi: 10.1002/jmv.27108.
    >> Share

  1401. AKAMA-GARREN EH, Li JX
    Prior immunosuppressive therapy is associated with mortality in COVID-19 patients: a retrospective study of 835 patients.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27105.
    >> Share

  1402. SOYTAS RB, Cengiz M, Islamoglu MS, Uysal BB, et al
    Does the COVID-19 seroconversion in older adults resemble the young?
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27106.
    >> Share

  1403. GUARIN G, Lo KB, Bhargav R, Salacup G, et al
    Factors Associated with Hospital Readmissions among Patients with COVID-19: A Single Center Experience.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27104.
    >> Share

  1404. DAO MH, Phan LT, Cao TM, Luong QC, et al
    Genome-wide analysis of SARS-CoV-2 in VietnamGenome-wide analysis of SARS-CoV-2 strains circulating in Vietnam: understanding the nature of the epidemic and role of the D614G mutation.
    J Med Virol. 2021 May 27. doi: 10.1002/jmv.27103.
    >> Share

  1405. AGHBASH PS, Eslami N, Shirvaliloo M, Baghi HB, et al
    Viral Co-infections in COVID-19.
    J Med Virol. 2021 May 25. doi: 10.1002/jmv.27102.
    >> Share

  1406. BARDAKCI MI, Ozturk EN, Ozkarafakili MA, Ozkurt H, et al
    EVALUATION of LONG TERM RADIOLOGICAL FINDINGS, PULMONARY FUNCTIONS AND HEALTH-RELATED QUALITY OF LIFE IN SURVIVORS OF SEVERE COVID-19.
    J Med Virol. 2021 May 25. doi: 10.1002/jmv.27101.
    >> Share

  1407. BAYRAM A, Demirbakan H, Karadeniz PG, Erdogan M, et al
    Quantitation of antibodies against SARS-CoV-2 spike protein after two doses of CoronaVac in health care workers.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27098.
    >> Share

  1408. KERGET B, Kerget F, Aksakal A, Askin S, et al
    Evaluation of the relationship between KIM-1 and suPAR levels and clinical severity in COVID-19 patients: A different perspective on suPAR.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27099.
    >> Share

  1409. ERDOGAN A, Can FE, Gonullu H
    Evaluation of the prognostic role of NLR, LMR, PLR and LCR ratio in COVID-19 patients.
    J Med Virol. 2021 May 21. doi: 10.1002/jmv.27097.
    >> Share

  1410. GAO X, Liu Y, Zou S, Liu P, et al
    Genome-wide screening of SARS-CoV-2 infection-related genes based on the blood leucocytes sequencing dataset of patients with COVID-19.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27093.
    >> Share

  1411. ABORODE AT, Olofinsao OA, Osmond E, Batubo AP, et al
    Equal Access of COVID-19 Vaccine distribution in Africa: Challenges and Way Forward.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27095.
    >> Share

  1412. LAPIC I, Segulja D, Rogic D
    Assessment of salivary antibody response to BNT162b2 mRNA COVID-19 vaccination.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27096.
    >> Share

  1413. REZA S, Corentin D, Te-Din H, Pierre B, et al
    Rapid COVID-19 antigenic tests: Usefulness of a modified method for diagnosis.
    J Med Virol. 2021 May 19. doi: 10.1002/jmv.27094.
    >> Share

  1414. PEREZ-GARCIA F, Romanyk J, Gutierrez HM, Ballestero AL, et al
    Comparative evaluation of Panbio and SD Biosensor antigen rapid diagnostic tests for COVID-19 diagnosis.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27089.
    >> Share

  1415. HUBERT F, Chessa C, Beby-Defaux A, Bourgoin A, et al
    Emergence of the SARS-CoV-2 B.1.1.7 variant observed at the Poitiers University Hospital.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27092.
    >> Share

  1416. MAHMOUD SA, Ganesan S, Ibrahim E, Thakre B, et al
    Evaluation of six different rapid methods for nucleic acid detection of SARS-COV-2 virus.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27090.
    >> Share

  1417. MATIASHOVA L, Isayeva G, Shanker A, Tsagkaris C, et al
    COVID-19 vaccination in Ukraine: An update on the status of vaccination and the challenges at hand.
    J Med Virol. 2021 May 17. doi: 10.1002/jmv.27091.
    >> Share

  1418. KHO J, Mandal AKJ, Geraldes R, Tuzlali H, et al
    COVID-19 encephalitis and Wernicke's encephalopathy.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27088.
    >> Share

  1419. WU D, Rao Q, Zhang W
    The natural course of COVID-19 patients without clinical intervention.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27087.
    >> Share

  1420. ABBAS M, Verma S, Verma S, Siddiqui S, et al
    Association of GSTM1 and GSTT1 gene polymorphisms with COVID-19 susceptibility and its outcome.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27076.
    >> Share

  1421. VADAKEDATH S, Kandi V, Mohapatra RK, Pinnelli VBK, et al
    Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease-19 (COVID-19): a scoping review.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27081.
    >> Share

  1422. FINSTERER J, Scorza FA
    Consider differentials before diagnosing SARS-CoV-2 associated Guillain-Barre syndrome.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27084.
    >> Share

  1423. PEREIRA F, Tosta S, Lima MM, Reboredo de Oliveira da Silva L, et al
    Genomic surveillance activities unveil the introduction of the SARS-CoV-2 B.1.525 variant of interest in Brazil: Case Report.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27086.
    >> Share

  1424. VIANA-GARCIA A, Pina-Belmonte A, Salavert-Pamblanco S, Atienza-Garcia A, et al
    Multisystemic inflammatory syndrome in a young adult after SARS-CoV2 infection: case report.
    J Med Virol. 2021 May 15. doi: 10.1002/jmv.27083.
    >> Share

  1425. GETACHEW B, Tizabi Y
    Vitamin D and COVID-19: Role of ACE2, Age, Gender and Ethnicity.
    J Med Virol. 2021 May 14. doi: 10.1002/jmv.27075.
    >> Share

  1426. PUNEET G, Surender K, Sudhan SS
    SARS-CoV-2 prevalence, maternal and perinatal outcomes among pregnant women admitted for delivery: Experience from Covid-19 dedicated maternity hospital in Jammu, Jammu and Kashmir (India).
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27074.
    >> Share

  1427. HUANG C, Jiang Y, Yan J
    Comparative Analyses of ACE2 and TMPRSS2 gene: Implications for the Risk for Which Vertebrate Animals Are Susceptible to SARS-CoV-2.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27073.
    >> Share

  1428. HENRY BM, Szergyuk I, Oliveira MHS, Lippi G, et al
    Complement levels at admission as a reflection of Coronavirus Disease 19 (COVID-19) severity state.
    J Med Virol. 2021 May 11. doi: 10.1002/jmv.27077.
    >> Share

  1429. POURAKBARI B, Mahmoudi S, Mahmoudieh Y, Eshaghi H, et al
    SARS-CoV-2 RNAaemia in children: An Iranian referral hospital-based study.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27065.
    >> Share

  1430. KESHAVARZ P, Yazdanpanah F, Azhdari S, Kavandi H, et al
    Coronavirus Disease 2019 (COVID-19): A Systematic Review of 133 Children Presented with Kawasaki-like Multisystem Inflammatory Syndrome.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27067.
    >> Share

  1431. NOVAZZI F, Baj A, Genoni A, Spezia PG, et al
    SARS-CoV-2 B.1.1.7 reinfection after previous COVID-19 in two immunocompetent Italian patients.
    J Med Virol. 2021 May 10. doi: 10.1002/jmv.27066.
    >> Share

  1432. HOLZNER C, Pabst D, Anastasiou OE, Dittmer U, et al
    SARS-CoV-2 rapid antigen test: Fast-safe or dangerous? An analysis in the emergency department of an university hospital.
    J Med Virol. 2021 May 9. doi: 10.1002/jmv.27033.
    >> Share

  1433. HERNANDEZ MM, Banu R, Shrestha P, Patel A, et al
    RT-PCR/MALDI-TOF mass spectrometry-based detection of SARS-CoV-2 in saliva specimens.
    J Med Virol. 2021 May 8. doi: 10.1002/jmv.27069.
    >> Share

  1434. GURSOY B, Surmeli CD, Alkan M, Satici C, et al
    Cytokine Storm in Severe COVID-19 Pneumonia.
    J Med Virol. 2021 May 8. doi: 10.1002/jmv.27068.
    >> Share

  1435. DI GIACOMO S, Mercatelli D, Rakhimov A, Giorgi FM, et al
    Preliminary report on SARS-CoV-2 Spike mutation T478K.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27062.
    >> Share

  1436. EROL SA, Polat N, Akdas S, Ayral PA, et al
    Maternal Selenium Status has Crucial Role on Clinical Outcomes Of Pregnant Women With COVID-19 Infection.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27064.
    >> Share

  1437. MAK GC, Lau AW, Chan AM, Lam ET, et al
    The surveillance of spike protein for patients with COVID-19 detected in Hong Kong in 2020.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27063.
    >> Share

  1438. MANGANOTTI P, Bellavita G, Tommasini V, D'Acunto L, et al
    Cerebrospinal fluid and serum interleukins 6 and 8 during the acute and recovery phase in COVID-19 neuropathies patients.
    J Med Virol. 2021 May 5. doi: 10.1002/jmv.27061.
    >> Share

  1439. ZABOLI E, Majidi H, Alizadeh-Navaei R, Hedayatizadeh-Omran A, et al
    Lymphopenia and lung complications in patients with coronavirus disease-2019 (COVID-19): A retrospective study based on clinical data.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27060.
    >> Share

  1440. KUITUNEN I
    Influenza season 2020-2021 did not begin in Finland despite the looser social restrictions during the second wave of COVID-19: A nationwide register study.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27048.
    >> Share

  1441. DE GREEF J, Scohy A, Zech F, Frank A, et al
    Determinants of IgG antibodies kinetics after severe and critical COVID-19.
    J Med Virol. 2021 May 4. doi: 10.1002/jmv.27059.
    >> Share

  1442. TANVEER M, Ahmed A, Siddiqui A, Gudi SK, et al
    The mystery of plummeting cases of measles during COVID-19 pandemic in Pakistan: Hidden impact of collateral damage.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27045.
    >> Share

  1443. CAMOU F, Tinevez C, Beguet-Yachine M, Bellecave P, et al
    Feasibility of convalescent plasma therapy in severe COVID-19 patients with persistent SARS-CoV-2 viremia.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27032.
    >> Share

  1444. SAWAL I, Ahmad S, Tariq W, Tahir MJ, et al
    Unequal distribution of COVID-19 vaccine: A looming crisis.
    J Med Virol. 2021 May 3. doi: 10.1002/jmv.27031.
    >> Share

  1445. LOPES EN, Fonseca V, Frias D, Tosta S, et al
    Betacoronaviruses genome analysis reveals evolution toward specific codons usage: implications for SARS-CoV-2 mitigation strategies.
    J Med Virol. 2021 May 2. doi: 10.1002/jmv.27056.
    >> Share

  1446. PURUT YE, Giray B, Gurbuz E
    Effect of The Coronavirus Pandemic on Tumor Markers.
    J Med Virol. 2021 May 1. doi: 10.1002/jmv.27057.
    >> Share

  1447. ZERVOU FN, Louie P, Stachel A, Zacharioudakis IM, et al
    SARS-CoV-2 antibodies: IgA correlates with severity of disease in early COVID-19 infection.
    J Med Virol. 2021 May 1. doi: 10.1002/jmv.27058.
    >> Share

    April 2021
  1448. NIANOGO RA, Emeruwa, Gounder P, Manuel V, et al
    Optimal Uses of Pooled Testing for COVID-19 incorporating imperfect test performance and pool dilution effect: An Application to Congregate Settings in Los Angeles County.
    J Med Virol. 2021 Apr 30. doi: 10.1002/jmv.27054.
    >> Share

  1449. LEI G, Meng F, Wang C, Yan J, et al
    The breadth of concomitant virological features in a family cluster outbreak of COVID-19 pneumonia.
    J Med Virol. 2021 Apr 30. doi: 10.1002/jmv.27055.
    >> Share

  1450. TORRES I, Qualai J, Albert E, Bueno F, et al
    Real-life evaluation of a rapid extraction-free SARS-CoV-2 RT-PCR assay (COVID-19 PCR Fast-L) for the diagnosis of COVID-19.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27039.
    >> Share

  1451. HERNANDEZ C, Florez C, Castaneda S, Ballesteros N, et al
    Evaluation of the diagnostic performance of nine commercial RT-PCR kits for the detection of SARS-CoV-2 in Colombia.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27051.
    >> Share

  1452. KANG D, Ellgen C, Kulstad E
    Possible Effects of Air Temperature on COVID-19 Disease Severity and Transmission Rates.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27042.
    >> Share

  1453. RUSK DS, Strachan CC, Hunter BR
    Lack of Immune Response After mRNA Vaccination to SARS-CoV-2 in a Solid Organ Transplant Patient.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27044.
    >> Share

  1454. HAN L, Zhuang MW, Deng J, Zheng Y, et al
    SARS-CoV-2 ORF9b Antagonizes Type I and III Interferons by Targeting Multiple Components of the RIG-I/MDA-5-MAVS, TLR3-TRIF, and cGAS-STING Signaling Pathways.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27050.
    >> Share

  1455. AGHAJANI MH, Moradi O, Amini H, Tehrani HA, et al
    Decreased In-Hospital Mortality Associated with Aspirin Administration in Hospitalized Patients Due to Severe COVID-19.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27053.
    >> Share

  1456. LEACH S, Harandi AM, Bergstrom T, Andersson LM, et al
    Comparable endemic coronavirus nucleoprotein-specific antibodies in mild and severe Covid-19 patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27038.
    >> Share

  1457. EID E, Abdullah L, Kurban M, Abbas O, et al
    Herpes Zoster emergence following mRNA COVID-19 Vaccine.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27036.
    >> Share

  1458. FENOGLIO D, Dentone C, Parodi A, Di Biagio A, et al
    Characterization of T lymphocytes in severe COVID-19 patients.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27037.
    >> Share

  1459. OBANDO-PEREDA G
    Can molecular mimicry explain the cytokine storm of SARS-CoV-2?: an in silico approach.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27040.
    >> Share

  1460. GILLEZEAU C, Alpert N, Caltabiano M, Flores R, et al
    Informing the Global COVID-19 Response by Estimating Excess Deaths in Italy During the COVID-19 and 1918 Influenza Pandemics.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27052.
    >> Share

  1461. BEST JH, Kong AM, Kaplan-Lewis E, Brawley OW, et al
    Treatment Patterns in US Patients Hospitalized With COVID-19 and Pulmonary Involvement.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27049.
    >> Share

  1462. LEE J, Song JU
    Diagnostic accuracy of the Cepheid Xpert Xpress and the Abbott ID NOW assay for rapid detection of SARS-CoV-2: A systematic review and meta-analysis.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.26994.
    >> Share

  1463. DUBEY A, Kotnala G, Mandal TK, Sonkar SC, et al
    Evidence of presence of SARS-CoV-2 virus in atmospheric air and surfaces of dedicated COVID hospital.
    J Med Virol. 2021 Apr 29. doi: 10.1002/jmv.27029.
    >> Share

  1464. CAKIR B
    "Development and Validation of Clinical Prediction Models to Estimate the Probability of Death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database".
    J Med Virol. 2021 Apr 23. doi: 10.1002/jmv.27030.
    >> Share

  1465. CAVDAROGLU S, Hasan MM, Mohan A, Xenophontos E, et al
    The spread of Yellow fever amidst the COVID-19 pandemic in Africa and the ongoing efforts to mitigate it.
    J Med Virol. 2021 Apr 19. doi: 10.1002/jmv.27027.
    >> Share

  1466. MENDES CORREA MC, Leal FE, Villas Boas LS, Witkin SS, et al
    Prolonged presence of replication-competent SARS-CoV-2 in mildly symptomatic individuals: A Report of 2 Cases.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27021.
    >> Share

  1467. WILSON JM, Platts Mills TAE, Keshavarz B
    Reply to: The antibody response to the glycan alpha-Gal correlates with COVID-19 symptoms.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27022.
    >> Share

  1468. AKCAY N, Menetoglu ME, Bektas G, Sevketoglu E, et al
    Axonal Guillain-Barre syndrome associated with SARS-CoV-2 infection in a child.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27018.
    >> Share

  1469. HEMIDA MG, Alhammadi M, Almathen F, Alnaeem A, et al
    Exploring the potential roles of some rodents in the transmission of the Middle East respiratory syndrome coronavirus.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27023.
    >> Share

  1470. LABBE AC, Benoit P, Pare SG, Coutlee F, et al
    Comparison of saliva with oral and nasopharyngeal swabs for SARS-CoV-2 detection on various commercial and laboratory developed assays.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27026.
    >> Share

  1471. SIDDIQUI A, Ahmed A, Tanveer M, Arshad A, et al
    The crux of Pakistan's prolonged rabies vaccine shortage: a rising mortal threat in the COVID-19 pandemic.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27024.
    >> Share

  1472. ISHACK S, Lipner SR
    Bioinformatics and Immunoinformatics to Support COVID-19 Vaccine Development.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27017.
    >> Share

  1473. MURALIDAR S, Gopal G, Ambi SV
    Targeting the viral-entry facilitators of SARS-CoV-2 as a therapeutic strategy in COVID-19.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27019.
    >> Share

  1474. ALI Z, Sarwar M, Ansar S, Awan UA, et al
    COVID-19 vaccination hesitancy in patients with autoimmune diseases: A mystery that needs an immediate solution!
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27014.
    >> Share

  1475. SHENG H, Wu L, Wu T, Peng B, et al
    Network Dynamic Model of Epidemic Transmission Introducing a Heterogeneous Control Factor.
    J Med Virol. 2021 Apr 14. doi: 10.1002/jmv.27025.
    >> Share

  1476. GARCIA-CALAVARO C, Paternina-Caicedo A, Smith AD, Harrison LH, et al
    Covid-19 mortality needs age adjusting for international comparisons.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27007.
    >> Share

  1477. COSTA ACDS, Hasan MM, Xenophontos E, Mohanan P, et al
    COVID-19 And Zika: An emerging dilemma for Brazil.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27006.
    >> Share

  1478. TAHIR M
    Coronavirus genomic nsp14-ExoN, structure, role, mechanism, and potential application as a drug target.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27009.
    >> Share

  1479. RAPP JL, Tremblay D, Alpert N, Lieberman-Cribbin W, et al
    Red Cell Distribution Width is Associated with Mortality in Non-Anemic Patients with COVID-19.
    J Med Virol. 2021 Apr 10. doi: 10.1002/jmv.27011.
    >> Share

  1480. ALI KM, Ali AM, Tawfeeq HM, Figueredo G, et al
    Hypoalbuminemia in Patients Following Their Recovery from Severe Coronavirus Disease 2019.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27002.
    >> Share

  1481. NAEMI FMA, Al-Adwani S, Al-Khatabi H, Al-Nazawi A, et al
    Association between the HLA genotype and the severity of COVID-19 infection among South Asians.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27003.
    >> Share

  1482. WAN XF, Tang CY, Ritter D, Wang Y, et al
    SARS-CoV-2 show no infectivity at later stages in a prolonged COVID-19 patient despite positivity in RNA testing.
    J Med Virol. 2021 Apr 8. doi: 10.1002/jmv.27001.
    >> Share

  1483. NASIR N, Rehman F, Omair SF
    Article title: Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study.
    J Med Virol. 2021 Apr 6. doi: 10.1002/jmv.27000.
    >> Share

  1484. KADALI RAK, Janagama R, Peruru S, Gajula V, et al
    Adverse effects of COVID-19 mRNA-1273 vaccine: A randomized, cross-sectional study on healthcare workers with detailed self-reported symptoms.
    J Med Virol. 2021 Apr 6. doi: 10.1002/jmv.26996.
    >> Share

  1485. RANI PR, Imran M, Lakshmi JV, Jolly B, et al
    Symptomatic reinfection of SARS-CoV-2 with spike protein variant N440K associated with immune escape.
    J Med Virol. 2021 Apr 5. doi: 10.1002/jmv.26997.
    >> Share

  1486. FUKUDA Y, Homma T, Inoue H, Onitsuka C, et al
    Downregulation of type III interferons in patients with severe COVID-19.
    J Med Virol. 2021 Apr 3. doi: 10.1002/jmv.26993.
    >> Share

  1487. MOVAHED SMM, Akhavizadegan H, Dolatkhani F, Nejadghaderi SA, et al
    Different incidences of acute kidney injury (AKI) and outcomes in COVID-19 patients with and without non-azithromycin antibiotics: a retrospective study.
    J Med Virol. 2021 Apr 1. doi: 10.1002/jmv.26992.
    >> Share

  1488. KUMAR A, Sahu A, Kaushik J, Arora A, et al
    Unilateral sub-macular hemorrhage- novel presentation of COVID-19 infection.
    J Med Virol. 2021 Apr 1. doi: 10.1002/jmv.26991.
    >> Share

    March 2021
  1489. CINGOLANI V
    Hypothesis of Zinc Ascorbate as best zinc ionophore for raising anti-viral resistance against Covid-19.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26989.
    >> Share

  1490. PHADKE R, Mohan A, Cavdaroglu S, Dapke K, et al
    Dengue amidst COVID-19 in India: The mystery of plummeting cases.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26987.
    >> Share

  1491. CALLEGARO A, Borleri D, Farina C, Napolitano G, et al
    Antibody response to SARS-CoV-2 vaccination is extremely vivacious in subjects with previous SARS-CoV-2 infection.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26982.
    >> Share

  1492. SEITZ T, Schindler S, Winkelmeyer P, Zach B, et al
    Evaluation of rapid antigen tests based on saliva for the detection of SARS-CoV-2.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26983.
    >> Share

  1493. LAMPEJO DT
    Remdesivir for the treatment of COVID-19 in pregnancy.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26986.
    >> Share

  1494. MATSUDA EM, de Campos IB, de Oliveira IP, Colpas DR, et al
    Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity and low cost.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26985.
    >> Share

  1495. BOUAYED J, Bohn T
    The link between microglia and the severity of COVID-19: the 'two-hit' hypothesis.
    J Med Virol. 2021 Mar 31. doi: 10.1002/jmv.26984.
    >> Share

  1496. GUNDUZ A, Firat M, Turkoglu G
    Comparison of the Simultaneous Conjunctiva and Oropharynx-Nasopharynx Swab Results in Patients Applying to the SARS-CoV-2 Outpatient Clinic for the First Time.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26981.
    >> Share

  1497. SPAGNOLELLO O, Pierangeli A, Cedrone MC, Di Biagio V, et al
    Viral Community Acquired Pneumonia at the Emergency Department: Report From the Pre COVID-19 Age.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26980.
    >> Share

  1498. CHRISTOS P, Vasiliki V
    A reduction of the number of assays and turnaround time by optimizing Polymerase Chain Reaction (PCR) pooled testing for SARS-CoV-2.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26972.
    >> Share

  1499. BERAN A, Zink E, Mhanna M, Abugharbyeh A, et al
    Transmissibility and viral replication of SARS-COV-2 in immunocompromised patients.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26970.
    >> Share

  1500. UGINET M, Breville G, Assal F, Lovblad KO, et al
    COVID-19 encephalopathy: clinical and neurobiological features.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26973.
    >> Share

  1501. REHMAN HA, Ramzan F, Basharat Z, Shakeel M, et al
    Comprehensive Comparative Genomic and Microsatellite Analysis of SARS, MERS, BAT-SARS and COVID-19 Coronaviruses.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26974.
    >> Share

  1502. EISEN AKA, Gularte JS, Demoliner M, de Abreu Goes Pereira VM, et al
    Low circulation of Influenza A and coinfection with SARS-CoV-2 among other respiratory viruses during the COVID-19 pandemic in a region of southern Brazil.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26975.
    >> Share

  1503. HAFEEZ S, Din M, Zia F, Ali M, et al
    Emerging concerns regarding COVID-19; second wave and new variant.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26979.
    >> Share

  1504. TORTAJADA C, Anon S, Ortiz MM, Andreu-Ballester JC, et al
    Interferon beta-1b for patients with moderate to severe COVID-19 in the inflammatory phase of the disease.
    J Med Virol. 2021 Mar 30. doi: 10.1002/jmv.26976.
    >> Share

  1505. RONAN G, Kumar L, Davey M, O'Leary C, et al
    Factors associated with SARS-CoV-2 infection in patients attending an acute hospital ambulatory assessment unit.
    J Med Virol. 2021 Mar 26. doi: 10.1002/jmv.26966.
    >> Share

  1506. WOLF JM, Streck AF, Fonseca A, Ikuta N, et al
    Dissemination and evolution of SARS-CoV-2 in the early pandemic phase in South America.
    J Med Virol. 2021 Mar 25. doi: 10.1002/jmv.26967.
    >> Share

  1507. VALDESPINO-VAZQUEZ MY, Helguera-Repetto CA, Leon-Juarez M, Villavicencio-Carrisoza O, et al
    Fetal and placental infection with SARS-CoV-2 in early pregnancy.
    J Med Virol. 2021 Mar 25. doi: 10.1002/jmv.26965.
    >> Share

  1508. TANG JW, Bialasiewicz S, Dwyer DE, Dilcher M, et al
    Where have all the viruses gone? Disappearance of seasonal respiratory viruses during the COVID-19 pandemic.
    J Med Virol. 2021 Mar 24. doi: 10.1002/jmv.26964.
    >> Share

  1509. NAKAMURA A, Ando S, Endo H, Sato R, et al
    Seroprevalence of antibodies to SARS-CoV-2 in healthcare workers in a non-epidemic region, Japan: A hospital-based study on May, 2020.
    J Med Virol. 2021 Mar 24. doi: 10.1002/jmv.26962.
    >> Share

  1510. MALHOTRA V, Basu S, Sharma N, Kumar S, et al
    Outcomes among 10,314 hospitalized COVID-19 patients at a tertiary care government hospital in Delhi, India.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26956.
    >> Share

  1511. MANSUY JM, Bourcier M, Tremeaux P, Dimeglio C, et al
    COVID-19 pandemic period, where are the seasonal viruses?
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26959.
    >> Share

  1512. CHAKRABARTI S, Chakrabarti SS, Kaur U, Agrawal BK, et al
    Cross-immunity and trained immunity in explaining variable COVID-19 mortality- guidance for future pandemics.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26958.
    >> Share

  1513. RABIU AT, Mohan A, Cavdaroglu S, Xenophontos E, et al
    Dengue and COVID-19: A double burden to Brazil.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26955.
    >> Share

  1514. HANNA HUANG Y, Huang JT
    Use of Chlorhexidine to Eradicate Oropharyngeal SARS-CoV-2 in COVID-19 Patients.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26954.
    >> Share

  1515. MA C, Gong C
    ACE2 models of frequently contacted animals provide clues of their SARS-CoV-2 S protein affinity and viral susceptibility.
    J Med Virol. 2021 Mar 23. doi: 10.1002/jmv.26953.
    >> Share

  1516. DHAR MS, Vivekanand A, Uppili B, Tyagi N, et al
    Reinfection or Reactivation: Genome based two distinct SNP profile of SARS-CoV2 re-positivity in an Indian case.
    J Med Virol. 2021 Mar 22. doi: 10.1002/jmv.26948.
    >> Share

  1517. JAIN S, Rocha ICN, Maheshwari C, Santos Costa ACD, et al
    Chikungunya and COVID-19 in Brazil: the danger of overlapping crises.
    J Med Virol. 2021 Mar 22. doi: 10.1002/jmv.26952.
    >> Share

  1518. TSUCHIDA T, Nitahara Y, Suzuki S, Komase Y, et al
    Back to Normal; Serological Testing for COVID-19 Diagnosis Unveils Missed Infections.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26949.
    >> Share

  1519. ZHAO Y, Yin L, Jenil P, Tang L, et al
    The inflammatory markers of Multisystem Inflammatory Syndrome in children (MIS-C) and adolescents associated with COVID-19: A Meta-analysis.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26951.
    >> Share

  1520. FITOUSSI F, Dupont R, Tonen-Wolyec S, Belec L, et al
    Practicability and analytical performances of the novel VitaPCR(TM) SARS-CoV-2 Assay during the second wave of COVID-19 epidemic in France.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26950.
    >> Share

  1521. ZHAO X, Zhou Q, Wang A, Zhu F, et al
    The Impact of Awareness Diffusion on the Spread of COVID-19 based on Two-layer SEIR/V-UA Epidemic Model.
    J Med Virol. 2021 Mar 19. doi: 10.1002/jmv.26945.
    >> Share

  1522. CIOTTI M, Nicolai E, Marcuccilli F, Bernardini S, et al
    Use of a rapid point-of-care molecular test in the triage of suspected COVID-19 cases.
    J Med Virol. 2021 Mar 17. doi: 10.1002/jmv.26944.
    >> Share

  1523. YAN-CHAO L, Yan Z, Bai-Hong T
    What can cerebrospinal fluid testing and brain autopsies tell us about viral neuroinvasion of SARS-CoV-2.
    J Med Virol. 2021 Mar 16. doi: 10.1002/jmv.26943.
    >> Share

  1524. OTLU B, Yakupogullari Y, Tanriverdi ES, Bayindir Y, et al
    An Evaluation of Patients with A Previous Endemic Coronavirus Infection during the COVID-19 Pandemic.
    J Med Virol. 2021 Mar 16. doi: 10.1002/jmv.26942.
    >> Share

  1525. LEE CK, Tham JWM, Png S, Chai CN, et al
    Clinical Performance of Roche cobas 6800, Luminex ARIES, MiRXES Fortitude Kit 2.1, altona RealStar, and Applied Biosystems TaqPath for SARS-CoV-2 Detection in Nasopharyngeal Swabs.
    J Med Virol. 2021 Mar 14. doi: 10.1002/jmv.26940.
    >> Share

  1526. TERESA VALENZUELA M, Urquidi C, Rodriguez N, Castillo L, et al
    Development of neutralizing antibody responses against SARS-CoV-2 in COVID-19 patients.
    J Med Virol. 2021 Mar 13. doi: 10.1002/jmv.26939.
    >> Share

  1527. GIACOMELLI A, De Falco T, Oreni L, Pedroli A, et al
    Impact Of Gender On Patients Hospitalized For SARS-COV-2 Infection: A Prospective Observational Study.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26933.
    >> Share

  1528. MINKOBAME U, Nzoghe AM, Siawaya ACM, Alame-Emane AK, et al
    Case series of SARS-COV-2 infection in pregnant African women: focus on biological features.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26927.
    >> Share

  1529. YE Q, Zhang T, Lu D
    Potential false-positive reasons for SARS-CoV-2 antibody testing and its solution.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26937.
    >> Share

  1530. ALI N, Fariha KA, Islam F, Mohanto NC, et al
    Assessment of the role of zinc in the prevention of COVID-19 infections and mortality: a retrospective study in the Asian and European population.
    J Med Virol. 2021 Mar 12. doi: 10.1002/jmv.26932.
    >> Share

  1531. HUSSAIN M, Shabbir S, Amnaullah A, Raza F, et al
    Immunoinformatic Analysis of Structural and Epitope Variations in Spike and Orf8 Proteins of SARS-CoV-2/B.1.1.7.
    J Med Virol. 2021 Mar 11. doi: 10.1002/jmv.26931.
    >> Share

  1532. ATEYA AM
    CKD Patients: A High-Risk Category for Severe COVID-19.
    J Med Virol. 2021 Mar 11. doi: 10.1002/jmv.26929.
    >> Share

  1533. HEMIDA MG
    The next-generation coronavirus diagnostic techniques with particular emphasis on the SARS-CoV-2.
    J Med Virol. 2021 Mar 10. doi: 10.1002/jmv.26926.
    >> Share

  1534. RONCATI L, Corsi L
    Nucleoside-modified messenger RNA (modRNA) COVID-19 vaccine platform.
    J Med Virol. 2021 Mar 6. doi: 10.1002/jmv.26924.
    >> Share

  1535. CECCARELLI G, Alessandri F, Oliva A, Borrazzo C, et al
    The role of teicoplanin in the treatment of SARS-CoV-2 infection: a retrospective study in critically ill COVID-19 patients (Tei-COVID Study).
    J Med Virol. 2021 Mar 6. doi: 10.1002/jmv.26925.
    >> Share

  1536. MILLIERE L, Engelmann I, Tinez C, Bouarouro Y, et al
    Stool samples versus nasopharyngeal specimens for the initial diagnosis of SARS-CoV-2 infection.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26923.
    >> Share

  1537. HASHIM HT, Ramadhan MA
    The impact of COVID-19 Pandemic on Asthmatic patients.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26919.
    >> Share

  1538. DAMME EV, De Meyer S, Bojkova D, Ciesek S, et al
    In vitro activity of itraconazole against SARS-CoV-2.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26917.
    >> Share

  1539. ZHAN Y, Shang J, Gu Y, Huang Q, et al
    Efficacy of corticosteroid in patients with COVID-19: a multi-center retrospective study and meta-analysis.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26914.
    >> Share

  1540. KIRKUP C, Pawlowski C, Puranik A, Conrad I, et al
    Healthcare disparities among anticoagulation therapies for severe COVID-19 patients in the multi-site VIRUS registry.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26918.
    >> Share

  1541. MALEK AE, Dagher H, Hachem R, Chaftari AM, et al
    Is a single dose of mRNA vaccine sufficient for COVID-19 Survivors?
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26915.
    >> Share

  1542. GERBER V, Velay A, Boehn L, Solis M, et al
    Protracted SARS-CoV-2 Pneumonia with Rituximab Treatment: about two cases.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26921.
    >> Share

  1543. CELIKBILEK A
    Vitamin D axis status and the severity of COVID-19.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26920.
    >> Share

  1544. CHIRUMBOLO S
    Vaccination hesitancy and the "myth" on mRNA-based vaccines in Italy in the COVID-19 era: does urgency meet major safety criteria?
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26922.
    >> Share

  1545. STRAND R, Thelaus L, Fernstrom N, Sunnerhagen T, et al
    Rapid diagnostic testing for SARS-CoV-2: Validation and comparison of three point-of-care antibody tests.
    J Med Virol. 2021 Mar 5. doi: 10.1002/jmv.26913.
    >> Share

  1546. KHALILI F, Yarani R, Haghgoo SM, Emami Aleagha MS, et al
    Letter to Editor in response to the article "Vitamin D insufficiency as a potential culprit in critical COVID-19 patients".
    J Med Virol. 2021 Mar 3. doi: 10.1002/jmv.26912.
    >> Share

    February 2021
  1547. SAIED SM, Saied EM, Kabbash IA, Abdo SAE, et al
    Vaccine Hesitancy: Beliefs and Barriers Associated with COVID-19 Vaccination among Egyptian Medical Students.
    J Med Virol. 2021 Feb 28. doi: 10.1002/jmv.26910.
    >> Share

  1548. ZHOU J, Tse G, Lee S, Liu T, et al
    Interaction effects between angiotensin-converting enzyme inhibitors or angiotensin receptor blockers and steroid or anti-viral therapies in COVID-19: a population-based study.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26904.
    >> Share

  1549. DAO MH, Nguyen HT, Nguyen TV, Nguyen AH, et al
    New SARS-CoV-2 Variant of Concern Imported from the United Kingdom to Vietnam, December 2020.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26908.
    >> Share

  1550. ABBASI AZ, Kiyani DA, Hamid SM, Saalim M, et al
    Spiking dependence of SARS-CoV-2 pathogenicity on TMPRSS2.
    J Med Virol. 2021 Feb 27. doi: 10.1002/jmv.26911.
    >> Share

  1551. GEORGY JT, Jayakaran JAJ, Jacob AS, Gunasekaran K, et al
    Evans syndrome and immune thrombocytopenia in two patients with COVID-19.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26906.
    >> Share

  1552. ALTAMIMI AM, Obeid DA, Alaifan TA, Taha MT, et al
    Assessment of 12 Qualitative RT-PCR commercial kits for the detection of SARS-CoV-2.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26900.
    >> Share

  1553. PATEL O, Chinni V, El-Khoury J, Perera M, et al
    A pilot double-blind safety and feasibility randomised controlled trial of high-dose intravenous zinc in hospitalised COVID-19 patients.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26895.
    >> Share

  1554. GUNER OZENEN G, Sahbudak Bal Z, Umit Z, Bilen NM, et al
    Demographic, clinical and laboratory features of COVID-19 in children: The role of mean platelet volume in predicting the hospitalization and severity.
    J Med Virol. 2021 Feb 25. doi: 10.1002/jmv.26902.
    >> Share

  1555. PALLOTTO C, Suardi LR, Gabbuti A, Esperti S, et al
    Potential remdesivir-related transient bradycardia in patients with coronavirus disease 2019 (COVID-19).
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26898.
    >> Share

  1556. IMAI K, Kitagawa Y, Tabata S, Kubota K, et al
    Antibody response patterns in COVID-19 patients with different levels of disease severity-Japan.
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26899.
    >> Share

  1557. MAHAJAN A, Solanki R, Sivadas N
    Estimation of Undetected Symptomatic and Asymptomatic cases of COVID-19 Infection and prediction of its spread in USA.
    J Med Virol. 2021 Feb 23. doi: 10.1002/jmv.26897.
    >> Share

  1558. COURTELLEMONT L, Guinard J, Guillaume C, Giache S, et al
    High performance of a novel antigen detection test on nasopharyngeal specimens for diagnosing SARS-CoV-2 infection.
    J Med Virol. 2021 Feb 21. doi: 10.1002/jmv.26896.
    >> Share

  1559. RAHIMZADEH M, Naderi N
    Towards understanding of regulatory T cells in COVID-19: a systematic review.
    J Med Virol. 2021 Feb 19. doi: 10.1002/jmv.26891.
    >> Share

  1560. KARAISMAILOGLU E, Karaismailoglu S
    Two novel nomograms for predicting the risk of hospitalization or mortality due to COVID-19 by naive Bayesian classifier method.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26890.
    >> Share

  1561. HAGUET H, Douxfils J, Eucher C, Elsen M, et al
    Clinical performance of the Panbio assay for the detection of SARS-CoV-2 IgM and IgG in COVID-19 patients.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26884.
    >> Share

  1562. GAO D, Zhu X, Lu B
    Development and application of sensitive, specific and rapid CRISPR-Cas13-based diagnosis.
    J Med Virol. 2021 Feb 18. doi: 10.1002/jmv.26889.
    >> Share

  1563. CRETA M, Sagnelli C, Celentano G, Napolitano L, et al
    SARS-CoV-2 infection affects the lower urinary tract and male genital system: a systematic review.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26883.
    >> Share

  1564. ANDRADE JA, Muzykovsky K, Truong J
    Risk Factors for Mortality in COVID-19 Patients in a Community Teaching Hospital.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26885.
    >> Share

  1565. BIRD PW, Badhwar V, Kennedy B, Ladani S, et al
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroconversion in haematology-oncology patients.
    J Med Virol. 2021 Feb 17. doi: 10.1002/jmv.26886.
    >> Share

  1566. TANG K, Wu L, Luo Y, Gong B, et al
    Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with Coronavirus Disease 2019.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26876.
    >> Share

  1567. ELALFY H, Besheer T, El-Mesery A, El-Gilany AH, et al
    Effect of a combination of Nitazoxanide, Ribavirin and Ivermectin plus zinc supplement (MANS.NRIZ study) on the clearance of mild COVID-19.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26880.
    >> Share

  1568. FIORE BD, Paola L, Eugenio M, Gaetano B, et al
    Anti-Spike S1 Receptor-Binding Domain Antibodies against SARS-CoV-2 Persist Several Months after Infection Regardless of Disease Severity.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26878.
    >> Share

  1569. MARUOTTI A, Ciccozzi M, Divino F
    On the misuse of the reproduction number in the COVID-19 surveillance system in Italy.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26881.
    >> Share

  1570. GANDO A, Alexay S, Galan Nunez JP, Cano LN, et al
    Comment on Hadadi et al., Does recombinant human erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects? J. Med. Virol 2020; 92:915-918.
    J Med Virol. 2021 Feb 16. doi: 10.1002/jmv.26879.
    >> Share

  1571. GOSWAMI RP, Ganguli B, Chatterjee M
    Endemic infections, vaccinations and variability of SARS-COV2 worldwide epidemiology: a cross-sectional study.
    J Med Virol. 2021 Feb 13. doi: 10.1002/jmv.26875.
    >> Share

  1572. BRAMANTE CT, Buse J, Tamaritz L, Palacio A, et al
    Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity.
    J Med Virol. 2021 Feb 12. doi: 10.1002/jmv.26873.
    >> Share

  1573. HU S, Wang J, Zhang Y, Bai H, et al
    Three salvianolic acids inhibit 2019-nCoV spike pseudovirus viropexis by binding to both its RBD and receptor ACE2.
    J Med Virol. 2021 Feb 12. doi: 10.1002/jmv.26874.
    >> Share

  1574. ISOLDI S, Mallardo S, Marcellino A, Bloise S, et al
    Comprehensive Clinic, Laboratory and Instrumental Evaluation of Children with COVID-19: A 6-Months Prospective Study.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26871.
    >> Share

  1575. ROJAS-BOLIVAR D, Intimayta-Escalante C, Cardenas-Jara A, Jandarov R, et al
    COVID-19 case fatality rate and tuberculosis in a metropolitan setting.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26868.
    >> Share

  1576. KULUOZTURK M, In E, Telo S, Karabulut E, et al
    Efficacy of Copeptin in Distinguishing COVID-19 Pneumonia from Community-Acquired Pneumonia.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26870.
    >> Share

  1577. BADRAH M, Riad A, Kassem I, Boccuzzi M, et al
    Craniofacial Pain in COVID-19 Patients with Diabetes Mellitus: Clinical and Laboratory Description of Twenty-One Cases.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26866.
    >> Share

  1578. DE SIRE A, Giray E, Taskiran OO
    Chelsea Physical Assessment Tool for evaluating functioning in post-Intensive Care Unit COVID-19 patients.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26867.
    >> Share

  1579. UMAIR M, Ikram A, Salman M, Alam MM, et al
    Importation of SARS-CoV-2 Variant B.1.1.7 in Pakistan.
    J Med Virol. 2021 Feb 11. doi: 10.1002/jmv.26869.
    >> Share

  1580. BAUER G, Struck F, Schreiner P, Staschik E, et al
    The challenge of avidity determination in SARS-CoV-2 serology.
    J Med Virol. 2021 Feb 10. doi: 10.1002/jmv.26863.
    >> Share

  1581. SEYMEN CM
    Being pregnant in the COVID-19 pandemic: Effects on the placenta in all aspects.
    J Med Virol. 2021 Feb 9. doi: 10.1002/jmv.26857.
    >> Share

  1582. KAUSHIK J, Singh A, Kochhar D, Murari T, et al
    Receptors Modulation On The Ocular Surface: A Novel Insight Into The Ocular Infection And Disease Transmission Of SARS-CoV-2.
    J Med Virol. 2021 Feb 9. doi: 10.1002/jmv.26858.
    >> Share

  1583. VEYRENCHE N, Bollore K, Pisoni A, Bedin AS, et al
    Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
    J Med Virol. 2021 Feb 8. doi: 10.1002/jmv.26855.
    >> Share

  1584. LOFFREDO L, Campana A, Olivini N, Cotugno N, et al
    Hypoalbuminemia and Clinical Adverse Events in Children with COVID-19.
    J Med Virol. 2021 Feb 8. doi: 10.1002/jmv.26856.
    >> Share

  1585. MOELLER ME, Fock J, Pah P, Veras AC, et al
    Evaluation of commercially available immuno-magnetic agglutination in comparison to enzyme-linked immunosorbent assays for rapid point-of-care diagnostics of COVID-19.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26854.
    >> Share

  1586. AYKAC K, Cura Yayla BC, Ozsurekci Y, Evren K, et al
    The Association of Viral load and Disease Severity in Children with COVID-19.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26853.
    >> Share

  1587. BAHGAT MM, Nadeem R, Nasraa MH, Awad MA, et al
    Impact of both socioeconomic level and occupational nature on the antibody prevalence to SARS-CoV-2 in an Egyptian cohort: the first episode.
    J Med Virol. 2021 Feb 6. doi: 10.1002/jmv.26852.
    >> Share

  1588. OLUMADE TJ, Uzairue LI
    Clinical characteristics of 4499 COVID-19 patients in Africa: A meta-analysis.
    J Med Virol. 2021 Feb 5. doi: 10.1002/jmv.26848.
    >> Share

  1589. POURFRIDONI M, Pajokh M, Seyedi F
    Letter to Editor: Bladder and bowel incontinence in COVID-19.
    J Med Virol. 2021 Feb 5. doi: 10.1002/jmv.26849.
    >> Share

  1590. XIE W, Chen Z, Wang Q, Song M, et al
    Infection and disease spectrum in individuals with household exposure to SARS-CoV-2: A family cluster cohort study.
    J Med Virol. 2021 Feb 4. doi: 10.1002/jmv.26847.
    >> Share

  1591. TANBOGA IH, Canpolat U, Cetin EHO, Kundi H, et al
    Development and Validation of Clinical Prediction Models to Estimate the Probability of death in Hospitalized Patients with COVID-19: Insights from a Nationwide Database.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26844.
    >> Share

  1592. SEENI R, Firzli T, Riddle MS, Krasner C, et al
    Using COVID-19 Cycle Threshold and Other Lab Values as Predictors of Hospitalization Need.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26835.
    >> Share

  1593. KOH H, Moh AMC, Yeoh E, Lin Y, et al
    Diabetes predicts severity of COVID-19 infection in a retrospective cohort: A mediatory role of the inflammatory biomarker C-reactive protein.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26837.
    >> Share

  1594. SHAYESTEHPOUR M, Zamani B
    Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26838.
    >> Share

  1595. ELSHAZLI RM, Kline A, Elgaml A, Aboutaleb MH, et al
    Gastroenterology manifestations and COVID-19 outcomes: A meta-analysis of 25,252 cohorts among the first and second waves.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26836.
    >> Share

  1596. LINDEMANN M, Krawczyk A, Dolff S, Konik M, et al
    SARS-CoV-2-specific humoral and cellular immunity in two renal transplant and two haemodialysis patients treated with convalescent plasma.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26840.
    >> Share

  1597. ROSSOTTI R, Molteni SN, Faccini M, Puoti M, et al
    Reply to: Epidemiological evidence for association between higher influenza vaccine uptake in the elderly and lower COVID-19 deaths in Italy.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26841.
    >> Share

  1598. TAKAGI H
    Eyeglasses in Wonderland of COVID-19.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26845.
    >> Share

  1599. ECHAVARRIA M, Reyes NS, Rodriguez PE, Ypas M, et al
    Self-collected saliva for SARS-CoV-2 detection: a prospective study in the emergency room.
    J Med Virol. 2021 Feb 2. doi: 10.1002/jmv.26839.
    >> Share

  1600. KOMABAYASHI K, Matoba Y, Tanaka S, Seto J, et al
    Longitudinal epidemiology of human coronavirus OC43 in Yamagata, Japan, 2010-2017: Two groups based on spike gene appear one after another.
    J Med Virol. 2021;93:945-951.
    >> Share

  1601. VEIGA ABGD, Martins LG, Riediger I, Mazetto A, et al
    More than just a common cold: Endemic coronaviruses OC43, HKU1, NL63, and 229E associated with severe acute respiratory infection and fatality cases among healthy adults.
    J Med Virol. 2021;93:1002-1007.
    >> Share

  1602. CIOTTI M, Maurici M, Pieri M, Andreoni M, et al
    Performance of a rapid antigen test in the diagnosis of SARS-CoV-2 infection.
    J Med Virol. 2021 Feb 1. doi: 10.1002/jmv.26830.
    >> Share

  1603. VIZZUSO A, Piciucchi S, Tortola D, Grosso C, et al
    Single dose of subcutaneous tocilizumab in COVID-pneumonia: CT evidence of lymph nodal and parenchymal response.
    J Med Virol. 2021;93:599-600.
    >> Share

    January 2021
  1604. PERESON MJ, Flichman DM, Martinez AP, Bare P, et al
    Evolutionary analysis of SARS-CoV-2 spike protein for its different clades.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26834.
    >> Share

  1605. PIANTONI S, Salada L, Colombo E, Mendeni M, et al
    Reports of 3 long-term lung disease following SARS-CoV-2 infection.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26831.
    >> Share

  1606. DEMIR M, Demir F, Aygun H
    Vitamin D deficiency is associated with COVID-19 positivity and the severity of the disease.
    J Med Virol. 2021 Jan 29. doi: 10.1002/jmv.26832.
    >> Share

  1607. CUBEDDU LX, Cubeddu RJ
    Early Remdesivir Treatment in Covid-19: Why Wait Another Day?
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26792.
    >> Share

  1608. FANG ZF, Sun BQ, Zhu AR, Lin LC, et al
    Multiplexed analysis of circulating IgA antibodies for SARS-CoV-2 and Common Respiratory Pathogens in COVID-19 Patients.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26829.
    >> Share

  1609. RAMIREZ JD, Munoz M, Patino LH, Ballesteros N, et al
    Will the emergent SARS-CoV2 B.1.1.7 lineage affect molecular diagnosis of COVID19?
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26823.
    >> Share

  1610. GANGULY B
    A parsimonious approach for recognizing SARS-CoV-2 and host interactions.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26824.
    >> Share

  1611. NASREDDINE R, Florence E, Moutschen M, Yombi JC, et al
    Clinical characteristics and outcomes of COVID-19 in people living with HIV in Belgium: A multicenter, retrospective cohort.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26828.
    >> Share

  1612. KHANMOHAMMADI S, Rezaei N
    Role of Toll-like receptors in the pathogenesis of COVID-19.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26826.
    >> Share

  1613. AWAN UA, Khattak AA, Afzal MS, Iqbal N, et al
    Emergence of SARS-CoV-2 Variant: A Wake-Up Call for Pakistan's overburdened Healthcare System.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26825.
    >> Share

  1614. LIAO L, Yang GH
    Clinical Significance of Cellular Immunity Function and Inflammatory Factors Assays in Alveolar Lavage Fluid for Severe COVID-19 Pneumonia.
    J Med Virol. 2021 Jan 28. doi: 10.1002/jmv.26827.
    >> Share

  1615. CHIRUMBOLO S, Franzini M, Simonetti V, Valdenassi L, et al
    Oxygen-ozone autohemotherapy against COVID-19 needs to fit highly experienced, customized, and standardized protocols to succeed.
    J Med Virol. 2021 Jan 27. doi: 10.1002/jmv.26806.
    >> Share

  1616. ELBADAWY HM, Khattab A, Alalawi A, Aljohani F, et al
    The detection of SRAS-CoV-2 in outpatient clinics and public facilities during the COVID19 pandemic.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26819.
    >> Share

  1617. MUTNAL MB, Lanham JA, Walker K, Rao A, et al
    False positive Influenza rapid tests using newly EUA cleared multiplex assay in a low prevalence setting.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26820.
    >> Share

  1618. EDIZ TUTUNCU E, Ozgur D, Karamese M
    Saliva samples for detection of SARS-CoV-2 in mildly symptomatic and asymptomatic patients.
    J Med Virol. 2021 Jan 26. doi: 10.1002/jmv.26821.
    >> Share

  1619. ISLAM MT, Ul Alam ASMR, Sakib N, Hasan MS, et al
    A rapid and cost-effective multiplex ARMS-PCR method for the simultaneous genotyping of the circulating SARS-CoV-2 phylogenetic clades.
    J Med Virol. 2021 Jan 25. doi: 10.1002/jmv.26818.
    >> Share

  1620. LUCIANI L, Ninove L, Zandotti C, Nougairede A, et al
    COVID-19 pandemic and its consequences disrupt epidemiology of enterovirus meningitis, South-East France.
    J Med Virol. 2021 Jan 22. doi: 10.1002/jmv.26785.
    >> Share

  1621. PUNZO O, Bellino S, Palmieri L, Lo Noce C, et al
    Clinical characteristics of individuals under 40 years of age who died with COVID-19 in Italy.
    J Med Virol. 2021 Jan 22. doi: 10.1002/jmv.26788.
    >> Share

  1622. SAHU KK, George L, Jones N, Mangla A, et al
    COVID-19 in patients with sickle cell disease: A single center experience from Ohio, United States.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26816.
    >> Share

  1623. FINZI E, Harrington A
    Zinc treatment of outpatient COVID-19: A retrospective review of 28 consecutive patients.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26812.
    >> Share

  1624. ANIRUDHAN V, Lee H, Cheng H, Cooper L, et al
    Targeting SARS-CoV-2 Viral Proteases as a Therapeutic Strategy to Treat COVID-19.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26814.
    >> Share

  1625. CHENG Y, Ma J, Wang H, Wang X, et al
    Co-Infection of Influenza A Virus and SARS-CoV-2: A Retrospective Cohort Study.
    J Med Virol. 2021 Jan 21. doi: 10.1002/jmv.26817.
    >> Share

  1626. HOU CK, Qin YF, Wang G, Liu QL, et al
    Impact of a Long-Term Air Pollution Exposure on the Case Fatality Rate of COVID-19 Patients - A Multi-City Study.
    J Med Virol. 2021 Jan 20. doi: 10.1002/jmv.26807.
    >> Share

  1627. LIU H, Ye C, Wang Y, Zhu W, et al
    The effectiveness of active surveillance measures for COVID-19 cases in Pudong New Area Shanghai, China, 2020.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26805.
    >> Share

  1628. MEYERS KJ, Dillman B, Williams C, Jiang J, et al
    Follow-up of SARS-CoV-2 Positive Subgroup from the Asymptomatic novel CORonavirus iNfection (ACORN) Study.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26810.
    >> Share

  1629. KHEIRABADI D, Haddad F, Mousavi-Roknabadi RS, Rezaeisadrabadi M, et al
    A complementary critical appraisal on systematic reviews regarding the most efficient therapeutic strategies for current COVID-19 (SARS-CoV-2) pandemic.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26811.
    >> Share

  1630. FU W, Chen C, Chen XL, Wang K, et al
    A U-shaped association between baseline neutrophil count and COVID-19-related mortality: a retrospective cohort study.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26794.
    >> Share

  1631. PIERI M, Nuccetelli M, Nicolai E, Sarubbi S, et al
    Clinical validation of a second generation anti-SARS-CoV-2 IgG and IgM automated chemiluminescent immunoassay.
    J Med Virol. 2021 Jan 19. doi: 10.1002/jmv.26809.
    >> Share

  1632. UGOLOTTI MC, Pedrazzini M, Silini EM, Missale G, et al
    Vascular liver injury mimicking an intrahepatic cholangiocarcinoma in a COVID-19 patient.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26803.
    >> Share

  1633. SAFARI I, InanlooRahatloo K, Elahi E
    World-wide tracking of major SARS-CoV-2 genome haplotypes in sequences of June 1 to November 15, 2020 and discovery of rapid expansion of a new haplotype.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26802.
    >> Share

  1634. WANG G, Cai L, Chen D, Teng T, et al
    Influence of COVID-19 in patients with concurrent tuberculosis co-infections.
    J Med Virol. 2021 Jan 17. doi: 10.1002/jmv.26801.
    >> Share

  1635. LEE JJ, Montazerin SM, Jamil A, Jamil U, et al
    Association between Red Blood Cell Distribution Width and Mortality and Severity among Patients with COVID-19: A Systematic Review and Meta-Analysis.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26797.
    >> Share

  1636. XIA Q, Xu K, Ni Q, Li Y, et al
    Clinical efficacy of Methylprednisolone and the combined use of Lopinavir/Ritonavir with Arbidol in treatment of Coronavirus Disease 2019.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26798.
    >> Share

  1637. LARDARO T, Wang AZ, Bucca A, Croft A, et al
    Characteristics of COVID-19 Patients with Bacterial Co-infection Admitted to the Hospital from the Emergency Department in a Large Regional Healthcare System.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26795.
    >> Share

  1638. MANTERO V, Abate L, Salmaggi A, Cordano C, et al
    Multiple Sclerosis and COVID-19: how therapeutic scenarios could change during the pandemic?
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26796.
    >> Share

  1639. OCMANT A, Roisin S, De Meuter R, Brauner J, et al
    Clinical performance of the Advia Centaur anti-SARS-CoV-2 chemiluminescent immunoassay related to antibody kinetics.
    J Med Virol. 2021 Jan 15. doi: 10.1002/jmv.26800.
    >> Share

  1640. DENG K, Fan Q, Yang Y, Deng X, et al
    Prognostic roles of KL-6 in disease severity and lung injury in COVID-19 patients: a longitudinal retrospective analysis.
    J Med Virol. 2021 Jan 12. doi: 10.1002/jmv.26793.
    >> Share

  1641. RESHAMWALA SMS, Likhite V, Degani MS, Deb SS, et al
    Mutations in SARS-CoV-2 nsp7 and nsp8 proteins and their predicted impact on replication/transcription complex structure.
    J Med Virol. 2021 Jan 12. doi: 10.1002/jmv.26791.
    >> Share

  1642. HO YI, Wong AH, Tang KPS, Wong RCW, et al
    Comparison of three commercial SARS-CoV-2 assays for pooled testing of deep throat saliva for surveillance of patients attending general outpatient clinics.
    J Med Virol. 2021 Jan 11. doi: 10.1002/jmv.26764.
    >> Share

  1643. ANICHINI G, Gandolfo C, Terrosi C, Fabrizi S, et al
    Antibody response to SARS-CoV-2 in infected patients with different clinical outcome.
    J Med Virol. 2021 Jan 11. doi: 10.1002/jmv.26789.
    >> Share

  1644. FUMIAN TM, Malta FC, Dos Santos DRL, Pauvolid-Correa A, et al
    SARS-CoV-2 RNA Detection in Stool Samples from Acute Gastroenteritis Cases, Brazil.
    J Med Virol. 2021 Jan 9. doi: 10.1002/jmv.26786.
    >> Share

  1645. NISHANTH D, Jhuma S, Nitesh G, Ramesh Chand M, et al
    COVID-19 with and without anosmia/dysgeusia: A case-control study.
    J Med Virol. 2021 Jan 8. doi: 10.1002/jmv.26784.
    >> Share

  1646. BLAIRON L, Piteus S, Beukinga I, Tre-Hardy M, et al
    Development and implementation of a RT-qPCR extraction-free protocol for the detection of SARS-CoV-2 and impact on the turn-around-time.
    J Med Virol. 2021 Jan 7. doi: 10.1002/jmv.26782.
    >> Share

  1647. LI M, Guo X, Wang X
    Retrospective prediction of the epidemic trend of COVID-19 in Wuhan at four phases.
    J Med Virol. 2021 Jan 7. doi: 10.1002/jmv.26781.
    >> Share

  1648. SPANAKIS N, Kassela K, Dovrolis N, Bampali M, et al
    A main event and multiple introductions of SARS-Cov2 initiated the COVID-19 epidemic in Greece.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26778.
    >> Share

  1649. SAXENA S, Manchanda V, Sagar T, Nagi N, et al
    Clinical characteristic and epidemiological features of SARS CoV -2 disease patients from a COVID 19 designated Hospital in New Delhi.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26777.
    >> Share

  1650. RASTAWICKI W, Gierczynski R, Juszczyk G, Mitura K, et al
    Evaluation of PCL rapid point of care antigen test for detection of SARS-CoV-2 in nasopharyngeal swabs.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26765.
    >> Share

  1651. SINGH S, Widrich C, Nap M, Schokker E, et al
    Antihypertensive and its relation to mortality by SARS-CoV-2 infection.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26775.
    >> Share

  1652. CHOUDHURY A, Chandra Das N, Patra R, Mukherjee S, et al
    In silico analyses on the comparative sensing of SARS-CoV-2 mRNA by the intracellular TLRs of human.
    J Med Virol. 2021 Jan 6. doi: 10.1002/jmv.26776.
    >> Share

  1653. GARG P, Arora U, Kumar A, Malhotra A, et al
    Risk Factors for Prolonged Fatigue after Recovery from COVID-19.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26774.
    >> Share

  1654. WANG JH, Chen RD, Yang HK, Zeng LC, et al
    Inflammation-associated factors for predicting in-hospital mortality in patients with COVID-19.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26771.
    >> Share

  1655. RAO M, Rashid FA, Sabri FSAH, Jamil NN, et al
    COVID-19 screening test by using random oropharyngeal saliva.
    J Med Virol. 2021 Jan 4. doi: 10.1002/jmv.26773.
    >> Share

  1656. HE J, Huang JR, Zhang YL, Zhang J, et al
    SARS-CoV-2 nucleocapsid protein intranasal inoculation induces local and systemic T cell responses in mice.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26769.
    >> Share

  1657. KRUGER S, Leskien M, Schuller P, Prifert C, et al
    Performance and feasibility of universal PCR admission screening for SARS-CoV-2 in a German tertiary care hospital.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26770.
    >> Share

  1658. NEJADGHADERI SA, Safiri S
    The dilemma of herd immunity for COVID-19.
    J Med Virol. 2021 Jan 2. doi: 10.1002/jmv.26768.
    >> Share

    December 2020
  1659. GILIS M, Chagrot N, Koeberle S, Tannou T, et al
    Older adults with SARS-CoV2 infection: Utility of the Clinical Frailty Scale to predict mortality.
    J Med Virol. 2020 Dec 30. doi: 10.1002/jmv.26766.
    >> Share

  1660. MEYERS C, Robison R, Milici J, Alam S, et al
    Rebuttal to Overinterpretation of the antiviral results for human coronavirus 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus -2 (SARS-CoV-2) by Rowpar Pharmaceuticals.
    J Med Virol. 2020 Dec 29. doi: 10.1002/jmv.26762.
    >> Share

  1661. STROFFOLINI T, Lombardi A, Ciancio A, Niro GA, et al
    Low influenza vaccination coverage in subjects with liver cirrhosis. An alert waiting winter season 2020-2021 during COVID-19 pandemic.
    J Med Virol. 2020 Dec 28. doi: 10.1002/jmv.26763.
    >> Share

  1662. BUSTOS P, Tambley C, Acevedo A, Andrade W, et al
    Quantitative Detection of SARS-CoV-2 RNA in nasopharyngeal samples from infected patients with mild disease.
    J Med Virol. 2020 Dec 26. doi: 10.1002/jmv.26761.
    >> Share

  1663. SHEWALE JG, Ratcliff JL
    Overinterpretation of the antiviral results for human coronavirus strain 229E (HCoV-229E) relative to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    J Med Virol. 2020 Dec 25. doi: 10.1002/jmv.26722.
    >> Share

  1664. MAHAJAN NN, Gajbhiye R, Bahirat S, Lokhande PD, et al
    Co-infection of malaria and early clearance of SARS-CoV-2 in healthcare workers.
    J Med Virol. 2020 Dec 24. doi: 10.1002/jmv.26760.
    >> Share

  1665. TAHTASAKAL CA, Oncul A, Sevgi DY, Celik E, et al
    Could we predict the prognosis of the COVID-19 disease?
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26751.
    >> Share

  1666. HUDSON B S, Kolte V, Khan A, Sharma G, et al
    Dynamic tracking of variant frequencies depicts the evolution of mutation sites amongst SARS-CoV-2 genomes from India.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26756.
    >> Share

  1667. ZHOU B, Kojima S, Kawamoto A, Fukushima M, et al
    COVID-19 pathogenesis, prognostic factors and treatment strategy: urgent recommendations.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26754.
    >> Share

  1668. COEN M, Kaiser C, Naimi R, Uginet M, et al
    Beyond silent hypoxemia: Does COVID-19 can blunt pain perception? Comment on "The neuroinvasive potential of SARS CoV2 may play a role in the respiratory failure of COVID 19 patients".
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26753.
    >> Share

  1669. KUMAR A, Kumar P, Singh A, D S, et al
    Bilateral premacular sub-hyaloid hemorrhage-unmasking COVID-19 induced pancytopenia.
    J Med Virol. 2020 Dec 23. doi: 10.1002/jmv.26752.
    >> Share

  1670. MERUGU GP, Neishwat Z, Balla M, Patel M, et al
    Predictors of Mortality in 217 COVID-19 Patients in Northwest Ohio, United States: A Retrospective Study.
    J Med Virol. 2020 Dec 22. doi: 10.1002/jmv.26750.
    >> Share

  1671. CORDES AK, Rehrauer WM, Accola MA, Wolk B, et al
    Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion.
    J Med Virol. 2020 Dec 22. doi: 10.1002/jmv.26749.
    >> Share

  1672. MISHRA D, Suri GS, Kaur G, Tiwari M, et al
    A comparative insight into genomic landscape of SARS-CoV-2 and identification of mutations associated with origin of infection and diversity.
    J Med Virol. 2020 Dec 21. doi: 10.1002/jmv.26744.
    >> Share

  1673. ZANDIFAR A, Badrfam R
    COVID-19 and Anti-N-Methyl-D-Aspartate Receptor (Anti NMDAR) Encephalitis; Are we Facing an Increase in the Prevalence of Autoimmune Encephalitis?
    J Med Virol. 2020 Dec 18. doi: 10.1002/jmv.26745.
    >> Share

  1674. ZRELLI S, Amairia S, Zrelli M
    Respiratory Syndrome Coronavirus-2 response: Micorobiots as Lactobacilli could make the difference.
    J Med Virol. 2020 Dec 18. doi: 10.1002/jmv.26746.
    >> Share

  1675. CIZMECIOGLU A, Cizmecioglu HA, Goktepe MH, Emsen A, et al
    Apoptosis-Induced T Cell Lymphopenia Is Related to COVID-19 Severity.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26742.
    >> Share

  1676. SARKAR S, Khanna P, Singh AK
    Impact of COVID-19 in patients with concurrent co-infections: a systematic review and meta-analyses.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26740.
    >> Share

  1677. ZHOU C, Bu G, Sun Y, Ren C, et al
    Evaluation of serum IgM and IgG antibodies in COVID-19 patients by enzyme linked immunosorbent assay.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26741.
    >> Share

  1678. MARTI JLG, Wells A, Brufsky AM
    Dysregulation of the mevalonate pathway during SARS-CoV-2 infection: an in-silico study.
    J Med Virol. 2020 Dec 17. doi: 10.1002/jmv.26743.
    >> Share

  1679. LIU X, Li X, Sun T, Qin H, et al
    East-West differences in clinical manifestations of COVID-19 patients: A systematic literature review and meta-analysis.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26737.
    >> Share

  1680. HO KS, Narasimhan B, Sheehan J, Wu L, et al
    Controversy over Smoking in COVID-19 - A Real World Experience in New York City.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26738.
    >> Share

  1681. CHEN HL, Chao CM, Lai CC
    The safety of remdesivir for COVID-19 patients.
    J Med Virol. 2020 Dec 15. doi: 10.1002/jmv.26735.
    >> Share

  1682. LEUZINGER K, Gosert R, Sogaard KK, Naegele K, et al
    Epidemiology and precision of SARS-CoV-2 detection following lockdown and relaxation measures.
    J Med Virol. 2020 Dec 14. doi: 10.1002/jmv.26731.
    >> Share

  1683. KARAM BS, Morris RS, Bramante CT, Puskarich M, et al
    mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26728.
    >> Share

  1684. EROL SA, Tanacan A, Anuk AT, Tokalioglu EO, et al
    Evaluation of Maternal Serum Afamin and Vitamin E Levels in Pregnant Women with COVID-19 and Its Association with Composite Adverse Perinatal Outcomes.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26725.
    >> Share

  1685. MORADIMAJD P, Samaee H, Sedigh-Maroufi S, Kourosh-Aami M, et al
    Administration of intravenous immunoglobulin in the treatment of COVID-19: a review of available evidence.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26727.
    >> Share

  1686. ABDOLLAHI A, Sarvestani HK, Rafat Z, Ghaderkhani S, et al
    The Association Between the Level of Serum 25(OH) Vitamin D, Obesity, and underlying Diseases with the risk of Developing COVID-19 Infection: A case-control study of hospitalized patients in Tehran, Iran.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26726.
    >> Share

  1687. LIAO FL, Peng DH, Chen W, Hu HN, et al
    Evaluation of serum hepatic enzyme activities in different COVID-19 phenotypes.
    J Med Virol. 2020 Dec 12. doi: 10.1002/jmv.26729.
    >> Share

  1688. BODNAR B, Patel K, Ho W, Luo JJ, et al
    Cellular mechanisms underlying neurological/neuropsychiatric manifestations of COVID-19.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26720.
    >> Share

  1689. SOARES CD, Mosqueda-Taylor A, Hernandez-Guerrero JC, de Carvalho MGF, et al
    Immunohistochemical expression of angiotensin-converting enzyme 2 (ACE2) in minor salivary glands during SARS-CoV-2 infection.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26723.
    >> Share

  1690. DOGAN HO, Senol O, Bolat S, Yildiz SN, et al
    Understanding the Pathophysiological Changes Via Untargated Metabolomics in COVID-19 Patients.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26716.
    >> Share

  1691. DIMEGLIO C, Collot S, Abravanel F, Saune K, et al
    Diagnosis options in patients suffering from COVID-19- like symptoms.
    J Med Virol. 2020 Dec 10. doi: 10.1002/jmv.26724.
    >> Share

  1692. LIPPI G, Mattiuzzi C
    SARS-CoV-2 positive tests efficiently predict pressure on healthcare system.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26718.
    >> Share

  1693. AWAN UA, Khattak AA, Afzal MS, Khan HI, et al
    COVID-19 and Tuberculosis Overlapping epidemics: A holistic review from Pakistan.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26714.
    >> Share

  1694. BHATTACHARYA D, Parai D, Rout UK, Dash P, et al
    Saliva for diagnosis of SARS-CoV-2: first report from India.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26719.
    >> Share

  1695. FERRARO F, Calafiore D, Dambruoso F, Guidarini S, et al
    COVID-19 related fatigue: which role for rehabilitation in post-COVID-19 patients? A case series.
    J Med Virol. 2020 Dec 9. doi: 10.1002/jmv.26717.
    >> Share

  1696. DAI W, Wu J, Li T, Shen J, et al
    Clinical outcomes for COVID-19 patients with diabetes mellitus treated with convalescent plasma transfusion in Wuhan, China.
    J Med Virol. 2020 Dec 7. doi: 10.1002/jmv.26712.
    >> Share

  1697. CHEN H, Chen R, Yang H, Wang J, et al
    Development and Validation of a Nomogram Using on Admission Routine Laboratory Parameters to Predict In-hospital Survival of Patients With COVID-19.
    J Med Virol. 2020 Dec 7. doi: 10.1002/jmv.26713.
    >> Share

  1698. ZAYET S, Gendrin V, Royer PY, Toko L, et al
    Comparison of COVID-19 and influenza in adult patients: neurological symptoms input.
    J Med Virol. 2020 Dec 3. doi: 10.1002/jmv.26710.
    >> Share

  1699. CHAUHAN N, Soni S, Gupta A, Aslam M, et al
    Interpretative immune targets and contemporary position for vaccine development against SARS-CoV-2: A systematic review.
    J Med Virol. 2020 Dec 3. doi: 10.1002/jmv.26709.
    >> Share

  1700. WANG P
    Significance of IgA antibody testing for early detection of SARS-CoV-2.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26703.
    >> Share

  1701. RIAD A, Kassem I, Badrah M, Klugar M, et al
    COVID-19 Transient Snoring (CVTS): Clinical and Laboratory Description.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26705.
    >> Share

  1702. TORAIH EA, Sedhom JA, Dokunmu TM, Hussein MH, et al
    Hidden in plain sight: The effects of BCG vaccination in COVID-19 pandemic.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26707.
    >> Share

  1703. KLINGEN RL, Katschinski B, Anastasiou OE, Stefan Ross R, et al
    Over 90% of clinical swabs used for SARS-CoV-2 diagnostics contain sufficient nucleic acid concentrations.
    J Med Virol. 2020 Dec 2. doi: 10.1002/jmv.26706.
    >> Share

    November 2020
  1704. HENRIQUEZ-MARQUEZ KI, Lainez-Murillo DC, Sierra M, Munoz-Lara F, et al
    High impact of SARS-CoV-2/COVID-19 in the Honduran Health Personnel.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26702.
    >> Share

  1705. ALIZADEHSANI R, Sani ZA, Behjati M, Roshanzamir Z, et al
    Risk Factors Prediction, Clinical Outcomes and Mortality of COVID-19 Patients.
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26699.
    >> Share

  1706. LUCIANI M, Bentivegna E, Spuntarelli V, Lamberti PA, et al
    Recurrent Covid-19 Pneumonia in the course of chemotherapy: consequence of a weakened immune system?
    J Med Virol. 2020 Nov 28. doi: 10.1002/jmv.26701.
    >> Share

  1707. HARIYANTO TI, Kurniawan A
    Tocilizumab administration is associated with reduction in biomarkers of coronavirus disease 2019 (COVID-19) infection.
    J Med Virol. 2020 Nov 26. doi: 10.1002/jmv.26698.
    >> Share

  1708. VALDIVIA A, Torres I, Latorre V, Frances-Gomez C, et al
    Suitability of Two Rapid Lateral Flow Immunochromatographic Assays for Predicting SARS-CoV-2 Neutralizing Activity of Sera.
    J Med Virol. 2020 Nov 25. doi: 10.1002/jmv.26697.
    >> Share

  1709. KANG K, Huang L, Ouyang C, Du J, et al
    Development, Performance Evaluation and Clinical Application of A Rapid SARS-CoV-2 IgM and IgG Test Kit Based on Automated Fluorescence Immunoassay.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26696.
    >> Share

  1710. ZHANG G, Wu Y, Xu R, Du X, et al
    Effects of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors on Disease Severity and Mortality in Patients with COVID-19: A Meta-analysis.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26695.
    >> Share

  1711. AWAN UA, Zahoor S, Rehman K, Khattak AA, et al
    COVID-19 and Influenza H1N1: A dangerous combination for Pakistan in the upcoming winter season.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26687.
    >> Share

  1712. DESMET S, Ekinci E, Wouters I, Decru B, et al
    No SARS-CoV-2 carriage observed in children attending daycare centers during the first weeks of the epidemic in Belgium.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26689.
    >> Share

  1713. GARG A, Ghoshal U, Patel SS, Singh DV, et al
    Evaluation of seven commercial RT-PCR kits for COVID-19 testing in pooled clinical specimens.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26691.
    >> Share

  1714. BOSCHI C, Hoang VT, Giraud-Gatineau A, Ninove L, et al
    Co-infections with SARS-CoV-2 and other respiratory viruses in Southeastern France: a matter of sampling time.
    J Med Virol. 2020 Nov 24. doi: 10.1002/jmv.26692.
    >> Share

  1715. OZSUREKCI Y, Aykac K, Er AG, Halacli B, et al
    Predictive Value of Cytokine/Chemokine Responses for the Disease Severity and Management in Children and Adult Cases with COVID-19.
    J Med Virol. 2020 Nov 23. doi: 10.1002/jmv.26683.
    >> Share

  1716. ALSHARRAH D, Alhaddad F, Alyaseen M, Aljamaan S, et al
    Clinical Characteristics of Pediatric SARS-CoV-2 Infection and Coronavirus Disease 2019 (COVID-19) in Kuwait.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26684.
    >> Share

  1717. GIULIANI J, Bonetti A
    COVID-19 and Cancer: A Clear Change Not Only in Daily Clinical Practice But Also in Clinical Research Management.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26680.
    >> Share

  1718. AKINOSOGLOU K, Gogos A, Papageorgiou C, Angelopoulos E, et al
    Ketamine in COVID-19 patients: Thinking out of the box.
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26681.
    >> Share

  1719. TAKAGI H
    A red mirage - Did the association of the 2016 presidential election results with the COVID-19 epidemic magically disappear in 2020?
    J Med Virol. 2020 Nov 20. doi: 10.1002/jmv.26682.
    >> Share

  1720. VERALDI S, Spigariolo CB
    Pityriasis rosea and COVID-19.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26679.
    >> Share

  1721. MERCATELLI D, Triboli L, Fornasari E, Ray F, et al
    coronapp: A Web Application to Annotate and Monitor SARS-CoV-2 Mutations.
    J Med Virol. 2020 Nov 18. doi: 10.1002/jmv.26678.
    >> Share

  1722. FAVRESSE J, Cadrobbi J, Eucher C, Elsen M, et al
    Clinical performances of three fully automated anti-SARS-CoV-2 immunoassays targeting the nucleocapsid or spike proteins.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26669.
    >> Share

  1723. HILL JA, Menon MP, Dhanireddy S, Wurfel MM, et al
    Tocilizumab in hospitalized patients with COVID-19: Clinical outcomes, inflammatory marker kinetics, and safety.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26674.
    >> Share

  1724. YANG J, Tian C, Chen Y, Zhu C, et al
    Obesity aggravates COVID-19: an updated systematic review and meta-analysis.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26677.
    >> Share

  1725. SPOTO S, Agro FE, Sambuco F, Travaglino F, et al
    High value of Mid-regional proAdrenomedullin in COVID-19: a marker of widespread endothelial damage, disease severity and mortality.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26676.
    >> Share

  1726. SWAMINATHAN N, Moussa P, Mody N, Bryan Lo K, et al
    COVID-19 in HIV infected patients: A Case series and Literature Review.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26671.
    >> Share

  1727. AWAN UA, Zahoor S, Ayub A, Ahmed H, et al
    COVID-19 and Arboviral Diseases: Another Challenge for Pakistan's Delipidated Healthcare System.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26668.
    >> Share

  1728. ATEYA AM, Sabri NA
    Angiotensin-converting enzyme inhibitors (ACEIs) and Angiotensin-receptor blockers (ARBs) benefits outweigh the risks in COVID-19 hypertensive patients.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26672.
    >> Share

  1729. SEYMEN CM
    The other side of COVID-19 pandemic: Effects on male fertility.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26667.
    >> Share

  1730. SYAL K
    Newly identified limitations of diagnostic tools for COVID-19 and consequences.
    J Med Virol. 2020 Nov 17. doi: 10.1002/jmv.26673.
    >> Share

  1731. WANG J, Zhu L, Xue L, Liu L, et al
    Risk factors of liver injury in patients with coronavirus disease 2019 in Jiangsu, China: a retrospective, multi-center study.
    J Med Virol. 2020 Nov 11. doi: 10.1002/jmv.26663.
    >> Share

  1732. SHARMA B
    Does use of propofol aggravate the inflammatory markers and cause propofol infusion syndrome (PRIS) in intubated cases of severe COVID-19 infections?
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26657.
    >> Share

  1733. LARROSA JMC
    Sars-Cov-2 in Argentina: Lockdown, Mobility, and Contagion.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26659.
    >> Share

  1734. HO YI, Wong AH, Leung EC, Wong RC, et al
    Rapid adaptation and continuous performance evaluation of SARS-CoV-2 envelope gene (E-gene) real-time RT-PCR assays to support the hospital surge in test demand.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26660.
    >> Share

  1735. TAKAGI H
    Survey of COVID-19 dynamics across US states.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26658.
    >> Share

  1736. MONREAL E, de la Maza SS, Gullon P, Natera-Villalba E, et al
    Non-severe immunosuppression might be associated with a lower risk of moderate-severe acute respiratory distress syndrome in COVID-19: a pilot study.
    J Med Virol. 2020 Nov 9. doi: 10.1002/jmv.26656.
    >> Share

  1737. SAID EA, Al-Reesi I, Al-Shizawi N, Jaju S, et al
    Defining IL-6 Levels in Healthy Individuals: A Meta-Analysis.
    J Med Virol. 2020 Nov 6. doi: 10.1002/jmv.26654.
    >> Share

  1738. HAN X, Ye Q
    Kidney involvement in COVID-19 and its treatments.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26653.
    >> Share

  1739. MASCOLO S, Carleo MA, Contieri M, Izzo S, et al
    SARS-CoV-2 and inflammatory responses: from mechanisms to the potential therapeutic use of intravenous immunoglobulin.
    J Med Virol. 2020 Nov 5. doi: 10.1002/jmv.26651.
    >> Share

  1740. LIN SF, Lai CC, Chao CM, Tang HJ, et al
    Impact of COVID-19 preventative measures on dengue infections in Taiwan.
    J Med Virol. 2020 Nov 3. doi: 10.1002/jmv.26650.
    >> Share

  1741. ALBERT E, Bracho MA, Serrano A, Ferrer B, et al
    Assessing the potential association between SARS-CoV-2 RNA load in the respiratory tract and COVID-19 mortality.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26644.
    >> Share

  1742. OZCELIK N, Ozyurt S, Yilmaz Kara B, Gumus A, et al
    The Value of Platelet Count and Platelet Indices in Differentiation of COVID-19 and Influenza Pneumonia.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26645.
    >> Share

  1743. LIU C, Yu X, Gao C, Zhang L, et al
    Characterization of Antibody Responses to SARS-CoV-2 in Convalescent COVID-19 Patients.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26646.
    >> Share

  1744. HOANG T
    Systematic review and meta-analysis of factors associated with re-positive viral RNA after recovery from COVID-19.
    J Med Virol. 2020 Nov 2. doi: 10.1002/jmv.26648.
    >> Share

    October 2020
  1745. ALSHARIF KF, Alzahrani AB, Alharbi AO, Algregri TO, et al
    The prevalence of MERS-CoV among military personnel and their families: A single center study.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26642.
    >> Share

  1746. PENROD Y, Garcia D, Dunn ST
    Evaluation of transport media for laboratory detection of SARS-CoV-2 in upper respiratory tract swab specimens.
    J Med Virol. 2020 Oct 31. doi: 10.1002/jmv.26643.
    >> Share

  1747. KOW CS, Aldeyab M, Hasan SS
    Effect of remdesivir on mortality in patients with COVID-19: A meta-analysis of randomized control trials.
    J Med Virol. 2020 Oct 29. doi: 10.1002/jmv.26638.
    >> Share

  1748. TORRES DA, Ribeiro LDCB, Riello APFL, Horovitz DDG, et al
    Reinfection of COVID-19 after 3 months with a distinct and more aggressive clinical presentation: case report.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26637.
    >> Share

  1749. ARAIMO F, Imperiale C, Tordiglione P, Ceccarelli G, et al
    Ozone as Adjuvant Support in the Treatment of COVID-19: A Preliminary Report of Probiozovid Trial.
    J Med Virol. 2020 Oct 28. doi: 10.1002/jmv.26636.
    >> Share

  1750. ZHANG C, Wu Z, Li JW, Tan K, et al
    Discharge may not be the end of treatment: pay attention to pulmonary fibrosis caused by severe COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26634.
    >> Share

  1751. RAGAB D, Salah Eldin H, Afify M, Soliman W, et al
    A case of COVID-19, with cytokine storm, treated by consecutive use of therapeutic plasma exchange followed by convalescent plasma transfusion: a case report.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26630.
    >> Share

  1752. MENG M, Zhou X, Zhang Q, Zou J, et al
    The positive rate of saliva for the detection of 2019-nCoV and possible factors related to the sensitivity results.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26627.
    >> Share

  1753. BISHBURG E, Okoh A, Nagarakanti SR, Lindner M, et al
    Fungemia in COVID -19 ICU Patients, a Single Medical Center Experience.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26633.
    >> Share

  1754. CHEN F, Geng Z, Wang J, Liuchang W, et al
    Comparing two sample pooling strategies for SARS-CoV-2 RNA detection for efficient screening of COVID-19.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26632.
    >> Share

  1755. TORTAJADA C, Colomer E, Andreu-Ballester JC, Esparcia A, et al
    Corticosteroids for COVID-19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and Intensive Care Unit admission in patients with COVID-19 according to patients' oxygen requirements.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26635.
    >> Share

  1756. YAZIHAN N, Tanacan A, Erol SA, Anuk AT, et al
    Comparison of VEGF-A Values between Pregnant Women with COVID-19 and Healthy Pregnancies and Its Association with Composite Adverse Outcomes.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26631.
    >> Share

  1757. BOUASSA RM, Pere H, Tonen-Wolyec S, Longo JD, et al
    Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points IgM as Achilles heel.
    J Med Virol. 2020 Oct 27. doi: 10.1002/jmv.26628.
    >> Share

  1758. WANG Y, Chen B, Li Y, Zhang L, et al
    The Use of Renin-Angiotensin-Aldosterone System (RAAS) Inhibitors is Associated with a Lower Risk of Mortality in Hypertensive COVID-19 Patients: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26625.
    >> Share

  1759. BAIG AM
    Chronic COVID Syndrome: Need for an appropriate medical terminology for Long-COVID and COVID Long-Haulers.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26624.
    >> Share

  1760. SHAMINUR RAHMAN M, Rafiul Islam M, Rubayet Ul Alam ASM, Islam I, et al
    Evolutionary dynamics of SARS-CoV-2 nucleocapsid (N) protein and its consequences.
    J Med Virol. 2020 Oct 23. doi: 10.1002/jmv.26626.
    >> Share

  1761. BWIRE GM, Njiro BJ, Mwakawanga DL, Sabas D, et al
    Possible vertical transmission and antibodies against SARS-CoV-2 among infants born to mothers with COVID-19: A living systematic review.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26622.
    >> Share

  1762. TAKAGI H
    Presidential vote 2016 and COVID-19 epidemic.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26620.
    >> Share

  1763. SREENIVASAN CC, Thomas M, Wang D, Li F, et al
    Susceptibility of livestock and companion animals to COVID-19.
    J Med Virol. 2020 Oct 22. doi: 10.1002/jmv.26621.
    >> Share

  1764. MOHANTY S, Ravindra A, Gupta K, Hallur V, et al
    Intricacies in characterizing positivity in pooled sample testing for SARS-CoV-2.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26618.
    >> Share

  1765. CHEN Y, Ke Y, Liu X, Wang Z, et al
    Clinical features and antibody response of patients from a COVID-19 treatment hospital in Wuhan, China.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26617.
    >> Share

  1766. MATTOS EC, Matsuda EM, Colpas DR, Carvalho F, et al
    Can urine be a potential biohazard in times of SARS-CoV-2 pandemic?
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26616.
    >> Share

  1767. KUMAR A, Prasoon P, Kumari C, Pareek V, et al
    SARS-CoV-2 specific virulence factors in COVID-19.
    J Med Virol. 2020 Oct 21. doi: 10.1002/jmv.26615.
    >> Share

  1768. KIVELA JM, Jarva H, Lappalainen M, Kurkela S, et al
    Saliva-based testing for diagnosis of SARS-CoV-2 infection: A meta-analysis.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26613.
    >> Share

  1769. SELINGEROVA I, Valik D, Gescheidtova L, Sramek V, et al
    Interpretive discrepancies caused by target values inter-batch variations in chemiluminescence immunoassay for SARS-CoV-2 IgM/IgG by MAGLUMI.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26612.
    >> Share

  1770. YUN HE, Ryu BY, Choe YJ
    Impact of Social Distancing on Incidence of Vaccine-Preventable Diseases, South Korea.
    J Med Virol. 2020 Oct 20. doi: 10.1002/jmv.26614.
    >> Share

  1771. CAVALIERE AF, Marchi L, Aquilini D, Brunelli T, et al
    Passive Immunity in Newborn from SARS-CoV-2 Infected Mother.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26609.
    >> Share

  1772. YANG P, Wang N, Wang J, Luo A, et al
    Admission fasting plasma glucose is an independent risk factor for 28-day mortality in patients with COVID-19.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26608.
    >> Share

  1773. STRATTON CW, Tang YW, Lu H
    Pathogenesis-Directed Therapy of 2019 Novel Coronavirus Disease.
    J Med Virol. 2020 Oct 19. doi: 10.1002/jmv.26610.
    >> Share

  1774. CRISCUOLO E, Diotti RA, Strollo M, Rolla S, et al
    Weak correlation between antibody titers and neutralizing activity in sera from SARS-CoV-2 infected subjects.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26605.
    >> Share

  1775. YIGENOGLU TN, Basci S, Sinan Dal M, Korkmaz S, et al
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 16. doi: 10.1002/jmv.26607.
    >> Share

  1776. SILVA JUNIOR JVJ, Lopes TRR, Weiblen R, Flores EF, et al
    Background immunity: how important is it for SARS-CoV-2?
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26602.
    >> Share

  1777. YAZDANPANAH Y
    Impact on disease mortality of clinical, biological and virological characteristics at hospital admission and over time in COVID-19 patients.
    J Med Virol. 2020 Oct 15. doi: 10.1002/jmv.26601.
    >> Share

  1778. HE J, Huang F, Zhang J, Chen Q, et al
    Vaccine design based on 16 epitopes of SARS-CoV-2 spike protein.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26596.
    >> Share

  1779. HIGUCHI T, Nishida T, Iwahashi H, Morimura O, et al
    Early Clinical Factors Predicting the Development of Critical Disease in Japanese Patients with COVID-19: A Single-Center, Retrospective, Observational Study.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26599.
    >> Share

  1780. ROSEN HR, O'Connell C, Nadim MK, DeClerck B, et al
    Extrapulmonary Manifestations of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) Infection.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26595.
    >> Share

  1781. WU S, Tian C, Liu P, Guo D, et al
    Effects of SARS-CoV-2 mutations on protein structures and intraviral protein-protein interactions.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26597.
    >> Share

  1782. PODDER S, Ghosh A, Ghosh T
    Mutations in membrane-fusion subunit of spike glycoprotein play crucial role in the recent outbreak of COVID-19.
    J Med Virol. 2020 Oct 14. doi: 10.1002/jmv.26598.
    >> Share

  1783. HERNANDEZ-HUERTA MT, Mayoral LP, Diaz CR, Cruz MM, et al
    Analysis of SARS-CoV-2 mutations in Mexico, Belize and isolated regions of Guatemala and its implication in the diagnosis.
    J Med Virol. 2020 Oct 13. doi: 10.1002/jmv.26591.
    >> Share

  1784. MANSOOR SR, Ghasemi-Kasman M
    Impact of disease-modifying drugs on severity of COVID-19 infection in multiple sclerosis patients.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26593.
    >> Share

  1785. DAUNT A, Perez-Guzman PN, Cafferkey J, Manalan K, et al
    Factors associated with re-attendance to emergency services following COVID-19 hospitalisation.
    J Med Virol. 2020 Oct 12. doi: 10.1002/jmv.26594.
    >> Share

  1786. YOKOYAMA Y, Aikawa T, Takagi H, Briasoulis A, et al
    Association of Renin-Angiotensin-Aldosterone System Inhibitors with Mortality and Testing Positive of COVID-19; Meta-Analysis.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26588.
    >> Share

  1787. CHIRUMBOLO S
    SARS-CoV2 virions in PM10 pollutants. May further research reject this thesis?
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26590.
    >> Share

  1788. KERGET B, Kerget F, Aksakal A, Askin S, et al
    Evaluation of alpha defensin, IL-1 receptor antagonist, and IL-18 levels in COVID-19 patients with macrophage activation syndrome and acute respiratory distress syndrome.
    J Med Virol. 2020 Oct 10. doi: 10.1002/jmv.26589.
    >> Share

  1789. HALPIN S, O'Connor R, Sivan M
    Long COVID and chronic COVID syndromes.
    J Med Virol. 2020 Oct 9. doi: 10.1002/jmv.26587.
    >> Share

  1790. SPEROTTO A, Candoni A, Petruzzellis G, Mullai R, et al
    Screening Procedure for SARS-CoV-2 infection combining Triage, nasopharyngeal swab and serological test in allogeneic stem cell transplantation Recipients Undergoing Outpatient Post Transplant Follow-Up.
    J Med Virol. 2020 Oct 8. doi: 10.1002/jmv.26586.
    >> Share

  1791. LENG Y, Chen M, Dai M, Wu Y, et al
    Minimize glycemic fluctuation decrease the risk of severe illness and death in patients with COVID-19.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26584.
    >> Share

  1792. PEZZUTO A, Tammaro A, Tonini G, Ciccozzi M, et al
    COPD influences survival in patients affected by Covid-19, comparison between subjects admitted to an internal medicine unit and subjects admitted to an intensive care unit :an Italian experience.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26585.
    >> Share

  1793. YUEN CK, Wong WM, Mak LF, Wang X, et al
    Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase.
    J Med Virol. 2020 Oct 7. doi: 10.1002/jmv.26583.
    >> Share

  1794. FINSTERER J, Stollberger C
    SARS-CoV-2 triggered Takotsubo in 38 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26581.
    >> Share

  1795. HUANG F, Liu X, Sun X, Li Z, et al
    IL-10 served as an indicator in severe COVID-19 patients.
    J Med Virol. 2020 Oct 6. doi: 10.1002/jmv.26580.
    >> Share

  1796. URRA JM, Ferreras-Colino E, Contreras M, Cabrera CM, et al
    The antibody response to the glycan alpha-Gal correlates with COVID-19 disease symptoms.
    J Med Virol. 2020 Oct 3. doi: 10.1002/jmv.26575.
    >> Share

  1797. CAKIR B
    The outcome of COVID-19 in patients with hematological malignancy.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26576.
    >> Share

  1798. D'ALESSANDRO M, Bergantini L, Cameli P, Curatola G, et al
    Peripheral biomarkers' panel for severe COVID-19 patients.
    J Med Virol. 2020 Oct 2. doi: 10.1002/jmv.26577.
    >> Share

  1799. LIU JM, Tan BH, Wu S, Gui Y, et al
    Evidence of central nervous system infection and neuroinvasive routes, as well as neurological involvement in the lethality of SARS-CoV-2 infection.
    J Med Virol. 2020 Oct 1. doi: 10.1002/jmv.26570.
    >> Share

  1800. KASIBHATLA SM, Kinikar M, Limaye S, Kale MM, et al
    Understanding evolution of SARS-CoV-2: A perspective from analysis of genetic diversity of RdRp gene.
    J Med Virol. 2020;92:1932-1937.
    >> Share

  1801. LA MAESTRA S, Abbondandolo A, De Flora S
    Epidemiological trends of COVID-19 epidemic in Italy over March 2020: From 1000 to 100 000 cases.
    J Med Virol. 2020;92:1956-1961.
    >> Share

  1802. MORRISON AR, Johnson JM, Ramesh M, Bradley P, et al
    Acute hypertriglyceridemia in patients with COVID-19 receiving tocilizumab.
    J Med Virol. 2020;92:1791-1792.
    >> Share

  1803. LI Y, Hu Y, Yu Y, Zhang X, et al
    Positive result of Sars-Cov-2 in faeces and sputum from discharged patients with COVID-19 in Yiwu, China.
    J Med Virol. 2020;92:1938-1947.
    >> Share

  1804. CIMOLAI N
    Defining protective epitopes for COVID-19 vaccination models.
    J Med Virol. 2020;92:1772-1773.
    >> Share

  1805. ZAYET S, Kadiane-Oussou NJ, Royer PY, Toko L, et al
    Coronavirus disease 2019: New things to know!
    J Med Virol. 2020;92:1767-1768.
    >> Share

  1806. NATAF S
    An alteration of the dopamine synthetic pathway is possibly involved in the pathophysiology of COVID-19.
    J Med Virol. 2020;92:1743-1744.
    >> Share

  1807. CIULLA MM
    Coronavirus uses as binding site in humans angiotensin-converting enzyme 2 functional receptor that is involved in arterial blood pressure control and fibrotic response to damage and is a drug target in cardiovascular disease. Is this just a phylogene
    J Med Virol. 2020;92:1713-1714.
    >> Share

  1808. GUO F, Du Z, Wang T
    An effective screening and management process in the outpatient clinic for patients requiring hospitalization during the COVID-19 pandemic.
    J Med Virol. 2020;92:1797-1798.
    >> Share

  1809. WU X, Fu B, Chen L, Feng Y, et al
    Serological tests facilitate identification of asymptomatic SARS-CoV-2 infection in Wuhan, China.
    J Med Virol. 2020;92:1795-1796.
    >> Share

  1810. FINSTERER J, Stollberger C
    Causes of hypogeusia/hyposmia in SARS-CoV2 infected patients.
    J Med Virol. 2020;92:1793-1794.
    >> Share

  1811. LIU J, Xiao Y, Shen Y, Shi C, et al
    Detection of SARS-CoV-2 by RT-PCR in anal from patients who have recovered from coronavirus disease 2019.
    J Med Virol. 2020;92:1769-1771.
    >> Share

  1812. WANG W, Zhou D, Jia X, Feng Y, et al
    Influenza-like illnesses caused by a cluster of imported Italian COVID-19.
    J Med Virol. 2020;92:1764-1766.
    >> Share

  1813. TRESOLDI I, Sangiuolo CF, Manzari V, Modesti A, et al
    SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.
    J Med Virol. 2020;92:1741-1742.
    >> Share

  1814. WU W, Zhang Y, Wang P, Zhang L, et al
    Psychological stress of medical staffs during outbreak of COVID-19 and adjustment strategy.
    J Med Virol. 2020;92:1962-1970.
    >> Share

  1815. WANG G, Chen W, Jin X, Chen YP, et al
    Description of COVID-19 cases along with the measures taken on prevention and control in Zhejiang, China.
    J Med Virol. 2020;92:1948-1955.
    >> Share

  1816. SAHU KK, Mishra AK, Lal A
    A twin challenge to handle: COVID-19 with pregnancy.
    J Med Virol. 2020;92:1718-1720.
    >> Share

  1817. LENG Z, Yin D, Zhao Z, Yan M, et al
    A survey of 434 clinical trials about coronavirus disease 2019 in China.
    J Med Virol. 2020;92:1715-1717.
    >> Share

    September 2020
  1818. GUMUS T, Cengiz D, Kartal F, Atceken Z, et al
    Changes in Computed Tomography Findings of COVID-19 Pneumonia: Less Extensive Lung Involvement with Decreasing Disease Prevalence.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26573.
    >> Share

  1819. WONG RC, Wong AH, Ho YI, Leung EC, et al
    Performance evaluation of Panther Fusion SARS-CoV-2 assay for detection of SARS-CoV-2 from deep throat saliva, nasopharyngeal and lower-respiratory-tract specimens.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26574.
    >> Share

  1820. CHEN Y, Linli Z, Lei Y, Yang Y, et al
    Risk Factors for Mortality in Critically Ill Patients with COVID-19 in Huanggang, China: A Single-Centre Multivariate Pattern Analysis.
    J Med Virol. 2020 Sep 30. doi: 10.1002/jmv.26572.
    >> Share

  1821. RANA MS, Alam MM, Ikram A, Zaidi SSZ, et al
    Co-circulation of COVID-19 and dengue: A perspective from Pakistan.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26567.
    >> Share

  1822. ZHAO Y, He J, Wang J, Li WM, et al
    Development of Pancytopenia in a Patient with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26566.
    >> Share

  1823. BONGIOVANNI M
    COVID-19 re-infection in an healthcare worker.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26565.
    >> Share

  1824. MANDAL AKJ, Baktash V, Hosack T, Van den Abbeele K, et al
    Vitamin D status may indeed be a prognosticator for morbidity and mortality in patients with COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26569.
    >> Share

  1825. HU J, Li S, Wu Y, Xiong Z, et al
    Surveillance and re-Positive RNA test in Patients recovered from COVID-19.
    J Med Virol. 2020 Sep 29. doi: 10.1002/jmv.26568.
    >> Share

  1826. ROMERO-LOPEZ JP, Carnalla-Cortes M, Pacheco-Olvera DL, Ocampo-Godinez JM, et al
    A bioinformatic prediction of antigen presentation from SARS-CoV-2 spike protein revealed a theorical correlation of HLA-DRB1*01 with COVID-19 fatality in Mexican population: an ecological approach.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26561.
    >> Share

  1827. ALMAGHLOUTH NK, Davis MG, Davis MA, Anyiam FE, et al
    Risk factors for mortality among patients with SARS-CoV-2 infection: A longitudinal observational study.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26560.
    >> Share

  1828. HAUSLER M, van Helden J, Kleines M
    Retarded decline of the share of SARS-CoV-2-positive children in North Rhine-Westphalia, Germany.
    J Med Virol. 2020 Sep 28. doi: 10.1002/jmv.26564.
    >> Share

  1829. TAKAGI H
    Government's policy, citizens' behavior, and COVID-19 pandemic.
    J Med Virol. 2020 Sep 26. doi: 10.1002/jmv.26559.
    >> Share

  1830. SAFARI I, InanlooRahatloo K, Elahi E
    11Evolution of SARS-CoV-2 genome from December 2019 to late March 2020: emerged haplotypes and informative Tag nucleotide variations.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26553.
    >> Share

  1831. GUDMUNDSDOTTIR A, Scheving R, Lindberg F, Stefansson B, et al
    Inactivation of SARS-CoV-2 and HCoV-229E in vitro by ColdZyme(R) a medical device mouth spray against common cold.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26554.
    >> Share

  1832. MONDI A, Cimini E, Colavita F, Cicalini S, et al
    COVID-19 in people living with HIV: clinical implications of dynamics of immune response to SARS-CoV-2.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26556.
    >> Share

  1833. XU R, Cui J, Hu L, Wang Y, et al
    Development and validation of a simplified nomogram predicting individual critical illness of risk in COVID-19: a retrospective study.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26551.
    >> Share

  1834. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26550.
    >> Share

  1835. MALIK P, Patel U, Patel K, Martin M, et al
    Obesity a predictor of outcomes of COVID-19 hospitalized patients- A systematic Review and Meta-Analysis.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26555.
    >> Share

  1836. LO YL
    Covid-19, fatigue and dysautonomia.
    J Med Virol. 2020 Sep 25. doi: 10.1002/jmv.26552.
    >> Share

  1837. BADUA CLDC, Baldo KAT, Medina PMB
    Genomic and Proteomic Mutation Landscapes of SARS-CoV-2.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26548.
    >> Share

  1838. DRAGO F, Ciccarese G, Rebora A, Parodi A, et al
    Human herpesvirus 6, 7 and Epstein Barr virus reactivation in pityriasis rosea during COVID-19.
    J Med Virol. 2020 Sep 24. doi: 10.1002/jmv.26549.
    >> Share

  1839. AMBADE V
    Biochemical rationale for hypoalbuminemia in COVID-19 patients.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26542.
    >> Share

  1840. PERESON MJ, Mojsiejczuk L, Martinez AP, Flichman DM, et al
    Phylogenetic analysis of SARS-CoV-2 IN THE FIRST MONTHS SINCE ITS EMERGENCE.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26545.
    >> Share

  1841. GONCHAROVA EA, Dedkov VG, Dolgova AS, Kassirov IS, et al
    One-Step Quantitative RT-PCR Assay with Armored RNA Controls for Detection of SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26540.
    >> Share

  1842. YASRI S, Wiwanitkit V
    Systemic lupus erythematosus, varicella-like rash and COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26547.
    >> Share

  1843. LIPPI G, Mattiuzzi C
    Clinical value anti-SARS-COV-2 serum IgA titration in patients with COVID-19.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26539.
    >> Share

  1844. OMRANI AS, Zaqout A, Baiou A, Daghfal J, et al
    Convalescent Plasma for the Treatment of Patients with Severe Coronavirus Disease 2019; a Preliminary Report.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26537.
    >> Share

  1845. TURAL ONUR S, Altin S, Nedime Sokucu S, Ileri Fikri B, et al
    Could ferritin level be an indicator of COVID-19 disease mortality?
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26543.
    >> Share

  1846. YUE L, Cao H, Xie T, Long R, et al
    N-terminally truncated nucleocapsid protein of SARS-CoV-2 as a better serological marker than whole nucleocapsid protein in evaluating the immunogenicity of inactive SARS-CoV-2.
    J Med Virol. 2020 Sep 23. doi: 10.1002/jmv.26541.
    >> Share

  1847. YAN H, Lu S, Chen L, Wang Y, et al
    Multiple Organ Injury on Admission Predicts In-Hospital Mortality in Patients with COVID -19.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26534.
    >> Share

  1848. SILVA SJRD, Pena L
    A Word of Caution in Interpreting Covid-19 Diagnostics Tests.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26531.
    >> Share

  1849. BENOIT JL, Benoit SW, Oliveira MHS, Lippi G, et al
    Anemia and COVID-19: a prospective perspective.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26530.
    >> Share

  1850. LI L, Lowe CF, Ritchie G, Stefanovic A, et al
    SARS-CoV-2 molecular testing for the diagnosis of COVID-19: One test does not fit all.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26532.
    >> Share

  1851. AKIYAMA S, Yamada A, Sakuraba A
    Safety of non-tumor necrosis factor-targeted biologics in the COVID-19 pandemic.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26528.
    >> Share

  1852. NAGARAKANTI SR, Okoh AK, Grinberg S, Bishburg E, et al
    Clinical outcomes of patients with COVID-19 and HIV coinfection.
    J Med Virol. 2020 Sep 19. doi: 10.1002/jmv.26533.
    >> Share

  1853. FEI F, Smith JA, Cao L
    Clinical laboratory characteristics in patients with suspected COVID-19: one single institution experience.
    J Med Virol. 2020 Sep 18. doi: 10.1002/jmv.26527.
    >> Share

  1854. BREWER J, Marti JLG, Brufsky A
    Potential Interventions for SARS-CoV-2 Infections: Zinc Showing Promise.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26523.
    >> Share

  1855. NOROOZNEZHAD AH, Eskandarion S, Akbari R, Alimohammadi S, et al
    Changes of Leukocytes, Neutrophils, and Lymphocytes Count and Dependent Variables in Pregnant Women with Coronavirus Disease 2019 (COVID-19) Before and After Cesarean Delivery.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26525.
    >> Share

  1856. MEYERS C, Robison R, Milici J, Alam S, et al
    Lowering the Transmission and Spread of Human Coronavirus.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26514.
    >> Share

  1857. YANG S, Shan T, Xiao Y, Zhang H, et al
    Digging metagenomic data of pangolins revealed SARS-CoV-2 related viruses and other significant viruses.
    J Med Virol. 2020 Sep 17. doi: 10.1002/jmv.26524.
    >> Share

  1858. BATEMAN AC, Mueller S, Guenther K, Shult P, et al
    Assessing the Dilution Effect of Specimen Pooling on the Sensitivity of SARS-CoV-2 PCR Tests.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26519.
    >> Share

  1859. ZHOU P, Li Z, Xie L, An D, et al
    Research progress and challenges to coronavirus vaccine development.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26517.
    >> Share

  1860. DEY J, Alam MT, Chandra S, Gupta J, et al
    Neuroinvasion of SARS-CoV-2 may play a role in the breakdown of respiratory center of the brain.
    J Med Virol. 2020 Sep 16. doi: 10.1002/jmv.26521.
    >> Share

  1861. CARUSO A, Caccuri F, Bugatti A, Zani A, et al
    Methotrexate inhibits SARS-CoV-2 virus replication "in vitro".
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26512.
    >> Share

  1862. CHEN T, Li G, Liu H, Wan W, et al
    Clinical characteristics of 132 healthcare workers cases with COVID-19: a retrospective study from a single center in Wuhan, China.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26511.
    >> Share

  1863. SLIMANI Y, Abbassi R, El Fatoiki FZ, Barrou L, et al
    Systemic lupus erythematosus and varicella-like rash following COVID-19 in a previously healthy patient.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26513.
    >> Share

  1864. YANG C, Ma X, Wu J, Han J, et al
    Low serum calcium and phosphorus and their clinical performance in detecting COVID-19 patients.
    J Med Virol. 2020 Sep 14. doi: 10.1002/jmv.26515.
    >> Share

  1865. AZIZ M, Haghbin H, Sitta EA, Nawras Y, et al
    Efficacy of Tocilizumab in COVID-19: A Systematic review and Meta-Analysis.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26509.
    >> Share

  1866. SPEECKAERT MM, De Buyzere ML, Delanghe JR
    Vitamin D binding protein polymorphism and COVID-19.
    J Med Virol. 2020 Sep 12. doi: 10.1002/jmv.26508.
    >> Share

  1867. HENDERSON CE, Rezai S, Jackman JM
    Universal Screening for Novel Coronavirus Disease 2019 (COVID-19) for Asymptomatic Parturients - May Not Be Beneficial At This Time.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26507.
    >> Share

  1868. TAN Y, Zhou J, Zhou Q, Hu L, et al
    Role of Eosinophils in the Diagnosis and Prognostic Evaluation of COVID-19.
    J Med Virol. 2020 Sep 11. doi: 10.1002/jmv.26506.
    >> Share

  1869. FINSTERER J, Scorza FA, Scorza CA, Fiorini AC, et al
    SARS-CoV-2 and myasthenia.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26501.
    >> Share

  1870. TAKAGI H
    COVID-19 epidemic and community mobility in Tokyo.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26502.
    >> Share

  1871. TAKAHASHI M, Egorova NN, Kuno T
    COVID-19 and influenza testing in New York City.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26500.
    >> Share

  1872. ZHANG B, Yue D, Wang Y, Wang F, et al
    The dynamics of immune response in COVID-19 patients with different illness severity.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26504.
    >> Share

  1873. TAGHILOO S, Aliyali M, Abedi S, Mehravaran H, et al
    Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients; clinical and laboratory characteristics.
    J Med Virol. 2020 Sep 10. doi: 10.1002/jmv.26505.
    >> Share

  1874. DE FLORA S, La Maestra S
    Growth and decline of the COVID-19 epidemic wave in Italy from March to June 2020.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26499.
    >> Share

  1875. KANDEEL M, Kitade Y, Fayez M, Venugopala KN, et al
    The Emerging SARS-CoV-2 Papain-like Protease: Its Relationship with Recent Coronavirus Epidemics.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26497.
    >> Share

  1876. KOW CS, Hasan SS
    Mortality of COVID-19 with preadmission metformin use in patients with diabetes: a meta-analysis.
    J Med Virol. 2020 Sep 9. doi: 10.1002/jmv.26498.
    >> Share

  1877. YAMAMOTO S, Saito M, Nagai E, Toriuchi K, et al
    Seroconversion against SARS-CoV-2 occurred after the recovery in patients with COVID-19.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26495.
    >> Share

  1878. ARAFKAS M, Khosrawipour T, Kocbach P, Zielinski K, et al
    Current meta-analysis does not support the possibility of COVID-19 reinfections.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26496.
    >> Share

  1879. KAWAMURA Y, Higashimoto Y, Miura H, Ihira M, et al
    Immune response against SARS-CoV-2 in pediatric patients including young infants.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26493.
    >> Share

  1880. LIU X, Liu Y, Wang L, Hu L, et al
    Analysis of the prophylactic effect of thymosin drugs on COVID-19 for 435 medical staff: A hospital-based retrospective study.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26492.
    >> Share

  1881. GRECO G, Ripamonti D, Binda F, Fabretti F, et al
    Potential role of subcutaneous tocilizumab injections in patients with COVID-19 associated pneumonia.
    J Med Virol. 2020 Sep 8. doi: 10.1002/jmv.26494.
    >> Share

  1882. LI Y, Ji D, Cai W, Hu Y, et al
    Clinical characteristics, cause analysis and infectivity of COVID-19 nucleic acid re-positive patients: A literature review.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26491.
    >> Share

  1883. BIGUENET A, Bouiller K, Marty-Quinternet S, Brunel AS, et al
    SARS-CoV-2 respiratory viral loads and association with clinical and biological features.
    J Med Virol. 2020 Sep 5. doi: 10.1002/jmv.26489.
    >> Share

  1884. ABBAS HM, Nassir KF, Al Khames Aga QA, Al-Gharawi AA, et al
    Presenting characteristics, smoking versus diabetes and outcome among patients hospitalized with COVID-19.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26487.
    >> Share

  1885. DAUBY N, Van Praet S, Vanhomwegen C, Veliziotis I, et al
    Tolerability of Favipiravir therapy in critically-ill patients with COVID-19: a report of 4 cases.
    J Med Virol. 2020 Sep 4. doi: 10.1002/jmv.26488.
    >> Share

  1886. GIRIJA A S S
    Fox3(+) CD25(+) CD4(+) T regulatory cells (Tregs) may transform the n-CoV's final destiny to CNS!
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26482.
    >> Share

  1887. TAN JY, Sim XYJ, Liang En W, Chua YY, et al
    A comparative study on the clinical features of COVID-19 with non-SARS-CoV-2 respiratory viral infections.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26486.
    >> Share

  1888. ESTOFOLETE CF, Machado LF, Zini N, Luckemeyer GD, et al
    Fatal stroke as presentation of SARS-CoV-2 and dengue virus coinfection.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26476.
    >> Share

  1889. CAPETTI AF, Borgonovo F, Morena V, Lupo A, et al
    Short-term inhibition of SARS-CoV-2 by hydrogen peroxide in persistent nasopharyngeal carriers.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26485.
    >> Share

  1890. CLIFT AK
    Deriving 'definitive' results in observational COVID-19 research: a problematic endeavour.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26481.
    >> Share

  1891. KHAN AW, Ullah I, Khan KS
    Ischemic stroke leading to bilateral vision loss in COVID-19 patient- A rare case report.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26484.
    >> Share

  1892. SARKAR S, Khanna P, Soni KD
    Are the steroids a blanket solution for COVID-19? a systematic review and meta-analysis.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26483.
    >> Share

  1893. SEYRAN M, Pizzol D, Adadi P, El-Aziz TMA, et al
    Questions concerning the proximal origin of SARS-CoV-2.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26478.
    >> Share

  1894. ANASTASIOU OE, Theodoropoulos F, Taube C, Fiedler M, et al
    Common respiratory viral infections: Bilateral vs unilateral bronchoalveolar lavage vs endotracheal aspiration.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26477.
    >> Share

  1895. HENRY BM, Benoit J, Berger B, Pulvino C, et al
    Coronavirus Disease 2019 (COVID-19) is Associated with Low Circulating Plasma Levels of Angiotensin 1 and Angiotensin 1,7.
    J Med Virol. 2020 Sep 3. doi: 10.1002/jmv.26479.
    >> Share

  1896. GARG J, Singh V, Pandey P, Verma A, et al
    Evaluation of sample pooling for diagnosis of COVID-19 by Real time PCR- A resource saving combat strategy.
    J Med Virol. 2020 Sep 1. doi: 10.1002/jmv.26475.
    >> Share

  1897. LEUNG C
    Comment on Li et al: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
    J Med Virol. 2020;92:1431-1432.
    >> Share

  1898. BRUFSKY A
    Distinct viral clades of SARS-CoV-2: Implications for modeling of viral spread.
    J Med Virol. 2020;92:1386-1390.
    >> Share

  1899. SYAL K
    COVID-19: Herd immunity and convalescent plasma transfer therapy.
    J Med Virol. 2020;92:1380-1382.
    >> Share

  1900. CHENG H, Wang Y, Wang GQ
    Reply to: "Reporting of all cardiac medications and their outcome in COVID-19".
    J Med Virol. 2020;92:1421-1422.
    >> Share

  1901. CARLETTI F, Lalle E, Messina F, Ippolito G, et al
    About the origin of the first two Sars-CoV-2 infections in Italy: Inference not supported by appropriate sequence analysis.
    J Med Virol. 2020;92:1404-1405.
    >> Share

  1902. ZHANG C, Huang S, Zheng F, Dai Y, et al
    Controversial treatments: An updated understanding of the coronavirus disease 2019.
    J Med Virol. 2020;92:1441-1448.
    >> Share

  1903. KANDEEL M, Al-Taher A, Park BK, Kwon HJ, et al
    A pilot study of the antiviral activity of anionic and cationic polyamidoamine dendrimers against the Middle East respiratory syndrome coronavirus.
    J Med Virol. 2020;92:1665-1670.
    >> Share

  1904. HUSSAIN M, Jabeen N, Raza F, Shabbir S, et al
    Structural variations in human ACE2 may influence its binding with SARS-CoV-2 spike protein.
    J Med Virol. 2020;92:1580-1586.
    >> Share

  1905. MO C, Tan D, Mai T, Bei C, et al
    An analysis of spatiotemporal pattern for COIVD-19 in China based on space-time cube.
    J Med Virol. 2020;92:1587-1595.
    >> Share

  1906. HAN YN, Feng ZW, Sun LN, Ren XX, et al
    A comparative-descriptive analysis of clinical characteristics in 2019-coronavirus-infected children and adults.
    J Med Virol. 2020;92:1596-1602.
    >> Share

    August 2020
  1907. OZGER HS, Dizbay M, Corbacioglu SK, Aysert P, et al
    The prognostic role of neopterin in COVID-19 patients.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26472.
    >> Share

  1908. OKOH AK, Bishburg E, Grinberg S, Nagarakanti S, et al
    Tocilizumab use in COVID -19 associated pneumonia.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26471.
    >> Share

  1909. ERDEN A, Ozdemir B, Karakas O, Mutlu NM, et al
    Evaluation of seventeen patients with COVID-19 pneumonia treated with anakinra according to HScore, SOFA, MuLBSTA and Brescia-COVID respiratory severity scale (BCRSS) scoring systems.
    J Med Virol. 2020 Aug 29. doi: 10.1002/jmv.26473.
    >> Share

  1910. ZHANG J, Ding D, Huang X, Zhang J, et al
    Differentiation of COVID-19 from seasonal influenza: a multicenter comparative study.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26469.
    >> Share

  1911. SAGNELLI C, Celia B, Monari C, Cirillo S, et al
    Management of SARS-CoV-2 Pneumonia.
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26470.
    >> Share

  1912. CHRISTOU MS, Mohamed MS, Tsigarides J
    Tocilizumab - A beacon of hope in the management of severe COVID-19?
    J Med Virol. 2020 Aug 28. doi: 10.1002/jmv.26466.
    >> Share

  1913. GARG P, Arora U, Kumar A, Wig N, et al
    The "Post-COVID" Syndrome: How Deep is the Damage?
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26465.
    >> Share

  1914. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Dengue Fever and COVID-19 Co-Infection; A Threat to Public Health for Co-epidemic in Pakistan.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26464.
    >> Share

  1915. AMIN D, McKitish K, Shah PS
    Association of Mortality and Recent M. Pneumoniae Infection in COVID-19 Patients.
    J Med Virol. 2020 Aug 27. doi: 10.1002/jmv.26467.
    >> Share

  1916. SERGI CM, Chiu B
    Targeting NLRP3 Inflammasome in an Animal Model for SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26461.
    >> Share

  1917. PASOMSUB E, Watcharananan SP, Watthanachockchai T, Rakmanee K, et al
    Saliva sample pooling for the detection of SARS-CoV-2.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26460.
    >> Share

  1918. REDDY RK, Charles WN, Sklavounos A, Seed PT, et al
    Impact of smoking on COVID-19 severity.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26456.
    >> Share

  1919. MASSAROTTI C, Adriano M, Cagnacci A, Gorlero F, et al
    Asymptomatic SARS-CoV-2 infections in pregnant patients in an Italian city during complete lockdown.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26458.
    >> Share

  1920. MITTAL S, Madan K, Mohan A, Tiwari P, et al
    Diabetes in COVID-19: Steroid effect.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26457.
    >> Share

  1921. TOMASONI D, Bai F, Castoldi R, Barbanotti D, et al
    Anxiety and depression symptoms after virological clearance of COVID-19: a cross-sectional study in Milan, Italy.
    J Med Virol. 2020 Aug 25. doi: 10.1002/jmv.26459.
    >> Share

  1922. CHEN JM
    Live unattenuated vaccines for controlling viral diseases including COVID-19.
    J Med Virol. 2020 Aug 24. doi: 10.1002/jmv.26453.
    >> Share

  1923. DE SOUSA FACG, Paradella TC
    Considerations on oral manifestations of COVID-19.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26451.
    >> Share

  1924. ISLAM MZ, E-Zahan MK, Al-Bari MAA
    Convergence between global BCG vaccination and COVID-19 pandemic.
    J Med Virol. 2020 Aug 22. doi: 10.1002/jmv.26450.
    >> Share

  1925. MICHELI V, Rimoldi SG, Romeri F, Comandatore F, et al
    Geographical reconstruction of the SARS-CoV-2 outbreak in Lombardy (Italy) during the early phase.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26447.
    >> Share

  1926. KHOURY NC, Russi TJ
    A Case of Gastrointestinal-Predominant COVID-19 Demonstrates Value of Stool PCR Test.
    J Med Virol. 2020 Aug 20. doi: 10.1002/jmv.26448.
    >> Share

  1927. TAO Z, Xu J, Chen W, Yang Z, et al
    Anaemia is associated with severe illness in COVID-19: a retrospective cohort study.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26444.
    >> Share

  1928. BOUAYED J, Bohn T
    Behavioural manipulation - key to the successful global spread of the new Coronavirus SARS-Cov-2?
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26446.
    >> Share

  1929. JIANG Y, Chen D, Cai D, Yi Y, et al
    Effectiveness of remdesivir for the treatment of hospitalized Covid-19 persons: a network meta-analysis.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26443.
    >> Share

  1930. XU R, Huang J, Duan C, Liao Q, et al
    Low prevalence of antibodies against SARS-CoV-2 among voluntary blood donors in Guangzhou, China.
    J Med Virol. 2020 Aug 19. doi: 10.1002/jmv.26445.
    >> Share

  1931. ELSAWAH HK, Elsokary MA, Elrazzaz MG, ElShafey AH, et al
    Hydroxychloroquine for treatment of non-severe COVID-19 patients; systematic review and meta-analysis of controlled clinical trials.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26442.
    >> Share

  1932. GONCALVES MENDES NETO A, Lo KB, Wattoo A, Salacup G, et al
    Bacterial Infections and Patterns of Antibiotic Use in Patients with COVID-19.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26441.
    >> Share

  1933. JOVANI V, Pascual E, Vela P, Andres M, et al
    Acute arthritis following SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 18. doi: 10.1002/jmv.26440.
    >> Share

  1934. XUE M, Zhang T, Hu H, Huang Z, et al
    Predictive effects of IgA and IgG combination to assess pulmonary exudation progression in COVID-19 patients.
    J Med Virol. 2020 Aug 17. doi: 10.1002/jmv.26437.
    >> Share

  1935. SOLEIMANI R, Khourssaji M, Gruson D, Rodriguez-Villalobos H, et al
    Clinical usefulness of fully automated chemiluminescent immunoassay for quantitative antibody measurements in COVID-19 patients.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26430.
    >> Share

  1936. D'ALESSANDRO M, Cameli P, Bergantini L, Franchi F, et al
    Serum concentrations of Krebs von den Lungen-6 in different COVID-19 phenotypes.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26431.
    >> Share

  1937. ALONSO FOM, Sabino BD, Guimaraes MAAM, Varella RB, et al
    Recurrence of SARS-CoV-2 infection with a more severe case after mild COVID-19, reversion of RT-qPCR for positive and late antibody response: case report.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26432.
    >> Share

  1938. BASIRJAFARI S, Rafiee M, Shahhosseini B, Mohammadi M, et al
    Association of Pediatric COVID-19 and Subarachnoid Hemorrhage.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26434.
    >> Share

  1939. CHOE SA, An HS, Choe YJ
    No Temporal Association between Human Coronavirus and Kawasaki Disease: National Data from South Korea.
    J Med Virol. 2020 Aug 14. doi: 10.1002/jmv.26435.
    >> Share

  1940. BARTILOTTI-MATOS F, Davies P
    Pearls and Pitfalls: two contrasting HIV diagnoses in the COVID-19 era and the case for screening.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26428.
    >> Share

  1941. SAM IC, Chong YM, Tan CW, Chan YF, et al
    Low post-pandemic wave SARS-CoV-2 seroprevalence in Kuala Lumpur and Selangor, Malaysia.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26426.
    >> Share

  1942. TAKAGI H
    Risk and protective factors of SARS-CoV-2 infection.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26427.
    >> Share

  1943. INFANTINO M, Manfredi M, Grossi V, Lari B, et al
    Closing the Serological Gap in the Diagnostic Testing for COVID-19: The Value of Anti-SARS-CoV-2 IgA Antibodies.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26422.
    >> Share

  1944. LI J, Huang DQ, Zou B, Yang H, et al
    Epidemiology of COVID-19: A Systematic Review and Meta-analysis of Clinical Characteristics, Risk factors and Outcomes.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26424.
    >> Share

  1945. FIORE JR, Centra M, De Carlo A, Granato T, et al
    Results from a survey in healthy blood donors in South Eastern Italy indicate that we are far away from herd immunity to SARS-CoV-2.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26425.
    >> Share

  1946. PETTIT NN, Nguyen CT, Mutlu GM, Wu D, et al
    Late Onset Infectious Complications and Safety of Tocilizumab in the Management of COVID-19.
    J Med Virol. 2020 Aug 13. doi: 10.1002/jmv.26429.
    >> Share

  1947. BURGOS-BLASCO B, Guemes-Villahoz N, Vidal-Villegas B, Donate-Lopez J, et al
    Evaluation of retinotoxicity of COVID-19 treatment: hydroxychloroquine and lopinavir/ritonavir.
    J Med Virol. 2020 Aug 12. doi: 10.1002/jmv.26420.
    >> Share

  1948. BANERJEE S, Seal S, Dey R, Mondal KK, et al
    Mutational spectra of SARS-CoV-2 orf1ab polyprotein and signature mutations in the United States of America.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26417.
    >> Share

  1949. SHU L, Wang X, Li M, Chen X, et al
    Clinical Characteristics of Moderate COVID-19 Patients Aggravation in Wuhan Stadium Cabin Hospital: A 571 Cases of Retrospective Cohort Study.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26414.
    >> Share

  1950. PATEL RH, Acharya A, Mohan M, Byrareddy SN, et al
    COVID-19 and AIDS: outcomes from the co-existence of two global pandemics and the importance of chronic antiretroviral therapy.
    J Med Virol. 2020 Aug 11. doi: 10.1002/jmv.26416.
    >> Share

  1951. ONCUL H, Oncul FY, Alakus MF, Caglayan M, et al
    Ocular findings in patients with coronavirus disease 2019 (COVID-19) in an outbreak hospital.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26412.
    >> Share

  1952. YIGENOGLU TN, Ata N, Altuntas F, Basci S, et al
    The Outcome of COVID-19 in Patients with Hematological Malignancy.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26404.
    >> Share

  1953. SARKAR S, Soni KD, Khanna P
    Convalescent plasma a clutch at straws in COVID-19 management! A systematic review and meta-analysis.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26408.
    >> Share

  1954. LU W, Liu X, Wang T, Liu F, et al
    Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical ill COVID-19 Patients.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26406.
    >> Share

  1955. KHINDA J, Janjua NZ, Cheng S, van den Heuvel ER, et al
    Association between markers of immune response at hospital admission and COVID-19 disease severity and mortality: A meta-analysis and meta-regression.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26411.
    >> Share

  1956. MIYAZAWA D, Kaneko G
    Clinical trials of inhaled beclomethasone and mometasone for COVID-19 should be conducted.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26413.
    >> Share

  1957. SAHU KK, Borogovac A, Cerny J
    COVID-19 related immune hemolysis and thrombocytopenia.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26402.
    >> Share

  1958. GIACOMELLI A, Pagani G, Ridolfo AL, Bit LO, et al
    Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study.
    J Med Virol. 2020 Aug 10. doi: 10.1002/jmv.26407.
    >> Share

  1959. BATUR LK, Hekim N
    The role of DBP gene polymorphisms in the prevalence of new coronavirus disease 2019 infection and mortality rate.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26409.
    >> Share

  1960. HARTNACK S, Eusebi P, Kostoulas P
    Bayesian latent class models to estimate diagnostic test accuracies of COVID-19 tests.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26405.
    >> Share

  1961. ALPAYDIN AO, Gezer NS, Simsek GO, Tertemiz KC, et al
    Clinical and Radiological Diagnosis of Non-SARS-CoV-2 Viruses in the Era of Covid-19 Pandemic.
    J Med Virol. 2020 Aug 8. doi: 10.1002/jmv.26410.
    >> Share

  1962. MALTEZOU HC, Vorou R, Papadima K, Kossyvakis A, et al
    Transmission dynamics of SARS-CoV-2 within families with children in Greece: a study of 23 clusters.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26394.
    >> Share

  1963. KO M, Jeon S, Ryu WS, Kim S, et al
    Comparative analysis of antiviral efficacy of FDA-approved drugs against SARS-CoV-2 in human lung cells.
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26397.
    >> Share

  1964. HASHEMI SA, Safamanesh S, Zadeh-Moghaddam HG, Ghafouri M, et al
    Report of death in children with SARS-CoV-2 and Human metapneumovirus (hMPV) co-infection: is hMPV the trigger?
    J Med Virol. 2020 Aug 7. doi: 10.1002/jmv.26401.
    >> Share

  1965. FINSTERER J, Scorza FA
    SARS-CoV-2 myopathy.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26399.
    >> Share

  1966. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Caveats in interpreting SARS-CoV-2 IgM positive/IgG negative antibody profile in asymptomatic health care workers.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26400.
    >> Share

  1967. RAMIREZ JD, Florez C, Munoz M, Hernandez C, et al
    The arrival and spread of SARS-CoV2 in Colombia.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26393.
    >> Share

  1968. FAQIHI F, Alharthy A, Memish ZA, Karakitsos D, et al
    Comment on Hu et al: The cytokine storm and COVID-19.
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26396.
    >> Share

  1969. CUI X, Zhao Z, Zhang T, Guo W, et al
    A systematic review and meta-analysis of children with Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 6. doi: 10.1002/jmv.26398.
    >> Share

  1970. BUTT MH, Ahmad A, Misbah S, Mallhi TH, et al
    Crimean-Congo Haemorrhagic Fever and Eid-Ul-Adha; A potential threat during the COVID-19 Pandemic.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26388.
    >> Share

  1971. HSU AL, Guan M, Johannesen E, Stephens AJ, et al
    Placental SARS-CoV-2 in a Pregnant Woman with Mild COVID-19 Disease.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26386.
    >> Share

  1972. CHEN J, Pan Y, Li G, Xu W, et al
    Distinguishing between COVID-19 and influenza during the early stages by measurement of peripheral blood parameters.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26384.
    >> Share

  1973. CAMPANA P, Flocco V, Aruta F, Cacciatore F, et al
    Can Aldosterone increase Interleukin-6 levels in Covid-19 Pneumonia?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26382.
    >> Share

  1974. REDDY RK, Charles WN, Sklavounos A, Dutt A, et al
    The effect of smoking on COVID-19 severity: a systematic review and meta-analysis.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26389.
    >> Share

  1975. COLLINS GS, Wilkinson J
    Statistical issues in the development a COVID-19 prediction models.
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26390.
    >> Share

  1976. PATRA R, Chandra Das N, Mukherjee S
    Targeting human TLRs to combat COVID-19: A solution?
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26387.
    >> Share

  1977. MATTIUZZI C, Lippi G
    Serum prealbumin values predict the severity of coronavirus disease 2019 (COVID-19).
    J Med Virol. 2020 Aug 4. doi: 10.1002/jmv.26385.
    >> Share

  1978. GOES LGB, Zerbinati RM, Tateno AF, de Souza AV, et al
    Typical epidemiology of respiratory virus infections in a Brazilian slum.
    J Med Virol. 2020;92:1316-1321.
    >> Share

    July 2020
  1979. ZHAO T, Xuan K, Uy JP, Sun C, et al
    In the shadow of COVID-19: HIV-infected individuals need more attention.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26378.
    >> Share

  1980. SHANG Y, Liu T, Li J, Wang X, et al
    Factors affecting antibody response to SARS-CoV-2 in patients with severe COVID-19.
    J Med Virol. 2020 Jul 31. doi: 10.1002/jmv.26379.
    >> Share

  1981. TATIANA S
    Could an acute respiratory distress syndrome (ARDS) in COVID-19 infected patients be calmed down simply by iron withdrawal from lung tissues?
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26372.
    >> Share

  1982. BANSAL N, Bansal Y, Ralta A
    Thrombocytopenia in COVID-19 patients in Himachal Pradesh (India) and the absence of dengue false positive tests: Insights for patient management.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26373.
    >> Share

  1983. HALPIN SJ, McIvor C, Whyatt G, Adams A, et al
    Post-discharge symptoms and rehabilitation needs in survivors of COVID-19 infection: a cross-sectional evaluation.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26368.
    >> Share

  1984. KHAN KS, Torpiano G, McLellan M, Mahmud S, et al
    The impact of socioeconomic status on 30-day mortality in hospitalised patients with COVID-19 infection.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26371.
    >> Share

  1985. TALMY T, Tsur A, Shabtay O
    Duration of SARS-CoV-2 Detection in Israel Defense Forces Soldiers with Mild COVID-19.
    J Med Virol. 2020 Jul 30. doi: 10.1002/jmv.26374.
    >> Share

  1986. SUWANWONGSE K, Shabarek N
    Variation in mortality of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 Jul 29. doi: 10.1002/jmv.26370.
    >> Share

  1987. ZHENG X, Chen J, Deng L, Fang Z, et al
    Risk factors for the COVID-19 severity and its correlation with viral shedding: a retrospective cohort study.
    J Med Virol. 2020 Jul 29. doi: 10.1002/jmv.26367.
    >> Share

  1988. KANEKO S, Nukui Y, Arashiro T, Aiso Y, et al
    Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26363.
    >> Share

  1989. HASHEMI SA, Safamanesh S, Ghasemzadeh-Moghaddam H, Ghafouri M, et al
    High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26364.
    >> Share

  1990. MAEDA T, Obata R, Rizk DO D, Kuno T, et al
    The Association of Interleukin-6 value, Interleukin inhibitors and Outcomes of Patients with COVID-19 in New York City.
    J Med Virol. 2020 Jul 28. doi: 10.1002/jmv.26365.
    >> Share

  1991. MUNSHI R, Hussein MH, Toraih EA, Elshazli RM, et al
    Vitamin D insufficiency as a potential culprit in critical COVID-19 patients.
    J Med Virol. 2020 Jul 27. doi: 10.1002/jmv.26360.
    >> Share

  1992. POTERICO JA, Mestanza O
    Response to Comment on "Genetic Variants and Source of Introduction of SARS-CoV-2 in South America".
    J Med Virol. 2020 Jul 27. doi: 10.1002/jmv.26359.
    >> Share

  1993. PAIVA KJ, Grisson RD, Chan PA, Huard RC, et al
    Validation and Performance Comparison of Three SARS-CoV-2 Antibody Assays.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26341.
    >> Share

  1994. ZHANG C, Lin L, Tang D, Liu F, et al
    Antibody responses to SARS-CoV-2 in healthy individuals returning to Shenzhen.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26355.
    >> Share

  1995. HARMOUCH F, Shah K, Hippen J, Kumar A, et al
    Is it all in the heart? Myocardial injury as major predictor of mortality among hospitalized COVID-19 patients.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26347.
    >> Share

  1996. BARILLARI MR, Bastiani L, Lechien JR, Mannelli G, et al
    A Structural Equation Model to Examine the Clinical Features of Mild-to-Moderate Covid-19: A Multicenter Italian Study.
    J Med Virol. 2020 Jul 25. doi: 10.1002/jmv.26354.
    >> Share

  1997. LIN J, Yan H, Chen H, He C, et al
    COVID-19 and Coagulation Dysfunction in Adults: A Systematic Review and Meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26346.
    >> Share

  1998. ZHOU W, Xu X, Chang Z, Wang H, et al
    The dynamic changes of serum IgM and IgG against SARS-CoV-2 in patients with COVID-19.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26353.
    >> Share

  1999. VALDIVIA A, Torres I, Huntley D, Alcaraz MJ, et al
    Qualitative assessment of SARS-CoV-2-specific antibody avidity by lateral flow immunochromatographic IgG/IgM antibody assay.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26344.
    >> Share

  2000. BARRERA-LOPEZ P, Perez-Riveros ED, Moreno-Montoya J, Ballesteros SM, et al
    Co-infection of other respiratory pathogens and HIV in COVID-19 patients: is there a pattern?
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26331.
    >> Share

  2001. KHAN KS, Ullah I
    SARS-CoV-2 Causes Kawasaki like Disease in children; Cases reported in Pakistan.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26340.
    >> Share

  2002. MAGGIOLO F, Zoboli F, Arosio M, Valenti D, et al
    SARS-CoV-2 infection in persons living with HIV: a single center prospective cohort.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26352.
    >> Share

  2003. DIN M, Asghar M, Ali M
    COVID-19 and dengue coepidemics: A double trouble for overburdened health systems in developing countries.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26348.
    >> Share

  2004. BRITO-AZEVEDO A, Pinto EC, de Cata Preta Correa GA, Bouskela E, et al
    SARS-Cov-2 infection causes pulmonary shunt by vasodilatation.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26342.
    >> Share

  2005. ZHU J, Pang J, Ji P, Zhong Z, et al
    Coagulation dysfunction is associated with severity of COVID-19: a meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26336.
    >> Share

  2006. SUWANWONGSE K, Shabarek N
    Newly diagnosed diabetes mellitus, DKA and COVID-19: causality or coincidence? - A report of 3 cases.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26339.
    >> Share

  2007. BWIRE GM, Majigo MV, Njiro BJ, Mawazo A, et al
    Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26349.
    >> Share

  2008. VAN GERWEN M, Alsen M, Little C, Barlow J, et al
    Risk factors and outcomes of COVID-19 in New York City; a retrospective cohort study.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26337.
    >> Share

  2009. COMAS C, Carreras E
    COVID-19 and pregnancy: an opportunity to correct an historic gender bias.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26350.
    >> Share

  2010. VENKATESULU BP, Thoguluva Chandrasekar V, Girdhar P, Pragathee V, et al
    The mechanistic rationale of drugs, Primary endpoints, Geographical distribution of clinical trials against Severe acute respiratory syndrome-related coronavirus-2: A Systematic Review.
    J Med Virol. 2020 Jul 24. doi: 10.1002/jmv.26338.
    >> Share

  2011. ADAMS NM, Leelawong M, Benton A, Quinn C, et al
    COVID-19 diagnostics for resource-limited settings: Evaluation of "unextracted" qRT-PCR.
    J Med Virol. 2020 Jul 23. doi: 10.1002/jmv.26328.
    >> Share

  2012. ZHENG Y, Yan M, Wang L, Luan L, et al
    Analysis of the application value of serum antibody detection for staging of COVID-19 infection.
    J Med Virol. 2020 Jul 23. doi: 10.1002/jmv.26330.
    >> Share

  2013. WANG P
    Recurrent presence of SARS-CoV-2 RNA in a 33-year-old man.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26334.
    >> Share

  2014. TURRIZIANI O, Sciandra I, Mazzuti L, Di Carlo D, et al
    SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26332.
    >> Share

  2015. TAKAGI H, Kuno T, Yokoyama Y, Ueyama H, et al
    Meta-regression of COVID-19 prevalence/fatality on socioeconomic characteristics of data from top 50 U.S. large cities.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26335.
    >> Share

  2016. NABIL B, Sabrina B, Abdelhakim B
    Transmission route and introduction of Pandemic SARS-CoV-2 between China, Italy and Spain.
    J Med Virol. 2020 Jul 22. doi: 10.1002/jmv.26333.
    >> Share

  2017. KANWUGU ON, Adadi P
    HIV/SARS-CoV-2 coinfection: a global perspective.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26321.
    >> Share

  2018. DENG K, Li H, Ma X, Yu B, et al
    Analysis of the positive rate of 4254 cases of COVID-19 nucleic acid tests in Different Sites in Wuhan, China.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26323.
    >> Share

  2019. DIOTALLEVI F, Campanati A, Radi G, Luchetti MM, et al
    Hydroxychloroquine, Dermatology and SARS-CoV-2: Updating an Old Association.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26322.
    >> Share

  2020. TORRE-FUENTES L, Matias-Guiu J, Hernandez-Lorenzo L, Montero-Escribano P, et al
    ACE2, TMPRSS2, and Furin variants and SARS-CoV-2 infection in Madrid, Spain.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26319.
    >> Share

  2021. HE J, Guo Y, Mao R, Zhang J, et al
    Proportion of asymptomatic coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26326.
    >> Share

  2022. HOANG T, Thi Anh TT
    Ambient Air Pollution, Meteorology, and COVID-19 Infection in Korea.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26325.
    >> Share

  2023. WANG Y, Wang L, Cao H, Liu C, et al
    SARS-CoV-2 S1 is superior to the RBD as a COVID-19 subunit vaccine antigen.
    J Med Virol. 2020 Jul 21. doi: 10.1002/jmv.26320.
    >> Share

  2024. GEORGE S, Ansari MS, Kalliath A, Khan MJ, et al
    COVID-19 in children in Brunei Darussalam: Higher incidence but mild manifestations.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26310.
    >> Share

  2025. GAO Y, Liu M, Chen Y, Shi S, et al
    Association between tuberculosis and COVID-19 severity and mortality: a rapid systematic review and meta-analysis.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26311.
    >> Share

  2026. LIU X, Liu Y, Chen K, Yan S, et al
    Efficacy of ACEIs/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: A hospital-based retrospective cohort study.
    J Med Virol. 2020 Jul 20. doi: 10.1002/jmv.26315.
    >> Share

  2027. ZARIFIAN A, Bidary MZ, Arekhi S, Rafiee M, et al
    Gastrointestinal and hepatic abnormalities in patients with confirmed COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26314.
    >> Share

  2028. DA SILVA PEDROSA M
    Are salivary glands the key players in spreading COVID-19 asymptomatic infection?
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26316.
    >> Share

  2029. ZAIDI SZA, Zaidi FZ, AlShehry N, Zaidi ARZ, et al
    Aging and Therapy-Related Hypogammaglobulinemia causing Pneumonia: An Overlooked Curable Entity in the Chaotic COVID-19 Pandemic.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26318.
    >> Share

  2030. MONNERET G, Benlyamani I, Gossez M, Martin JB, et al
    COVID-19: what type of cytokine storm are we dealing with?
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26317.
    >> Share

  2031. CHEN JM
    SARS-CoV-2 replicating in non-primate mammalian cells probably have critical advantages for COVID-19 vaccines due to anti-Gal antibodies: A minireview and proposals.
    J Med Virol. 2020 Jul 18. doi: 10.1002/jmv.26312.
    >> Share

  2032. FERNANDEZ-RUIZ M, Lopez-Medrano F, Asin MAP, de la Calle GM, et al
    Tocilizumab for the treatment of adult patients with severe COVID-19 pneumonia: a single-center cohort study.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26308.
    >> Share

  2033. GAYAM V, Chobufo MD, Merghani MA, Lamichanne S, et al
    Clinical characteristics and predictors of mortality in African-Americans with COVID-19 from an inner-city community teaching hospital in New York.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26306.
    >> Share

  2034. POUGA L
    Encephalitic syndrome and anosmia in COVID-19: do these clinical presentations really reflect SARS-CoV-2 neurotropism? A theory based on the review of 25 COVID-19 cases.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26309.
    >> Share

  2035. LIN W, Xie Z, Li Y, Li L, et al
    Association between detectable SARS-COV-2 RNA in anal swabs and disease severity in patients with Coronavirus Disease 2019.
    J Med Virol. 2020 Jul 16. doi: 10.1002/jmv.26307.
    >> Share

  2036. TRE-HARDY M, Wilmet A, Beukinga I, Favresse J, et al
    Analytical and clinical validation of an ELISA for specific SARS-CoV-2 IgG, IgA and IgM antibodies.
    J Med Virol. 2020 Jul 15. doi: 10.1002/jmv.26303.
    >> Share

  2037. CHANDRASEKAR VT, Venkatesalu B, Patel HK, Spadaccini M, et al
    Systematic Review and Meta-analysis of Effectiveness of Treatment Options Against SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 15. doi: 10.1002/jmv.26302.
    >> Share

  2038. MANGANOTTI P, Bellavita G, D'Acunto L, Tommasini V, et al
    Clinical neurophysiology and cerebrospinal liquor analysis to detect Guillain Barre syndrome and polyneuritis cranialis in COVID-19 patients: a case series.
    J Med Virol. 2020 Jul 14. doi: 10.1002/jmv.26289.
    >> Share

  2039. OK F, Erdogan O, Durmus E, Carkci S, et al
    Predictive Values of Blood Urea Nitrogen/Creatinine Ratio and Other Routine Blood Parameters on Disease Severity and Survival of COVID-19 Patients.
    J Med Virol. 2020 Jul 14. doi: 10.1002/jmv.26300.
    >> Share

  2040. COPERTINO DC JR, Duarte RRR, Powell TR, Rougvie MM, et al
    Montelukast drug activity and potential against SARS-CoV-2.
    J Med Virol. 2020 Jul 13. doi: 10.1002/jmv.26299.
    >> Share

  2041. SARICAOGLU EM, Hasanoglu I, Guner R
    The First Reactive Arthritis Case Associated with COVID-19.
    J Med Virol. 2020 Jul 11. doi: 10.1002/jmv.26296.
    >> Share

  2042. ZHENG KI, Feng G, Liu WY, Targher G, et al
    Extra-pulmonary complications of COVID-19: a multi-system disease?
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26294.
    >> Share

  2043. HAQQI A, Khurram M, Din MSU, Aftab MN, et al
    COVID-19 and Salmonella Typhi co-epidemics in Pakistan: A real problem.
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26293.
    >> Share

  2044. BURGOS-BLASCO B, Guemes-Villahoz N, Donate-Lopez J, Vidal-Villegas B, et al
    Optic nerve analysis in COVID-19 patients.
    J Med Virol. 2020 Jul 10. doi: 10.1002/jmv.26290.
    >> Share

  2045. YU HB, Wang WJ, Tang S, Chen DX, et al
    Immune responses and pathogenesis in persistently PCR-positive patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26287.
    >> Share

  2046. ANTONY SJ, Davis MA, Davis MG, Almaghlouth NK, et al
    Early use of tocilizumab in the prevention of adult respiratory failure in SARS-CoV-2 infections and the utilization of interleukin-6 levels in the management.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26288.
    >> Share

  2047. AHMED A, Tahir MJ, Siddiqi AR, Dujaili J, et al
    Possibility of Crimean-Congo Hemorrhagic Fever outbreak around Eid-ul-Adha in COVID-19 Pandemic: A way forward for Pakistan.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26285.
    >> Share

  2048. FERREIRA A, Oliveira-E-Silva A, Bettencourt P
    Chronic treatment with hydroxychloroquine and SARS-CoV-2 infection.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26286.
    >> Share

  2049. LI TZ, Cao ZH, Chen Y, Cai MT, et al
    Duration of SARS-CoV-2 RNA shedding and factors associated with prolonged viral shedding in patients with COVID-19.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26280.
    >> Share

  2050. CARALLO C, Pugliese F, Tripolino C, Lenzi L, et al
    Early-stage predictors of the acute phase duration in uncomplicated COVID-19 pneumonia.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26281.
    >> Share

  2051. BRENNER SR
    Erythropoietin Induced Hemoglobin Sub-Unit Beta may Stimulate Innate Immune RNA Virus Pattern Recognition, Suppress Reactive Oxygen Species, Reduce ACE2 Viral Doorway Opening and Neutrophil Extracellular Traps against Covid-19.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26284.
    >> Share

  2052. GOMEZ-MAYORDOMO V, Montero-Escribano P, Matias-Guiu JA, Gonzalez-Garcia N, et al
    Clinical exacerbation of SARS-CoV2 infection after fingolimod withdrawal.
    J Med Virol. 2020 Jul 9. doi: 10.1002/jmv.26279.
    >> Share

  2053. OZARAS R, Cirpin R, Duman H, Duran A, et al
    AN OPEN CALL FOR INFLUENZA VACCINATION PENDING THE NEW WAVE OF COVID-19.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26272.
    >> Share

  2054. NUCKCHADY DC
    Hyperpyrexia and metabolic alkalosis in a COVID-19 patient.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26276.
    >> Share

  2055. WASZKIEWICZ N
    Comments on Wu et al: Possible special needs for mental online support in female and male health care workers during the COVID-19.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26273.
    >> Share

  2056. TOOMBS J, Van den Abbeele K, Democratis J, Mandal AKJ, et al
    Pneumococcal co-infection in Covid-19 patients.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26278.
    >> Share

  2057. ZHENG H, Tan J, Ma K, Meng W, et al
    Changes in RT-PCR test results and symptoms during the menstrual cycle of female individuals infected with SARS-CoV-2: report of two cases.
    J Med Virol. 2020 Jul 8. doi: 10.1002/jmv.26275.
    >> Share

  2058. COSMA S, Borella F, Carosso A, Sciarrone A, et al
    The "scar" of a pandemic: cumulative incidence of COVID-19 during the first trimester of pregnancy.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26267.
    >> Share

  2059. PARK MH, Kwon DY
    A Retrospective Review of Memantine Use and COVID-19-associated Mortality from a National Database.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26266.
    >> Share

  2060. DIBNER J
    Fecal-Oral Transmission of COVID-19: Could Hypochlorhydria Play a Role?
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26265.
    >> Share

  2061. MASUKUME G, Mapanga W, Grinberg S, van Zyl DS, et al
    COVID-19 and HIV co-infection an emerging consensus.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26270.
    >> Share

  2062. MARIMUTHU J, Kumar BS, Aravind Gandhi P
    HIV and SARS CoV-2 co-infection: A retrospective, record based, case series from South India.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26271.
    >> Share

  2063. NAKAMURA H, Miyagi K, Otsuki M, Higure Y, et al
    Serum KL-6 can distinguish between different phenotypes of severe COVID-19.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26268.
    >> Share

  2064. BAUER G
    The variability of the serological response to SARS corona virus-2: Potential resolution of ambiguity through determination of avidity (functional affinity).
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26262.
    >> Share

  2065. WANG Y, Anirudhan V, Du R, Cui Q, et al
    RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26264.
    >> Share

  2066. MIAH MA, Husna A
    Co-infection, co-epidemics of Covid-19 and Dengue in dengue endemic countries: a serious health concern.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26269.
    >> Share

  2067. MALAIYAN J, Arumugam S, Mohan K, Radhakrishnan GG, et al
    An update on origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and Pangolin derived Coronaviruses varied in the critical binding site and O-linked glycan residues.
    J Med Virol. 2020 Jul 7. doi: 10.1002/jmv.26261.
    >> Share

  2068. YU C, Zhang Z, Guo Y, Shi J, et al
    Lopinavir/ritonavir is associated with pneumonia resolution in COVID-19 patients with influenza coinfection: a retrospective matched-pair cohort study.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26260.
    >> Share

  2069. MA L, Xie W, Li D, Shi L, et al
    Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26259.
    >> Share

  2070. LEUNG EC, Chow VC, Lee MK, Lai RW, et al
    Deep throat saliva as an alternative diagnostic specimen type for the detection of SARS-CoV-2.
    J Med Virol. 2020 Jul 4. doi: 10.1002/jmv.26258.
    >> Share

  2071. SAHU KK, Siddiqui AD, Rezaei N, Cerny J, et al
    Challenges for management of immune thrombocytopenia during COVID-19 pandemic.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26251.
    >> Share

  2072. PRZYDZIAL P, Tchomobe G, Amin K, Christian E, et al
    When COVID-19 Crosses Paths with AIDS in the Homeless.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26255.
    >> Share

  2073. BELINGHERI M, Paladino ME, Piacenti S, Riva MA, et al
    Effects of COVID-19 lockdown on epidemic diseases of childhood.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26253.
    >> Share

  2074. HUANG D, Yu H, Wang T, Yang H, et al
    Efficacy and safety of umifenovir for coronavirus disease 2019 (COVID-19): A systematic review and meta-analysis.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26256.
    >> Share

  2075. SINGH SP, Pritam M, Pandey B, Yadav TP, et al
    Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26254.
    >> Share

  2076. SALACUP G, Lo KB, Gul F, Peterson E, et al
    Characteristics and Clinical Outcomes of COVID-19 Patients in an Underserved-Inner City Population: A Single Tertiary Center Cohort.
    J Med Virol. 2020 Jul 3. doi: 10.1002/jmv.26252.
    >> Share

  2077. LI YC, Bai WZ, Hashikawa T
    Response to Commentary on "The neuroinvasive potential of SARS-CoV-2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020;92:707-709.
    >> Share

  2078. PANIZ-MONDOLFI A, Bryce C, Grimes Z, Gordon RE, et al
    Central nervous system involvement by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
    J Med Virol. 2020;92:699-702.
    >> Share

  2079. ZHU J, Zhong Z, Li H, Ji P, et al
    CT imaging features of 4121 patients with COVID-19: A meta-analysis.
    J Med Virol. 2020;92:891-902.
    >> Share

  2080. TAN C, Huang Y, Shi F, Tan K, et al
    C-reactive protein correlates with computed tomographic findings and predicts severe COVID-19 early.
    J Med Virol. 2020;92:856-862.
    >> Share

  2081. TURTLE L
    Respiratory failure alone does not suggest central nervous system invasion by SARS-CoV-2.
    J Med Virol. 2020;92:705-706.
    >> Share

  2082. LI Y, Yao L, Li J, Chen L, et al
    Stability issues of RT-PCR testing of SARS-CoV-2 for hospitalized patients clinically diagnosed with COVID-19.
    J Med Virol. 2020;92:903-908.
    >> Share

  2083. CHEN Y, Li Z, Zhang YY, Zhao WH, et al
    Maternal health care management during the outbreak of coronavirus disease 2019.
    J Med Virol. 2020;92:731-739.
    >> Share

  2084. HAN Z, Battaglia F, Terlecky SR
    Discharged COVID-19 Patients Testing Positive Again for SARS-CoV-2 RNA: A Minireview of Published Studies from China.
    J Med Virol. 2020 Jul 1. doi: 10.1002/jmv.26250.
    >> Share

    June 2020
  2085. ZENG Z, Ma Y, Zeng H, Huang P, et al
    Simple nomogram based on initial laboratory data for predicting the probability of ICU transfer of COVID-19 patients: Multicenter retrospective study.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26244.
    >> Share

  2086. RONG Y, Wang F, Liu J, Zhou Y, et al
    Clinical characteristics and risk factors of mild-to-moderate COVID-19 patients with false negative SARS-CoV-2 nucleic acid.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26242.
    >> Share

  2087. FALAHI S, Kenarkoohi A
    Sex and gender differences in the outcome of patients with COVID-19.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26243.
    >> Share

  2088. HAQQI A, Zahoor S, Aftab MN, Tipu I, et al
    COVID-19 in Pakistan; Impact on Global Polio Eradication Initiative.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26240.
    >> Share

  2089. LIU A, Li Y, Peng J, Huang Y, et al
    Antibody responses against SARS-CoV-2 in COVID-19 patients.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26241.
    >> Share

  2090. SHI S, Su M, Shen G, Hu Y, et al
    Matrix Metalloproteinase 3 as a Valuable Marker for Patients with COVID-19.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26235.
    >> Share

  2091. YANG J, Hu J, Zhu C
    Obesity aggravates COVID-19: a systematic review and meta-analysis.
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26237.
    >> Share

  2092. CHERUIYOT I
    Comment on "Encephalopathy in patients with COVID-19: A review".
    J Med Virol. 2020 Jun 30. doi: 10.1002/jmv.26238.
    >> Share

  2093. BENEDETTI F, Pachetti M, Marini B, Ippodrino R, et al
    SARS-CoV-2: march toward adaptation.
    J Med Virol. 2020 Jun 29. doi: 10.1002/jmv.26233.
    >> Share

  2094. YAN M, Zheng Y, Sun Y, Wang L, et al
    Analysis of the diagnostic value of serum specific antibody testing for coronavirus disease 2019.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26230.
    >> Share

  2095. HU B, Huang S, Yin L
    The cytokine storm and COVID-19.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26232.
    >> Share

  2096. HERNANDEZ-HUERTA MT, Mayoral LP, Navarro LMS, Mayoral-Andrade G, et al
    Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26228.
    >> Share

  2097. BETTACH E, Zadok D, Weill Y, Brosh K, et al
    Bilateral anterior uveitis as a part of a multisystem inflammatory syndrome secondary to COVID-19 infection.
    J Med Virol. 2020 Jun 27. doi: 10.1002/jmv.26229.
    >> Share

  2098. SMITH SM, Boppana A, Traupman JA, Unson E, et al
    Impaired glucose metabolism in patients with diabetes, prediabetes and obesity is associated with severe Covid-19.
    J Med Virol. 2020 Jun 26. doi: 10.1002/jmv.26227.
    >> Share

  2099. ZHAO Y, Zhou J, Pan L, Zhang Y, et al
    Detection and analysis of clinical features of patients with different COVID-19 types.
    J Med Virol. 2020 Jun 26. doi: 10.1002/jmv.26225.
    >> Share

  2100. RIOLLANO-CRUZ M, Akkoyun E, Briceno-Brito E, Kowalsky S, et al
    Multisystem Inflammatory Syndrome in Children (MIS-C) Related to COVID-19: A New York City Experience.
    J Med Virol. 2020 Jun 25. doi: 10.1002/jmv.26224.
    >> Share

  2101. RUAN L, Zhang Y, Luo Y, Yu X, et al
    Clinical features and outcomes of four HIV patients with COVID-19 in Wuhan, China.
    J Med Virol. 2020 Jun 25. doi: 10.1002/jmv.26223.
    >> Share

  2102. MOHAPATRA PR, Mishra B, Behera B
    Immunity and Protection from COVID-19 - Environmental Mycobacteria play a role.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26214.
    >> Share

  2103. GIMENEZ E, Albert E, Torres I, Remigia MJ, et al
    SARS-CoV-2-reactive interferon-gamma-producing CD8(+) T cells in patients hospitalized with Coronavirus Disease 2019.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26213.
    >> Share

  2104. GUEMES-VILLAHOZ N, Burgos-Blasco B, Vilela AA, Arriola-Villalobos P, et al
    Detecting SARS-CoV-2 RNA in conjunctival secretions: is it a valuable diagnostic method of COVID-19?
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26219.
    >> Share

  2105. RUAN Z, Liu C, Guo Y, He Z, et al
    SARS-CoV-2 and SARS-CoV: Virtual Screening of Potential inhibitors targeting RNA-dependent RNA polymerase activity (NSP12).
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26222.
    >> Share

  2106. LUCCHESI A, Silimbani P, Musuraca G, Cerchione C, et al
    Clinical and biological data on the use of hydroxychloroquine against SARS-CoV-2 could support the role of the NLRP3 inflammasome in the pathogenesis of respiratory disease.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26217.
    >> Share

  2107. CICCARESE G, Drago F, Boatti M, Porro A, et al
    Oral erosions and petechiae during SARS-CoV-2 infection.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26221.
    >> Share

  2108. ZHENG Y, Wang L, Ben S
    Meta-analysis of chest CT features of patients with COVID-19 pneumonia.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26218.
    >> Share

  2109. MIYAZAWA D
    Why obesity, hypertension, diabetes, and ethnicities are common risk factors for COVID-19 and H1N1 influenza infections.
    J Med Virol. 2020 Jun 24. doi: 10.1002/jmv.26220.
    >> Share

  2110. BAIG AM, Khaleeq A, Hira S
    Elucidation of Cellular Targets and Exploitation of the Receptor Binding Domain of SARS-CoV-2 for vaccine and monoclonal antibody synthesis.
    J Med Virol. 2020 Jun 23. doi: 10.1002/jmv.26212.
    >> Share

  2111. NG KF, Kothari T, Bandi S, Bird PW, et al
    COVID-19 Multisystem Inflammatory Syndrome in Three Teenagers with Confirmed SARS-CoV-2 Infection.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26206.
    >> Share

  2112. ZHANG ZL, Hou YL, Li DT, Li FZ, et al
    Diagnostic efficacy of anti-SARS-CoV-2 IgG/IgM test for Covid-19: A meta-analysis.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26211.
    >> Share

  2113. ANDRIANOPOULOS I, Papathanasiou A, Papathanakos G, Chaidos A, et al
    Tocilizumab's efficacy in COVID-19 patients is determined by the presence of cytokine storm.
    J Med Virol. 2020 Jun 22. doi: 10.1002/jmv.26209.
    >> Share

  2114. WENG CH, Saal A, Butt WWW, Chan PA, et al
    Characteristics and Clinical Course and Outcome of COVID-19 in Hispanic/Latino Patients in a Community Setting: A Retrospective Cohort Study.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26196.
    >> Share

  2115. CARDONA-OSPINA JA, Arteaga-Livias K, Villamil-Gomez WE, Perez-Diaz CE, et al
    Dengue and COVID-19, overlapping epidemics? An Analysis from Colombia.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26194.
    >> Share

  2116. SICA A, Casale D, Rossi G, Casale B, et al
    The impact of the SARS-CoV-2 infection, with special reference to the haematological setting.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26197.
    >> Share

  2117. MUHAMMAD MOOSA M, Banerjee PR
    Subversion of host stress granules by coronaviruses: Potential roles of pi-rich disordered domains of viral nucleocapsids.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26195.
    >> Share

  2118. GARG RK, Paliwal VK, Gupta A
    Encephalopathy in patients with COVID-19: A review.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26207.
    >> Share

  2119. MA X, Liu S, Chen L, Zhuang L, et al
    The clinical characteristics of pediatric inpatients with SARS-CoV-2 infection: a meta-analysis and systematic review.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26208.
    >> Share

  2120. WONG J, Koh WC, Momin RN, Alikhan MF, et al
    Probable causes and risk factors for positive SARS-CoV-2 test in recovered patients: Evidence from Brunei Darussalam.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26199.
    >> Share

  2121. LIAO Y, Li X, Mou T, Zhou X, et al
    Distinct infection process of SARS-CoV-2 in human bronchial epithelial cells line.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26200.
    >> Share

  2122. LI Y, Li C, Wang J, Zhu C, et al
    A case series of COVID-19 patients with chronic hepatitis B virus infection.
    J Med Virol. 2020 Jun 19. doi: 10.1002/jmv.26201.
    >> Share

  2123. KNORR JP, Colomy V, Mauriello CM, Ha S, et al
    Tocilizumab in patients with severe COVID-19: A single-center observational analysis.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26191.
    >> Share

  2124. GIULIANI J, Bonetti A
    Cancer prevales on COVID-19: To maintain high quality standard concerning diagnosis and oncological care even during a pandemic.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26190.
    >> Share

  2125. WANG G, Yu N, Xiao W, Zhao C, et al
    Consecutive false-negative rRT-PCR test results for SARS-CoV-2 in patients after clinical recovery from COVID-19.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26192.
    >> Share

  2126. XUE H, Liu Y, Luo P, Liu X, et al
    Hydroxychloroquine treatment in COVID-19: a descriptive observational analysis of 30 cases from a single center in Wuhan, China.
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26193.
    >> Share

  2127. GIANNATTASIO A, Maglione M, Zenzeri L, Mauro A, et al
    A child with a severe multisystem inflammatory syndrome following an asymptomatic COVID-19 infection: A novel management for a new disease?
    J Med Virol. 2020 Jun 17. doi: 10.1002/jmv.26189.
    >> Share

  2128. WEI Y, Lu Y, Xia L, Yuan X, et al
    Analysis of 2019 novel coronavirus infection and clinical characteristics of outpatients: An epidemiological study from a fever clinic in Wuhan, China.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26175.
    >> Share

  2129. HE J, Hu P, Gao Y, Zheng S, et al
    Comparison and Application of Different Immunoassay Methods for the Detection of SARS-CoV-2.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26187.
    >> Share

  2130. WEI LL, Wang WJ, Chen DX, Xu B, et al
    Dysregulation of the immune response affects the outcome of critical COVID-19 patients.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26181.
    >> Share

  2131. MEYERS KJ, Jones ME, Goetz IA, Botros FT, et al
    A cross-sectional community-based observational study of asymptomatic SARS-CoV-2 prevalence in the greater Indianapolis area.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26182.
    >> Share

  2132. YE C, Zhang S, Zhang X, Cai H, et al
    Impact of comorbidities on patients with COVID-19: A large retrospective study in Zhejiang, China.
    J Med Virol. 2020 Jun 16. doi: 10.1002/jmv.26183.
    >> Share

  2133. HUA CZ, Miao ZP, Zheng JS, Huang Q, et al
    Epidemiological features and viral shedding in children with SARS-CoV-2 infection.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26180.
    >> Share

  2134. TOOMBS JM, Van den Abbeele K, Democratis J, Merricks R, et al
    COVID-19 in 3 people living with HIV in the United Kingdom.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26178.
    >> Share

  2135. ARANDA-ABREU GE, Aranda-Martinez JD, Araujo R
    Use of amantadine in a patient with SARS-Cov-2.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26179.
    >> Share

  2136. PATEL RH
    Clinical Outcomes and Prognosis of Patients with HIV and SARS-CoV-2 Co-infection.
    J Med Virol. 2020 Jun 15. doi: 10.1002/jmv.26177.
    >> Share

  2137. HUANG H, Zhang M, Chen C, Zhang H, et al
    Clinical Characteristics of COVID-19 in patients with pre-existing ILD: A retrospective study in a single center in Wuhan, China.
    J Med Virol. 2020 Jun 13. doi: 10.1002/jmv.26174.
    >> Share

  2138. FANG Y
    Large-scale National Screening for COVID-19 in China.
    J Med Virol. 2020 Jun 13. doi: 10.1002/jmv.26173.
    >> Share

  2139. ALLALI G, Marti C, Grosgurin O, Morelot-Panzini C, et al
    Dyspnea: the vanished warning symptom of COVID-19 pneumonia.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26172.
    >> Share

  2140. ANTONY SJ, Almaghlouth NK, Heydemann EL
    Are co-infections with COVID-19 and Influenza low or underreported? An observational study examining current published literature including three new unpublished cases.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26167.
    >> Share

  2141. HAN D, Fang Q, Wang X
    SARS-CoV-2 was found in the bile juice from a patient with severe COVID-19.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26169.
    >> Share

  2142. TORAIH EA, Elshazli RM, Hussein MH, Elgaml A, et al
    Association of cardiac biomarkers and comorbidities with increased mortality, severity, and cardiac injury in COVID-19 patients: A meta-regression and Decision tree analysis.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26166.
    >> Share

  2143. KOLILEKAS L, Loverdos K, Giannakaki S, Vlassi L, et al
    Can steroids reverse the severe COVID-19 induced 'cytokine storm'?
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26165.
    >> Share

  2144. CIMOLAI N
    Environmental and Decontamination Issues for Human Coronaviruses and Their Potential Surrogates.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26170.
    >> Share

  2145. YUE H, Zhang M, Xing L, Wang K, et al
    The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26163.
    >> Share

  2146. WU Y, Guo W, Liu H, Qi B, et al
    Clinical outcomes of 402 patients with COVID-2019 from a single center in Wuhan, China.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26168.
    >> Share

  2147. FUKADA A, Kitagawa Y, Matsuoka M, Sakai J, et al
    Presepsin as a predictive biomarker of severity in COVID-19: a case series.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26164.
    >> Share

  2148. SON HA, Hang DTT, Thuan ND, Quyen LTB, et al
    A Simple Method for Detection of a Novel Coronavirus (SARS-CoV-2) using One-step RT-PCR followed by Restriction Fragment Length Polymorphism.
    J Med Virol. 2020 Jun 12. doi: 10.1002/jmv.26171.
    >> Share

  2149. CHEN JM, Sun YX, Chen JW
    Potential for elimination of SAR-CoV-2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26162.
    >> Share

  2150. TAN BH, Zhang Y, Gui Y, Wu S, et al
    The possible impairment of respiratory-related neural loops may be associated with the silent pneumonia induced by SARS-CoV-2.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26158.
    >> Share

  2151. DZINAMARIRA T, Dzobo M, Chitungo I
    Covid-19: A Perspective on Africa's Capacity and Response.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26159.
    >> Share

  2152. BENTIVEGNA E, Sentimentale A, Luciani M, Speranza ML, et al
    New IgM seroconversion and positive RT-PCR test after exposure to the virus in recovered COVID-19 patient.
    J Med Virol. 2020 Jun 11. doi: 10.1002/jmv.26160.
    >> Share

  2153. ABOBAKER A, Raba AA, Alzwi A
    Extrapulmonary and atypical clinical presentations of COVID-19.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26157.
    >> Share

  2154. HERLEKAR R, Roy AS, Matson M
    Hypoalbuminaemia in COVID-19 infection: a predictor of severity or a potential therapeutic target?
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26151.
    >> Share

  2155. BAHLOUL M, Ketata W, Lahyeni D, Mayoufi H, et al
    Pulmonary Capillary Leak Syndrome following COVID-19 Virus Infection.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26152.
    >> Share

  2156. LUO W, Zhang JW, Zhang W, Lin YL, et al
    Circulating Levels of IL-2, IL-4, TNF-alpha, IFN-gamma and C reactive protein Are Not Associated with Severity of COVID-19 Symptoms.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26156.
    >> Share

  2157. SUWANWONGSE K, Shabarek N
    Hyperpyrexia in COVID-19 patients.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26154.
    >> Share

  2158. KOW CS, Hasan SS
    Could melatonin be used in COVID-19 patients with laryngopharyngeal reflux disease?
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26150.
    >> Share

  2159. LI W, Ma Q, Wang X, Tang M, et al
    Letter to the Editor: The characteristics of two patients co-infected with SARS-CoV-2 and HIV in Wuhan, China.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26155.
    >> Share

  2160. SCHILLER M, Wydra S, Kerl HU, Kick W, et al
    Diagnosis of COVID-19 pneumonia despite missing detection of viral nucleic acid and initially inconspicuous radiologic findings.
    J Med Virol. 2020 Jun 10. doi: 10.1002/jmv.26153.
    >> Share

  2161. BIAGI A, Rossi L, Malagoli A, Zanni A, et al
    Clinical and epidemiological characteristics of 320 deceased Covid-19 patients in an Italian Province: a retrospective observational study.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26147.
    >> Share

  2162. QUARTUCCIO L, Sonaglia A, Pecori D, Peghin M, et al
    Higher levels of IL-6 early after tocilizumab distinguish survivors from non-survivors in COVID-19 pneumonia: a possible indication for deeper targeting IL-6.
    J Med Virol. 2020 Jun 9. doi: 10.1002/jmv.26149.
    >> Share

  2163. HAQQI A, Awan UA, Ali M, Saqib MAN, et al
    COVID-19 and dengue virus co-epidemics in Pakistan: A dangerous combination for overburdened healthcare system.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26144.
    >> Share

  2164. ZHENG T, Yang C, Wang HY, Chen X, et al
    Clinical characteristics and outcomes of COVID-19 patients with gastrointestinal symptoms admitted to Jianghan Fangcang Shelter Hospital in Wuhan, China.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26146.
    >> Share

  2165. CHEN W, Yao M, Fang Z, Lv X, et al
    A study on clinical effect of Arbidol combined with adjuvant therapy on COVID-19.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26142.
    >> Share

  2166. KOHMER N, Westhaus S, Ruhl C, Ciesek S, et al
    Clinical performance of different SARS-CoV-2 IgG antibody tests.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26145.
    >> Share

  2167. HUANG D, Wang T, Chen Z, Yang H, et al
    A novel risk score to predict diagnosis with Coronavirus Disease 2019 (COVID-19) in suspected patients: A retrospective, multi-center, observational study.
    J Med Virol. 2020 Jun 8. doi: 10.1002/jmv.26143.
    >> Share

  2168. ZHANG Z, Wang S, Tu X, Peng X, et al
    A comparative study on the time to achieve negative nucleic acid testing and hospital stays between Danoprevir and Lopinavir/Ritonavir in the treatment of patients with COVID-19.
    J Med Virol. 2020 Jun 5. doi: 10.1002/jmv.26141.
    >> Share

  2169. CHAN WM, Ip JD, Chu AW, Yip CC, et al
    Identification of nsp1 gene as the target of SARS-CoV-2 real-time RT-PCR using nanopore whole genome sequencing.
    J Med Virol. 2020 Jun 5. doi: 10.1002/jmv.26140.
    >> Share

  2170. MURT A, Eskazan AE, Yilmaz U, Ozkan T, et al
    COVID-19 presenting with immune thrombocytopenia: a case report and review of the literature.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26138.
    >> Share

  2171. GRAJEWSKI RS, Rokohl AC, Becker M, Dewald F, et al
    Letter to the Editor: A Missing Link between SARS-CoV-2 and the Eye?: ACE2 Expression on the Ocular Surface.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26136.
    >> Share

  2172. ZHUANG MW, Cheng Y, Zhang J, Jiang XM, et al
    Increasing Host Cellular Receptor-Angiotensin-Converting Enzyme 2 (ACE2) Expression by Coronavirus may Facilitate 2019-nCoV (or SARS-CoV-2) Infection.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26139.
    >> Share

  2173. BRUNO G, Fabrizio C, Santoro CR, Buccoliero GB, et al
    Pancreatic injury in the course of coronavirus disease 2019 (COVID-19): a not-so-rare occurrence.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26134.
    >> Share

  2174. QIN L, Li X, Shi J, Yu M, et al
    Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26137.
    >> Share

  2175. ROMERO PE
    Comment on "Genetic variants and source of introduction of SARS-CoV-2 in South America".
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26122.
    >> Share

  2176. MARIN-HERNANDEZ D, Schwartz RE, Nixon DF
    Epidemiological Evidence for Association between Higher Influenza Vaccine Uptake in the Elderly and Lower COVID-19 Deaths in Italy.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26120.
    >> Share

  2177. FINSTERER J, Scorza FA, Ghosh R
    COVID-19 polyradiculitis in 24 patients without SARS-CoV-2 in the cerebro-spinal fluid.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26121.
    >> Share

  2178. MANRIQUE JV, Ghosh K, Boma N
    Anticardiolipin antibodies and COVID-19 - A Case Report from America.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26135.
    >> Share

  2179. OZARAS R, Cirpin R, Duran A, Duman H, et al
    Influenza and COVID-19 Co-infection: Report of 6 cases and review of the Literature.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26125.
    >> Share

  2180. ADADI P, Kanwugu ON
    Living with HIV in the time of COVID-19: a glimpse of hope.
    J Med Virol. 2020 Jun 4. doi: 10.1002/jmv.26118.
    >> Share

  2181. KANG H, Wang Y, Tong Z, Liu X, et al
    Re-test Positive for SARS-CoV-2 RNA of "Recovered" Patients with COVID-19: Persistence, Sampling issues, or Re-infection?
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26114.
    >> Share

  2182. ZUO Y, Liu Y, Zhong Q, Zhang K, et al
    Lopinavir/ritonavir and interferon combination therapy may help shorten the duration of viral shedding in patients with COVID-19: a retrospective study in two designated hospitals in Anhui, China.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26127.
    >> Share

  2183. SHABANI M, Shokouhi S, Moradi O, Saffaei A, et al
    Tocilizumab Administration in Patients with SARS-CoV-2 Infection: Subcutaneous Injection versus Intravenous Infusion.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26124.
    >> Share

  2184. IKITIMUR H, Borku Uysal B, Cengiz M, Ikitimur B, et al
    ''Determining Host Factors Contributing to Disease Severity in a Family Cluster of 29 Hospitalized SARS-CoV-2 Patients: Could Genetic Factors Be Relevant in the Clinical Course of COVID-19?''.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26106.
    >> Share

  2185. UL ALAM ASMR, Rafiul Islam M, Shaminur Rahman M, Islam OK, et al
    Understanding the possible origin and genotyping of first Bangladeshi SARS-CoV-2 strain.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26115.
    >> Share

  2186. YU T, Tian C, Chu S, Zhou H, et al
    COVID-19 patients benefit from early antiviral treatment: a comparative, retrospective study.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26129.
    >> Share

  2187. SAGKAN RI, Akin-Bali DF
    Structural variations and expression profiles of the SARS-CoV-2 host invasion genes in Lung cancer.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26107.
    >> Share

  2188. AKINOSOGLOU K, Velissaris D, Ziazias D, Davoulos C, et al
    Remdesivir and Tocilizumab: Mix or Match.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26117.
    >> Share

  2189. CARNEVALE S, Beretta P, Morbini P
    Direct endothelial damage and vasculitis due to SARS-CoV-2 in small bowel submucosa of CoViD-19 patient with diarrhea.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26119.
    >> Share

  2190. LOTFI M, Rezaei N
    SARS-CoV-2: A comprehensive review from pathogenicity of the virus to clinical consequences.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26123.
    >> Share

  2191. WEN S, Sun C, Zheng H, Wang L, et al
    High-Coverage SARS-CoV-2 Genome Sequences Acquired by Target Capture Sequencing.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26116.
    >> Share

  2192. CRUZ JO, Conceicao IMCA, Sousa SMB, Luizon MR, et al
    Functional prediction and frequency of coding variants in human ACE2 at binding sites with SARS-CoV-2 spike protein on different populations.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26126.
    >> Share

  2193. BAIG AM, Sanders EC
    Potential Neuroinvasive Pathways of SARS-CoV-2: Deciphering the Spectrum of Neurological Deficit Seen in Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26105.
    >> Share

  2194. NAKAMOTO T, Kutsuna S, Yanagawa Y, Kanda K, et al
    A case of SARS-CoV-2 infection in an untreated HIV patient in Tokyo, Japan.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26102.
    >> Share

  2195. BENVENUTO D, Demir AB, Giovanetti M, Bianchi M, et al
    Evidence for mutations in SARS-CoV-2 Italian isolates potentially affecting virus transmission.
    J Med Virol. 2020 Jun 3. doi: 10.1002/jmv.26104.
    >> Share

  2196. ELGAMASY S, Kamel MG, Ghozy S, Khalil A, et al
    First Case of Focal Epilepsy Associated with SARS-Coronavirus-2.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26113.
    >> Share

  2197. AIKAWA T, Takagi H, Ishikawa K, Kuno T, et al
    Myocardial injury characterized by elevated cardiac troponin and in-hospital mortality of COVID-19: an insight from a meta-analysis.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26108.
    >> Share

  2198. CARMO A, Pereira-Vaz J, Mota V, Mendes A, et al
    Clearance and Persistence of SARS-CoV-2 RNA in COVID-19 patients.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26103.
    >> Share

  2199. ALBERT E, Ferrer B, Torres I, Serrano A, et al
    Amplification of human beta-glucoronidase gene for appraising the accuracy of negative SARS-CoV-2 RT-PCR results in upper respiratory tract specimens.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26112.
    >> Share

  2200. BELEC L, Pere H, Bouassa RM, Veyer D, et al
    Potential pitfalls of routine SARS-CoV-2 serology for mass screening.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26034.
    >> Share

  2201. BORKU UYSAL B, Ikitimur H, Yavuzer S, Ikitimur B, et al
    ''Tociluzumab challenge: A series of cytokine storm therapy experience in hospitalized Covid-19 pneumonia patients''.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26111.
    >> Share

  2202. ISSA N, Dumery M, Guisset O, Mourissoux G, et al
    Feasibility of Tocilizumab in ICU patients with COVID-19.
    J Med Virol. 2020 Jun 2. doi: 10.1002/jmv.26110.
    >> Share

  2203. LIU X, Mondal AM
    Conditional Cell Reprogramming for Modeling Host-Virus Interactions and Human Viral Diseases.
    J Med Virol. 2020 Jun 1. doi: 10.1002/jmv.26093.
    >> Share

  2204. SAHU KK, Lal A, Mishra AK
    Latest updates on COVID-2019: A changing paradigm shift.
    J Med Virol. 2020;92:533-535.
    >> Share

  2205. ANGELETTI S, Benvenuto D, Bianchi M, Giovanetti M, et al
    COVID-2019: The role of the nsp2 and nsp3 in its pathogenesis.
    J Med Virol. 2020;92:584-588.
    >> Share

    May 2020
  2206. PALMIERI B, Vadala M, Roncati L, Garelli A, et al
    The Long-Standing History of Corynebacterium Parvum, Immunity and Viruses.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26100.
    >> Share

  2207. BENUCCI M, Giannasi G, Cecchini P, Gobbi FL, et al
    COVID-19 pneumonia treated with Sarilumab: a clinical series of eight patients.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26062.
    >> Share

  2208. ALI N
    Elevated level of C-reactive protein may be an early marker to predict risk for severity of COVID-19.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26097.
    >> Share

  2209. ZHANG B, Zhang J, Qian B, Han W, et al
    Comment on Han et al: Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26099.
    >> Share

  2210. PINKY L, Dobrovolny HM
    SARS-CoV-2 coinfections: Could influenza and the common cold be beneficial?
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26098.
    >> Share

  2211. SEHRA ST, Fundin S, Lavery C, Baker JF, et al
    Differences in race and other state-level characteristics and associations with mortality from COVID-19 infection.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26095.
    >> Share

  2212. CAI J, Sun W, Huang J, Gamber M, et al
    Clinical features and the treatment of children with COVID-19: A case series from Wenzhou, China.
    J Med Virol. 2020 May 30. doi: 10.1002/jmv.26092.
    >> Share

  2213. LIU M, Dai C, Lv X, Li B, et al
    Letter to the Editor: Are severe COVID-19 patients more susceptible to conjunctivitis?
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26084.
    >> Share

  2214. SANCHEZ-DUQUE JA, Orozco-Hernandez JP, Marin-Medina DS, Cvetkovic-Vega A, et al
    Are we now observing an increasing number of coinfections between SARS-CoV-2 and other respiratory pathogens?
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26089.
    >> Share

  2215. SIANG KC, Hasan SS
    Metformin use amid COVID-19 pandemic.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26090.
    >> Share

  2216. DUAN J, Wang X, Chi J, Chen H, et al
    Correlation between the variables collected at admission and progression to severe cases during hospitalization among COVID-19 patients in Chongqing.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26082.
    >> Share

  2217. MIRI SM, Noorbakhsh F, Mohebbi SR, Ghaemi A, et al
    Higher prevalence of asymptomatic or mild COVID-19 in children, claims and clues.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26069.
    >> Share

  2218. BEZERRA RDS, Valenca IN, de Cassia Ruy P, Ximenez JPB, et al
    The Novel Coronavirus SARS-CoV-2: From a Zoonotic Infection to Coronavirus Disease-19 (COVID19).
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26072.
    >> Share

  2219. LIU T, Wu S, Zeng G, Zhou F, et al
    Recurrent positive SARS-CoV-2 - immune certificate may not be valid.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26074.
    >> Share

  2220. WANG CZ, Hu SL, Wang L, Li M, et al
    Early risk factors of the exacerbation of Coronavirus disease 2019 pneumonia.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26071.
    >> Share

  2221. HE W, Yi GY, Zhu Y
    Estimation of the basic reproduction number, average incubation time, asymptomatic infection rate, and case fatality rate for COVID-19: Meta-analysis and sensitivity analysis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26041.
    >> Share

  2222. MA SQ, Zhang J, Wang YS, Xia J, et al
    Glucocorticoid therapy delays the clearance of SARS-CoV-2 RNA in an asymptomatic COVID-19 patient.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26086.
    >> Share

  2223. LI T, Cheng GS, Pipavath S, Kicska G, et al
    The Novel Coronavirus Disease (COVID-19) Complicated by Pulmonary Embolism and Acute Respiratory Distress Syndrome.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26068.
    >> Share

  2224. NI M, Tian FB, Xiang DD, Yu B, et al
    Characteristics of inflammatory factors and lymphocyte subsets in patients with severe COVID-19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26070.
    >> Share

  2225. KERBOUA KE
    The perplexing question of trained immunity versus adaptive memory in COVID-19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26083.
    >> Share

  2226. D'ALESSANDRO M, Cameli P, Refini RM, Bergantini L, et al
    Serum KL-6 concentrations as a novel biomarker of severe COVID19.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26087.
    >> Share

  2227. ZHU J, Pang J, Ji P, Zhong Z, et al
    Elevated interleukin-6 is associated with severity of COVID-19: a meta-analysis.
    J Med Virol. 2020 May 29. doi: 10.1002/jmv.26085.
    >> Share

  2228. ZHENG Z, Yao Z, Wu K, Zheng J, et al
    The Diagnosis of SARS-CoV2 Pneumonia: A Review of Laboratory and Radiological Testing Results.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26081.
    >> Share

  2229. CHAKRABORTY C, Sharma AR, Bhattacharya M, Sharma G, et al
    COVID-19: Consider IL6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26078.
    >> Share

  2230. PHAN LT, Nguyen TV, Huynh LKT, Dao MH, et al
    Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26075.
    >> Share

  2231. LI ZT, Chen ZM, Chen LD, Zhan YQ, et al
    Coinfection with SARS-CoV-2 and other respiratory pathogens in COVID-19 patients in Guangzhou, China.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26073.
    >> Share

  2232. CIMOLAI N
    Features of Enteric Disease from Human Coronaviruses: Implications for COVID-19.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26066.
    >> Share

  2233. RIBEIRO VST, Telles JP, Tuon FF
    Arboviral diseases and COVID-19 in Brazil: Concerns regarding climatic, sanitation and endemic scenario.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26079.
    >> Share

  2234. LECHIEN JR, Bartaire E, Bobin F, Hans S, et al
    The Association between Laryngopharyngeal Reflux and COVID-19 is still not Demonstrated.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26080.
    >> Share

  2235. SUWANWONGSE K, Shabarek N
    Clinical features and outcome of HIV/SARS-CoV-2 co-infected patients in the Bronx, New York City.
    J Med Virol. 2020 May 28. doi: 10.1002/jmv.26077.
    >> Share

  2236. BYRNES S, Bisen M, Syed B, Huda S, et al
    COVID-19 encephalopathy masquerading as substance withdrawal.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26065.
    >> Share

  2237. DING H, Deng W, Ding L, Ye X, et al
    Glycyrrhetinic acid and its derivatives as potential alternative medicine to relieve symptoms in non-hospitalized COVID-19 patients.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26064.
    >> Share

  2238. BRUFSKY A, Lotze MT
    Ratcheting Down the Virulence of SARS-CoV-2 in the COVID-19 Pandemic.
    J Med Virol. 2020 May 27. doi: 10.1002/jmv.26067.
    >> Share

  2239. TEHERAN AA, Camero G, Hernandez C, Perez-Garcia L, et al
    Potential negative effects of the free use of chloroquine to manage COVID-19 in Colombia.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26059.
    >> Share

  2240. CHOE JY, Kim JW, Kwon HH, Hong HL, et al
    Diagnostic performance of immunochromatography assay for rapid detection of IgM and IgG in coronavirus disease 2019.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26060.
    >> Share

  2241. YAN X, Li F, Wang X, Yan J, et al
    Neutrophil to Lymphocyte Ratio as Prognostic and Predictive Factor in Patients with Coronavirus Disease 2019: A Retrospective Cross-sectional Study.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26061.
    >> Share

  2242. KANG CK, Choe PG, Park S, Kim TS, et al
    Compassionate use of hzVSF-v13 in two patients with severe COVID-19.
    J Med Virol. 2020 May 26. doi: 10.1002/jmv.26063.
    >> Share

  2243. GAYAM V, Konala VM, Naramala S, Garlapati PR, et al
    Presenting characteristics, comorbidities, and outcomes of patients coinfected with COVID-19 and Mycoplasma pneumoniae in the USA.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26026.
    >> Share

  2244. IORDANOU S, Koukios D, Matsentidou CT, Markoulaki D, et al
    Severe SARS-CoV-2 pneumonia in a 58-year-old patient with HIV: a clinical case report from the Republic of Cyprus.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26053.
    >> Share

  2245. HOANG VT, Dao TL, Gautret P
    Recurrence of positive SARS-CoV-2 in patients recovered from COVID-19.
    J Med Virol. 2020 May 25. doi: 10.1002/jmv.26056.
    >> Share

  2246. YOUSSEF M, Hussein M, Attia AS, Elshazli R, et al
    COVID-19 and Liver Dysfunction: a systematic review and meta-analysis of retrospective studies.
    J Med Virol. 2020 May 23. doi: 10.1002/jmv.26055.
    >> Share

  2247. SONG J, Li Y, Huang X, Chen Z, et al
    Systematic Analysis of ACE2 and TMPRSS2 Expression in Salivary Glands Reveals Underlying Transmission Mechanism Caused by SARS-CoV-2.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26045.
    >> Share

  2248. TIAN W, Jiang W, Yao J, Nicholson CJ, et al
    Predictors of mortality in hospitalized COVID-19 patients: A systematic review and meta-analysis.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26050.
    >> Share

  2249. YANG Y, Zhao J, Wu J, Teng Y, et al
    A Rare Case of Immune Thrombocytopenic Purpura Secondary to COVID-19.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26051.
    >> Share

  2250. GONG Y, Guan L, Jin Z, Chen S, et al
    Effects of methylprednisolone use on viral genomic nucleic acid negative conversion and CT imaging lesion absorption in COVID-19 patients under 50 years old.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26052.
    >> Share

  2251. PATEL RH, Pella PM
    COVID-19 in a patient with HIV infection.
    J Med Virol. 2020 May 22. doi: 10.1002/jmv.26049.
    >> Share

  2252. JI W, Li X
    Response to "Comments on "Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human" and "Codon bias analysis alone is uninformative for identifying host(s) of n
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26048.
    >> Share

  2253. KARADAG E
    Increase in Covid-19 Cases and Case Fatality and Case Recovery Rates in Europe: A Cross Temporal Meta-Analysis.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26035.
    >> Share

  2254. SAHU KK, Jindal V, Siddiqui AD, Cerny J, et al
    Convalescent Plasma Therapy: A Passive Therapy for An Aggressive COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26047.
    >> Share

  2255. LO CAPUTO S, Corso G, Clerici M, Santantonio TA, et al
    Baricitinib: a chance to treat COVID-19?
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26033.
    >> Share

  2256. XI A, Zhuo M, Dai J, Ding Y, et al
    Epidemiological and clinical characteristics of discharged patients infected with SARS-CoV-2 on the Qinghai plateau.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26032.
    >> Share

  2257. ZHANG F, Xiong Y, Wei Y, Hu Y, et al
    Obesity predisposes to the risk of higher mortality in young COVID-19 patients.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26039.
    >> Share

  2258. ZHENG Z, Dong M, Hu K
    A preliminary evaluation on the efficacy of ozone therapy in the treatment of COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26040.
    >> Share

  2259. TIAN D, Ye Q
    Hepatic complications of COVID-19 and its treatment.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26036.
    >> Share

  2260. TARTAGLIONE M, Gamberini L, Semeraro F, Lupi C, et al
    COVID-19 suspicion and diagnosis: are we still chasing epidemiological criteria?
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26042.
    >> Share

  2261. BALUKU JB, Mwebaza S, Ingabire G, Nsereko C, et al
    HIV and SARS-CoV-2 co-infection: A case report from Uganda.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26044.
    >> Share

  2262. PERRONE S, Giordano M, Meoli A, Deolmi M, et al
    Lack of viral transmission to preterm newborn from a COVID-19 positive breastfeeding mother at 11 days postpartum.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26037.
    >> Share

  2263. SHANG W, Dong J, Ren Y, Tian M, et al
    The value of clinical parameters in predicting the severity of COVID-19.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26031.
    >> Share

  2264. BRENNER SR
    The Potential of Memantine and related adamantanes such as amantadine, to reduce the neurotoxic effects of COVID-19, including ARDS and to reduce viral replication through lysosomal effects.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26030.
    >> Share

  2265. ANTWI-AMOABENG D, Kanji Z, Ford B, Beutler BD, et al
    Clinical Outcomes in COVID-19 Patients Treated with Tocilizumab: An Individual Patient Data Systematic Review.
    J Med Virol. 2020 May 21. doi: 10.1002/jmv.26038.
    >> Share

  2266. BENKOVIC S, Kim M, Sin E
    4 Cases: HIV and SARS-CoV-2 Co-infection in patients from Long Island, New York.
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26029.
    >> Share

  2267. ZAYET S, Ben Abdallah Y, Royer PY, Toko-Tchiundzie L, et al
    Encephalopathy in patients with COVID-19: 'Causality or coincidence?'
    J Med Virol. 2020 May 19. doi: 10.1002/jmv.26027.
    >> Share

  2268. COEN M, Allali G, Adler D, Serratrice J, et al
    Hypoxemia in COVID-19; Comment on: "The neuroinvasive potential of SARS - CoV2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.26020.
    >> Share

  2269. CUI X, Zhang T, Zheng J, Zhang J, et al
    Children with Coronavirus Disease 2019 (COVID-19): A Review of Demographic, Clinical, Laboratory and Imaging Features in 2,597 Pediatric Patients.
    J Med Virol. 2020 May 17. doi: 10.1002/jmv.26023.
    >> Share

  2270. HASHEMI SA, Safamanesh S, Ghafouri M, Taghavi MR, et al
    Co-infection with COVID-19 and Influenza A Virus in two died patients with Acute Respiratory Syndrome, Bojnurd, Iran.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26014.
    >> Share

  2271. ODJIDJA EN, Longo VL, Rizzatti G, Bandoh S, et al
    Coronavirus Disease 2019 and Viral Hepatitis coinfection: Provide guidelines for integrated screening and treatment.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26021.
    >> Share

  2272. YANG P, Wang P, Song Y, Zhang A, et al
    A retrospective study on the epidemiological characteristics and establishment of early warning system of severe COVID-19 patients.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26022.
    >> Share

  2273. ZHENG Y, Li R, Liu S
    Immunoregulation with mTOR inhibitors to prevent COVID-19 severity: A novel intervention strategy beyond vaccines and specific antiviral medicines.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26009.
    >> Share

  2274. CAO H, Ruan L, Liu J, Liao W, et al
    The clinical characteristic of eight patients of COVID-19 with positive RT-PCR test after discharge.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26017.
    >> Share

  2275. DIOTALLEVI F, Campanati A, Bianchelli T, Bobyr I, et al
    Skin Involvement in SARS-CoV-2 Infection: Case Series.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26012.
    >> Share

  2276. MUTNAL MB, Arroliga AC, Walker K, Mohammad A, et al
    Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26010.
    >> Share

  2277. MAZZITELLI M, Arrighi E, Serapide F, Pelle MC, et al
    Use of subcutaneous tocilizumab in patients with COVID-19 pneumonia.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26016.
    >> Share

  2278. CASTELLS M, Lopez-Tort F, Colina R, Cristina J, et al
    Evidence of Increasing Diversification of Emerging SARS-CoV-2 Strains.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26018.
    >> Share

  2279. WANG Y, Shi L, Yang H, Duan G, et al
    Acute kidney injury is associated with the mortality of Coronavirus Disease 2019.
    J Med Virol. 2020 May 15. doi: 10.1002/jmv.26019.
    >> Share

  2280. HUANG J, Cheng A, Kumar R, Fang Y, et al
    Hypoalbuminemia predicts the outcome of COVID-19 independent of age and co-morbidity.
    J Med Virol. 2020 May 14. doi: 10.1002/jmv.26003.
    >> Share

  2281. KIPKORIR V, Cheruiyot I, Ngure B, Misiani M, et al
    Prolonged SARS-Cov-2 RNA Detection in Anal/Rectal Swabs and Stool Specimens in COVID-19 Patients After Negative Conversion in Nasopharyngeal RT-PCR Test.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26007.
    >> Share

  2282. CHONG VH, Chong PL, Metussin D, Asli R, et al
    Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26004.
    >> Share

  2283. CHEN M, An W, Xia F, Yang P, et al
    Clinical Characteristics of Re-hospitalized Patients with COVID-19 in China.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26002.
    >> Share

  2284. WU Q, Chen T, Zhang H
    Recovery from COVID-19 in two patients with coexisted HIV infection.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26006.
    >> Share

  2285. FINSTERER J, Stollberger C
    Update on the neurology of COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26000.
    >> Share

  2286. POTERICO JA, Mestanza O
    Genetic variants and source of introduction of SARS-CoV-2 in South America.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26001.
    >> Share

  2287. WACHARAPLUESADEE S, Kaewpom T, Ampoot W, Ghai S, et al
    Evaluating the efficiency of specimen pooling for PCR-based detection of COVID-19.
    J Med Virol. 2020 May 13. doi: 10.1002/jmv.26005.
    >> Share

  2288. JIANG G, Cai Y, Yi X, Li Y, et al
    The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: A retrospective study.
    J Med Virol. 2020 May 12. doi: 10.1002/jmv.25998.
    >> Share

  2289. CHAKRABORTY C, Sharma AR, Bhattacharya M, Sharma G, et al
    Consider TLR5 for new therapeutic development against COVID-19.
    J Med Virol. 2020 May 11. doi: 10.1002/jmv.25997.
    >> Share

  2290. ZHENG Z, Yao Z, Wu K, Zheng J, et al
    Patient Follow-up after Discharge after COVID-19 Pneumonia: Considerations for Infectious Control.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25994.
    >> Share

  2291. CHOUDHURY A, Mukherjee S
    In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25987.
    >> Share

  2292. CHEN S, Lu H, Liu Z, Yuan W, et al
    Comment on "Central Nervous System Involvement by Severe Acute Respiratory Syndrome Coronavirus -2 (SARS-CoV-2)".
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25991.
    >> Share

  2293. MANENTI A, Maggetti M, Casa E, Martinuzzi D, et al
    Evaluation of SARS-CoV-2 neutralizing antibodies using of a CPE-based Colorimetric live virus micro-neutralization assay in human serum samples.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25986.
    >> Share

  2294. ZENG F, Dai C, Cai P, Wang J, et al
    A comparison study of SARS-CoV-2 IgG antibody between male and female COVID-19 patients: a possible reason underlying different outcome between sex.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25989.
    >> Share

  2295. DRAME M, Teguo MT, Proye E, Hequet F, et al
    Should RT-PCR be considered a gold standard in the diagnosis of Covid-19?
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25996.
    >> Share

  2296. PUJADAS E, Ibeh N, Hernandez MM, Waluszko A, et al
    Comparison of SARS-CoV-2 Detection from Nasopharyngeal Swab Samples by the Roche cobas(R) 6800 SARS-CoV-2 Test and a Laboratory-Developed Real-Time RT-PCR test.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25988.
    >> Share

  2297. DE MARIA A, Varese P, Dentone C, Barisione E, et al
    High prevalence of olfactory and taste disorder during SARS-CoV-2 infection in outpatients.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25995.
    >> Share

  2298. WANG Y, Kang H, Liu X, Tong Z, et al
    Asymptomatic Cases with SARS-CoV-2 Infection.
    J Med Virol. 2020 May 8. doi: 10.1002/jmv.25990.
    >> Share

  2299. GONG Y, Wen G, Jiang J, Feng X, et al
    Complete title: Codon bias analysis may be insufficient for identifying host(s) of a novel virus.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25977.
    >> Share

  2300. JAKHAR R, Kaushik S, Gakhar SK
    3CL Hydrolase Based Multi Epitope Peptide Vaccine Against Sars-CoV-2 Using Immunoinformatics.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25993.
    >> Share

  2301. PUERTAS RR
    ACE2 Activators for the Treatment of Covid 19 Patients.
    J Med Virol. 2020 May 7. doi: 10.1002/jmv.25992.
    >> Share

  2302. QIAN J, Feng Y, Li J
    Comments on "Cross-species transmission of the newly identified coronavirus 2019-nCoV".
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25983.
    >> Share

  2303. MUSARRAT F, Chouljenko V, Dahal A, Nabi R, et al
    The anti-HIV Drug Nelfinavir Mesylate (Viracept) is a Potent Inhibitor of Cell Fusion Caused by the SARS-CoV-2 Spike (S) Glycoprotein Warranting further Evaluation as an Antiviral against COVID-19 infections.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25985.
    >> Share

  2304. DABRAVOLSKI SA, Kavalionak YK
    SARS-CoV-2: Spike glycoprotein structural diversity, phylogeny and potential animal host identification.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25976.
    >> Share

  2305. BRUFSKY A, Lotze MT
    DC/L-SIGNs of Hope in the COVID-19 Pandemic.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25980.
    >> Share

  2306. LANGE C, Wolf J, Auw-Haedrich C, Schlecht A, et al
    Expression of the COVID-19 receptor ACE2 in the human conjunctiva.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25981.
    >> Share

  2307. CALO LA, Davis PA, Rigato M, Sgarabotto L, et al
    ACE2 and prognosis of COVID-19. Insights from Bartter's and Gitelman's syndromes patients.
    J Med Virol. 2020 May 6. doi: 10.1002/jmv.25978.
    >> Share

  2308. LIU J, Liu S
    The management of coronavirus disease 2019 (COVID-19).
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25965.
    >> Share

  2309. QIU C, Deng Z, Xiao Q, Shu Y, et al
    Transmission and clinical characteristics of coronavirus disease 2019 in 104 outside-Wuhan patients, China.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25975.
    >> Share

  2310. FU W, Chen Q, Wang T
    Letter to the Editor: Three cases of re-detectable positive SARS-CoV-2 RNA in recovered COVID-19 patients with antibodies.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25968.
    >> Share

  2311. FROLDI G
    What could be the better choice between ACE inhibitors and AT1R antagonists in coronavirus disease 2019 (COVID-19) patients?
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25974.
    >> Share

  2312. YANG F, Shi S, Zhu J, Shi J, et al
    Clinical characteristics and outcomes of cancer patients with COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25972.
    >> Share

  2313. SUN L, Shen L, Fan J, Gu F, et al
    Clinical Features of Patients with Coronavirus Disease 2019 (COVID-19) from a Designated Hospital in Beijing, China.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25966.
    >> Share

  2314. HUANG J, Cheng A, Lin S, Zhu Y, et al
    Individualized prediction nomograms for disease progression in mild COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25969.
    >> Share

  2315. LI Y, Xiao SY
    Hepatic involvement in COVID-19 patients: pathology, pathogenesis and clinical implications [Review].
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25973.
    >> Share

  2316. GUO FR
    Smoking links to the severity of Covid-19: An update of a meta-analysis.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25967.
    >> Share

  2317. TORRES I, Albert E, Navarro D
    Pooling of Nasopharyngeal Swab Specimens for SARS-CoV-2 detection by RT-PCR.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25971.
    >> Share

  2318. ALATTAR R, Ibrahim TBH, Shaar SH, Abdalla S, et al
    Tocilizumab for the Treatment of Severe COVID-19.
    J Med Virol. 2020 May 5. doi: 10.1002/jmv.25964.
    >> Share

  2319. RAJENDRAN K, Narayanasamy K, Rangarajan J, Rathinam J, et al
    Convalescent plasma transfusion for the treatment of COVID-19: Systematic review.
    J Med Virol. 2020 May 1. doi: 10.1002/jmv.25961.
    >> Share

  2320. DU SQ, Yuan W
    Mathematical Modeling of Interaction between Innate and Adaptive Immune Responses in COVID-19 and Implications for Viral Pathogenesis.
    J Med Virol. 2020 May 1. doi: 10.1002/jmv.25866.
    >> Share

  2321. GORSE GJ, Donovan MM, Patel GB
    Antibodies to coronaviruses are higher in older compared with younger adults and binding antibodies are more sensitive than neutralizing antibodies in identifying coronavirus-associated illnesses.
    J Med Virol. 2020;92:512-517.
    >> Share

    April 2020
  2322. MEHAN A, Venkatesh A, Girish M
    COVID-19 in pregnancy: risk of adverse neonatal outcomes.
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25959.
    >> Share

  2323. CHIGR F, Merzouki M, Najimi M
    Comment on "The neuroinvasive potential of SARS-CoV2 may play a role in the respiratory failure of COVID-19 patients".
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25960.
    >> Share

  2324. NOWAK MD, Sordillo EM, Gitman MR, Paniz Mondolfi AE, et al
    Co-infection in SARS-CoV-2 infected Patients: Where Are Influenza Virus and Rhinovirus/Enterovirus?
    J Med Virol. 2020 Apr 30. doi: 10.1002/jmv.25953.
    >> Share

  2325. LI N, Wang X, Lv T
    Prolonged SARS-CoV-2 RNA shedding: Not a rare phenomenon.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25952.
    >> Share

  2326. ALTUNTAS AYDIN O, Kumbasar Karaosmanoglu H, Kart Yasar K
    HIV/SARS-CoV-2 co-infected patients in Istanbul, Turkey.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25955.
    >> Share

  2327. EL-ARABEY AA, Abdalla M
    Metformin and COVID-19: A novel deal of an Old Drug.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25958.
    >> Share

  2328. WEI X, Su J, Yang K, Wei J, et al
    Elevations of serum cancer biomarkers correlate with severity of COVID-19.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25957.
    >> Share

  2329. LU H, Stratton CW, Tang YW
    An Evolving Approach to the Laboratory Assessment of COVID-19.
    J Med Virol. 2020 Apr 29. doi: 10.1002/jmv.25954.
    >> Share

  2330. ALI M, Zaid M, Saqib MAN, Ahmed H, et al
    SARS-CoV-2 and the Hidden Carriers - Sewage, Feline, and Blood Transfusion.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25956.
    >> Share

  2331. XU T, Huang R, Zhu L, Wang J, et al
    Epidemiological and clinical features of asymptomatic patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25944.
    >> Share

  2332. AZIZ M, Fatima R, Assaly R
    Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25948.
    >> Share

  2333. LIU SF, Kuo NY, Kuo HC
    Three Taiwan's domestic family cluster infections of coronavirus disease 2019.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25949.
    >> Share

  2334. STRICKER RB, Fesler MC
    A Novel Plan to Deal with SARS-CoV-2 and COVID-19 Disease.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25945.
    >> Share

  2335. YUAN Y, Qiu T, Wang T, Zhou J, et al
    The application of Temporary Ark Hospitals in controlling COVID-19 spread: the experiences of one Temporary Ark Hospital, Wuhan, China.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25947.
    >> Share

  2336. WANG B, Wang L, Kong X, Geng J, et al
    Long-term Coexistence of SARS-CoV-2 with Antibody Response in COVID-19 Patients.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25946.
    >> Share

  2337. RUBEL AR, Chong PL, Abdullah MS, Asli R, et al
    Letter to the Editor: Lipemic serum in patients with COVID-19 undergoing treatment.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25942.
    >> Share

  2338. HE G, Wu J, Shi J, Dai J, et al
    COVID-19 in Tuberculosis patients: a report of three cases.
    J Med Virol. 2020 Apr 28. doi: 10.1002/jmv.25943.
    >> Share

  2339. LU D, Sang L, Du S, Li T, et al
    Asymptomatic COVID-19 infection in late pregnancy indicated no vertical transmission.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25927.
    >> Share

  2340. TRIPATHY JP
    Does pandemic justify the use of Hydroxychloroquine for treatment and prevention of COVID-19 in India?
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25933.
    >> Share

  2341. JIANG X, Luo M, Zou Z, Wang X, et al
    Asymptomatic SARS-CoV-2 infected case with viral detection positive in stool but negative in nasopharyngeal samples lasts for 42 days.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25941.
    >> Share

  2342. PENG L, Liu J, Xu W, Luo Q, et al
    SARS-CoV-2 can be detected in urine, blood, anal swabs and oropharyngeal swabs specimens.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25936.
    >> Share

  2343. LOFFREDO L, Pacella F, Pacella E, Tiscione G, et al
    Conjunctivitis and COVID-19: a meta-analysis.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25938.
    >> Share

  2344. XIE J, Ding C, Li J, Wang Y, et al
    Characteristics of Patients with Coronavirus Disease (COVID-19) Confirmed using an IgM-IgG Antibody Test.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25930.
    >> Share

  2345. HU S
    Comment on "Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19".
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25937.
    >> Share

  2346. SUN T, Weng D
    Estimating the Effects of Asymptomatic and Imported Patients on COVID-19 Epidemic Using Mathematical Modeling.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25939.
    >> Share

  2347. ARAGON-CAQUEO D, Fernandez-Salinas J, Laroze D
    Optimization of group size in pool testing strategy for SARS-CoV-2: A simple mathematical model.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25929.
    >> Share

  2348. LI BZ, Cao NW, Zhou HY, Chu XJ, et al
    Strong policies control the spread of COVID-19 in China.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25934.
    >> Share

  2349. YANG JR, Deng DT, Wu N, Yang B, et al
    Persistent viral RNA positivity during recovery period of a patient with SARS-CoV-2 infection.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25940.
    >> Share

  2350. INFANTINO M, Grossi V, Lari B, Bambi R, et al
    Diagnostic accuracy of an automated chemiluminescent immunoassay for anti-SARS-CoV-2 IgM and IgG antibodies: an Italian experience.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25932.
    >> Share

  2351. HOSEINPOUR DEHKORDI A, Alizadeh M, Derakhshan P, Babazadeh P, et al
    Understanding epidemic data and statistics: A case study of COVID-19.
    J Med Virol. 2020 Apr 24. doi: 10.1002/jmv.25885.
    >> Share

  2352. LONG-QUAN L, Tian H, Yong-Qing W, Zheng-Ping W, et al
    Response to Char's comment: Comment on Li et al.: COVID-19 patients' clinical characteristics, discharge rate, and fatality rate of meta-analysis.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25924.
    >> Share

  2353. MA QX, Shan H, Zhang CM, Zhang HL, et al
    Decontamination of face masks with steam for mask reuse in fighting the pandemic COVID-19: experimental supports.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25921.
    >> Share

  2354. BLASCO ML, Buesa J, Colomina J, Forner MJ, et al
    Co-detection of respiratory pathogens in patients hospitalized with Coronavirus viral disease-2019 pneumonia.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25922.
    >> Share

  2355. YASHAVANTHA RAO HC, Jayabaskaran C
    The emergence of a novel coronavirus (SARS-CoV-2) disease and their neuroinvasive propensity may affect in COVID-19 patients.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25918.
    >> Share

  2356. YONG G, Yi Y, Tuantuan L, Xiaowu W, et al
    Evaluation of the auxiliary diagnostic value of antibody assays for the detection of novel coronavirus (SARS-CoV-2).
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25919.
    >> Share

  2357. HARA T, Yamamoto C, Sawada R, Ohara T, et al
    Infection risk in a gastroenterological ward during a nosocomial COVID-19 infection event.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25853.
    >> Share

  2358. CHEN JW, Chen JM
    Potential of live pathogen vaccines for defeating the COVID-19 pandemic: history and mechanism.
    J Med Virol. 2020 Apr 22. doi: 10.1002/jmv.25920.
    >> Share

  2359. YU Y, Shi Q, Zheng P, Gao L, et al
    Assessment of the quality of systematic reviews on COVID-19: A comparative study of previous coronavirus outbreaks.
    J Med Virol. 2020 Apr 17. doi: 10.1002/jmv.25901.
    >> Share

  2360. LAGUNAS-RANGEL FA, Chavez-Valencia V
    High IL-6/IFN-gamma ratio could be associated with severe disease in COVID-19 patients.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25900.
    >> Share

  2361. SARMA P, Kaur H, Kumar H, Mahendru D, et al
    Virological and Clinical Cure in Covid-19 Patients Treated with Hydroxychloroquine: A Systematic Review and Meta-Analysis.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25898.
    >> Share

  2362. DI GIAMBENEDETTO S, Ciccullo A, Borghetti A, Gambassi G, et al
    Off-label Use of Tocilizumab in Patients with SARS-CoV-2 Infection.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25897.
    >> Share

  2363. SHI X, Lu Y, Li R, Tang Y, et al
    Evaluation of Antiviral Therapies for Coronavirus Disease 2019 (COVID-19) Pneumonia in Shanghai, China.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25893.
    >> Share

  2364. GIANGRECO G
    Case fatality rate analysis of Italian COVID-19 outbreak.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25894.
    >> Share

  2365. SONG F, Zhang X, Zha Y, Liu W, et al
    COVID-19: Recommended sampling sites at different stage of the disease.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25892.
    >> Share

  2366. KHOSRAWIPOUR V, Lau H, Khosrawipour T, Kocbach P, et al
    Failure in initial stage containment of global COVID-19 epicenters.
    J Med Virol. 2020 Apr 16. doi: 10.1002/jmv.25883.
    >> Share

  2367. ZHAO Q, Meng M, Kumar R, Wu Y, et al
    The impact of COPD and smoking history on the severity of Covid-19: A systemic review and meta-analysis.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25889.
    >> Share

  2368. CHAUNG J, Chan D, Pada S, Tambyah PA, et al
    Coinfection with COVID-19 and Coronavirus HKU1 - the critical need for repeat testing if clinically indicated.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25890.
    >> Share

  2369. YANG F, Shi S, Zhu J, Shi J, et al
    Analysis of 92 deceased patients with COVID-19.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25891.
    >> Share

  2370. ZHU J, Ji P, Pang J, Zhong Z, et al
    Clinical characteristics of 3,062 COVID-19 patients: a meta-analysis.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25884.
    >> Share

  2371. YIN R, Feng W, Wang T, Chen G, et al
    Concomitant neurological symptoms observed in a patient diagnosed with coronavirus disease 2019.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25888.
    >> Share

  2372. YE M, Fu D, Ren Y, Wang F, et al
    Treatment with convalescent plasma for COVID-19 patients in Wuhan, China.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25882.
    >> Share

  2373. HAN G, Zhou YH
    Possibly critical role of wearing masks in general population in controlling COVID-19.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25886.
    >> Share

  2374. BRUFSKY A
    Hyperglycemia, Hydroxychloroquine, and the COVID-19 Epidemic.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25887.
    >> Share

  2375. MASCOLO S, Romanelli A, Carleo MA, Esposito V, et al
    Could HIV infection alter the clinical course of SARS-CoV-2 infection? When less is better.
    J Med Virol. 2020 Apr 15. doi: 10.1002/jmv.25881.
    >> Share

  2376. CHEN J, Cheng X, Wang R, Zeng X, et al
    Computed Tomography Imaging of an HIV-infected Patient with Coronavirus Disease 2019 (COVID-19).
    J Med Virol. 2020 Apr 14. doi: 10.1002/jmv.25879.
    >> Share

  2377. DE ANGEL SOLA DE, Wang L, Vazquez M, Mendez Lazaro PA, et al
    Weathering the pandemic: How the Caribbean Basin can use viral and environmental patterns to predict, prepare and respond to COVID-19.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25864.
    >> Share

  2378. LIU Z, Sun CB
    Conjunctiva is not a preferred gateway of entry for SARS-CoV-2 to infect respiratory tract.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25859.
    >> Share

  2379. PU T, Ding C, Li Y, Liu X, et al
    Evaluate Severe Acute Respiratory Syndrome Coronavirus 2 Infectivity by Pseudoviral Particles.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25865.
    >> Share

  2380. GUO D, Xia J, Shen Y, Tong J, et al
    SARS-CoV-2 may be related to conjunctivitis but not necessarily spread through the conjunctiva SARS-CoV-2 and conjunctiva.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25856.
    >> Share

  2381. LIPPI G, Mattiuzzi C, Sanchis-Gomar F, Henry BM, et al
    Clinical and demographic characteristics of patients dying from COVID-19 in Italy versus China.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25860.
    >> Share

  2382. HE G, Sun W, Fang P, Huang J, et al
    The clinical feature of silent infections of novel coronavirus infection (COVID-19) in Wenzhou.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25861.
    >> Share

  2383. CICCOZZI M, Benvenuto D, Giovanetti M, Bianchi M, et al
    Response to Ribeiro da Silva et al.,"Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25863.
    >> Share

  2384. XIONG X, Wei H, Zhang Z, Chang J, et al
    Vaginal Delivery Report of a Healthy Neonate Born to a Convalescent Mother with COVID-19.
    J Med Virol. 2020 Apr 10. doi: 10.1002/jmv.25857.
    >> Share

  2385. DA SILVA SJR, da Silva CTA, Mendes RPG, Pena L, et al
    Role of Nonstructural Proteins in the Pathogenesis of SARS-CoV-2.
    J Med Virol. 2020 Apr 9. doi: 10.1002/jmv.25858.
    >> Share

  2386. XIAO AT, Tong YX, Zhang S
    False-negative of RT-PCR and prolonged nucleic acid conversion in COVID-19: Rather than recurrence.
    J Med Virol. 2020 Apr 9. doi: 10.1002/jmv.25855.
    >> Share

  2387. AL-ROUSAN N, Al-Najjar H
    Data Analysis of Coronavirus CoVID-19 Epidemic in South Korea Based on Recovered and Death Cases.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25850.
    >> Share

  2388. HADADI A, Mortezazadeh M, Kolahdouzan K, Alavian G, et al
    Does recombinant human Erythropoietin administration in critically ill COVID-19 patients have miraculous therapeutic effects?
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25839.
    >> Share

  2389. CHEN D, Li Y, Deng X, Huang H, et al
    Four cases from a family cluster were diagnosed as COVID-19 after 14-day of quarantine period.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25849.
    >> Share

  2390. AHMED AE
    Limited transmissibility of coronavirus (SARS-1, MERS, and SARS-2) in certain regions of Africa.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25852.
    >> Share

  2391. ZHOU ZG, Yue DS, Mu CL, Zhang L, et al
    Mask is the possible key for self-isolation in COVID-19 pandemic.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25846.
    >> Share

  2392. MISHRA AK, Sahu KK, Lal A, Sargent J, et al
    Patterns of heart Injury in COVID - 19 and relation to outcome.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25847.
    >> Share

  2393. ZHU F, Cao Y, Xu S, Zhou M, et al
    Reply to Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25838.
    >> Share

  2394. CURE E, Cumhur Cure M
    Comment on "Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19".
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25848.
    >> Share

  2395. MISHRA AK, Sahu KK, Lal A
    Reporting of all cardiac medications and their outcome in COVID - 19.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25843.
    >> Share

  2396. QAZI A, Qazi J, Naseer K, Zeeshan M, et al
    Analyzing Situational Awareness through Public Opinion to Predict Adoption of Social Distancing Amid Pandemic COVID-19.
    J Med Virol. 2020 Apr 8. doi: 10.1002/jmv.25840.
    >> Share

  2397. LUO P, Liu Y, Qiu L, Liu X, et al
    Tocilizumab treatment in COVID-19: a single center experience.
    J Med Virol. 2020 Apr 6. doi: 10.1002/jmv.25801.
    >> Share

  2398. DU Z, Zhu F, Guo F, Yang B, et al
    Detection of antibodies against SARS-CoV-2 in patients with COVID-19.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25820.
    >> Share

  2399. CHEN Y, Chen L, Deng Q, Zhang G, et al
    The Presence of SARS-CoV-2 RNA in Feces of COVID-19 Patients.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25825.
    >> Share

  2400. HOU C, Chen J, Zhou Y, Hua L, et al
    The effectiveness of the quarantine of Wuhan city against the Corona Virus Disease 2019 (COVID-19): well-mixed SEIR model analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25827.
    >> Share

  2401. CORACI D, Fusco A, Frizziero A, Giovannini S, et al
    Global approaches for global challenges: the possible support of rehabilitation in the management of COVID-19.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25829.
    >> Share

  2402. OKYERE MA, Forson R, Essel-Gaisey F
    Positive Externalities of an Epidemic: The Case of the Corona Virus (COVID-19) in China.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25830.
    >> Share

  2403. LAGUNAS-RANGEL FA
    Neutrophil-to-Lymphocyte ratio and Lymphocyte-to-C-reactive protein ratio in patients with severe coronavirus disease 2019 (COVID-19): A meta-analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25819.
    >> Share

  2404. CICCOZZI M, Giovanetti M, Benvenuto D, Angeletti S, et al
    Response to Carletti et al., "About the origin of the first two Sars-CoV-2 infections in Italy: inference not supported by appropriate sequence analysis."
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25823.
    >> Share

  2405. CAO Y, Liu X, Xiong L, Cai K, et al
    Imaging and Clinical Features of Patients With 2019 Novel Coronavirus SARS-CoV-2: A systematic review and meta-analysis.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25822.
    >> Share

  2406. NIXON DF
    Comments on 'Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China'.
    J Med Virol. 2020 Apr 3. doi: 10.1002/jmv.25821.
    >> Share

  2407. SUN P, Ren J, Li K, Qie S, et al
    Response to: Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
    J Med Virol. 2020 Apr 2. doi: 10.1002/jmv.25818.
    >> Share

  2408. LUAN J, Jin X, Lu Y, Zhang L, et al
    SARS-CoV-2 spike protein favors ACE2 from Bovidae and Cricetidae.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25817.
    >> Share

  2409. NOURI-VASKEH M, Alizadeh L
    Fecal Transmission in COVID-19: A Potential Shedding Rout.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25816.
    >> Share

  2410. YU Y, Shi Q, Chen H
    Comments on Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25806.
    >> Share

  2411. LOVATO A, Rossettini G, de Filippis C
    Sore throat in COVID-19: comment on "Clinical characteristics of hospitalized patients with SARS-CoV-2 infection: A single arm meta-analysis".
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25815.
    >> Share

  2412. KHAN S, Khan M, Maqsood K, Hussain T, et al
    Is Pakistan prepared for the COVID-19 epidemic? A questionnaire-based survey.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25814.
    >> Share

  2413. YE Q, Wang B, Mao J, Fu J, et al
    Epidemiological analysis of COVID-19 and practical experience from China.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25813.
    >> Share

  2414. CHEN X, Yang Y, Huang M, Liu L, et al
    Differences between COVID-19 and suspected then confirmed SARS-CoV-2-negative pneumonia: a retrospective study from a single center.
    J Med Virol. 2020 Apr 1. doi: 10.1002/jmv.25810.
    >> Share

    March 2020
  2415. MA QX, Shan H, Zhang HL, Li GM, et al
    Potential utilities of mask wearing and instant hand hygiene for fighting SARS-CoV-2.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25805.
    >> Share

  2416. JIATONG S, Lanqin L, Wenjun L
    COVID-19 epidemic: disease characteristics in children.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25807.
    >> Share

  2417. HAN H, Xie L, Liu R, Yang J, et al
    Analysis of heart injury laboratory parameters in 273 COVID-19 patients in one hospital in Wuhan, China.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25809.
    >> Share

  2418. ZHANG Q, Wang Y, Qi C, Shen L, et al
    Response to "Comments on 'Zhang et al.: Clinical trial analysis of 2019-nCoV therapy registered in China '".
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25803.
    >> Share

  2419. SUN P, Lu X, Xu C, Wang Y, et al
    CD-sACE2 Inclusion Compounds: An Effective Treatment for Corona Virus Disease 2019 (COVID-19).
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25804.
    >> Share

  2420. YAJUNYUAN, Wang N, Ou X
    Caution should be exercised for the detection of SARS-CoV-2, especially in the elderly.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25796.
    >> Share

  2421. KHALILI JS, Zhu H, Mak A, Yan Y, et al
    Novel coronavirus treatment with ribavirin: Groundwork for evaluation concerning COVID-19.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25798.
    >> Share

  2422. CASSANITI I, Novazzi F, Giardina F, Salivaro F, et al
    Performance of VivaDiagTM COVID-19 IgM/IgG Rapid Test is inadequate for diagnosis of COVID-19 in acute patients referring to emergency room department.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25800.
    >> Share

  2423. KEMPTON M
    Concerns regarding calculation of fatality rate of Chinese samples in COVID-19 meta-analysis.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25799.
    >> Share

  2424. DENG Z, Yuxing HU, Yang P, Zheng P, et al
    Diagnosis and Treatment of an Acute Severe Pneumonia Patient with COVID-19: Case Report.
    J Med Virol. 2020 Mar 30. doi: 10.1002/jmv.25802.
    >> Share

  2425. CASTILLO AE, Parra B, Tapia P, Acevedo A, et al
    Phylogenetic analysis of the first four SARS-CoV-2 cases in Chile.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25797.
    >> Share

  2426. ZEHENDER G, Lai A, Bergna A, Meroni L, et al
    GENOMIC CHARACTERISATION AND PHYLOGENETIC ANALYSIS OF SARS-COV-2 IN ITALY.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25794.
    >> Share

  2427. ZHANG T, Cui X, Zhao X, Wang J, et al
    Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795.
    >> Share

  2428. CHU J, Yang N, Wei Y, Yue H, et al
    Clinical Characteristics of 54 medical staff with COVID-19: A retrospective study in a single center in Wuhan, China.
    J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25793.
    >> Share

  2429. CHEN S, Liao E, Shao Y
    Clinical analysis of pregnant women with 2019 novel coronavirus pneumonia.
    J Med Virol. 2020 Mar 28. doi: 10.1002/jmv.25789.
    >> Share

  2430. CHENG H, Wang Y, Wang GQ
    Organ-protective Effect of Angiotensin-converting Enzyme 2 and its Effect on the Prognosis of COVID-19.
    J Med Virol. 2020 Mar 27. doi: 10.1002/jmv.25785.
    >> Share

  2431. JOOB B, Wiwanitkit V
    SARS-CoV-2 and HIV.
    J Med Virol. 2020 Mar 27. doi: 10.1002/jmv.25782.
    >> Share

  2432. WAN S, Xiang Y, Fang W, Zheng Y, et al
    Clinical Features and Treatment of COVID-19 Patients in Northeast Chongqing.
    J Med Virol. 2020 Mar 21. doi: 10.1002/jmv.25783.
    >> Share

  2433. DING Q, Lu P, Fan Y, Xia Y, et al
    The clinical characteristics of pneumonia patients co-infected with 2019 novel coronavirus and influenza virus in Wuhan, China.
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25781.
    >> Share

  2434. AGYEMAN AA, Laar A, Ofori-Asenso R
    Will COVID-19 be a litmus test for post-Ebola Sub-Saharan Africa?
    J Med Virol. 2020 Mar 20. doi: 10.1002/jmv.25780.
    >> Share

  2435. GIOVANETTI M, Angeletti S, Benvenuto D, Ciccozzi M, et al
    A doubt of multiple introduction of SARS-CoV-2 in Italy: a preliminary overview.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25773.
    >> Share

  2436. LU S, Lin J, Zhang Z, Xiao L, et al
    Alert for non-respiratory symptoms of Coronavirus Disease 2019 (COVID-19) patients in epidemic period: A case report of familial cluster with three asymptomatic COVID-19 patients.
    J Med Virol. 2020 Mar 19. doi: 10.1002/jmv.25776.
    >> Share

  2437. GAO Y, Li T, Han M, Li X, et al
    Diagnostic Utility of Clinical Laboratory Data Determinations for Patients with the Severe COVID-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25770.
    >> Share

  2438. JIAO J
    Under the epidemic situation of COVID-19, should special attention to pregnant women be given?
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25771.
    >> Share

  2439. QU R, Ling Y, Zhang YH, Wei LY, et al
    Platelet-to-lymphocyte ratio is associated with prognosis in patients with Corona Virus Disease-19.
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25767.
    >> Share

  2440. DONG S, Sun J, Mao Z, Wang L, et al
    A guideline for homology modeling of the proteins from newly discovered betacoronavirus, 2019 novel coronavirus (2019-nCoV).
    J Med Virol. 2020 Mar 17. doi: 10.1002/jmv.25768.
    >> Share

  2441. CIMOLAI N
    Potentially repurposing adamantanes for COVID-19.
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25752.
    >> Share

  2442. PENG Y, Zhou YH
    Is novel coronavirus disease (COVID-19) transmitted through conjunctiva?
    J Med Virol. 2020 Mar 16. doi: 10.1002/jmv.25753.
    >> Share

  2443. HE F, Deng Y, Li W
    Coronavirus Disease 2019 (COVID-19): What we know?
    J Med Virol. 2020 Mar 14. doi: 10.1002/jmv.25766.
    >> Share

  2444. ZHU W, Xie K, Lu H, Xu L, et al
    Initial clinical features of suspected Coronavirus Disease 2019 in two emergency departments outside of Hubei, China.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25763.
    >> Share

  2445. WANG C, Liu Z, Chen Z, Huang X, et al
    The establishment of reference sequence for SARS-CoV-2 and variation analysis.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25762.
    >> Share

  2446. LUNG J, Lin YS, Yang YH, Chou YL, et al
    The potential chemical structure of anti-SARS-CoV-2 RNA-dependent RNA polymerase.
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25761.
    >> Share

  2447. CARDENAS-CONEJO Y, Linan-Rico A, Garcia-Rodriguez DA, Centeno-Leija S, et al
    An exclusive 42 amino acid signature in pp1ab protein provides insights into the evolutive history of the 2019 novel human-pathogenic coronavirus (SARS-CoV2).
    J Med Virol. 2020 Mar 13. doi: 10.1002/jmv.25758.
    >> Share

  2448. LI LQ, Huang T, Wang YQ, Wang ZP, et al
    2019 novel coronavirus patients' clinical characteristics, discharge rate and fatality rate of meta-analysis.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25757.
    >> Share

  2449. CHEN Q, Quan B, Li X, Gao G, et al
    A report of clinical diagnosis and treatment of 9 cases of coronavirus disease 2019.
    J Med Virol. 2020 Mar 12. doi: 10.1002/jmv.25755.
    >> Share

  2450. ZHU F, Cao Y, Xu S, Zhou M, et al
    Co-infection of SARS-CoV-2 and HIV in a patient in Wuhan city, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25732.
    >> Share

  2451. KANDEEL M, Ibrahim AA, Fayez M, Al-Nazawi M, et al
    From SARS and MERS CoVs to SARS-CoV-2: moving toward more biased codon usage in viral structural and non-structural genes.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25754.
    >> Share

  2452. CONWAY MJ
    Identification of Coronavirus Sequences in Carp cDNA from Wuhan, China.
    J Med Virol. 2020 Mar 11. doi: 10.1002/jmv.25751.
    >> Share

  2453. FANG Y, Nie Y, Penny M
    Transmission dynamics of the COVID-19 outbreak and effectiveness of government interventions: A data-driven analysis.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25750.
    >> Share

  2454. HAN Y, Yang H
    The transmission and diagnosis of 2019 novel coronavirus infection disease (COVID-19): A Chinese perspective.
    J Med Virol. 2020 Mar 6. doi: 10.1002/jmv.25749.
    >> Share

  2455. WANG Y, Wang Y, Chen Y, Qin Q, et al
    Unique epidemiological and clinical features of the emerging 2019 novel coronavirus pneumonia (COVID-19) implicate special control measures.
    J Med Virol. 2020 Mar 5. doi: 10.1002/jmv.25748.
    >> Share

  2456. ZHANG J, Wang S, Xue Y
    Fecal specimen diagnosis 2019 Novel Coronavirus-Infected Pneumonia.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25742.
    >> Share

  2457. DEY SK, Rahman MM, Siddiqi UR, Howlader A, et al
    Analyzing the Epidemiological Outbreak of COVID-19: A Visual Exploratory Data Analysis (EDA) Approach.
    J Med Virol. 2020 Mar 3. doi: 10.1002/jmv.25743.
    >> Share

  2458. LU Q, Shi Y
    Coronavirus disease (COVID-19) and neonate: What neonatologist need to know.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25740.
    >> Share

  2459. LU H, Stratton CW, Tang YW
    The Wuhan SARS-CoV-2 - What's Next for China.
    J Med Virol. 2020 Mar 1. doi: 10.1002/jmv.25738.
    >> Share

    February 2020
  2460. BHATTACHARYA M, Ranjan Sharma A, Patra P, Ghosh P, et al
    Development of epitope-based peptide vaccine against novel Coronavirus 2019 (SARS-COV-2): Immunoinformatics approach.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25736.
    >> Share

  2461. ZHANG Q, Wang Y, Qi C, Shen L, et al
    Clinical trial analysis of 2019-nCoV therapy registered in China.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25733.
    >> Share

  2462. SUN P, Qie S, Liu Z, Ren J, et al
    Clinical characteristics of 50466 hospitalized patients with 2019-nCoV infection.
    J Med Virol. 2020 Feb 28. doi: 10.1002/jmv.25735.
    >> Share

  2463. LI Z, Yi Y, Luo X, Xiong N, et al
    Development and Clinical Application of A Rapid IgM-IgG Combined Antibody Test for SARS-CoV-2 Infection Diagnosis.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25727.
    >> Share

  2464. LI YC, Bai WZ, Hashikawa T
    The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25728.
    >> Share

  2465. LI X, Zai J, Zhao Q, Nie Q, et al
    Evolutionary history, potential intermediate animal host, and cross-species analyses of SARS-CoV-2.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25731.
    >> Share

  2466. YAO TT, Qian JD, Zhu WY, Wang Y, et al
    A Systematic Review of Lopinavir Therapy for SARS Coronavirus and MERS Coronavirus-A Possible Reference for Coronavirus Disease-19 Treatment Option.
    J Med Virol. 2020 Feb 27. doi: 10.1002/jmv.25729.
    >> Share

  2467. LIU Z, Xiao X, Wei X, Li J, et al
    Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25726.
    >> Share

  2468. XIA J, Tong J, Liu M, Shen Y, et al
    Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection.
    J Med Virol. 2020 Feb 26. doi: 10.1002/jmv.25725.
    >> Share

  2469. SUN P, Lu X, Xu C, Sun W, et al
    Understanding of COVID-19 based on current evidence.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25722.
    >> Share

  2470. LAI A, Bergna A, Acciarri C, Galli M, et al
    Early Phylogenetic Estimate of the Effective Reproduction Number Of Sars-CoV-2.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25723.
    >> Share

  2471. WANG Y, Kang H, Liu X, Tong Z, et al
    Combination of RT-qPCR Testing and Clinical Features For Diagnosis of COVID-19 facilitates management of SARS-CoV-2 Outbreak.
    J Med Virol. 2020 Feb 25. doi: 10.1002/jmv.25721.
    >> Share

  2472. YANG Y, Shang W, Rao X
    Facing the COVID-19 outbreak: What should we know and what could we do?
    J Med Virol. 2020 Feb 24. doi: 10.1002/jmv.25720.
    >> Share

  2473. HAN W, Quan B, Guo Y, Zhang J, et al
    The course of clinical diagnosis and treatment of a case infected with coronavirus disease 2019.
    J Med Virol. 2020 Feb 19. doi: 10.1002/jmv.25711.
    >> Share

  2474. LIU J, Zheng X, Tong Q, Li W, et al
    Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25709.
    >> Share

  2475. JIANG X, Rayner S, Luo MH
    Does SARS-CoV-2 has a longer incubation period than SARS and MERS?
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25708.
    >> Share

  2476. ZHANG L, Liu Y
    Potential Interventions for Novel Coronavirus in China: A Systemic Review.
    J Med Virol. 2020 Feb 13. doi: 10.1002/jmv.25707.
    >> Share

  2477. GUAN W, Xian J
    The progress of 2019 Novel Coronavirus (2019-nCoV) event in China.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25705.
    >> Share

  2478. AYITTEY FK, Ayittey MK, Chiwero NB, Kamasah JS, et al
    Economic Impacts of Wuhan 2019-nCoV on China and the World.
    J Med Virol. 2020 Feb 12. doi: 10.1002/jmv.25706.
    >> Share

  2479. XIAO SY, Wu Y, Liu H
    Evolving status of the 2019 novel coronavirus Infection: proposal of conventional serologic assays for disease diagnosis and infection monitoring [Commentary/Review].
    J Med Virol. 2020 Feb 7. doi: 10.1002/jmv.25702.
    >> Share

  2480. CERAOLO C, Giorgi FM
    Genomic variance of the 2019-nCoV coronavirus.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25700.
    >> Share

  2481. LI X, Wang W, Zhao X, Zai J, et al
    Transmission dynamics and evolutionary history of 2019-nCoV.
    J Med Virol. 2020 Feb 6. doi: 10.1002/jmv.25701.
    >> Share

  2482. BARUAH V, Bose S
    Immunoinformatics-aided identification of T cell and B cell epitopes in the surface glycoprotein of 2019-nCoV.
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25698.
    >> Share

  2483. GIOVANETTI M, Benvenuto D, Angeletti S, Ciccozzi M, et al
    The first two cases of 2019-nCoV in Italy: where they come from?
    J Med Virol. 2020 Feb 5. doi: 10.1002/jmv.25699.
    >> Share

  2484. KOFI AYITTEY F, Dzuvor C, Kormla Ayittey M, Bennita Chiwero N, et al
    Updates on Wuhan 2019 Novel Coronavirus Epidemic.
    J Med Virol. 2020 Feb 4. doi: 10.1002/jmv.25695.
    >> Share

    January 2020
  2485. LI X, Zai J, Wang X, Li Y, et al
    Potential of large 'first generation' human-to-human transmission of 2019-nCoV.
    J Med Virol. 2020 Jan 30. doi: 10.1002/jmv.25693.
    >> Share

  2486. WANG W, Tang J, Wei F
    Updated understanding of the outbreak of 2019 novel coronavirus (2019-nCoV) in Wuhan, China.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25689.
    >> Share

  2487. BENVENUTO D, Giovanetti M, Ciccozzi A, Spoto S, et al
    The 2019-new coronavirus epidemic: Evidence for virus evolution.
    J Med Virol. 2020 Jan 29. doi: 10.1002/jmv.25688.
    >> Share

  2488. CHEN Y, Liu Q, Guo D
    Emerging coronaviruses: Genome structure, replication, and pathogenesis.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25681.
    >> Share

  2489. JI W, Wang W, Zhao X, Zai J, et al
    Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross-species transmission from snake to human.
    J Med Virol. 2020 Jan 22. doi: 10.1002/jmv.25682.
    >> Share

  2490. LU H, Stratton CW, Tang YW
    Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle.
    J Med Virol. 2020 Jan 16. doi: 10.1002/jmv.25678.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016